www.fiercepharma.com Open in urlscan Pro
104.18.14.141 Public Scan

Go To Rescan
Add Verdict Report

URL:
https://www.fiercepharma.com/special-report/10-most-anticipated-drug-launches-2022-4-deucravacitinib
Submission: On February 08 via manual (February 8th 2022, 2:03:40 pm UTC) from IN — Scanned from DE

Summary HTTP 233 Redirects Links 13 Behaviour Indicators

Summary

This website contacted 89 IPs in 12 countries across 67 domains to perform 233 HTTP transactions. The main IP is 104.18.14.141, located in and belongs to CLOUDFLARENET, US. The main domain is www.fiercepharma.com. The Cisco Umbrella rank of the primary domain is 116131.
TLS certificate: Issued by Cloudflare Inc ECC CA-3 on July 14th 2021. Valid for: a year.

This is the only time www.fiercepharma.com was scanned on urlscan.io!

urlscan.io Verdict: No classification

Domain & IP information

	IP Address	AS Autonomous System
12	104.18.14.141 104.18.14.141	13335 (CLOUDFLAR...) (CLOUDFLARENET)
1	2a00:1450:400... 2a00:1450:4001:82b::200a	15169 (GOOGLE) (GOOGLE)
1	65.9.63.73 65.9.63.73	16509 (AMAZON-02) (AMAZON-02)
1	104.16.92.165 104.16.92.165	13335 (CLOUDFLAR...) (CLOUDFLARENET)
3	45.133.44.3 45.133.44.3	39572 (ADVANCEDH...) (ADVANCEDHOSTERS-AS)
6	142.250.184.226 142.250.184.226	15169 (GOOGLE) (GOOGLE)
3	2606:4700:10:... 2606:4700:10::6816:47c5	13335 (CLOUDFLAR...) (CLOUDFLARENET)
1	2a00:1450:400... 2a00:1450:4001:827::200a	15169 (GOOGLE) (GOOGLE)
1	104.16.94.80 104.16.94.80	13335 (CLOUDFLAR...) (CLOUDFLARENET)
2	2a00:1450:400... 2a00:1450:4001:808::2008	15169 (GOOGLE) (GOOGLE)
2	2a00:1450:400... 2a00:1450:4001:810::2003	15169 (GOOGLE) (GOOGLE)
1	54.72.7.92 54.72.7.92	16509 (AMAZON-02) (AMAZON-02)
2 4	66.155.71.150 66.155.71.150	13768 (COGECO-PEER1) (COGECO-PEER1)
1 10	204.180.130.190 204.180.130.190	53866 (QTS-AS) (QTS-AS)
1	65.9.58.62 65.9.58.62	16509 (AMAZON-02) (AMAZON-02)
4	45.133.44.4 45.133.44.4	39572 (ADVANCEDH...) (ADVANCEDHOSTERS-AS)
5	2a00:1450:400... 2a00:1450:4001:810::200e	15169 (GOOGLE) (GOOGLE)
4	2606:4700::68... 2606:4700::6813:9308	13335 (CLOUDFLAR...) (CLOUDFLARENET)
2	104.111.234.67 104.111.234.67	16625 (AKAMAI-AS) (AKAMAI-AS)
1	143.204.215.21 143.204.215.21	16509 (AMAZON-02) (AMAZON-02)
1	2606:4700::68... 2606:4700::6810:a852	13335 (CLOUDFLAR...) (CLOUDFLARENET)
13	204.180.130.159 204.180.130.159	53866 (QTS-AS) (QTS-AS)
1	65.9.61.60 65.9.61.60	16509 (AMAZON-02) (AMAZON-02)
2 11	37.252.172.37 37.252.172.37	29990 (ASN-APPNEX) (ASN-APPNEX)
3	3.226.203.17 3.226.203.17	14618 (AMAZON-AES) (AMAZON-AES)
2	52.208.138.90 52.208.138.90	16509 (AMAZON-02) (AMAZON-02)
1	192.28.147.68 192.28.147.68	15224 (OMNITURE) (OMNITURE)
10	2a0c:5c81:514... 2a0c:5c81:5142::2	55081 (24SHELLS) (24SHELLS)
1	2a00:1450:400... 2a00:1450:400c:c08::9c	15169 (GOOGLE) (GOOGLE)
1	34.194.161.83 34.194.161.83	14618 (AMAZON-AES) (AMAZON-AES)
1	99.86.3.25 99.86.3.25	16509 (AMAZON-02) (AMAZON-02)
1	18.66.248.91 18.66.248.91	16509 (AMAZON-02) (AMAZON-02)
1	34.200.182.42 34.200.182.42	14618 (AMAZON-AES) (AMAZON-AES)
2	169.197.150.8 169.197.150.8	398989 (DEEPINTENT) (DEEPINTENT)
1	37.252.161.190 37.252.161.190	29990 (ASN-APPNEX) (ASN-APPNEX)
11	18.156.195.47 18.156.195.47	16509 (AMAZON-02) (AMAZON-02)
8	2602:803:c003... 2602:803:c003:200::41	26667 (RUBICONPR...) (RUBICONPROJECT)
1	178.162.133.150 178.162.133.150	60781 (LEASEWEB-...) (LEASEWEB-NL-AMS-01 Netherlands)
1	8.2.111.126 8.2.111.126	46636 (NATCOWEB) (NATCOWEB)
2	185.64.189.112 185.64.189.112	62713 (AS-PUBMATIC) (AS-PUBMATIC)
1	34.251.249.129 34.251.249.129	16509 (AMAZON-02) (AMAZON-02)
1	5.178.65.246 5.178.65.246	50673 (SERVERIUS-AS) (SERVERIUS-AS)
1	185.184.10.30 185.184.10.30	203690 (RTB-HOUSE...) (RTB-HOUSE-ASH)
1	213.19.147.42 213.19.147.42	26120 (RHYTHMONE) (RHYTHMONE)
1	216.52.2.48 216.52.2.48	29791 (VOXEL-DOT...) (VOXEL-DOT-NET)
1	198.148.27.133 198.148.27.133	19189 (PULSEPOINT) (PULSEPOINT)
1	23.37.38.181 23.37.38.181	16625 (AKAMAI-AS) (AKAMAI-AS)
2	35.244.159.8 35.244.159.8	15169 (GOOGLE) (GOOGLE)
1	146.0.227.109 146.0.227.109	20773 (GODADDY) (GODADDY)
2	147.75.38.124 147.75.38.124	54825 (PACKET) (PACKET)
11	51.38.120.206 51.38.120.206	16276 (OVH) (OVH)
1	88.212.252.22 88.212.252.22	7979 (SERVERS-COM) (SERVERS-COM)
6	178.250.0.165 178.250.0.165	44788 (ASN-CRITE...) (ASN-CRITEO-EUROPE)
1	34.107.148.139 34.107.148.139	15169 (GOOGLE) (GOOGLE)
1	63.32.247.12 63.32.247.12	16509 (AMAZON-02) (AMAZON-02)
1	2a00:1450:400... 2a00:1450:4001:813::2002	15169 (GOOGLE) (GOOGLE)
2	2a00:1450:400... 2a00:1450:4001:80f::2002	15169 (GOOGLE) (GOOGLE)
1	2a00:1450:400... 2a00:1450:4001:810::2001	15169 (GOOGLE) (GOOGLE)
1	34.249.212.247 34.249.212.247	16509 (AMAZON-02) (AMAZON-02)
5	185.184.8.65 185.184.8.65	204995 (RTB-HOUSE...) (RTB-HOUSE-AMS)
1	54.149.174.3 54.149.174.3	16509 (AMAZON-02) (AMAZON-02)
1	2606:4700:303... 2606:4700:3033::6815:3a2a	13335 (CLOUDFLAR...) (CLOUDFLARENET)
2	99.86.3.109 99.86.3.109	16509 (AMAZON-02) (AMAZON-02)
1 1	62.149.0.72 62.149.0.72	15497 (COLOCALL ...) (COLOCALL Internet Data Center ColoCALL)
1	193.200.65.5 193.200.65.5	6681 (GIVEME-CLOUD) (GIVEME-CLOUD)
1	37.18.16.16 37.18.16.16	205675 (HYBRID-AS) (HYBRID-AS)
5	54.144.118.149 54.144.118.149	14618 (AMAZON-AES) (AMAZON-AES)
5	205.162.42.5 205.162.42.5	53866 (QTS-AS) (QTS-AS)
2 3	142.250.185.66 142.250.185.66	15169 (GOOGLE) (GOOGLE)
1	35.244.174.68 35.244.174.68	15169 (GOOGLE) (GOOGLE)
1 3	2606:4700:20:... 2606:4700:20::681a:723	13335 (CLOUDFLAR...) (CLOUDFLARENET)
2	204.180.130.165 204.180.130.165	53866 (QTS-AS) (QTS-AS)
2	2a00:1450:400... 2a00:1450:4001:827::2002	15169 (GOOGLE) (GOOGLE)
1	52.35.70.100 52.35.70.100	16509 (AMAZON-02) (AMAZON-02)
1	44.230.193.23 44.230.193.23	16509 (AMAZON-02) (AMAZON-02)
1 2	185.33.221.91 185.33.221.91	29990 (ASN-APPNEX) (ASN-APPNEX)
2 9	52.43.149.174 52.43.149.174	16509 (AMAZON-02) (AMAZON-02)
2 2	52.223.40.198 52.223.40.198	16509 (AMAZON-02) (AMAZON-02)
2 2	185.64.190.80 185.64.190.80	62713 (AS-PUBMATIC) (AS-PUBMATIC)
2 2	3.251.21.8 3.251.21.8	16509 (AMAZON-02) (AMAZON-02)
2 2	52.50.101.149 52.50.101.149	16509 (AMAZON-02) (AMAZON-02)
1	69.173.144.165 69.173.144.165	26667 (RUBICONPR...) (RUBICONPROJECT)
1	54.185.136.237 54.185.136.237	16509 (AMAZON-02) (AMAZON-02)
2	99.86.3.4 99.86.3.4	16509 (AMAZON-02) (AMAZON-02)
2	2a00:1450:400... 2a00:1450:4001:812::2002	15169 (GOOGLE) (GOOGLE)
1	35.83.23.20 35.83.23.20	16509 (AMAZON-02) (AMAZON-02)
1	2001:4de0:ac1... 2001:4de0:ac18::1:a:2a	20446 (HIGHWINDS3) (HIGHWINDS3)
1	2a00:1450:400... 2a00:1450:4001:82a::2002	15169 (GOOGLE) (GOOGLE)
2	2a02:2638::3 2a02:2638::3	44788 (ASN-CRITE...) (ASN-CRITEO-EUROPE)
1	151.101.1.108 151.101.1.108	54113 (FASTLY) (FASTLY)
1 2	2a02:2638::1c 2a02:2638::1c	44788 (ASN-CRITE...) (ASN-CRITEO-EUROPE)
2	178.250.2.146 178.250.2.146	44788 (ASN-CRITE...) (ASN-CRITEO-EUROPE)
1	51.89.7.110 51.89.7.110	16276 (OVH) (OVH)
233	89

12 104.18.14.141 (None, )

ASN13335 (CLOUDFLARENET, US)

www.fiercepharma.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

1 2a00:1450:4001:82b::200a (Frankfurt am Main, Germany)

ASN15169 (GOOGLE, US)

fonts.googleapis.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

1 65.9.63.73 (United States)

ASN16509 (AMAZON-02, US)
PTR: server-65-9-63-73.fra56.r.cloudfront.net

cdn.blueconic.net	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

1 104.16.92.165 (None, )

ASN13335 (CLOUDFLARENET, US)

qtxasset.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

3 45.133.44.3 (Philadelphia, United States)

ASN39572 (ADVANCEDHOSTERS-AS, NL)

player.mediafuse.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools
sync.medidexs.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

6 142.250.184.226 (United States)

ASN15169 (GOOGLE, US)
PTR: fra24s12-in-f2.1e100.net

securepubads.g.doubleclick.net	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

3 2606:4700:10::6816:47c5 (United States)

ASN13335 (CLOUDFLARENET, US)

static.addtoany.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

1 2a00:1450:4001:827::200a (Frankfurt am Main, Germany)

ASN15169 (GOOGLE, US)

ajax.googleapis.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

1 104.16.94.80 (None, )

ASN13335 (CLOUDFLARENET, US)

app-sj10.marketo.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

2 2a00:1450:4001:808::2008 (Frankfurt am Main, Germany)

ASN15169 (GOOGLE, US)

www.googletagmanager.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

2 2a00:1450:4001:810::2003 (Frankfurt am Main, Germany)

ASN15169 (GOOGLE, US)

fonts.gstatic.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

1 54.72.7.92 (Dublin, Ireland)

ASN16509 (AMAZON-02, US)
PTR: ec2-54-72-7-92.eu-west-1.compute.amazonaws.com

questex.blueconic.net	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

4 66.155.71.150 (Portsmouth, United Kingdom) 2 redirects

ASN13768 (COGECO-PEER1, CA)

pixel-a.basis.net	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools
pixel.sitescout.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

10 204.180.130.190 (United States) 1 redirects

ASN53866 (QTS-AS, US)

sample.dragonforms.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

1 65.9.58.62 (United States)

ASN16509 (AMAZON-02, US)
PTR: server-65-9-58-62.fra56.r.cloudfront.net

d1z2jf7jlzjs58.cloudfront.net	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

4 45.133.44.4 (Philadelphia, United States)

ASN39572 (ADVANCEDHOSTERS-AS, NL)

player.hbmp.mediafuse.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools
p.nodserving.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools
player.adtelligent.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

5 2a00:1450:4001:810::200e (Frankfurt am Main, Germany)

ASN15169 (GOOGLE, US)

www.google-analytics.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

4 2606:4700::6813:9308 (United States)

ASN13335 (CLOUDFLARENET, US)

script.crazyegg.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

2 104.111.234.67 (Frankfurt am Main, Germany)

ASN16625 (AKAMAI-AS, US)
PTR: a104-111-234-67.deploy.static.akamaitechnologies.com

munchkin.marketo.net	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

1 143.204.215.21 (United States)

ASN16509 (AMAZON-02, US)
PTR: server-143-204-215-21.fra53.r.cloudfront.net

s.dpmsrv.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

1 2606:4700::6810:a852 (United States)

ASN13335 (CLOUDFLARENET, US)

ws.zoominfo.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

13 204.180.130.159 (United States)

ASN53866 (QTS-AS, US)
PTR: my.omedastaging.com

olytics.omeda.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

1 65.9.61.60 (United States)

ASN16509 (AMAZON-02, US)
PTR: server-65-9-61-60.fra56.r.cloudfront.net

cdn.parsely.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

11 37.252.172.37 (Frankfurt am Main, Germany) 2 redirects

ASN29990 (ASN-APPNEX, US)
PTR: 691.bm-nginx-loadbalancer.mgmt.fra1.adnexus.net

ib.adnxs.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

3 3.226.203.17 (Ashburn, United States)

ASN14618 (AMAZON-AES, US)
PTR: ec2-3-226-203-17.compute-1.amazonaws.com

a.dpmsrv.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

2 52.208.138.90 (Dublin, Ireland)

ASN16509 (AMAZON-02, US)
PTR: ec2-52-208-138-90.eu-west-1.compute.amazonaws.com

ml314.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

1 192.28.147.68 (United States)

ASN15224 (OMNITURE, US)

294-mqf-056.mktoresp.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

10 2a0c:5c81:5142::2 (London, United Kingdom)

ASN55081 (24SHELLS, US)

ghb.hbmp.mediafuse.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools
ghb.adtelligent.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

1 2a00:1450:400c:c08::9c (Brussels, Belgium)

ASN15169 (GOOGLE, US)

stats.g.doubleclick.net	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

1 34.194.161.83 (Ashburn, United States)

ASN14618 (AMAZON-AES, US)
PTR: ec2-34-194-161-83.compute-1.amazonaws.com

p1.parsely.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

1 99.86.3.25 (United States)

ASN16509 (AMAZON-02, US)
PTR: server-99-86-3-25.fra6.r.cloudfront.net

pagestates-tracking.crazyegg.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

1 18.66.248.91 (United States)

ASN16509 (AMAZON-02, US)
PTR: server-18-66-248-91.dus51.r.cloudfront.net

assets-tracking.crazyegg.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

1 34.200.182.42 (Ashburn, United States)

ASN14618 (AMAZON-AES, US)
PTR: ec2-34-200-182-42.compute-1.amazonaws.com

in.ml314.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

2 169.197.150.8 (United States)

ASN398989 (DEEPINTENT, US)
PTR: g.deepintent.com

prebid.deepintent.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

1 37.252.161.190 (Southall, United Kingdom)

ASN29990 (ASN-APPNEX, US)
PTR: prebid.ams1.adnexus.net

prebid.adnxs.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

11 18.156.195.47 (Frankfurt am Main, Germany)

ASN16509 (AMAZON-02, US)
PTR: ec2-18-156-195-47.eu-central-1.compute.amazonaws.com

c2shb.ssp.yahoo.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

8 2602:803:c003:200::41 (Amsterdam, Netherlands)

ASN26667 (RUBICONPROJECT, US)

fastlane.rubiconproject.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

1 178.162.133.150 (Rotterdam, Netherlands)

ASN60781 (LEASEWEB-NL-AMS-01 Netherlands, NL)
PTR: ams-1-apex.go.sonobi.com

apex.go.sonobi.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

1 8.2.111.126 (United States)

ASN46636 (NATCOWEB, US)

colossusssp.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

2 185.64.189.112 (United Kingdom)

ASN62713 (AS-PUBMATIC, US)

hbopenbid.pubmatic.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

1 34.251.249.129 (Dublin, Ireland)

ASN16509 (AMAZON-02, US)
PTR: ec2-34-251-249-129.eu-west-1.compute.amazonaws.com

ads.yieldmo.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

1 5.178.65.246 (Amsterdam, Netherlands)

ASN50673 (SERVERIUS-AS, NL)
PTR: ads.us.e-planning.net

pbjs.e-planning.net	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

1 185.184.10.30 (Poland)

ASN203690 (RTB-HOUSE-ASH, PL)
PTR: ip-185-184-10-30.rtbhouse.net

prebid-us.creativecdn.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

1 213.19.147.42 (United Kingdom)

ASN26120 (RHYTHMONE, US)

tag.1rx.io	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

1 216.52.2.48 (United States)

ASN29791 (VOXEL-DOT-NET, US)

ap.lijit.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

1 198.148.27.133 (New York, United States)

ASN19189 (PULSEPOINT, US)

bid.contextweb.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

1 23.37.38.181 (Frankfurt am Main, Germany)

ASN16625 (AKAMAI-AS, US)
PTR: a23-37-38-181.deploy.static.akamaitechnologies.com

htlb.casalemedia.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

2 35.244.159.8 (Kansas City, United States)

ASN15169 (GOOGLE, US)
PTR: 8.159.244.35.bc.googleusercontent.com

adtelligent-d.openx.net	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools
u.openx.net	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

1 146.0.227.109 (Ascension Island)

ASN20773 (GODADDY, DE)

inv-nets.admixer.net	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

2 147.75.38.124 (Amsterdam, Netherlands)

ASN54825 (PACKET, US)

prebid.a-mo.net	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

11 51.38.120.206 (France)

ASN16276 (OVH, FR)
PTR: ip206.ip-51-38-120.eu

onetag-sys.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

1 88.212.252.22 (Russian Federation)

ASN7979 (SERVERS-COM, US)

ads.betweendigital.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

6 178.250.0.165 (France)

ASN44788 (ASN-CRITEO-EUROPE, FR)
PTR: bidder.par.vip.prod.criteo.com

bidder.criteo.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

1 34.107.148.139 (Kansas City, United States)

ASN15169 (GOOGLE, US)
PTR: 139.148.107.34.bc.googleusercontent.com

prebid.media.net	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

1 63.32.247.12 (Dublin, Ireland)

ASN16509 (AMAZON-02, US)
PTR: ec2-63-32-247-12.eu-west-1.compute.amazonaws.com

ads.servenobid.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

1 2a00:1450:4001:813::2002 (Frankfurt am Main, Germany)

ASN15169 (GOOGLE, US)

adservice.google.de	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

2 2a00:1450:4001:80f::2002 (Frankfurt am Main, Germany)

ASN15169 (GOOGLE, US)

adservice.google.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

1 2a00:1450:4001:810::2001 (Frankfurt am Main, Germany)

ASN15169 (GOOGLE, US)

88de716fcdb80ed5cefd22d492c50498.safeframe.googlesyndication.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

1 34.249.212.247 (Dublin, Ireland)

ASN16509 (AMAZON-02, US)
PTR: ec2-34-249-212-247.eu-west-1.compute.amazonaws.com

tracking.crazyegg.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

5 185.184.8.65 (Amsterdam, Netherlands)

ASN204995 (RTB-HOUSE-AMS, PL)
PTR: ip-185-184-8-65.rtbhouse.net

prebid-eu.creativecdn.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

1 54.149.174.3 (Boardman, United States)

ASN16509 (AMAZON-02, US)
PTR: ec2-54-149-174-3.us-west-2.compute.amazonaws.com

a.ad.gt	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

1 2606:4700:3033::6815:3a2a (United States)

ASN13335 (CLOUDFLARENET, US)

api.fouanalytics.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

2 99.86.3.109 (United States)

ASN16509 (AMAZON-02, US)
PTR: server-99-86-3-109.fra6.r.cloudfront.net

c405.fiercepharma.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

1 62.149.0.72 (Ukraine) 1 redirects

ASN15497 (COLOCALL Internet Data Center ColoCALL, UA)
PTR: 0-72.cc86365-03-tmp.cc.colocall.com

sync.adtelligent.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

1 193.200.65.5 (Amsterdam, Netherlands)

ASN6681 (GIVEME-CLOUD, PL)
PTR: t.trafmag.com

t.trafmag.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

1 37.18.16.16 (Russian Federation)

ASN205675 (HYBRID-AS, RU)

dm.hybrid.ai	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

5 54.144.118.149 (Ashburn, United States)

ASN14618 (AMAZON-AES, US)
PTR: ec2-54-144-118-149.compute-1.amazonaws.com

creative.spotible.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

5 205.162.42.5 (United States)

ASN53866 (QTS-AS, US)
PTR: cdn.omeda.com

cdn.omeda.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools
hostedcontent.dragonforms.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

3 142.250.185.66 (United States) 2 redirects

ASN15169 (GOOGLE, US)
PTR: fra16s48-in-f2.1e100.net

cm.g.doubleclick.net	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

1 35.244.174.68 (Kansas City, United States)

ASN15169 (GOOGLE, US)
PTR: 68.174.244.35.bc.googleusercontent.com

idsync.rlcdn.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

3 2606:4700:20::681a:723 (United States) 1 redirects

ASN13335 (CLOUDFLARENET, US)

api-54-185-136-237.b2c.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

2 204.180.130.165 (United States)

ASN53866 (QTS-AS, US)

oqs.omeda.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

2 2a00:1450:4001:827::2002 (Frankfurt am Main, Germany)

ASN15169 (GOOGLE, US)

pagead2.googlesyndication.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

1 52.35.70.100 (Boardman, United States)

ASN16509 (AMAZON-02, US)
PTR: ec2-52-35-70-100.us-west-2.compute.amazonaws.com

aufp.io	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

1 44.230.193.23 (Boardman, United States)

ASN16509 (AMAZON-02, US)
PTR: ec2-44-230-193-23.us-west-2.compute.amazonaws.com

p.ad.gt	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

2 185.33.221.91 (Amsterdam, Netherlands) 1 redirects

ASN29990 (ASN-APPNEX, US)
PTR: 721.bm-nginx-loadbalancer.mgmt.ams1.adnexus.net

secure.adnxs.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

9 52.43.149.174 (Boardman, United States) 2 redirects

ASN16509 (AMAZON-02, US)
PTR: ec2-52-43-149-174.us-west-2.compute.amazonaws.com

ids.ad.gt	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

2 52.223.40.198 (United States) 2 redirects

ASN16509 (AMAZON-02, US)
PTR: a6370ebea231e0c9a.awsglobalaccelerator.com

match.adsrvr.org	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

2 185.64.190.80 (United Kingdom) 2 redirects

ASN62713 (AS-PUBMATIC, US)

image2.pubmatic.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

2 3.251.21.8 (Dublin, Ireland) 2 redirects

ASN16509 (AMAZON-02, US)
PTR: ec2-3-251-21-8.eu-west-1.compute.amazonaws.com

ad.360yield.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

2 52.50.101.149 (Dublin, Ireland) 2 redirects

ASN16509 (AMAZON-02, US)
PTR: ec2-52-50-101-149.eu-west-1.compute.amazonaws.com

match.prod.bidr.io	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

1 69.173.144.165 (Frankfurt am Main, Germany)

ASN26667 (RUBICONPROJECT, US)

token.rubiconproject.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

1 54.185.136.237 (Boardman, United States)

ASN16509 (AMAZON-02, US)
PTR: ec2-54-185-136-237.us-west-2.compute.amazonaws.com

v4-api-54-185-136-237.b2c.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

2 99.86.3.4 (United States)

ASN16509 (AMAZON-02, US)
PTR: server-99-86-3-4.fra6.r.cloudfront.net

cdn.spotible.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

2 2a00:1450:4001:812::2002 (Frankfurt am Main, Germany)

ASN15169 (GOOGLE, US)

www.googletagservices.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

1 35.83.23.20 (Boardman, United States)

ASN16509 (AMAZON-02, US)
PTR: ec2-35-83-23-20.us-west-2.compute.amazonaws.com

pixels.ad.gt	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

1 2001:4de0:ac18::1:a:2a (Netherlands)

ASN20446 (HIGHWINDS3, US)

code.jquery.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

1 2a00:1450:4001:82a::2002 (Frankfurt am Main, Germany)

ASN15169 (GOOGLE, US)

adservice.google.de	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

2 2a02:2638::3 (France)

ASN44788 (ASN-CRITEO-EUROPE, FR)

static.criteo.net	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

1 151.101.1.108 (United States)

ASN54113 (FASTLY, US)

acdn.adnxs.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

2 2a02:2638::1c (France) 1 redirects

ASN44788 (ASN-CRITEO-EUROPE, FR)

gum.criteo.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

2 178.250.2.146 (France)

ASN44788 (ASN-CRITEO-EUROPE, FR)

mug.criteo.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

1 51.89.7.110 (London, United Kingdom)

ASN16276 (OVH, FR)
PTR: p23.id5-sync.com

id5-sync.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

	Apex Domain Subdomains	Transfer
16	omeda.com olytics.omeda.com — Cisco Umbrella Rank: 30868 cdn.omeda.com — Cisco Umbrella Rank: 47954 oqs.omeda.com — Cisco Umbrella Rank: 33396	165 KB
15	adnxs.com 3 redirects ib.adnxs.com — Cisco Umbrella Rank: 241 prebid.adnxs.com — Cisco Umbrella Rank: 1759 secure.adnxs.com — Cisco Umbrella Rank: 404 acdn.adnxs.com — Cisco Umbrella Rank: 565	13 KB
14	dragonforms.com 1 redirects sample.dragonforms.com — Cisco Umbrella Rank: 122221 hostedcontent.dragonforms.com — Cisco Umbrella Rank: 88834	89 KB
14	fiercepharma.com www.fiercepharma.com — Cisco Umbrella Rank: 116131 c405.fiercepharma.com — Cisco Umbrella Rank: 406279 Failed	138 KB
12	ad.gt 2 redirects a.ad.gt — Cisco Umbrella Rank: 5184 p.ad.gt — Cisco Umbrella Rank: 5806 ids.ad.gt — Cisco Umbrella Rank: 4690 pixels.ad.gt — Cisco Umbrella Rank: 5709	17 KB
11	onetag-sys.com onetag-sys.com — Cisco Umbrella Rank: 1056	6 KB
11	yahoo.com c2shb.ssp.yahoo.com — Cisco Umbrella Rank: 693	1 KB
10	criteo.com 1 redirects bidder.criteo.com — Cisco Umbrella Rank: 722 gum.criteo.com — Cisco Umbrella Rank: 369 mug.criteo.com — Cisco Umbrella Rank: 2864	3 KB
10	doubleclick.net 2 redirects securepubads.g.doubleclick.net — Cisco Umbrella Rank: 184 stats.g.doubleclick.net — Cisco Umbrella Rank: 96 cm.g.doubleclick.net — Cisco Umbrella Rank: 197	153 KB
9	rubiconproject.com fastlane.rubiconproject.com — Cisco Umbrella Rank: 467 token.rubiconproject.com — Cisco Umbrella Rank: 689	11 KB
8	mediafuse.com player.mediafuse.com — Cisco Umbrella Rank: 53525 player.hbmp.mediafuse.com — Cisco Umbrella Rank: 36214 ghb.hbmp.mediafuse.com — Cisco Umbrella Rank: 50582	173 KB
7	spotible.com ads.spotible.com Failed creative.spotible.com — Cisco Umbrella Rank: 70958 cdn.spotible.com — Cisco Umbrella Rank: 76793	211 KB
7	adtelligent.com 1 redirects player.adtelligent.com — Cisco Umbrella Rank: 5710 ghb.adtelligent.com — Cisco Umbrella Rank: 5988 sync.adtelligent.com — Cisco Umbrella Rank: 2849	6 KB
7	crazyegg.com script.crazyegg.com — Cisco Umbrella Rank: 2008 pagestates-tracking.crazyegg.com — Cisco Umbrella Rank: 3843 assets-tracking.crazyegg.com — Cisco Umbrella Rank: 3846 tracking.crazyegg.com — Cisco Umbrella Rank: 3831	29 KB
6	creativecdn.com prebid-us.creativecdn.com — Cisco Umbrella Rank: 9562 prebid-eu.creativecdn.com — Cisco Umbrella Rank: 5646	1 KB
5	google-analytics.com www.google-analytics.com — Cisco Umbrella Rank: 42	41 KB
4	b2c.com 1 redirects api-54-185-136-237.b2c.com v4-api-54-185-136-237.b2c.com	7 KB
4	pubmatic.com 2 redirects hbopenbid.pubmatic.com — Cisco Umbrella Rank: 459 image2.pubmatic.com — Cisco Umbrella Rank: 1032	806 B
4	dpmsrv.com s.dpmsrv.com — Cisco Umbrella Rank: 27632 a.dpmsrv.com — Cisco Umbrella Rank: 23211	42 KB
3	googlesyndication.com 88de716fcdb80ed5cefd22d492c50498.safeframe.googlesyndication.com pagead2.googlesyndication.com — Cisco Umbrella Rank: 100	4 KB
3	ml314.com ml314.com — Cisco Umbrella Rank: 1557 in.ml314.com — Cisco Umbrella Rank: 8786	13 KB
3	addtoany.com static.addtoany.com — Cisco Umbrella Rank: 4404	60 KB
2	criteo.net static.criteo.net — Cisco Umbrella Rank: 645	56 KB
2	googletagservices.com www.googletagservices.com — Cisco Umbrella Rank: 165
2	bidr.io 2 redirects match.prod.bidr.io — Cisco Umbrella Rank: 524	1 KB
2	360yield.com 2 redirects ad.360yield.com — Cisco Umbrella Rank: 675	684 B
2	adsrvr.org 2 redirects match.adsrvr.org — Cisco Umbrella Rank: 329	965 B
2	google.com adservice.google.com — Cisco Umbrella Rank: 80	671 B
2	google.de adservice.google.de — Cisco Umbrella Rank: 8028	914 B
2	a-mo.net prebid.a-mo.net — Cisco Umbrella Rank: 1204	557 B
2	openx.net adtelligent-d.openx.net — Cisco Umbrella Rank: 17971 u.openx.net — Cisco Umbrella Rank: 710	514 B
2	deepintent.com prebid.deepintent.com — Cisco Umbrella Rank: 5893	235 B
2	nodserving.com p.nodserving.com — Cisco Umbrella Rank: 23868	14 KB
2	parsely.com cdn.parsely.com — Cisco Umbrella Rank: 2931 p1.parsely.com — Cisco Umbrella Rank: 2249	18 KB
2	marketo.net munchkin.marketo.net — Cisco Umbrella Rank: 3672	6 KB
2	sitescout.com pixel.sitescout.com — Cisco Umbrella Rank: 3536	191 B
2	basis.net 2 redirects pixel-a.basis.net — Cisco Umbrella Rank: 16750	132 B
2	gstatic.com fonts.gstatic.com	54 KB
2	googletagmanager.com www.googletagmanager.com — Cisco Umbrella Rank: 78	93 KB
2	blueconic.net cdn.blueconic.net — Cisco Umbrella Rank: 7691 questex.blueconic.net — Cisco Umbrella Rank: 164216	42 KB
2	googleapis.com fonts.googleapis.com — Cisco Umbrella Rank: 47 ajax.googleapis.com — Cisco Umbrella Rank: 293	7 KB
1	id5-sync.com id5-sync.com — Cisco Umbrella Rank: 596	538 B
1	jquery.com code.jquery.com — Cisco Umbrella Rank: 584	29 KB
1	aufp.io aufp.io — Cisco Umbrella Rank: 6490	3 KB
1	rlcdn.com idsync.rlcdn.com — Cisco Umbrella Rank: 316	66 B
1	hybrid.ai dm.hybrid.ai — Cisco Umbrella Rank: 6197	238 B
1	trafmag.com t.trafmag.com — Cisco Umbrella Rank: 6679	351 B
1	fouanalytics.com api.fouanalytics.com — Cisco Umbrella Rank: 10665	929 B
1	medidexs.com sync.medidexs.com — Cisco Umbrella Rank: 33627	21 KB
1	servenobid.com ads.servenobid.com — Cisco Umbrella Rank: 1823	638 B
1	media.net prebid.media.net — Cisco Umbrella Rank: 1360	869 B
1	betweendigital.com ads.betweendigital.com — Cisco Umbrella Rank: 1818	916 B
1	admixer.net inv-nets.admixer.net — Cisco Umbrella Rank: 2627	510 B
1	casalemedia.com htlb.casalemedia.com — Cisco Umbrella Rank: 461	336 B
1	contextweb.com bid.contextweb.com — Cisco Umbrella Rank: 2792	572 B
1	lijit.com ap.lijit.com — Cisco Umbrella Rank: 690	526 B
1	1rx.io tag.1rx.io — Cisco Umbrella Rank: 1334	176 B
1	e-planning.net pbjs.e-planning.net — Cisco Umbrella Rank: 7058	162 B
1	yieldmo.com ads.yieldmo.com — Cisco Umbrella Rank: 670	229 B
1	colossusssp.com colossusssp.com — Cisco Umbrella Rank: 2462	247 B
1	sonobi.com apex.go.sonobi.com — Cisco Umbrella Rank: 1699	887 B
1	mktoresp.com 294-mqf-056.mktoresp.com — Cisco Umbrella Rank: 163244	311 B
1	zoominfo.com ws.zoominfo.com — Cisco Umbrella Rank: 9204	1 KB
1	cloudfront.net d1z2jf7jlzjs58.cloudfront.net	1 KB
1	marketo.com app-sj10.marketo.com — Cisco Umbrella Rank: 162030	68 KB
1	qtxasset.com qtxasset.com — Cisco Umbrella Rank: 90567	111 KB
0	adxpremium.services Failed rtb.adxpremium.services Failed
233	67

	Domain	Requested by
13	olytics.omeda.com	www.fiercepharma.com www.googletagmanager.com olytics.omeda.com sample.dragonforms.com
12	www.fiercepharma.com	www.fiercepharma.com
11	onetag-sys.com	player.mediafuse.com p.nodserving.com
11	c2shb.ssp.yahoo.com	player.mediafuse.com
11	ib.adnxs.com	2 redirects player.mediafuse.com p.nodserving.com www.fiercepharma.com
10	sample.dragonforms.com	1 redirects www.fiercepharma.com sample.dragonforms.com code.jquery.com
9	ids.ad.gt	2 redirects www.fiercepharma.com
8	fastlane.rubiconproject.com	player.mediafuse.com
6	bidder.criteo.com	player.mediafuse.com p.nodserving.com
6	securepubads.g.doubleclick.net	www.fiercepharma.com securepubads.g.doubleclick.net
5	creative.spotible.com	securepubads.g.doubleclick.net creative.spotible.com www.fiercepharma.com
5	prebid-eu.creativecdn.com	p.nodserving.com
5	ghb.adtelligent.com	p.nodserving.com player.mediafuse.com
5	ghb.hbmp.mediafuse.com	player.hbmp.mediafuse.com
5	www.google-analytics.com	www.googletagmanager.com www.google-analytics.com
4	hostedcontent.dragonforms.com	sample.dragonforms.com hostedcontent.dragonforms.com
4	script.crazyegg.com	www.googletagmanager.com script.crazyegg.com
3	api-54-185-136-237.b2c.com	1 redirects www.fiercepharma.com
3	cm.g.doubleclick.net	2 redirects www.fiercepharma.com
3	a.dpmsrv.com	www.fiercepharma.com s.dpmsrv.com
3	static.addtoany.com	www.fiercepharma.com static.addtoany.com
2	mug.criteo.com	www.fiercepharma.com
2	gum.criteo.com	1 redirects
2	static.criteo.net	player.mediafuse.com static.criteo.net
2	www.googletagservices.com	olytics.omeda.com
2	cdn.spotible.com	www.fiercepharma.com
2	match.prod.bidr.io	2 redirects
2	ad.360yield.com	2 redirects
2	image2.pubmatic.com	2 redirects
2	match.adsrvr.org	2 redirects
2	secure.adnxs.com	1 redirects acdn.adnxs.com
2	pagead2.googlesyndication.com	olytics.omeda.com
2	oqs.omeda.com	olytics.omeda.com
2	adservice.google.com	securepubads.g.doubleclick.net
2	adservice.google.de	securepubads.g.doubleclick.net
2	prebid.a-mo.net	player.mediafuse.com
2	hbopenbid.pubmatic.com	player.mediafuse.com
2	prebid.deepintent.com	player.mediafuse.com
2	p.nodserving.com	player.mediafuse.com p.nodserving.com
2	ml314.com	www.fiercepharma.com ml314.com
2	c405.fiercepharma.com	cdn.blueconic.net
2	munchkin.marketo.net	www.fiercepharma.com munchkin.marketo.net
2	pixel.sitescout.com	www.fiercepharma.com
2	pixel-a.basis.net	2 redirects
2	fonts.gstatic.com	fonts.googleapis.com
2	www.googletagmanager.com	www.fiercepharma.com sample.dragonforms.com
2	player.mediafuse.com	www.fiercepharma.com
1	id5-sync.com	player.mediafuse.com
1	acdn.adnxs.com	p.nodserving.com
1	code.jquery.com	sample.dragonforms.com
1	u.openx.net	www.fiercepharma.com
1	pixels.ad.gt	p.ad.gt
1	v4-api-54-185-136-237.b2c.com	www.fiercepharma.com
1	token.rubiconproject.com	www.fiercepharma.com
1	p.ad.gt	a.ad.gt
1	aufp.io	a.ad.gt
1	idsync.rlcdn.com	www.fiercepharma.com
1	cdn.omeda.com	sample.dragonforms.com
1	dm.hybrid.ai	www.fiercepharma.com
1	t.trafmag.com	www.fiercepharma.com
1	sync.adtelligent.com	1 redirects
1	api.fouanalytics.com	player.hbmp.mediafuse.com
1	a.ad.gt	player.hbmp.mediafuse.com
1	sync.medidexs.com	player.hbmp.mediafuse.com
1	tracking.crazyegg.com	script.crazyegg.com
1	88de716fcdb80ed5cefd22d492c50498.safeframe.googlesyndication.com	securepubads.g.doubleclick.net
1	ads.servenobid.com	player.mediafuse.com
1	prebid.media.net	player.mediafuse.com
1	ads.betweendigital.com	player.mediafuse.com
1	inv-nets.admixer.net	player.mediafuse.com
1	adtelligent-d.openx.net	player.mediafuse.com
1	htlb.casalemedia.com	player.mediafuse.com
1	bid.contextweb.com	player.mediafuse.com
1	ap.lijit.com	player.mediafuse.com
1	tag.1rx.io	player.mediafuse.com
1	prebid-us.creativecdn.com	player.mediafuse.com
1	pbjs.e-planning.net	player.mediafuse.com
1	ads.yieldmo.com	player.mediafuse.com
1	colossusssp.com	player.mediafuse.com
1	apex.go.sonobi.com	player.mediafuse.com
1	prebid.adnxs.com	player.mediafuse.com
1	in.ml314.com	ml314.com
1	assets-tracking.crazyegg.com	script.crazyegg.com
1	pagestates-tracking.crazyegg.com	script.crazyegg.com
1	p1.parsely.com	www.fiercepharma.com
1	player.adtelligent.com	player.mediafuse.com
1	stats.g.doubleclick.net	www.google-analytics.com
1	294-mqf-056.mktoresp.com	munchkin.marketo.net
1	cdn.parsely.com	d1z2jf7jlzjs58.cloudfront.net
1	ws.zoominfo.com	www.fiercepharma.com
1	s.dpmsrv.com	www.fiercepharma.com
1	player.hbmp.mediafuse.com	player.mediafuse.com
1	d1z2jf7jlzjs58.cloudfront.net	www.fiercepharma.com
1	questex.blueconic.net	cdn.blueconic.net
1	app-sj10.marketo.com	www.fiercepharma.com
1	ajax.googleapis.com	www.fiercepharma.com
1	qtxasset.com	www.fiercepharma.com
1	cdn.blueconic.net	www.fiercepharma.com
1	fonts.googleapis.com	www.fiercepharma.com
0	ads.spotible.com Failed	www.fiercepharma.com
0	rtb.adxpremium.services Failed	p.nodserving.com
233	101

This site contains links to these domains. Also see Links.

Domain
www.fiercelifesciences.com
www.fiercebiotech.com
jobs.fiercebiotech.com
fiercepharma.questexinfo.com
twitter.com
www.linkedin.com
www.addtoany.com
questex.com
www.questex.com

Subject Issuer	Validity	Valid
sni.cloudflaressl.com Cloudflare Inc ECC CA-3	`2021-07-14` - `2022-07-13`	a year	crt.sh
upload.video.google.com GTS CA 1C3	`2022-01-10` - `2022-04-04`	3 months	crt.sh
*.blueconic.net Amazon	`2021-08-07` - `2022-09-05`	a year	crt.sh
player.mediafuse.com R3	`2022-01-15` - `2022-04-15`	3 months	crt.sh
*.g.doubleclick.net GTS CA 1C3	`2022-01-17` - `2022-04-11`	3 months	crt.sh
app-sj10.marketo.com Cloudflare Inc ECC CA-3	`2021-06-08` - `2022-06-07`	a year	crt.sh
*.google-analytics.com GTS CA 1C3	`2022-01-10` - `2022-04-04`	3 months	crt.sh
*.gstatic.com GTS CA 1C3	`2022-01-10` - `2022-04-04`	3 months	crt.sh
*.sitescout.com GeoTrust TLS DV RSA Mixed SHA256 2020 CA-1	`2021-12-15` - `2023-01-15`	a year	crt.sh
*.omeda.com SSL.com RSA SSL subCA	`2021-07-16` - `2022-07-21`	a year	crt.sh
*.cloudfront.net Amazon	`2021-03-19` - `2022-03-17`	a year	crt.sh
player.hbmp.mediafuse.com R3	`2021-12-12` - `2022-03-12`	3 months	crt.sh
*.marketo.net DigiCert SHA2 Secure Server CA	`2021-03-29` - `2022-04-06`	a year	crt.sh
*.dpmsrv.com Amazon	`2021-05-17` - `2022-06-15`	a year	crt.sh
zoominfo.com Cloudflare Inc ECC CA-3	`2021-06-04` - `2022-06-03`	a year	crt.sh
*.parsely.com Amazon	`2021-07-05` - `2022-08-03`	a year	crt.sh
*.ml314.com Amazon	`2021-12-17` - `2023-01-14`	a year	crt.sh
*.mktoresp.com DigiCert TLS RSA SHA256 2020 CA1	`2021-11-30` - `2022-11-30`	a year	crt.sh
ghb.hbmp.mediafuse.com ZeroSSL ECC Domain Secure Site CA	`2022-02-06` - `2022-05-07`	3 months	crt.sh
p.nodserving.com R3	`2021-12-19` - `2022-03-19`	3 months	crt.sh
player.adtelligent.com R3	`2022-01-18` - `2022-04-18`	3 months	crt.sh
ghb.adtelligent.com ZeroSSL ECC Domain Secure Site CA	`2022-02-06` - `2022-05-07`	3 months	crt.sh
*.crazyegg.com DigiCert SHA2 Secure Server CA	`2020-07-26` - `2022-07-23`	2 years	crt.sh
*.deepintent.com Go Daddy Secure Certificate Authority - G2	`2020-04-09` - `2022-06-08`	2 years	crt.sh
prebid.adnxs.com GeoTrust TLS RSA CA G1	`2020-03-29` - `2022-03-29`	2 years	crt.sh
web.ssp.yahoo.com DigiCert SHA2 High Assurance Server CA	`2021-10-14` - `2022-04-06`	6 months	crt.sh
*.rubiconproject.com DigiCert TLS RSA SHA256 2020 CA1	`2021-03-30` - `2022-04-04`	a year	crt.sh
*.go.sonobi.com Go Daddy Secure Certificate Authority - G2	`2021-12-08` - `2023-01-09`	a year	crt.sh
*.colossusssp.com Go Daddy Secure Certificate Authority - G2	`2021-11-07` - `2022-11-07`	a year	crt.sh
*.pubmatic.com DigiCert Baltimore TLS RSA SHA256 2020 CA1	`2021-08-04` - `2022-09-04`	a year	crt.sh
*.yieldmo.com Amazon	`2021-05-25` - `2022-06-23`	a year	crt.sh
*.e-planning.net R3	`2021-12-30` - `2022-03-30`	3 months	crt.sh
*.creativecdn.com RapidSSL TLS DV RSA Mixed SHA256 2020 CA-1	`2021-03-30` - `2022-04-12`	a year	crt.sh
*.1rx.io Sectigo RSA Domain Validation Secure Server CA	`2021-06-01` - `2022-07-02`	a year	crt.sh
*.lijit.com Go Daddy Secure Certificate Authority - G2	`2021-03-11` - `2022-04-12`	a year	crt.sh
*.contextweb.com DigiCert SHA2 Secure Server CA	`2020-05-07` - `2022-05-12`	2 years	crt.sh
san.casalemedia.com GeoTrust RSA CA 2018	`2021-12-12` - `2022-12-13`	a year	crt.sh
*.openx.net GeoTrust RSA CA 2018	`2021-07-08` - `2022-08-08`	a year	crt.sh
*.adnxs.com GeoTrust ECC CA 2018	`2021-03-05` - `2022-02-19`	a year	crt.sh
*.admixer.net Sectigo ECC Domain Validation Secure Server CA	`2021-11-16` - `2022-12-17`	a year	crt.sh
*.a-mo.net R3	`2021-12-28` - `2022-03-28`	3 months	crt.sh
*.onetag-sys.com DigiCert TLS Hybrid ECC SHA384 2020 CA1	`2022-01-10` - `2023-01-03`	a year	crt.sh
*.ads.betweendigital.com Sectigo RSA Domain Validation Secure Server CA	`2021-12-15` - `2023-01-15`	a year	crt.sh
*.criteo.com DigiCert TLS Hybrid ECC SHA384 2020 CA1	`2022-02-04` - `2022-05-03`	3 months	crt.sh
*.media.net Sectigo RSA Domain Validation Secure Server CA	`2021-04-12` - `2022-05-05`	a year	crt.sh
ads.servenobid.com Amazon	`2021-06-28` - `2022-07-27`	a year	crt.sh
*.google.de GTS CA 1C3	`2022-01-10` - `2022-04-04`	3 months	crt.sh
*.google.com GTS CA 1C3	`2022-01-17` - `2022-04-11`	3 months	crt.sh
sync.medidexs.com R3	`2022-01-09` - `2022-04-09`	3 months	crt.sh
*.ad.gt Amazon	`2021-06-09` - `2022-07-08`	a year	crt.sh
s827.travelagentcentral.com Amazon	`2021-10-12` - `2022-11-10`	a year	crt.sh
*.hybrid.ai Sectigo RSA Domain Validation Secure Server CA	`2020-07-07` - `2022-10-05`	2 years	crt.sh
*.spotible.com Sectigo RSA Domain Validation Secure Server CA	`2021-11-02` - `2022-12-03`	a year	crt.sh
*.rlcdn.com Sectigo RSA Domain Validation Secure Server CA	`2021-02-25` - `2022-03-28`	a year	crt.sh
aufp.io Amazon	`2021-11-26` - `2022-12-24`	a year	crt.sh
*.jquery.com Sectigo RSA Domain Validation Secure Server CA	`2021-07-14` - `2022-08-14`	a year	crt.sh
*.criteo.net DigiCert TLS Hybrid ECC SHA384 2020 CA1	`2022-02-02` - `2022-05-03`	3 months	crt.sh
cdn.adnxs.com GlobalSign Organization Validated CA - SHA256 - G4	`2021-05-10` - `2022-06-11`	a year	crt.sh
*.id5-sync.com R3	`2021-12-20` - `2022-03-20`	3 months	crt.sh

This page contains 15 frames:

Primary Page: https://www.fiercepharma.com/special-report/10-most-anticipated-drug-launches-2022-4-deucravacitinib
Frame ID: CDF0DAF442230834A8670964E41C5686
Requests: 159 HTTP requests in this frame

Frame: https://pixel.sitescout.com/dmp/asyncPixelSync
Frame ID: 651231E5D93932E5CA89C8F4CDA5D814
Requests: 1 HTTP requests in this frame

Frame: https://sample.dragonforms.com/loading.do?omedasite=FiercePharma_short
Frame ID: 8E4AEC592B3324920FBED30A41B56473
Requests: 22 HTTP requests in this frame

Frame: https://static.addtoany.com/menu/sm.23.html
Frame ID: 50062B843FD0E39FF16CCE6FE6B11B6A
Requests: 1 HTTP requests in this frame

Frame: https://p.nodserving.com/prebidlink/19031/j.html?i=11600
Frame ID: 447C03AC66B0E66C1A800AC242D2F308
Requests: 31 HTTP requests in this frame

Frame: https://88de716fcdb80ed5cefd22d492c50498.safeframe.googlesyndication.com/safeframe/1-0-38/html/container.html
Frame ID: 657DE867F8F6D3E99EF8B7A61D529066
Requests: 1 HTTP requests in this frame

Frame: https://ads.spotible.com/tag/universal-tag.js
Frame ID: 8F33F88E35F3AE1545909852532FA4D8
Requests: 2 HTTP requests in this frame

Frame: https://creative.spotible.com/tag/allstream.js
Frame ID: 8C21DAA01D0775930482FA637BD00421
Requests: 1 HTTP requests in this frame

Frame: https://creative.spotible.com/tag/storage-delegate.html
Frame ID: 9E390FF88D32E381A20508B3DA779214
Requests: 1 HTTP requests in this frame

Frame: https://acdn.adnxs.com/ib/static/usersync/v3/async_usersync.html
Frame ID: 4A1D415D12B99C0B530739A8DAA6A58C
Requests: 2 HTTP requests in this frame

Frame: https://onetag-sys.com/usync/?cb=1644329015956
Frame ID: 7C7680E15D3D681AC207B285B2DF27C6
Requests: 1 HTTP requests in this frame

Frame: https://onetag-sys.com/usync/?cb=1644329015958
Frame ID: C0BB7D4C792C5DA92064F718BC584B31
Requests: 1 HTTP requests in this frame

Frame: https://onetag-sys.com/usync/?cb=1644329015960
Frame ID: 6B8E311C3E8B78D1915E3992A72DB135
Requests: 1 HTTP requests in this frame

Frame: https://onetag-sys.com/usync/?cb=1644329015961
Frame ID: 717D7C5599079B03F234F8D239012494
Requests: 1 HTTP requests in this frame

Frame: https://onetag-sys.com/usync/?cb=1644329015963
Frame ID: 19DD3CCB736C41D6F2621838F03C9C67
Requests: 1 HTTP requests in this frame

Screenshot
Live screenshot

Full Image

Page Title

4. Deucravacitinib | FiercePharma

Detected technologies

AddToAny (Widgets) Expand

Overall confidence: 100%
Detected patterns

addtoany\.com/menu/page\.js

AppNexus (Advertising Networks) Expand

Overall confidence: 100%
Detected patterns

adnxs\.(?:net|com)

Crazy Egg (Analytics) Expand

Overall confidence: 100%
Detected patterns

script\.crazyegg\.com/pages/scripts/\d+/\d+\.js

DoubleClick for Publishers (DFP) (Advertising Networks) Expand

Overall confidence: 100%
Detected patterns

googletagservices\.com/tag/js/gpt(?:_mobile)?\.js

Google AdSense (Advertising Networks) Expand

Overall confidence: 100%
Detected patterns

googlesyndication\.com/

Google Analytics (Analytics) Expand

Overall confidence: 100%
Detected patterns

google-analytics\.com/(?:ga|urchin|analytics)\.js

Google Font API (Font Scripts) Expand

Overall confidence: 100%
Detected patterns

googleapis\.com/.+webfont

Google Tag Manager (Tag Managers) Expand

Overall confidence: 100%
Detected patterns

googletagmanager\.com/gtm\.js

Marketo (Marketing Automation) Expand

Overall confidence: 100%
Detected patterns

munchkin\.marketo\.\w+/(?:([\d.]+)/)?munchkin\.js

Marketo Forms (Widgets) Expand

Overall confidence: 100%
Detected patterns

marketo\.\w+/js/forms(?:[\d.]+)/js/forms([\d.]+)\.min\.js

OpenX (Advertising Networks) Expand

Overall confidence: 100%
Detected patterns

https?://[^/]*\.openx\.net

Prebid (Advertising Networks) Expand

Overall confidence: 100%
Detected patterns

adnxs\.com/[^"]*(?:prebid|/pb\.js)

PubMatic (Advertising Networks) Expand

Overall confidence: 100%
Detected patterns

https?://[^/]*\.pubmatic\.com

Rubicon Project (Advertising Networks) Expand

Overall confidence: 100%
Detected patterns

https?://[^/]*\.rubiconproject\.com

jQuery (JavaScript Libraries) Expand

Overall confidence: 100%
Detected patterns

jquery[.-]([\d.]*\d)[^/]*\.js
jquery.*\.js(?:\?ver(?:sion)?=([\d.]+))?

Page Statistics

233
Requests

91 %
HTTPS

24 %
IPv6

67
Domains

101
Subdomains

89
IPs

12
Countries

1713 kB
Transfer

4568 kB
Size

79
Cookies

13 Outgoing links

These are links going to different origins than the main page.

URL: https://www.fiercelifesciences.com/
Title: Fierce Events

Search URL Search Domain Scan URL

URL: https://www.fiercebiotech.com/
Title: FierceBiotech

Search URL Search Domain Scan URL

URL: http://jobs.fiercebiotech.com/
Title: Jobs

Search URL Search Domain Scan URL

URL: https://fiercepharma.questexinfo.com/loading.do?omedasite=Pharma_full
Title: Subscribe

Search URL Search Domain Scan URL

URL: https://twitter.com/fiercepharma
Title: Twitter

Search URL Search Domain Scan URL

URL: https://www.linkedin.com/showcase/fierce-pharma/
Title: LinkedIn

Search URL Search Domain Scan URL

URL: https://www.addtoany.com/share#url=https%3A%2F%2Fwww.fiercepharma.com%2Fspecial-report%2F10-most-anticipated-drug-launches-2022-4-deucravacitinib&title=4.%20Deucravacitinib%20
Title: Share

Search URL Search Domain Scan URL

URL: https://www.fiercebiotech.com/biotech/bristol-myers-deucravacitinib-beats-out-exiled-otezla-eyes-2022-launch
Title: topped

Search URL Search Domain Scan URL

URL: https://www.fiercebiotech.com/biotech/bristol-myers-deucravacitinib-flunks-midphase-ibd-trial-raising-questions-about-potential
Title: failed

Search URL Search Domain Scan URL

URL: https://questex.com/

Search URL Search Domain Scan URL

URL: https://www.questex.com/privacy-policy
Title: Privacy

Search URL Search Domain Scan URL

URL: https://www.questex.com/terms-of-use
Title: Terms of Use

Search URL Search Domain Scan URL

URL: https://www.addtoany.com/
Title: AddToAny

Search URL Search Domain Scan URL

Redirected requests

There were HTTP redirect chains for the following requests:

Request Chain 23

https://pixel-a.basis.net/dmp/asyncPixelSync HTTP 301
https://pixel.sitescout.com/dmp/asyncPixelSync

Request Chain 24

https://pixel-a.basis.net/iap/7f1874304d399254 HTTP 301
https://pixel.sitescout.com/iap/7f1874304d399254

Request Chain 25

https://sample.dragonforms.com/FiercePharma_short HTTP 302
https://sample.dragonforms.com/init.do?omedasite=FiercePharma_short

Request Chain 44

https://ib.adnxs.com/getuid?https://a.dpmsrv.com/dpmpxl/index.php?id=$UID&q%3DxImp%26v%3D1.x%26cl%3D913%26pixelIndex%3D0%26r%3D718462%26tzOffset%3D0%26url%3Dhttps%253A%252F%252Fwww.fiercepharma.com%252Fspecial-report%252F10-most-anticipated-drug-launches-2022-4-deucravacitinib&_=1644329013515 HTTP 307
https://ib.adnxs.com/bounce?%2Fgetuid%3Fhttps%3A%2F%2Fa.dpmsrv.com%2Fdpmpxl%2Findex.php%3Fid%3D%24UID%26q%253DxImp%2526v%253D1.x%2526cl%253D913%2526pixelIndex%253D0%2526r%253D718462%2526tzOffset%253D0%2526url%253Dhttps%25253A%25252F%25252Fwww.fiercepharma.com%25252Fspecial-report%25252F10-most-anticipated-drug-launches-2022-4-deucravacitinib%26_%3D1644329013515 HTTP 302
https://a.dpmsrv.com/dpmpxl/index.php?id=5611407578940007418&q=xImp&v=1.x&cl=913&pixelIndex=0&r=718462&tzOffset=0&url=https%3A%2F%2Fwww.fiercepharma.com%2Fspecial-report%2F10-most-anticipated-drug-launches-2022-4-deucravacitinib&_=1644329013515

Request Chain 146

https://sync.adtelligent.com/csync?&redir=https%3A%2F%2Ft.trafmag.com%2Fimages%2Fimages%2F1px-matching-adtelligent.gif%3Fid%3D%7Buid%7D HTTP 302
https://t.trafmag.com/images/images/1px-matching-adtelligent.gif?id=dee7590cecd5b9a6

Request Chain 152

https://cm.g.doubleclick.net/pixel?google_nid=datapoint_dmp&google_cm&ap_id=5611407578940007418&pixelIndex=0&_=1644329013516 HTTP 302
https://a.dpmsrv.com/dpmpxl/index.php?q=dfp&ap_id=5611407578940007418&pixelIndex=0&_=1644329013516&google_gid=CAESEA3-l_Gnaz_pvXyZ-K0qbeA&google_cver=1

Request Chain 164

https://secure.adnxs.com/getuid?https://ids.ad.gt/api/v1/match?id=71ea94e0-0093-44cb-b4dd-d08066fc43e4&adnxs_id=$UID HTTP 302
https://ids.ad.gt/api/v1/match?id=71ea94e0-0093-44cb-b4dd-d08066fc43e4&adnxs_id=5611407578940007418

Request Chain 165

https://match.adsrvr.org/track/cmf/generic?ttd_pid=8gkxb6n&ttd_tpi=1&gpdr=0&ttd_puid=71ea94e0-0093-44cb-b4dd-d08066fc43e4 HTTP 302
https://match.adsrvr.org/track/cmb/generic?ttd_pid=8gkxb6n&ttd_tpi=1&gpdr=0&ttd_puid=71ea94e0-0093-44cb-b4dd-d08066fc43e4 HTTP 302
https://ids.ad.gt/api/v1/t_match?tdid=5f6d2359-c211-4f10-9b58-14dbad0adcf8&id=71ea94e0-0093-44cb-b4dd-d08066fc43e4

Request Chain 166

https://image2.pubmatic.com/AdServer/UCookieSetPug?rd=https%3A%2F%2Fids.ad.gt%2Fapi%2Fv1%2Fpbm_match%3Fpbm%3D%23PM_USER_ID%26id%3D71ea94e0-0093-44cb-b4dd-d08066fc43e4 HTTP 302
https://image2.pubmatic.com/AdServer/UCookieSetPug?ird=1&rd=https%3A%2F%2Fids.ad.gt%2Fapi%2Fv1%2Fpbm_match%3Fpbm%3D%23PM_USER_ID%26id%3D71ea94e0-0093-44cb-b4dd-d08066fc43e4 HTTP 302
https://ids.ad.gt/api/v1/pbm_match?pbm=BBFBF67E-52FE-430F-93B6-E6A55E905C12&id=71ea94e0-0093-44cb-b4dd-d08066fc43e4

Request Chain 167

https://cm.g.doubleclick.net/pixel?google_nid=audigent_w_appnexus_3985&google_cm&google_sc&google_ula=450542624&id=71ea94e0-0093-44cb-b4dd-d08066fc43e4 HTTP 302
https://ids.ad.gt/api/v1/g_match?id=71ea94e0-0093-44cb-b4dd-d08066fc43e4&google_gid=CAESEK46dYDDn1ptvDyhgNKmnDA&google_cver=1&google_ula=450542624,0

Request Chain 168

https://ids.ad.gt/api/v1/g_hosted?id=71ea94e0-0093-44cb-b4dd-d08066fc43e4 HTTP 302
https://cm.g.doubleclick.net/pixel?google_nid=audigent_w_appnexus_3985&google_hm=NzFlYTk0ZTAtMDA5My00NGNiLWI0ZGQtZDA4MDY2ZmM0M2U0

Request Chain 169

https://ad.360yield.com/ux?&publisher_dmp_id=15&r=https%3A%2F%2Fids.ad.gt%2Fapi%2Fv1%2Fimpr_match%3Fid%3D71ea94e0-0093-44cb-b4dd-d08066fc43e4%26impr_uid%3D%7BPUB_USER_ID%7D HTTP 302
https://ad.360yield.com/ul_cb/ux?&publisher_dmp_id=15&r=https%3A%2F%2Fids.ad.gt%2Fapi%2Fv1%2Fimpr_match%3Fid%3D71ea94e0-0093-44cb-b4dd-d08066fc43e4%26impr_uid%3D%7BPUB_USER_ID%7D HTTP 302
https://ids.ad.gt/api/v1/impr_match?id=71ea94e0-0093-44cb-b4dd-d08066fc43e4&impr_uid=bcc9beb1-8e48-4422-8855-3bd127e27e5e

Request Chain 170

https://match.prod.bidr.io/cookie-sync/audigent?buyer_user_id=71ea94e0-0093-44cb-b4dd-d08066fc43e4 HTTP 303
https://match.prod.bidr.io/cookie-sync/audigent?buyer_user_id=71ea94e0-0093-44cb-b4dd-d08066fc43e4&_bee_ppp=1 HTTP 303
https://ids.ad.gt/api/v1/beeswax_match?beeswax_id=AAFhKk7EBPAAAAJ4odOVww&id=71ea94e0-0093-44cb-b4dd-d08066fc43e4

Request Chain 171

https://ids.ad.gt/api/v1/rub?id=71ea94e0-0093-44cb-b4dd-d08066fc43e4 HTTP 302
https://token.rubiconproject.com/token?pid=50242&puid=71ea94e0-0093-44cb-b4dd-d08066fc43e4&gdpr=0

Request Chain 172

https://api-54-185-136-237.b2c.com/api/x?OgzmBuJbPLPWQouR$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 HTTP 302
https://v4-api-54-185-136-237.b2c.com:444/api/4?OgzmBuJbPLPWQouR

Request Chain 230

https://gum.criteo.com/sid/json?origin=prebid&topUrl=https%3A%2F%2Fwww.fiercepharma.com%2F&domain=www.fiercepharma.com&cw=1&pbt=1&lsw=1 HTTP 302
https://mug.criteo.com/sid?cpp=DvZvzHwzWWNyRS9zbCtmQWFwQVBoT1BxeS9yMlhVc0pYbG9GZTczMWFZS3VVbE9OKzZBb0dWejV4ZHAyVjJwcmY4QUJGemFRdkg2Mmk4WWtXMmlUYVU0N2Rab04vUzBlNTJJR1d5SHRCelBJaStLeGhwZjdGZVdYWXlJTFhQZDFPc25DdmtueStDU29SUjlWNy83bnlhY09UOVRJOXMzd2h5RGlWdFhrNTAwRmc0RGw1d3VyeFVSdVNxbzR3TStYWmFScVhkTGdOOURZWnN4L1dlNW9GcHdnNlN1UkpiQmt3THFuNDVUNFNwYjU3RWhHN0d2Y2xlVXNIT2JJZTMyakRoMzlwfA&cppv=2

233 HTTP transactions
2 data transactions

Method
Protocol Status Resource
Path Size
x-fer Time
Latency Type
MIME-Type IP
Location

GET
H2 200 Primary Request 10-most-anticipated-drug-launches-2022-4-deucravacitinib Show response
www.fiercepharma.com/special-report/ 70 KB
20 KB 739ms
674ms Document
text/html 104.18.14.141
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

https://www.fiercepharma.com/special-report/10-most-anticipated-drug-launches-2022-4-deucravacitinib

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

104.18.14.141 -, , ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

f43e5763cdf16e65fd23b9ff525d27d8cdc7a8a681708ee51026991d76e3c79a

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Frame-Options	SAMEORIGIN

Request headers

Upgrade-Insecure-Requests: 1
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Accept-Language: de-DE,de;q=0.9

Response headers

date: Tue, 08 Feb 2022 14:03:32 GMT
content-type: text/html; charset=UTF-8
cache-control: max-age=16588800, public
x-drupal-dynamic-cache: MISS
link: <https://www.fiercepharma.com/special-report/10-most-anticipated-drug-launches-2022-4-deucravacitinib>; rel="canonical" <https://www.fiercepharma.com/node/518261>; rel="shortlink" <https://www.fiercepharma.com/special-report/10-most-anticipated-drug-launches-2022-4-deucravacitinib>; rel="revision"
x-ua-compatible: IE=edge
content-language: en
x-content-type-options: nosniff
x-frame-options: SAMEORIGIN
expires: Sun, 19 Nov 1978 05:00:00 GMT
last-modified: Tue, 08 Feb 2022 14:03:32 GMT
vary: Cookie,Accept-Encoding
x-generator: Drupal 8 (https://www.drupal.org)
x-drupal-cache: MISS
x-request-id: v-e6327892-88e7-11ec-aef1-cba2e6898830
x-ah-environment: prod
via: varnish
x-cache: MISS
cf-cache-status: EXPIRED
expect-ct: max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
server: cloudflare
cf-ray: 6da566e5fafb90d6-FRA
content-encoding: br
alt-svc: h3=":443"; ma=86400, h3-29=":443"; ma=86400

GET
H2 200 css2
fonts.googleapis.com/ 7 KB
1 KB 72ms
27ms Stylesheet
text/css 2a00:1450:4001:82b::200a
GOOGLE

General

Check archive.org

Show headers Download Go to

Full URL

https://fonts.googleapis.com/css2?family=Overpass:ital,wght@0,400;0,700;0,900;1,400&display=swap

Requested by

Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/special-report/10-most-anticipated-drug-launches-2022-4-deucravacitinib

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2a00:1450:4001:82b::200a Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),

Reverse DNS

Software

ESF /

Resource Hash

16bc5aa9539869018f77eb2a7edc3e56864ce7a05117202d044c7aed8caea080

Security Headers

Name	Value
Strict-Transport-Security	max-age=31536000
X-Content-Type-Options	nosniff
X-Frame-Options	SAMEORIGIN
X-Xss-Protection	0

Request headers

Accept-Language: de-DE,de;q=0.9
Referer: https://www.fiercepharma.com/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

strict-transport-security: max-age=31536000
content-encoding: gzip
x-content-type-options: nosniff
cross-origin-resource-policy: cross-origin
alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
x-xss-protection: 0
last-modified: Tue, 08 Feb 2022 14:03:33 GMT
server: ESF
cross-origin-opener-policy: same-origin-allow-popups
date: Tue, 08 Feb 2022 14:03:33 GMT
x-frame-options: SAMEORIGIN
content-type: text/css; charset=utf-8
access-control-allow-origin: *
cache-control: private, max-age=86400, stale-while-revalidate=604800
timing-allow-origin: *
link: <https://fonts.gstatic.com>; rel=preconnect; crossorigin
expires: Tue, 08 Feb 2022 14:03:33 GMT

GET
H2 200 css_2cUrMdLa05pOjEKh0y2Vv3GJVjJ1S9FlveDonq3CWE8.css
www.fiercepharma.com/sites/fiercepharma/files/css/ 8 KB
2 KB 30ms
30ms Stylesheet
text/css 104.18.14.141
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

https://www.fiercepharma.com/sites/fiercepharma/files/css/css_2cUrMdLa05pOjEKh0y2Vv3GJVjJ1S9FlveDonq3CWE8.css

Requested by

Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/special-report/10-most-anticipated-drug-launches-2022-4-deucravacitinib

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

104.18.14.141 -, , ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

2df8f7fcaa40376591e17d73d42fb68111d13f05c2feabbb9b89499d5a935ea0

Security Headers

Name	Value
X-Content-Type-Options	nosniff

Request headers

Accept-Language: de-DE,de;q=0.9
Referer: https://www.fiercepharma.com/special-report/10-most-anticipated-drug-launches-2022-4-deucravacitinib
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

date: Tue, 08 Feb 2022 14:03:33 GMT
via: varnish
x-content-type-options: nosniff
cf-cache-status: HIT
age: 404659
cf-polished: origSize=8029
x-cache: MISS
cf-bgj: minify
x-ah-environment: prod
content-encoding: br
alt-svc: h3=":443"; ma=86400, h3-29=":443"; ma=86400
x-request-id: v-884fe0da-6f5a-11ec-86a3-d3781fb1013f
x-robots-tag: noindex, nofollow
last-modified: Thu, 30 Dec 2021 18:15:55 GMT
server: cloudflare
expect-ct: max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary: Accept-Encoding
content-type: text/css
cache-control: max-age=1209600
cf-ray: 6da566eb6e9190d6-FRA
expires: Thu, 03 Feb 2022 07:03:31 GMT

GET
H2 200 css_OQCYQjGiXoYAdYeo0QfNaDBCZWYOPDNshs8IYXccnsY.css
www.fiercepharma.com/sites/fiercepharma/files/css/ 605 KB
55 KB 40ms
40ms Stylesheet
text/css 104.18.14.141
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

https://www.fiercepharma.com/sites/fiercepharma/files/css/css_OQCYQjGiXoYAdYeo0QfNaDBCZWYOPDNshs8IYXccnsY.css

Requested by

Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/special-report/10-most-anticipated-drug-launches-2022-4-deucravacitinib

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

104.18.14.141 -, , ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

7533826884f96d6479ad16c923fb9ad6d9dad65930f9e3a4a5c82ebcdfd92f5c

Security Headers

Name	Value
X-Content-Type-Options	nosniff

Request headers

Accept-Language: de-DE,de;q=0.9
Referer: https://www.fiercepharma.com/special-report/10-most-anticipated-drug-launches-2022-4-deucravacitinib
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

date: Tue, 08 Feb 2022 14:03:33 GMT
via: varnish
x-content-type-options: nosniff
cf-cache-status: HIT
age: 15361
cf-polished: origSize=627000
x-cache: HIT
last-modified: Thu, 30 Dec 2021 18:15:55 GMT
x-cache-hits: 67
x-ah-environment: prod
content-encoding: br
alt-svc: h3=":443"; ma=86400, h3-29=":443"; ma=86400
x-request-id: v-ce82ec8e-77c3-11ec-82b5-bf6f4cf2aaa7
x-robots-tag: noindex, nofollow
cf-bgj: minify
server: cloudflare
expect-ct: max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary: Accept-Encoding
content-type: text/css
cache-control: max-age=1209600
cf-ray: 6da566eb6e9490d6-FRA
expires: Mon, 14 Feb 2022 18:32:56 GMT

GET
H2 200 questex.js Show response
cdn.blueconic.net/ 141 KB
42 KB 83ms
20ms Script
text/javascript 65.9.63.73
AMAZON-02

General

Check archive.org

Show headers Download Go to

Full URL

https://cdn.blueconic.net/questex.js

Requested by

Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/special-report/10-most-anticipated-drug-launches-2022-4-deucravacitinib

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

65.9.63.73 , United States, ASN16509 (AMAZON-02, US),

Reverse DNS

server-65-9-63-73.fra56.r.cloudfront.net

Software

- /

Resource Hash

365bca218653492c7ccd4b2e285a3242b8f7d76fda1f62cd194eebf8f4a480a3

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Xss-Protection	1; mode=block

Request headers

Accept-Language: de-DE,de;q=0.9
Referer: https://www.fiercepharma.com/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

date: Tue, 08 Feb 2022 13:57:57 GMT
content-encoding: gzip
x-content-type-options: nosniff
x-permitted-cross-domain-policies: master-only
age: 418
x-cache: Hit from cloudfront
content-length: 42354
x-xss-protection: 1; mode=block
last-modified: Wed, 19 Jan 2022 14:47:53 GMT
server: -
etag: "233e2-5d5f0787c7150-gzip"
vary: Accept-Encoding
content-type: text/javascript; charset=utf-8
via: 1.1 910fc18161f0602555cc5b6397ca26f2.cloudfront.net (CloudFront)
cache-control: public, max-age=600, s-maxage=500
x-amz-cf-pop: FRA56-C1
accept-ranges: none
x-robots-tag: noindex, nofollow
x-amz-cf-id: ePp5u9iSPPLtlRXF1guKlG4T6YUlLxUSReiqVZnm9kMAyfhKD_fMLw==

GET
H3 200 logo-pharma.svg
www.fiercepharma.com/themes/custom/tektite_fierce/assets/images/logo/ 4 KB
2 KB 63ms
57ms Image
image/svg+xml 104.18.14.141
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to Show image

Full URL

https://www.fiercepharma.com/themes/custom/tektite_fierce/assets/images/logo/logo-pharma.svg?v=1.03

Requested by

Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/special-report/10-most-anticipated-drug-launches-2022-4-deucravacitinib

Protocol

Security

QUIC, , AES_128_GCM

Server

104.18.14.141 -, , ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

5f18dc38e84dbadb36b6e7d6da27e45e6fdf4c41ddac6a53452503922e96a73a

Security Headers

Name	Value
X-Content-Type-Options	nosniff

Request headers

Accept-Language: de-DE,de;q=0.9
Referer: https://www.fiercepharma.com/special-report/10-most-anticipated-drug-launches-2022-4-deucravacitinib
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

date: Tue, 08 Feb 2022 14:03:33 GMT
via: varnish
x-content-type-options: nosniff
cf-cache-status: HIT
age: 15454
x-cache: HIT
x-cache-hits: 1
x-ah-environment: prod
content-encoding: br
alt-svc: h3=":443"; ma=86400, h3-29=":443"; ma=86400
x-request-id: v-0a9452a2-1947-11ec-986b-8bfed097753d
x-robots-tag: noindex, nofollow
last-modified: Tue, 31 Aug 2021 05:57:18 GMT
server: cloudflare
expect-ct: max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary: Accept-Encoding
content-type: image/svg+xml
cache-control: max-age=1209600
cf-ray: 6da566ec289e5bed-FRA
expires: Tue, 01 Feb 2022 12:27:41 GMT

GET
H2 200 BristolMyersSquibb.jpg
qtxasset.com/styles/breakpoint_xl_880px_w/s3/fiercepharma/1642681602/BristolMyersSquibb.jpg/ 111 KB
111 KB 84ms
27ms Image
image/webp 104.16.92.165
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://qtxasset.com/styles/breakpoint_xl_880px_w/s3/fiercepharma/1642681602/BristolMyersSquibb.jpg/BristolMyersSquibb.jpg?VersionId=AdZaqoFVRhdd3ZBuZzyhgWxAM7Es0gtz&itok=z94mDW5-
Requested by: Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/special-report/10-most-anticipated-drug-launches-2022-4-deucravacitinib
Protocol: H2
Security: TLS 1.2, ECDHE_ECDSA, AES_128_GCM
Server: 104.16.92.165 -, , ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software: cloudflare /
Resource Hash: f05e455f97196795150073bcafe8d53f9f41a7defd1e6033c37b4bd34ec51231

Request headers

Accept-Language: de-DE,de;q=0.9
Referer: https://www.fiercepharma.com/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

date: Tue, 08 Feb 2022 14:03:33 GMT
cf-cache-status: HIT
age: 102438
cf-polished: qual=85, origFmt=jpeg, origSize=402939
x-amz-replication-status: COMPLETED
content-length: 113460
content-disposition: inline; filename="BristolMyersSquibb.webp"
alt-svc: h3=":443"; ma=86400, h3-29=":443"; ma=86400
x-amz-request-id: V0MVCZ03N361ND01
x-amz-id-2: l8U4HrbI/Y7ul2QutHOGY2QxGO1bY7FnPHx1K/5N55Xgau9+NPBUNugU8jFQfpqiKvNNoo54fs0=
last-modified: Thu, 20 Jan 2022 12:27:29 GMT
server: cloudflare
etag: "bb5678f142e86a1c2d1121f66e095e94"
expect-ct: max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary: Accept
content-type: image/webp
cache-control: public, max-age=604800
x-amz-version-id: AdZaqoFVRhdd3ZBuZzyhgWxAM7Es0gtz
accept-ranges: bytes
cf-ray: 6da566ec793b905b-FRA
cf-bgj: imgq:85,h2pri

GET
H3 200 questex-logo-white.svg
www.fiercepharma.com/themes/custom/tektite/assets/images/ 4 KB
2 KB 63ms
57ms Image
image/svg+xml 104.18.14.141
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to Show image

Full URL

https://www.fiercepharma.com/themes/custom/tektite/assets/images/questex-logo-white.svg?v=0.1

Requested by

Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/special-report/10-most-anticipated-drug-launches-2022-4-deucravacitinib

Protocol

Security

QUIC, , AES_128_GCM

Server

104.18.14.141 -, , ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

680030a41d9b8dcd5edc79e159a420da353dd6638a041a6db69eb0df8b5073b2

Security Headers

Name	Value
X-Content-Type-Options	nosniff

Request headers

Accept-Language: de-DE,de;q=0.9
Referer: https://www.fiercepharma.com/special-report/10-most-anticipated-drug-launches-2022-4-deucravacitinib
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

date: Tue, 08 Feb 2022 14:03:33 GMT
via: varnish
x-content-type-options: nosniff
cf-cache-status: HIT
age: 498228
x-cache: HIT
x-cache-hits: 3
x-ah-environment: prod
content-encoding: br
alt-svc: h3=":443"; ma=86400, h3-29=":443"; ma=86400
x-request-id: v-3fa602e8-23aa-11ec-8f9e-075ba2d22459
x-robots-tag: noindex, nofollow
last-modified: Tue, 31 Aug 2021 05:57:18 GMT
server: cloudflare
expect-ct: max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary: Accept-Encoding
content-type: image/svg+xml
cache-control: max-age=1209600
cf-ray: 6da566ec28a15bed-FRA
expires: Tue, 01 Feb 2022 12:27:41 GMT

GET
H2 200 hb_302826_6936.js Show response
player.mediafuse.com/prebidlink/456758/ 467 KB
140 KB 94ms
28ms Script
application/javascript 45.133.44.3
ADVANCEDHOSTERS-AS

General

Check archive.org

Show headers Download Go to

Full URL: https://player.mediafuse.com/prebidlink/456758/hb_302826_6936.js
Requested by: Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/special-report/10-most-anticipated-drug-launches-2022-4-deucravacitinib
Protocol: H2
Security: TLS 1.3, , AES_256_GCM
Server: 45.133.44.3 Philadelphia, United States, ASN39572 (ADVANCEDHOSTERS-AS, NL),
Reverse DNS
Software: nginx /
Resource Hash: cfe7744f8ac2b57c06c2b660fca24158c1856b663b0644355ddef5b32e3d1b63

Request headers

Accept-Language: de-DE,de;q=0.9
Referer: https://www.fiercepharma.com/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

date: Tue, 08 Feb 2022 14:03:33 GMT
content-encoding: gzip
last-modified: Tue, 08 Feb 2022 02:12:46 GMT
server: nginx
etag: W/"6201d19e-74a4d"
content-type: application/javascript; charset=utf-8
access-control-allow-origin: *
cache-control: max-age=3600
expires: Tue, 08 Feb 2022 15:03:33 GMT

GET
H2 200 gpt.js Show response
securepubads.g.doubleclick.net/tag/js/ 80 KB
27 KB 163ms
113ms Script
text/javascript 142.250.184.226
GOOGLE

General

Check archive.org

Show headers Download Go to

Full URL

https://securepubads.g.doubleclick.net/tag/js/gpt.js

Requested by

Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/special-report/10-most-anticipated-drug-launches-2022-4-deucravacitinib

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

142.250.184.226 , United States, ASN15169 (GOOGLE, US),

Reverse DNS

fra24s12-in-f2.1e100.net

Software

sffe /

Resource Hash

f67a5337a8e4032d7c3a506c5065bf6aaf5cbde4a2d53756608dff852111ce48

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Xss-Protection	0

Request headers

Accept-Language: de-DE,de;q=0.9
Referer: https://www.fiercepharma.com/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

date: Tue, 08 Feb 2022 14:03:33 GMT
content-encoding: gzip
x-content-type-options: nosniff
cross-origin-resource-policy: cross-origin
alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length: 27199
x-xss-protection: 0
server: sffe
etag: "1125 / 680 of 1000 / last-modified: 1644322105"
vary: Accept-Encoding
report-to: {"group":"ads-gpt-scs","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/ads-gpt-scs"}]}
content-type: text/javascript
cache-control: private, max-age=900, stale-while-revalidate=3600
timing-allow-origin: *
cross-origin-opener-policy-report-only: same-origin; report-to="ads-gpt-scs"
expires: Tue, 08 Feb 2022 14:03:33 GMT

GET
H2 200 wrapper_hb_302826_6936.js Show response
player.mediafuse.com/prebidlink/456758/ 1 KB
841 B 114ms
50ms Script
application/javascript 45.133.44.3
ADVANCEDHOSTERS-AS

General

Check archive.org

Show headers Download Go to

Full URL: https://player.mediafuse.com/prebidlink/456758/wrapper_hb_302826_6936.js
Requested by: Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/special-report/10-most-anticipated-drug-launches-2022-4-deucravacitinib
Protocol: H2
Security: TLS 1.3, , AES_256_GCM
Server: 45.133.44.3 Philadelphia, United States, ASN39572 (ADVANCEDHOSTERS-AS, NL),
Reverse DNS
Software: nginx /
Resource Hash: 6325f7a25c4403ed680a95172069a4571086cbcbf4aac2ea1f028e8ced4818d8

Request headers

Accept-Language: de-DE,de;q=0.9
Referer: https://www.fiercepharma.com/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

date: Tue, 08 Feb 2022 14:03:33 GMT
content-encoding: gzip
last-modified: Tue, 08 Feb 2022 05:07:50 GMT
server: nginx
etag: W/"6201faa6-421"
content-type: application/javascript; charset=utf-8
access-control-allow-origin: *
cache-control: max-age=3600
expires: Tue, 08 Feb 2022 15:03:33 GMT

GET
H3 200 js_c8LbWbHV1txem3q8oAzuadnL-HiBShaQH_WRviNqT_g.js Show response
www.fiercepharma.com/sites/fiercepharma/files/js/ 87 KB
32 KB 57ms
57ms Script
text/javascript 104.18.14.141
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

https://www.fiercepharma.com/sites/fiercepharma/files/js/js_c8LbWbHV1txem3q8oAzuadnL-HiBShaQH_WRviNqT_g.js

Requested by

Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/special-report/10-most-anticipated-drug-launches-2022-4-deucravacitinib

Protocol

Security

QUIC, , AES_128_GCM

Server

104.18.14.141 -, , ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

b541d631712bc34f7472aabf9cdeaf0fcb2257fd2436ffced1530f5d4f5a0383

Security Headers

Name	Value
X-Content-Type-Options	nosniff

Request headers

Accept-Language: de-DE,de;q=0.9
Referer: https://www.fiercepharma.com/special-report/10-most-anticipated-drug-launches-2022-4-deucravacitinib
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

date: Tue, 08 Feb 2022 14:03:33 GMT
via: varnish
x-content-type-options: nosniff
cf-cache-status: HIT
age: 15459
cf-polished: origSize=89478
x-cache: HIT
last-modified: Thu, 30 Dec 2021 18:15:57 GMT
x-cache-hits: 41
x-ah-environment: prod
content-encoding: br
alt-svc: h3=":443"; ma=86400, h3-29=":443"; ma=86400
x-request-id: v-d25ab1a8-7164-11ec-9e34-1b558f64b334
x-robots-tag: noindex, nofollow
cf-bgj: minify
server: cloudflare
expect-ct: max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary: Accept-Encoding
content-type: text/javascript
cache-control: max-age=1209600
cf-ray: 6da566ebefe55bed-FRA
expires: Tue, 01 Feb 2022 13:57:21 GMT

GET
H3 200 js_hQSXU_zbJqof3y12MhPI7Ysd2kGl33cJXGVpYtnDbf0.js Show response
www.fiercepharma.com/sites/fiercepharma/files/js/ 16 KB
7 KB 58ms
57ms Script
text/javascript 104.18.14.141
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

https://www.fiercepharma.com/sites/fiercepharma/files/js/js_hQSXU_zbJqof3y12MhPI7Ysd2kGl33cJXGVpYtnDbf0.js

Requested by

Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/special-report/10-most-anticipated-drug-launches-2022-4-deucravacitinib

Protocol

Security

QUIC, , AES_128_GCM

Server

104.18.14.141 -, , ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

8111f22e56354c8880315afdd87fe63c7d82284596f7288969247a118accc642

Security Headers

Name	Value
X-Content-Type-Options	nosniff

Request headers

Accept-Language: de-DE,de;q=0.9
Referer: https://www.fiercepharma.com/special-report/10-most-anticipated-drug-launches-2022-4-deucravacitinib
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

date: Tue, 08 Feb 2022 14:03:33 GMT
via: varnish
x-content-type-options: nosniff
cf-cache-status: HIT
age: 15459
cf-polished: origSize=16281
x-cache: HIT
last-modified: Thu, 30 Dec 2021 18:15:57 GMT
x-cache-hits: 17
x-ah-environment: prod
content-encoding: br
alt-svc: h3=":443"; ma=86400, h3-29=":443"; ma=86400
x-request-id: v-874103aa-7215-11ec-a44a-83c705574550
x-robots-tag: noindex, nofollow
cf-bgj: minify
server: cloudflare
expect-ct: max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary: Accept-Encoding
content-type: text/javascript
cache-control: max-age=1209600
cf-ray: 6da566ec28805bed-FRA
expires: Mon, 31 Jan 2022 09:15:07 GMT

GET
H2 200 page.js Show response
static.addtoany.com/menu/ 72 KB
26 KB 76ms
32ms Script
application/javascript 2606:4700:10::6816:47c5
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

https://static.addtoany.com/menu/page.js

Requested by

Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/special-report/10-most-anticipated-drug-launches-2022-4-deucravacitinib

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2606:4700:10::6816:47c5 , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

f22120d1591b5397235fec8a01ffcc7d45fa6bd0b4cd6f93b8999c9365b359f1

Security Headers

Name	Value
Strict-Transport-Security	max-age=31536000; includeSubDomains; preload
X-Content-Type-Options	nosniff

Request headers

Accept-Language: de-DE,de;q=0.9
Referer: https://www.fiercepharma.com/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

date: Tue, 08 Feb 2022 14:03:33 GMT
via: e1s
x-content-type-options: nosniff
cf-cache-status: HIT
age: 105957
p3p: CP="ALL DSP COR CURa ADMa DEVa TAIa PSAa PSDa OUR IND UNI COM NAV INT"
content-encoding: br
alt-svc: h3=":443"; ma=86400, h3-29=":443"; ma=86400
last-modified: Wed, 01 Dec 2021 08:23:25 GMT
server: cloudflare
etag: W/"11ee2-5d2116348919c"
expect-ct: max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
strict-transport-security: max-age=31536000; includeSubDomains; preload
content-type: application/javascript; charset=utf-8
vary: Accept-Encoding
cache-control: public, max-age=172800
cf-ray: 6da566ec6cbe5bf5-FRA
cf-bgj: minify

GET
H3 200 js_K8WjWylJMuC9X7UPhFnx2PKpGfKXSmt2neJ09X-RgCQ.js Show response
www.fiercepharma.com/sites/fiercepharma/files/js/ 21 KB
8 KB 37ms
35ms Script
text/javascript 104.18.14.141
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

https://www.fiercepharma.com/sites/fiercepharma/files/js/js_K8WjWylJMuC9X7UPhFnx2PKpGfKXSmt2neJ09X-RgCQ.js

Requested by

Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/special-report/10-most-anticipated-drug-launches-2022-4-deucravacitinib

Protocol

Security

QUIC, , AES_128_GCM

Server

104.18.14.141 -, , ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

9b17ed6f201a539d617120eb2b829a3a32a661daf2f04893c5978b25dd781034

Security Headers

Name	Value
X-Content-Type-Options	nosniff

Request headers

Accept-Language: de-DE,de;q=0.9
Referer: https://www.fiercepharma.com/special-report/10-most-anticipated-drug-launches-2022-4-deucravacitinib
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

date: Tue, 08 Feb 2022 14:03:33 GMT
via: varnish
x-content-type-options: nosniff
cf-cache-status: HIT
age: 15459
cf-polished: origSize=21128
x-cache: HIT
last-modified: Thu, 30 Dec 2021 18:15:57 GMT
x-cache-hits: 16
x-ah-environment: prod
content-encoding: br
alt-svc: h3=":443"; ma=86400, h3-29=":443"; ma=86400
x-request-id: v-94fea102-6e2b-11ec-8e41-3325e2a98abd
x-robots-tag: noindex, nofollow
cf-bgj: minify
server: cloudflare
expect-ct: max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary: Accept-Encoding
content-type: text/javascript
cache-control: max-age=1209600
cf-ray: 6da566ec28865bed-FRA
expires: Fri, 04 Feb 2022 10:23:45 GMT

GET
H2 200 webfont.js Show response
ajax.googleapis.com/ajax/libs/webfont/1.6.26/ 13 KB
6 KB 65ms
17ms Script
text/javascript 2a00:1450:4001:827::200a
GOOGLE

General

Check archive.org

Show headers Download Go to

Full URL

https://ajax.googleapis.com/ajax/libs/webfont/1.6.26/webfont.js

Requested by

Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/special-report/10-most-anticipated-drug-launches-2022-4-deucravacitinib

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2a00:1450:4001:827::200a Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),

Reverse DNS

Software

sffe /

Resource Hash

81016ac6be850b72df5d4faa0c3cec8e2c1b0ba0045712144a6766adfad40bee

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Xss-Protection	0

Request headers

Accept-Language: de-DE,de;q=0.9
Referer: https://www.fiercepharma.com/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

date: Mon, 07 Feb 2022 22:38:54 GMT
content-encoding: gzip
x-content-type-options: nosniff
age: 55479
content-security-policy-report-only: require-trusted-types-for 'script'; report-uri https://csp.withgoogle.com/csp/hosted-libraries-pushers
cross-origin-resource-policy: cross-origin
alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length: 5437
x-xss-protection: 0
last-modified: Tue, 03 Mar 2020 19:15:00 GMT
server: sffe
cross-origin-opener-policy: same-origin; report-to="hosted-libraries-pushers"
vary: Accept-Encoding
report-to: {"group":"hosted-libraries-pushers","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/hosted-libraries-pushers"}]}
content-type: text/javascript; charset=UTF-8
access-control-allow-origin: *
cache-control: public, max-age=31536000, stale-while-revalidate=2592000
accept-ranges: bytes
timing-allow-origin: *
expires: Tue, 07 Feb 2023 22:38:54 GMT

GET
H3 200 js_6txShFh2kqJNyQ8zIiSXaxbK3dpMeRh5Z0PsEAh7qp8.js Show response
www.fiercepharma.com/sites/fiercepharma/files/js/ 762 B
722 B 62ms
57ms Script
text/javascript 104.18.14.141
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

https://www.fiercepharma.com/sites/fiercepharma/files/js/js_6txShFh2kqJNyQ8zIiSXaxbK3dpMeRh5Z0PsEAh7qp8.js

Requested by

Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/special-report/10-most-anticipated-drug-launches-2022-4-deucravacitinib

Protocol

Security

QUIC, , AES_128_GCM

Server

104.18.14.141 -, , ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

19d8552b92ae03e066893a9d818a5336bd0d107812dff3c05daef636d8750d38

Security Headers

Name	Value
X-Content-Type-Options	nosniff

Request headers

Accept-Language: de-DE,de;q=0.9
Referer: https://www.fiercepharma.com/special-report/10-most-anticipated-drug-launches-2022-4-deucravacitinib
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

date: Tue, 08 Feb 2022 14:03:33 GMT
via: varnish
x-content-type-options: nosniff
cf-cache-status: HIT
age: 15459
cf-polished: origSize=763
x-cache: HIT
last-modified: Thu, 30 Dec 2021 18:15:57 GMT
x-cache-hits: 12
x-ah-environment: prod
content-encoding: br
alt-svc: h3=":443"; ma=86400, h3-29=":443"; ma=86400
x-request-id: v-99d5f14a-72bc-11ec-9c36-17d9743aa17f
x-robots-tag: noindex, nofollow
cf-bgj: minify
server: cloudflare
expect-ct: max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary: Accept-Encoding
content-type: text/javascript
cache-control: max-age=1209600
cf-ray: 6da566ec28a45bed-FRA
expires: Fri, 04 Feb 2022 10:12:35 GMT

GET
H2 200 forms2.min.js Show response
app-sj10.marketo.com/js/forms2/js/ 205 KB
68 KB 363ms
38ms Script
application/x-javascript 104.16.94.80
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

https://app-sj10.marketo.com/js/forms2/js/forms2.min.js

Requested by

Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/special-report/10-most-anticipated-drug-launches-2022-4-deucravacitinib

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

104.16.94.80 -, , ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

2689a0237a95cfd8135f8da3ac79c430e903f3c542f8b862f68141c84c348c43

Security Headers

Name	Value
X-Content-Type-Options	nosniff

Request headers

Accept-Language: de-DE,de;q=0.9
Referer: https://www.fiercepharma.com/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

date: Tue, 08 Feb 2022 14:03:33 GMT
content-encoding: gzip
x-content-type-options: nosniff
cf-cache-status: HIT
last-modified: Wed, 12 Jan 2022 18:47:30 GMT
server: cloudflare
age: 941
etag: "1e40b8f-33210-5d567007b9480"
expect-ct: max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary: Accept-Encoding
content-type: application/x-javascript
cache-control: public, max-age=14400
cf-ray: 6da566ee2cc79249-FRA
expires: Tue, 08 Feb 2022 18:03:33 GMT

GET
H3 200 js_7D5NINMm97AVjKhvsRV_XgPiqQeouLiSNcG1CZ8eWQM.js Show response
www.fiercepharma.com/sites/fiercepharma/files/js/ 5 KB
2 KB 62ms
56ms Script
text/javascript 104.18.14.141
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

https://www.fiercepharma.com/sites/fiercepharma/files/js/js_7D5NINMm97AVjKhvsRV_XgPiqQeouLiSNcG1CZ8eWQM.js

Requested by

Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/special-report/10-most-anticipated-drug-launches-2022-4-deucravacitinib

Protocol

Security

QUIC, , AES_128_GCM

Server

104.18.14.141 -, , ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

8f00fec474ffe65144177c5c92038cc7ce0695fc9975ebf2130d3bc393a3e645

Security Headers

Name	Value
X-Content-Type-Options	nosniff

Request headers

Accept-Language: de-DE,de;q=0.9
Referer: https://www.fiercepharma.com/special-report/10-most-anticipated-drug-launches-2022-4-deucravacitinib
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

date: Tue, 08 Feb 2022 14:03:33 GMT
via: varnish
x-content-type-options: nosniff
cf-cache-status: HIT
age: 15459
cf-polished: origSize=4669
x-cache: HIT
last-modified: Thu, 30 Dec 2021 18:15:58 GMT
x-cache-hits: 1
x-ah-environment: prod
content-encoding: br
alt-svc: h3=":443"; ma=86400, h3-29=":443"; ma=86400
x-request-id: v-f4329574-6f1c-11ec-ae90-033872d0c646
x-robots-tag: noindex, nofollow
cf-bgj: minify
server: cloudflare
expect-ct: max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary: Accept-Encoding
content-type: text/javascript
cache-control: max-age=1209600
cf-ray: 6da566ec28985bed-FRA
expires: Thu, 03 Feb 2022 21:43:55 GMT

GET
H2 200 gtm.js Show response
www.googletagmanager.com/ 161 KB
56 KB 86ms
38ms Script
application/javascript 2a00:1450:4001:808::2008
GOOGLE

General

Check archive.org

Show headers Download Go to

Full URL

https://www.googletagmanager.com/gtm.js?id=GTM-KLQFWCZ

Requested by

Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/special-report/10-most-anticipated-drug-launches-2022-4-deucravacitinib

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2a00:1450:4001:808::2008 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),

Reverse DNS

Software

Google Tag Manager /

Resource Hash

3aefa9d4ae02d3109f5686b2c422bb5cd6c902098f31e5fc123ea3ffa4646736

Security Headers

Name	Value
Strict-Transport-Security	max-age=31536000; includeSubDomains
X-Xss-Protection	0

Request headers

Accept-Language: de-DE,de;q=0.9
Referer: https://www.fiercepharma.com/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

date: Tue, 08 Feb 2022 14:03:33 GMT
content-encoding: br
vary: Accept-Encoding
cross-origin-resource-policy: cross-origin
alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length: 56392
x-xss-protection: 0
last-modified: Tue, 08 Feb 2022 12:00:00 GMT
server: Google Tag Manager
strict-transport-security: max-age=31536000; includeSubDomains
content-type: application/javascript; charset=UTF-8
access-control-allow-origin: *
cache-control: private, max-age=900
access-control-allow-credentials: true
access-control-allow-headers: Cache-Control
expires: Tue, 08 Feb 2022 14:03:33 GMT

GET
H2 200 qFdH35WCmI96Ajtm81GlU9s.woff2
fonts.gstatic.com/s/overpass/v10/ 38 KB
38 KB 62ms
18ms Font
font/woff2 2a00:1450:4001:810::2003
GOOGLE

General

Check archive.org

Show headers Download Go to

Full URL

https://fonts.gstatic.com/s/overpass/v10/qFdH35WCmI96Ajtm81GlU9s.woff2

Requested by

Host: fonts.googleapis.com
URL: https://fonts.googleapis.com/css2?family=Overpass:ital,wght@0,400;0,700;0,900;1,400&display=swap

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2a00:1450:4001:810::2003 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),

Reverse DNS

Software

sffe /

Resource Hash

995dfb0c839090c9461662fca31b3d886f80dd9e881db8ea224374866eade55f

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Xss-Protection	0

Request headers

Referer: https://fonts.googleapis.com/
Origin: https://www.fiercepharma.com
Accept-Language: de-DE,de;q=0.9
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

date: Thu, 03 Feb 2022 03:01:59 GMT
x-content-type-options: nosniff
age: 471694
content-security-policy-report-only: require-trusted-types-for 'script'; report-uri https://csp.withgoogle.com/csp/apps-themes
cross-origin-resource-policy: cross-origin
alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length: 38496
x-xss-protection: 0
last-modified: Thu, 03 Feb 2022 00:25:12 GMT
server: sffe
report-to: {"group":"apps-themes","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/apps-themes"}]}
content-type: font/woff2
access-control-allow-origin: *
cache-control: public, max-age=31536000
accept-ranges: bytes
timing-allow-origin: *
cross-origin-opener-policy-report-only: same-origin; report-to="apps-themes"
expires: Fri, 03 Feb 2023 03:01:59 GMT

GET
H2 404 cs
questex.blueconic.net/DG/DEFAULT/ 0
0 138ms
39ms Script
text/html 54.72.7.92
AMAZON-02

General

Check archive.org

Show headers Download Go to

Full URL: https://questex.blueconic.net/DG/DEFAULT/cs?&callback=bc_json795
Requested by: Host: cdn.blueconic.net
URL: https://cdn.blueconic.net/questex.js
Protocol: H2
Security: TLS 1.2, ECDHE_RSA, AES_128_GCM
Server: 54.72.7.92 Dublin, Ireland, ASN16509 (AMAZON-02, US),
Reverse DNS: ec2-54-72-7-92.eu-west-1.compute.amazonaws.com
Software: /
Resource Hash

Request headers

Accept-Language: de-DE,de;q=0.9
Referer: https://www.fiercepharma.com/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

GET
H2 200 qFdU35WCmI96Ajtm81GgSdXCNs-VMF0vNLADeqqIncM.woff2
fonts.gstatic.com/s/overpass/v10/ 16 KB
16 KB 35ms
35ms Font
font/woff2 2a00:1450:4001:810::2003
GOOGLE

General

Check archive.org

Show headers Download Go to

Full URL

https://fonts.gstatic.com/s/overpass/v10/qFdU35WCmI96Ajtm81GgSdXCNs-VMF0vNLADeqqIncM.woff2

Requested by

Host: fonts.googleapis.com
URL: https://fonts.googleapis.com/css2?family=Overpass:ital,wght@0,400;0,700;0,900;1,400&display=swap

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2a00:1450:4001:810::2003 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),

Reverse DNS

Software

sffe /

Resource Hash

94e5daea972ac93120f8535bff5a2bd57f1dc36dd36e5dbfe70639b75f1f8e33

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Xss-Protection	0

Request headers

Referer: https://fonts.googleapis.com/
Origin: https://www.fiercepharma.com
Accept-Language: de-DE,de;q=0.9
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

date: Thu, 03 Feb 2022 10:53:47 GMT
x-content-type-options: nosniff
age: 443386
content-security-policy-report-only: require-trusted-types-for 'script'; report-uri https://csp.withgoogle.com/csp/apps-themes
cross-origin-resource-policy: cross-origin
alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length: 16324
x-xss-protection: 0
last-modified: Thu, 03 Feb 2022 00:25:41 GMT
server: sffe
report-to: {"group":"apps-themes","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/apps-themes"}]}
content-type: font/woff2
access-control-allow-origin: *
cache-control: public, max-age=31536000
accept-ranges: bytes
timing-allow-origin: *
cross-origin-opener-policy-report-only: same-origin; report-to="apps-themes"
expires: Fri, 03 Feb 2023 10:53:47 GMT

GET
H3 200 fontello.woff2
www.fiercepharma.com/themes/custom/tektite/assets/fonts/ 6 KB
7 KB 45ms
45ms Font
text/plain 104.18.14.141
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

https://www.fiercepharma.com/themes/custom/tektite/assets/fonts/fontello.woff2

Requested by

Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/sites/fiercepharma/files/css/css_OQCYQjGiXoYAdYeo0QfNaDBCZWYOPDNshs8IYXccnsY.css

Protocol

Security

QUIC, , AES_128_GCM

Server

104.18.14.141 -, , ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

1daf67a5a85e55210b5e212a8be8392f1f93c01ce54effd63eab78f0b80dfb44

Security Headers

Name	Value
X-Content-Type-Options	nosniff

Request headers

Referer: https://www.fiercepharma.com/sites/fiercepharma/files/css/css_OQCYQjGiXoYAdYeo0QfNaDBCZWYOPDNshs8IYXccnsY.css
Origin: https://www.fiercepharma.com
Accept-Language: de-DE,de;q=0.9
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

date: Tue, 08 Feb 2022 14:03:33 GMT
via: varnish
x-content-type-options: nosniff
cf-cache-status: HIT
age: 15350
x-cache: HIT
x-cache-hits: 231
x-ah-environment: prod
alt-svc: h3=":443"; ma=86400, h3-29=":443"; ma=86400
content-length: 6644
x-request-id: v-6f862608-28e3-11ec-a436-bbed65516c8b
x-robots-tag: noindex, nofollow
last-modified: Tue, 31 Aug 2021 05:57:18 GMT
server: cloudflare
expect-ct: max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary: Accept-Encoding
cache-control: max-age=1209600
accept-ranges: bytes
cf-ray: 6da566ec38ce5bed-FRA
expires: Sun, 30 Jan 2022 08:03:34 GMT

GET
H2

204

asyncPixelSync
pixel.sitescout.com/dmp/ Frame 6512
Redirect Chain

https://pixel-a.basis.net/dmp/asyncPixelSync
https://pixel.sitescout.com/dmp/asyncPixelSync

0
0

101ms
31ms

Document
text/plain

66.155.71.150
COGECO-PEER1

General

Check archive.org

Show headers Download Go to

Full URL: https://pixel.sitescout.com/dmp/asyncPixelSync
Requested by: Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/special-report/10-most-anticipated-drug-launches-2022-4-deucravacitinib
Protocol: H2
Security: TLS 1.2, ECDHE_RSA, CHACHA20_POLY1305
Server: 66.155.71.150 Portsmouth, United Kingdom, ASN13768 (COGECO-PEER1, CA),
Reverse DNS
Software: AC1.1 /
Resource Hash

Request headers

Upgrade-Insecure-Requests: 1
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Accept-Language: de-DE,de;q=0.9
Referer: https://www.fiercepharma.com/special-report/10-most-anticipated-drug-launches-2022-4-deucravacitinib

Response headers

cache-control: max-age=0,no-cache,no-store
pragma: no-cache
expires: Tue, 11 Oct 1977 12:34:56 GMT
p3p: CP="NON DEVa PSAa PSDa OUR NOR NAV",policyref="/w3c/p3p.xml"
date: Tue, 08 Feb 2022 14:03:32 GMT
server: AC1.1

Redirect headers

content-length: 0
location: https://pixel.sitescout.com/dmp/asyncPixelSync

GET
H2

204

7f1874304d399254
pixel.sitescout.com/iap/
Redirect Chain

https://pixel-a.basis.net/iap/7f1874304d399254
https://pixel.sitescout.com/iap/7f1874304d399254

0
191 B

100ms
31ms

Image
text/plain

66.155.71.150
COGECO-PEER1

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://pixel.sitescout.com/iap/7f1874304d399254
Requested by: Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/special-report/10-most-anticipated-drug-launches-2022-4-deucravacitinib
Protocol: H2
Server: 66.155.71.150 Portsmouth, United Kingdom, ASN13768 (COGECO-PEER1, CA),
Reverse DNS
Software: AC1.1 /
Resource Hash: e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Accept-Language: de-DE,de;q=0.9
Referer: https://www.fiercepharma.com/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

pragma: no-cache
date: Tue, 08 Feb 2022 14:03:32 GMT
cache-control: max-age=0,no-cache,no-store
server: AC1.1
p3p: CP="NON DEVa PSAa PSDa OUR NOR NAV",policyref="/w3c/p3p.xml"
expires: Tue, 11 Oct 1977 12:34:56 GMT

Redirect headers

location: https://pixel.sitescout.com/iap/7f1874304d399254
content-length: 0

GET
H/1.1

200

init.do Show response
sample.dragonforms.com/ Frame 8E4A
Redirect Chain

https://sample.dragonforms.com/FiercePharma_short
https://sample.dragonforms.com/init.do?omedasite=FiercePharma_short

279 B
620 B

125ms
125ms

Document
text/html

204.180.130.190
QTS-AS

General

Check archive.org

Show headers Download Go to

Full URL

https://sample.dragonforms.com/init.do?omedasite=FiercePharma_short

Requested by

Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/special-report/10-most-anticipated-drug-launches-2022-4-deucravacitinib

Protocol

HTTP/1.1

Security

TLS 1.2, ECDHE_RSA, AES_256_GCM

Server

204.180.130.190 , United States, ASN53866 (QTS-AS, US),

Reverse DNS

Software

Apache /

Resource Hash

82bf27f408e3d524f53a94492b845458ebb576e5873d57a452815f859953dff2

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Xss-Protection	1; mode=block

Request headers

Upgrade-Insecure-Requests: 1
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Accept-Language: de-DE,de;q=0.9
Referer: https://www.fiercepharma.com/

Response headers

X-Content-Type-Options: nosniff
X-XSS-Protection: 1; mode=block
Access-Control-Allow-Origin: *
Content-Type: text/html;charset=ISO-8859-1
Date: Tue, 08 Feb 2022 14:03:33 GMT
Server: Apache
Vary: Accept-Encoding
Content-Encoding: gzip
Transfer-Encoding: chunked

Redirect headers

Location: init.do?omedasite=FiercePharma_short
Content-Length: 0
Date: Tue, 08 Feb 2022 14:03:33 GMT
Server: Apache

GET
H/1.1 200
OK p.js Show response
d1z2jf7jlzjs58.cloudfront.net/ 930 B
1 KB 255ms
18ms Script
application/javascript 65.9.58.62
AMAZON-02

General

Check archive.org

Show headers Download Go to

Full URL: https://d1z2jf7jlzjs58.cloudfront.net/p.js
Requested by: Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/sites/fiercepharma/files/js/js_K8WjWylJMuC9X7UPhFnx2PKpGfKXSmt2neJ09X-RgCQ.js
Protocol: HTTP/1.1
Security: TLS 1.3, , AES_128_GCM
Server: 65.9.58.62 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS: server-65-9-58-62.fra56.r.cloudfront.net
Software: nginx /
Resource Hash: 62f586be8571b23584eb4a60a45a3157ff7c8388b1b1e3b4e8890e243b3e47de

Request headers

Accept-Language: de-DE,de;q=0.9
Referer: https://www.fiercepharma.com/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

Date: Tue, 08 Feb 2022 04:13:53 GMT
Via: 1.1 a383f82b5d4e98bbd66535c2c4b20c9e.cloudfront.net (CloudFront)
Age: 84652
X-Cache: Hit from cloudfront
Connection: keep-alive
Content-Length: 930
Pragma: public
Last-Modified: Wed, 06 May 2020 20:19:48 GMT
Server: nginx
ETag: "5eb31be4-3a2"
Content-Type: application/javascript
Cache-Control: max-age=86400, public
X-Amz-Cf-Pop: FRA56-C1
Accept-Ranges: bytes
X-Amz-Cf-Id: TGouGZfanYfJ1PqJTERCx1zN7qdqb2chkeaoTxV-35YJDawbxn6i3w==
Expires: Tue, 08 Feb 2022 14:32:41 GMT

GET
H3 200 sm.23.html Show response
static.addtoany.com/menu/ Frame 5006 741 B
784 B 294ms
74ms Document
text/html 2606:4700:10::6816:47c5
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

https://static.addtoany.com/menu/sm.23.html

Requested by

Host: static.addtoany.com
URL: https://static.addtoany.com/menu/page.js

Protocol

Security

QUIC, , AES_128_GCM

Server

2606:4700:10::6816:47c5 , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

4ca130786a2d2531241f8b8c7aaad6a4e27271f51b417b9c23f51bfb0c65c080

Security Headers

Name	Value
Strict-Transport-Security	max-age=31536000; includeSubDomains; preload
X-Content-Type-Options	nosniff

Request headers

Upgrade-Insecure-Requests: 1
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Accept-Language: de-DE,de;q=0.9
Referer: https://www.fiercepharma.com/

Response headers

date: Tue, 08 Feb 2022 14:03:33 GMT
content-type: text/html; charset=utf-8
p3p: CP="ALL DSP COR CURa ADMa DEVa TAIa PSAa PSDa OUR IND UNI COM NAV INT"
last-modified: Wed, 22 Sep 2021 23:42:51 GMT
etag: W/"2e5-5cc9e128a4c38"
cache-control: max-age=315360000, immutable
vary: Accept-Encoding
via: e4s
cf-cache-status: HIT
age: 1234996
expect-ct: max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
strict-transport-security: max-age=31536000; includeSubDomains; preload
x-content-type-options: nosniff
server: cloudflare
cf-ray: 6da566ee19b26949-FRA
content-encoding: br
alt-svc: h3=":443"; ma=86400, h3-29=":443"; ma=86400

GET
DATA 200
OK truncated
/ 34 B
0 Image
image/gif

General

Check archive.org

Show headers Download Go to Show image

Full URL: data:truncated
Protocol: DATA
Server: -, , ASN (),
Reverse DNS
Software: /
Resource Hash: 1e85ec81b9800b4c443d39caca0d0926089a3ac201120db1ceb45b93789480b8

Request headers

Accept-Language: de-DE,de;q=0.9
Referer
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

Content-Type: image/gif

GET
H3 200 icons.30.svg.js Show response
static.addtoany.com/menu/svg/ 77 KB
33 KB 273ms
57ms Script
application/javascript 2606:4700:10::6816:47c5
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

https://static.addtoany.com/menu/svg/icons.30.svg.js

Requested by

Host: static.addtoany.com
URL: https://static.addtoany.com/menu/page.js

Protocol

Security

QUIC, , AES_128_GCM

Server

2606:4700:10::6816:47c5 , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

7e6f3eacf6af919ace45f10e39eda3e72143e0f57aad29590a6d37d5ddd0292f

Security Headers

Name	Value
Strict-Transport-Security	max-age=31536000; includeSubDomains; preload
X-Content-Type-Options	nosniff

Request headers

Accept-Language: de-DE,de;q=0.9
Referer: https://www.fiercepharma.com/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

date: Tue, 08 Feb 2022 14:03:33 GMT
via: e3s
x-content-type-options: nosniff
cf-cache-status: HIT
age: 1272797
p3p: CP="ALL DSP COR CURa ADMa DEVa TAIa PSAa PSDa OUR IND UNI COM NAV INT"
content-encoding: br
alt-svc: h3=":443"; ma=86400, h3-29=":443"; ma=86400
last-modified: Wed, 10 Nov 2021 01:49:04 GMT
server: cloudflare
etag: W/"132a9-5d0656e4a26b3"
expect-ct: max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
strict-transport-security: max-age=31536000; includeSubDomains; preload
content-type: application/javascript; charset=utf-8
vary: Accept-Encoding
cache-control: max-age=315360000, immutable
cf-ray: 6da566ee199b6949-FRA
cf-bgj: minify

GET
H2 200 hbw_master_302826_6936.js Show response
player.hbmp.mediafuse.com/prebidlink/456758/ 95 KB
30 KB 217ms
17ms Script
application/javascript 45.133.44.4
ADVANCEDHOSTERS-AS

General

Check archive.org

Show headers Download Go to

Full URL: https://player.hbmp.mediafuse.com/prebidlink/456758/hbw_master_302826_6936.js
Requested by: Host: player.mediafuse.com
URL: https://player.mediafuse.com/prebidlink/456758/wrapper_hb_302826_6936.js
Protocol: H2
Security: TLS 1.3, , AES_256_GCM
Server: 45.133.44.4 Philadelphia, United States, ASN39572 (ADVANCEDHOSTERS-AS, NL),
Reverse DNS
Software: nginx /
Resource Hash: 4d31dc39c5de30ffabb9f461e50ba53f19f5b2453451d4c2dcb90687d0aa6775

Request headers

Accept-Language: de-DE,de;q=0.9
Referer: https://www.fiercepharma.com/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

date: Tue, 08 Feb 2022 14:03:33 GMT
content-encoding: gzip
last-modified: Tue, 08 Feb 2022 05:07:50 GMT
server: nginx
etag: W/"6201faa6-17d96"
content-type: application/javascript; charset=utf-8
access-control-allow-origin: *
cache-control: max-age=3600
expires: Tue, 08 Feb 2022 15:03:33 GMT

GET
H2 200 analytics.js Show response
www.google-analytics.com/ 49 KB
20 KB 212ms
17ms Script
text/javascript 2a00:1450:4001:810::200e
GOOGLE

General

Check archive.org

Show headers Download Go to

Full URL

https://www.google-analytics.com/analytics.js

Requested by

Host: www.googletagmanager.com
URL: https://www.googletagmanager.com/gtm.js?id=GTM-KLQFWCZ

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2a00:1450:4001:810::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),

Reverse DNS

Software

Golfe2 /

Resource Hash

a1925038db769477ab74b4df34350c35688a795bb718727b0f4292a4a78a6210

Security Headers

Name	Value
Strict-Transport-Security	max-age=10886400; includeSubDomains; preload
X-Content-Type-Options	nosniff

Request headers

Accept-Language: de-DE,de;q=0.9
Referer: https://www.fiercepharma.com/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

strict-transport-security: max-age=10886400; includeSubDomains; preload
content-encoding: gzip
x-content-type-options: nosniff
last-modified: Tue, 02 Nov 2021 17:39:06 GMT
server: Golfe2
age: 1719
date: Tue, 08 Feb 2022 13:34:54 GMT
vary: Accept-Encoding
content-type: text/javascript
cache-control: public, max-age=7200
cross-origin-resource-policy: cross-origin
alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length: 20006
expires: Tue, 08 Feb 2022 15:34:54 GMT

GET
H2 200 4740.js Show response
script.crazyegg.com/pages/scripts/0092/ 5 KB
2 KB 230ms
38ms Script
text/javascript 2606:4700::6813:9308
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL: https://script.crazyegg.com/pages/scripts/0092/4740.js
Requested by: Host: www.googletagmanager.com
URL: https://www.googletagmanager.com/gtm.js?id=GTM-KLQFWCZ
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 2606:4700::6813:9308 , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software: cloudflare /
Resource Hash: daaf47e176780239d864e64b1729d088b9e9a005e19b1bd39fda65dee2e26a6f

Request headers

Accept-Language: de-DE,de;q=0.9
Referer: https://www.fiercepharma.com/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

date: Tue, 08 Feb 2022 14:03:33 GMT
content-encoding: gzip
cf-cache-status: HIT
age: 3937
cf-polished: origSize=4899
cf-ray: 6da566ee2b2f5c68-FRA
ce-version: 11.1.381
last-modified: Tue, 08 Feb 2022 12:57:56 GMT
server: cloudflare
expect-ct: max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary: Accept-Encoding
content-type: text/javascript
access-control-allow-origin: *
access-control-expose-headers: CE-Version
cache-control: public, max-age=300, s-maxage=1209600
timing-allow-origin: *
cf-bgj: minify

GET
H/1.1 200
OK munchkin.js Show response
munchkin.marketo.net/ 1 KB
1 KB 203ms
16ms Script
application/x-javascript 104.111.234.67
AKAMAI-AS

General

Check archive.org

Show headers Download Go to

Full URL: https://munchkin.marketo.net/munchkin.js
Requested by: Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/special-report/10-most-anticipated-drug-launches-2022-4-deucravacitinib
Protocol: HTTP/1.1
Security: TLS 1.3, , AES_256_GCM
Server: 104.111.234.67 Frankfurt am Main, Germany, ASN16625 (AKAMAI-AS, US),
Reverse DNS: a104-111-234-67.deploy.static.akamaitechnologies.com
Software: AkamaiNetStorage /
Resource Hash: 4bf3aca933aa233702f890083af601fb16149ec8a17f8c1b90d30450562bde08

Request headers

Accept-Language: de-DE,de;q=0.9
Referer: https://www.fiercepharma.com/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

Date: Tue, 08 Feb 2022 14:03:33 GMT
Content-Encoding: gzip
Last-Modified: Fri, 29 Oct 2021 01:24:07 GMT
Server: AkamaiNetStorage
ETag: "461ce1cffaadfebf2e7659745618ba8e:1635470647.434977"
Vary: Accept-Encoding
P3P: policyref="http://www.marketo.com/w3c/p3p.xml", CP="NOI DSP COR NID CURi OUR NOR"
Connection: keep-alive
Accept-Ranges: bytes
Content-Type: application/x-javascript
Content-Length: 753

GET
H/1.1 200
OK dpm_fa5b7e293127b3837c39f7fbd05598f32c8ce1c9.min.js Show response
s.dpmsrv.com/ 127 KB
39 KB 209ms
18ms Script
application/x-javascript 143.204.215.21
AMAZON-02

General

Check archive.org

Show headers Download Go to

Full URL: https://s.dpmsrv.com/dpm_fa5b7e293127b3837c39f7fbd05598f32c8ce1c9.min.js
Requested by: Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/special-report/10-most-anticipated-drug-launches-2022-4-deucravacitinib
Protocol: HTTP/1.1
Security: TLS 1.3, , AES_128_GCM
Server: 143.204.215.21 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS: server-143-204-215-21.fra53.r.cloudfront.net
Software: AmazonS3 /
Resource Hash: 9d2da124cff01ac4a3756346555d1f2cf049de603f2fb44a5d9fcb973a85686d

Request headers

Accept-Language: de-DE,de;q=0.9
Referer: https://www.fiercepharma.com/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

Date: Mon, 07 Feb 2022 15:42:58 GMT
Content-Encoding: gzip
Last-Modified: Thu, 03 Feb 2022 15:40:11 GMT
Server: AmazonS3
Age: 80579
ETag: "bef77cacda1dde40b3506b2bde1566de"
X-Cache: Hit from cloudfront
Content-Type: application/x-javascript
Via: 1.1 ab39b007ab81966ada6e7fb1536bf376.cloudfront.net (CloudFront)
Connection: keep-alive
X-Amz-Cf-Pop: FRA53-C1
Accept-Ranges: bytes
Content-Length: 39698
X-Amz-Cf-Id: aa6gEEo0YVV1hGGbxeKHXV-tLYh_62huYGqGWFsholNeMRaPCB5TrQ==

GET
H2 200 WgRbL7NLS90BFPSb6pBa Show response
ws.zoominfo.com/pixel/ 1 KB
1 KB 358ms
167ms Script
text/javascript 2606:4700::6810:a852
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

https://ws.zoominfo.com/pixel/WgRbL7NLS90BFPSb6pBa

Requested by

Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/special-report/10-most-anticipated-drug-launches-2022-4-deucravacitinib

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2606:4700::6810:a852 , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare / Express

Resource Hash

ba8a68a79c27e3e5c5e617a1d99422de0ef3185b8937269e18c584ed86a6cb60

Security Headers

Name	Value
X-Content-Type-Options	nosniff

Request headers

Accept-Language: de-DE,de;q=0.9
Referer: https://www.fiercepharma.com/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

date: Tue, 08 Feb 2022 14:03:33 GMT
content-encoding: gzip
x-content-type-options: nosniff
cf-cache-status: DYNAMIC
server: cloudflare
x-powered-by: Express
expect-ct: max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary: Accept-Encoding
content-type: text/javascript
access-control-allow-origin: *
access-control-allow-credentials: true
cf-ray: 6da566ee3bbe92b1-FRA
access-control-allow-headers: Content-Type,cf-ipcountry,service-version,x-appengine-user-ip,x-forwarded-for
via: 1.1 google

GET
H/1.1 200 olytics.min.js Show response
olytics.omeda.com/olytics/js/v3/p/ 271 KB
73 KB 764ms
133ms Script
application/javascript 204.180.130.159
QTS-AS

General

Check archive.org

Show headers Download Go to

Full URL

https://olytics.omeda.com/olytics/js/v3/p/olytics.min.js

Requested by

Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/special-report/10-most-anticipated-drug-launches-2022-4-deucravacitinib

Protocol

HTTP/1.1

Security

TLS 1.2, ECDHE_RSA, AES_256_GCM

Server

204.180.130.159 , United States, ASN53866 (QTS-AS, US),

Reverse DNS

my.omedastaging.com

Software

Apache /

Resource Hash

d3db6456c45bfe697359d0c3c52564b0661ec8ad2f1b8de6e0c1926a90f44d8c

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Frame-Options	SAMEORIGIN
X-Xss-Protection	1; mode=block

Request headers

Accept-Language: de-DE,de;q=0.9
Referer: https://www.fiercepharma.com/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

Date: Tue, 08 Feb 2022 14:03:33 GMT
Content-Encoding: gzip
X-Content-Type-Options: nosniff
Last-Modified: Tue, 18 Jan 2022 16:42:56 GMT
Server: Apache
ETag: W/"277838-1642524176000"
X-Frame-Options: SAMEORIGIN
Content-Type: application/javascript
Access-Control-Allow-Origin: *
Cache-Control: max-age=21600
Transfer-Encoding: chunked
Accept-Ranges: bytes
vary: accept-encoding
X-XSS-Protection: 1; mode=block
Expires: Tue, 08 Feb 2022 20:03:33 GMT

GET
H/1.1 200 olytics.css
olytics.omeda.com/olytics/css/v3/p/ 28 KB
3 KB 752ms
124ms Stylesheet
text/css 204.180.130.159
QTS-AS

General

Check archive.org

Show headers Download Go to

Full URL

https://olytics.omeda.com/olytics/css/v3/p/olytics.css

Requested by

Host: www.googletagmanager.com
URL: https://www.googletagmanager.com/gtm.js?id=GTM-KLQFWCZ

Protocol

HTTP/1.1

Security

TLS 1.2, ECDHE_RSA, AES_256_GCM

Server

204.180.130.159 , United States, ASN53866 (QTS-AS, US),

Reverse DNS

my.omedastaging.com

Software

Apache /

Resource Hash

78057ff881c7ceb369c163fee7ab0d93ae4754f3a7503d5dbfd4a0b80e203a79

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Frame-Options	SAMEORIGIN
X-Xss-Protection	1; mode=block

Request headers

Accept-Language: de-DE,de;q=0.9
Referer: https://www.fiercepharma.com/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

Date: Tue, 08 Feb 2022 14:03:33 GMT
Content-Encoding: gzip
X-Content-Type-Options: nosniff
Last-Modified: Fri, 27 Aug 2021 04:05:28 GMT
Server: Apache
ETag: W/"28820-1630037128000"
X-Frame-Options: SAMEORIGIN
Content-Type: text/css
Access-Control-Allow-Origin: *
Cache-Control: max-age=21600
Transfer-Encoding: chunked
Accept-Ranges: bytes
vary: accept-encoding
X-XSS-Protection: 1; mode=block
Expires: Tue, 08 Feb 2022 20:03:33 GMT

POST 794
c405.fiercepharma.com/DG/DEFAULT/rest/rpc/ 0
0

GET
H3 200 pubads_impl_2022020301.js Show response
securepubads.g.doubleclick.net/gpt/ 351 KB
119 KB 41ms
17ms Script
text/javascript 142.250.184.226
GOOGLE

General

Check archive.org

Show headers Download Go to

Full URL

https://securepubads.g.doubleclick.net/gpt/pubads_impl_2022020301.js

Requested by

Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/tag/js/gpt.js

Protocol

Security

QUIC, , AES_128_GCM

Server

142.250.184.226 , United States, ASN15169 (GOOGLE, US),

Reverse DNS

fra24s12-in-f2.1e100.net

Software

sffe /

Resource Hash

05ed7424c6f3c3d2aec5dfe7fa92e5f617afe58a01666c1c584d342a8b57a0e7

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Xss-Protection	0

Request headers

Accept-Language: de-DE,de;q=0.9
Referer: https://www.fiercepharma.com/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

date: Tue, 08 Feb 2022 13:59:21 GMT
content-encoding: gzip
x-content-type-options: nosniff
age: 252
cross-origin-resource-policy: cross-origin
alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length: 122037
x-xss-protection: 0
last-modified: Thu, 03 Feb 2022 09:34:49 GMT
server: sffe
vary: Accept-Encoding
report-to: {"group":"ads-gpt-scs","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/ads-gpt-scs"}]}
content-type: text/javascript
cache-control: public, immutable, max-age=31536000
accept-ranges: bytes
timing-allow-origin: *
cross-origin-opener-policy-report-only: same-origin; report-to="ads-gpt-scs"
expires: Wed, 08 Feb 2023 13:59:21 GMT

GET
H3 200 ppub_config Show response
securepubads.g.doubleclick.net/pagead/ 39 B
79 B 53ms
27ms XHR
application/json 142.250.184.226
GOOGLE

General

Check archive.org

Show headers Download Go to

Full URL

https://securepubads.g.doubleclick.net/pagead/ppub_config?ippd=www.fiercepharma.com

Requested by

Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/tag/js/gpt.js

Protocol

Security

QUIC, , AES_128_GCM

Server

142.250.184.226 , United States, ASN15169 (GOOGLE, US),

Reverse DNS

fra24s12-in-f2.1e100.net

Software

cafe /

Resource Hash

2ad9341e45c5e7676ed8925d391b5a96802a29c898d1e4909c4537c0f5a6a2ce

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Xss-Protection	0

Request headers

Accept-Language: de-DE,de;q=0.9
Referer: https://www.fiercepharma.com/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

timing-allow-origin: *
date: Tue, 08 Feb 2022 14:03:33 GMT
content-encoding: gzip
x-content-type-options: nosniff
server: cafe
p3p: policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
access-control-allow-origin: *
cache-control: private, max-age=3600, stale-while-revalidate=3600
cross-origin-resource-policy: cross-origin
content-disposition: attachment; filename="f.txt"
content-type: application/json; charset=UTF-8
alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length: 55
x-xss-protection: 0
expires: Tue, 08 Feb 2022 14:03:33 GMT

GET
H2 200 p.js Show response
cdn.parsely.com/keys/fiercepharma.com/ 47 KB
18 KB 61ms
15ms Script
application/javascript 65.9.61.60
AMAZON-02

General

Check archive.org

Show headers Download Go to

Full URL: https://cdn.parsely.com/keys/fiercepharma.com/p.js
Requested by: Host: d1z2jf7jlzjs58.cloudfront.net
URL: https://d1z2jf7jlzjs58.cloudfront.net/p.js
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 65.9.61.60 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS: server-65-9-61-60.fra56.r.cloudfront.net
Software: nginx /
Resource Hash: e1feaafecf95d6dfa9fd5dc4ade49fcb29c6a697c713e423940b83e00ae3ad35

Request headers

Accept-Language: de-DE,de;q=0.9
Referer: https://www.fiercepharma.com/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

pragma: public
date: Mon, 07 Feb 2022 20:26:11 GMT
content-encoding: gzip
last-modified: Fri, 02 Jul 2021 02:33:20 GMT
server: nginx
age: 63442
etag: W/"60de7af0-bd27"
x-cache: Hit from cloudfront
content-type: application/javascript
via: 1.1 f358cf5f46d10c349187abd5e20e06ce.cloudfront.net (CloudFront)
cache-control: max-age=86400, public
x-amz-cf-pop: FRA56-C1
x-amz-cf-id: OFKeieNmfArq0Y-eqZhw7mgFqUnZY83IdYzDXx3Pu1VpF2FcJKrFHA==
expires: Tue, 08 Feb 2022 20:26:11 GMT

GET
H/1.1 200
OK munchkin.js Show response
munchkin.marketo.net/161/ 11 KB
5 KB 16ms
16ms Script
application/x-javascript 104.111.234.67
AKAMAI-AS

General

Check archive.org

Show headers Download Go to

Full URL: https://munchkin.marketo.net/161/munchkin.js
Requested by: Host: munchkin.marketo.net
URL: https://munchkin.marketo.net/munchkin.js
Protocol: HTTP/1.1
Security: TLS 1.3, , AES_256_GCM
Server: 104.111.234.67 Frankfurt am Main, Germany, ASN16625 (AKAMAI-AS, US),
Reverse DNS: a104-111-234-67.deploy.static.akamaitechnologies.com
Software: AkamaiNetStorage /
Resource Hash: c2aee78040b4ed46c2377e6825db12a9691a2eb584adf338e77312c8978d8537

Request headers

Accept-Language: de-DE,de;q=0.9
Referer: https://www.fiercepharma.com/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

Date: Tue, 08 Feb 2022 14:03:33 GMT
Content-Encoding: gzip
Last-Modified: Wed, 08 Sep 2021 00:38:21 GMT
Server: AkamaiNetStorage
ETag: "0e0eefac8daf874e8b1aa34aeb160c52:1631061501.737429"
Vary: Accept-Encoding
P3P: policyref="http://www.marketo.com/w3c/p3p.xml", CP="NOI DSP COR NID CURi OUR NOR"
Cache-Control: max-age=8640000
Connection: keep-alive
Accept-Ranges: bytes
Content-Type: application/x-javascript
Content-Length: 4681
Expires: Thu, 19 May 2022 14:03:33 GMT

POST
H3 200 collect Show response
www.google-analytics.com/j/ 2 B
22 B 52ms
27ms XHR
text/plain 2a00:1450:4001:810::200e
GOOGLE

General

Check archive.org

Show headers Download Go to

Full URL

https://www.google-analytics.com/j/collect?v=1&_v=j96&a=2005409921&t=pageview&_s=1&dl=https%3A%2F%2Fwww.fiercepharma.com%2Fspecial-report%2F10-most-anticipated-drug-launches-2022-4-deucravacitinib&ul=en-us&de=UTF-8&dt=4.%20Deucravacitinib%20%7C%20FiercePharma&sd=24-bit&sr=1600x1200&vp=1600x1200&je=0&_u=YGBACAABBAAAAC~&jid=1061368758&gjid=1052400620&cid=800578055.1644329014&tid=UA-336524-28&_gid=421591499.1644329014&_r=1&gtm=2wg220KLQFWCZ&z=457728274

Requested by

Host: www.google-analytics.com
URL: https://www.google-analytics.com/analytics.js

Protocol

Security

QUIC, , AES_128_GCM

Server

2a00:1450:4001:810::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),

Reverse DNS

Software

Golfe2 /

Resource Hash

de3246094525b21a870fc7d2a67490d0132535c6fa5993755c549f1a9d1bd8af

Security Headers

Name	Value
X-Content-Type-Options	nosniff

Request headers

Referer: https://www.fiercepharma.com/
Accept-Language: de-DE,de;q=0.9
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Content-Type: text/plain

Response headers

pragma: no-cache
date: Tue, 08 Feb 2022 14:03:33 GMT
x-content-type-options: nosniff
last-modified: Sun, 17 May 1998 03:00:00 GMT
server: Golfe2
content-type: text/plain
access-control-allow-origin: https://www.fiercepharma.com
cache-control: no-cache, no-store, must-revalidate
access-control-allow-credentials: true
cross-origin-resource-policy: cross-origin
alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length: 2
expires: Fri, 01 Jan 1990 00:00:00 GMT

GET
H/1.1

200
OK

index.php Show response
a.dpmsrv.com/dpmpxl/
Redirect Chain

https://ib.adnxs.com/getuid?https://a.dpmsrv.com/dpmpxl/index.php?id=$UID&q%3DxImp%26v%3D1.x%26cl%3D913%26pixelIndex%3D0%26r%3D718462%26tzOffset%3D0%26url%3Dhttps%253A%252F%252Fwww.fiercepharma.com...
https://ib.adnxs.com/bounce?%2Fgetuid%3Fhttps%3A%2F%2Fa.dpmsrv.com%2Fdpmpxl%2Findex.php%3Fid%3D%24UID%26q%253DxImp%2526v%253D1.x%2526cl%253D913%2526pixelIndex%253D0%2526r%253D718462%2526tzOffset%25...
https://a.dpmsrv.com/dpmpxl/index.php?id=5611407578940007418&q=xImp&v=1.x&cl=913&pixelIndex=0&r=718462&tzOffset=0&url=https%3A%2F%2Fwww.fiercepharma.com%2Fspecial-report%2F10-most-anticipated-drug-...

244 B
992 B

430ms
101ms

Script
text/javascript

3.226.203.17
AMAZON-AES

General

Check archive.org

Show headers Download Go to

Full URL: https://a.dpmsrv.com/dpmpxl/index.php?id=5611407578940007418&q=xImp&v=1.x&cl=913&pixelIndex=0&r=718462&tzOffset=0&url=https%3A%2F%2Fwww.fiercepharma.com%2Fspecial-report%2F10-most-anticipated-drug-launches-2022-4-deucravacitinib&_=1644329013515
Requested by: Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/special-report/10-most-anticipated-drug-launches-2022-4-deucravacitinib
Protocol: HTTP/1.1
Server: 3.226.203.17 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS: ec2-3-226-203-17.compute-1.amazonaws.com
Software: /
Resource Hash: 404035635d522c9a85543004f6d196333741e1def8b9301ce992f3e7ca6356eb

Request headers

Accept-Language: de-DE,de;q=0.9
Referer: https://www.fiercepharma.com/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

Pragma: no-cache
content-encoding: gzip
Access-Control-Max-Age: 10
Access-Control-Allow-Methods: GET, POST, PUT, DELETE, OPTIONS
P3P: CP="IDC DSP COR ADM DEVi TAIi PSA PSD IVAi IVDi CONi HIS OUR IND CNT"
Access-Control-Allow-Origin: *
Cache-Control: no-cache, no-store, must-revalidate
Connection: keep-alive
Content-Type: text/javascript
Access-Control-Allow-Headers: content-type, accept
Content-Length: 215
Expires: 0

Redirect headers

Pragma: no-cache
Date: Tue, 08 Feb 2022 14:03:33 GMT
X-Proxy-Origin: 84.19.175.183; 84.19.175.183; 691.bm-nginx-loadbalancer.mgmt.fra1; adnxs.com
AN-X-Request-Uuid: fe92bba4-32fa-4915-9a18-046e8427fd45
Server: nginx/1.17.9
Access-Control-Allow-Origin: *
P3P: policyref="http://cdn.adnxs-simple.com/w3c/policy/p3p.xml", CP="NOI DSP COR ADM PSAo PSDo OURo SAMo UNRo OTRo BUS COM NAV DEM STA PRE"
Location: https://a.dpmsrv.com/dpmpxl/index.php?id=5611407578940007418&q=xImp&v=1.x&cl=913&pixelIndex=0&r=718462&tzOffset=0&url=https%3A%2F%2Fwww.fiercepharma.com%2Fspecial-report%2F10-most-anticipated-drug-launches-2022-4-deucravacitinib&_=1644329013515
Cache-Control: no-store, no-cache, private
Access-Control-Allow-Credentials: true
Connection: keep-alive
Content-Type: text/html; charset=utf-8
Content-Length: 0
X-XSS-Protection: 0
Expires: Sat, 15 Nov 2008 16:00:00 GMT

GET
H2 200 4740.json Show response
script.crazyegg.com/pages/data-scripts/0092/ 18 KB
2 KB 78ms
42ms XHR
application/json 2606:4700::6813:9308
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL: https://script.crazyegg.com/pages/data-scripts/0092/4740.json?t=1
Requested by: Host: script.crazyegg.com
URL: https://script.crazyegg.com/pages/scripts/0092/4740.js
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 2606:4700::6813:9308 , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software: cloudflare /
Resource Hash: e062944d38e4916266dd0b916d7e59de57b659cf4fcd675e08a3a5c698780bbc

Request headers

Accept-Language: de-DE,de;q=0.9
Referer: https://www.fiercepharma.com/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

date: Tue, 08 Feb 2022 14:03:33 GMT
content-encoding: gzip
cf-cache-status: HIT
age: 3735
ce-version: 11.1.381
content-length: 1899
timing-allow-origin: *
last-modified: Tue, 08 Feb 2022 13:01:18 GMT
server: cloudflare
expect-ct: max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary: Accept-Encoding
content-type: application/json
access-control-allow-origin: *
access-control-expose-headers: CE-Version
cache-control: public, max-age=300, s-maxage=1209600
accept-ranges: bytes
cf-ray: 6da566eeff8e90a8-FRA

GET
H/1.1 200
OK tag.aspx Show response
ml314.com/ 27 KB
12 KB 199ms
40ms Script
application/javascript 52.208.138.90
AMAZON-02

General

Check archive.org

Show headers Download Go to

Full URL: https://ml314.com/tag.aspx?812022
Requested by: Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/special-report/10-most-anticipated-drug-launches-2022-4-deucravacitinib
Protocol: HTTP/1.1
Security: TLS 1.2, ECDHE_RSA, AES_128_GCM
Server: 52.208.138.90 Dublin, Ireland, ASN16509 (AMAZON-02, US),
Reverse DNS: ec2-52-208-138-90.eu-west-1.compute.amazonaws.com
Software: Microsoft-IIS/10.0 / ASP.NET
Resource Hash: e0eb74c400dded823098e4cdb9f71e9b360a3f33cad9b346879205851e70f887

Request headers

Accept-Language: de-DE,de;q=0.9
Referer: https://www.fiercepharma.com/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

Date: Tue, 08 Feb 2022 14:03:33 GMT
Content-Encoding: gzip
Server: Microsoft-IIS/10.0
X-AspNet-Version: 4.0.30319
X-Powered-By: ASP.NET
Vary: Accept-Encoding
Content-Type: application/javascript
Cache-Control: public, max-age=86400
Connection: keep-alive
Content-Length: 11617

GET
H3 200 lead Show response
www.fiercepharma.com/api/v1/marketo/ 34 B
563 B 29ms
29ms Fetch
application/json 104.18.14.141
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

https://www.fiercepharma.com/api/v1/marketo/lead?mkto=null&blueconicProfileId=null

Requested by

Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/special-report/10-most-anticipated-drug-launches-2022-4-deucravacitinib

Protocol

Security

QUIC, , AES_128_GCM

Server

104.18.14.141 -, , ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

336a2c6b0eaf929e5c5be1659be540dcc2cd6df5cc2971ecf4d65480f7505609

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Frame-Options	SAMEORIGIN

Request headers

Accept-Language: de-DE,de;q=0.9
Referer: https://www.fiercepharma.com/special-report/10-most-anticipated-drug-launches-2022-4-deucravacitinib
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

date: Tue, 08 Feb 2022 14:03:33 GMT
via: varnish
x-content-type-options: nosniff
cf-cache-status: HIT
age: 1104344
x-cache: HIT
content-type: application/json
x-drupal-dynamic-cache: UNCACHEABLE
x-ah-environment: prod
content-encoding: br
alt-svc: h3=":443"; ma=86400, h3-29=":443"; ma=86400
x-request-id: v-e2047ce8-76c7-11ec-a3f1-a3c97edf9918
x-ua-compatible: IE=edge
last-modified: Sun, 16 Jan 2022 12:29:00 GMT
server: cloudflare
x-frame-options: SAMEORIGIN
etag: W/"1642336140"
expect-ct: max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary: Cookie,Accept-Encoding
content-language: en
x-generator: Drupal 8 (https://www.drupal.org)
expires: Sun, 19 Nov 1978 05:00:00 GMT
cache-control: max-age=16588800, public
cf-ray: 6da566eedf535bed-FRA
x-drupal-cache: MISS
x-cache-hits: 54

POST
H/1.1 200
OK visitWebPage
294-mqf-056.mktoresp.com/webevents/ 2 B
311 B 714ms
163ms Ping
text/plain 192.28.147.68
OMNITURE

General

Check archive.org

Show headers Download Go to

Full URL: https://294-mqf-056.mktoresp.com/webevents/visitWebPage?_mchNc=1644329013575&_mchCn=&_mchId=294-MQF-056&_mchTk=_mch-fiercepharma.com-1644329013575-25283&_mchHo=www.fiercepharma.com&_mchPo=&_mchRu=%2Fspecial-report%2F10-most-anticipated-drug-launches-2022-4-deucravacitinib&_mchPc=https%3A&_mchVr=161&_mchEcid=&_mchHa=&_mchRe=&_mchQp=
Requested by: Host: munchkin.marketo.net
URL: https://munchkin.marketo.net/161/munchkin.js
Protocol: HTTP/1.1
Security: TLS 1.2, ECDHE_RSA, AES_256_GCM
Server: 192.28.147.68 , United States, ASN15224 (OMNITURE, US),
Reverse DNS
Software: nginx /
Resource Hash: 565339bc4d33d72817b583024112eb7f5cdf3e5eef0252d6ec1b9c9a94e12bb3

Request headers

Referer: https://www.fiercepharma.com/
Accept-Language: de-DE,de;q=0.9
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Content-Type: text/plain;charset=UTF-8

Response headers

Date: Tue, 08 Feb 2022 14:03:34 GMT
Content-Encoding: gzip
Server: nginx
Transfer-Encoding: chunked
Content-Type: text/plain; charset=UTF-8
Access-Control-Allow-Origin: *
Connection: keep-alive
X-Request-Id: 9795641b-ed8c-4d18-b158-1a8cde0bf456

GET
H/1.1 200
OK / Show response
ghb.hbmp.mediafuse.com/geo/ 142 B
398 B 193ms
29ms XHR
application/json 2a0c:5c81:5142::2
24SHELLS

General

Check archive.org

Show headers Download Go to

Full URL: https://ghb.hbmp.mediafuse.com/geo/
Requested by: Host: player.hbmp.mediafuse.com
URL: https://player.hbmp.mediafuse.com/prebidlink/456758/hbw_master_302826_6936.js
Protocol: HTTP/1.1
Security: TLS 1.3, , AES_128_GCM
Server: 2a0c:5c81:5142::2 London, United Kingdom, ASN55081 (24SHELLS, US),
Reverse DNS
Software: VertaMedia 1.0 /
Resource Hash: c1ec65706585d1f809e5c8e8eb105d5a55f9b3cbf20bea45cb546ec2b3f9fde3

Request headers

Accept-Language: de-DE,de;q=0.9
Referer: https://www.fiercepharma.com/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

Access-Control-Allow-Origin: https://www.fiercepharma.com
Date: Tue, 08 Feb 2022 14:03:33 GMT
Access-Control-Allow-Credentials: true
Server: VertaMedia 1.0
Connection: Keep-Alive
Content-Length: 142
Content-Type: application/json

GET
H/1.1 200
OK tracking Show response
ghb.hbmp.mediafuse.com/adunit/ 43 B
425 B 193ms
28ms XHR
image/gif 2a0c:5c81:5142::2
24SHELLS

General

Check archive.org

Show headers Download Go to

Full URL: https://ghb.hbmp.mediafuse.com/adunit/tracking?event=11&type=0&client_id=302826&site_id=6936&full_page_url=https%3A%2F%2Fwww.fiercepharma.com%2Fspecial-report%2F10-most-anticipated-drug-launches-2022-4-deucravacitinib&adid=e71ezv.sf&features=32&vpbv=N048&lifecycle_tte=1495
Requested by: Host: player.hbmp.mediafuse.com
URL: https://player.hbmp.mediafuse.com/prebidlink/456758/hbw_master_302826_6936.js
Protocol: HTTP/1.1
Security: TLS 1.3, , AES_128_GCM
Server: 2a0c:5c81:5142::2 London, United Kingdom, ASN55081 (24SHELLS, US),
Reverse DNS
Software: VertaMedia 1.0 /
Resource Hash: 2dfe28cbdb83f01c940de6a88ab86200154fd772d568035ac568664e52068363

Request headers

Accept-Language: de-DE,de;q=0.9
Referer: https://www.fiercepharma.com/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

Access-Control-Allow-Origin: https://www.fiercepharma.com
Date: Tue, 08 Feb 2022 14:03:33 GMT
Access-Control-Allow-Credentials: true
Server: VertaMedia 1.0
Connection: Keep-Alive
Content-Length: 43
Content-Type: image/gif

GET
H2 200 j.html Show response
p.nodserving.com/prebidlink/19031/ Frame 447C 1 KB
879 B 70ms
17ms Document
text/html 45.133.44.4
ADVANCEDHOSTERS-AS

General

Check archive.org

Show headers Download Go to

Full URL: https://p.nodserving.com/prebidlink/19031/j.html?i=11600
Requested by: Host: player.mediafuse.com
URL: https://player.mediafuse.com/prebidlink/456758/hb_302826_6936.js
Protocol: H2
Security: TLS 1.3, , AES_256_GCM
Server: 45.133.44.4 Philadelphia, United States, ASN39572 (ADVANCEDHOSTERS-AS, NL),
Reverse DNS
Software: nginx /
Resource Hash: cf35c9e8af47d8cd7233bebf1b785af16546782547f31501432cb7ad97d84714

Request headers

Upgrade-Insecure-Requests: 1
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Accept-Language: de-DE,de;q=0.9
Referer: https://www.fiercepharma.com/

Response headers

date: Tue, 08 Feb 2022 14:03:33 GMT
content-type: text/html; charset=utf-8
server: nginx
last-modified: Wed, 16 Sep 2020 14:50:15 GMT
etag: W/"5f622627-434"
cache-control: max-age=3600
content-encoding: gzip
expires: Tue, 08 Feb 2022 15:03:33 GMT
access-control-allow-origin: *

POST
H2 200 collect Show response
stats.g.doubleclick.net/j/ 1 B
443 B 78ms
24ms XHR
text/plain 2a00:1450:400c:c08::9c
GOOGLE

General

Check archive.org

Show headers Download Go to

Full URL

https://stats.g.doubleclick.net/j/collect?t=dc&aip=1&_r=3&v=1&_v=j96&tid=UA-336524-28&cid=800578055.1644329014&jid=1061368758&gjid=1052400620&_gid=421591499.1644329014&_u=YGBACAAABAAAAC~&z=779059295

Requested by

Host: www.google-analytics.com
URL: https://www.google-analytics.com/analytics.js

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2a00:1450:400c:c08::9c Brussels, Belgium, ASN15169 (GOOGLE, US),

Reverse DNS

Software

Golfe2 /

Resource Hash

6b86b273ff34fce19d6b804eff5a3f5747ada4eaa22f1d49c01e52ddb7875b4b

Security Headers

Name	Value
Strict-Transport-Security	max-age=10886400; includeSubDomains; preload
X-Content-Type-Options	nosniff

Request headers

Referer: https://www.fiercepharma.com/
Accept-Language: de-DE,de;q=0.9
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Content-Type: text/plain

Response headers

pragma: no-cache
strict-transport-security: max-age=10886400; includeSubDomains; preload
x-content-type-options: nosniff
last-modified: Sun, 17 May 1998 03:00:00 GMT
server: Golfe2
date: Tue, 08 Feb 2022 14:03:33 GMT
content-type: text/plain
access-control-allow-origin: https://www.fiercepharma.com
cache-control: no-cache, no-store, must-revalidate
access-control-allow-credentials: true
cross-origin-resource-policy: cross-origin
alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length: 1
expires: Fri, 01 Jan 1990 00:00:00 GMT

GET
H2 200 config.json Show response
player.adtelligent.com/exchange_rates/279934/ 9 KB
4 KB 57ms
17ms XHR
application/json 45.133.44.4
ADVANCEDHOSTERS-AS

General

Check archive.org

Show headers Download Go to

Full URL: https://player.adtelligent.com/exchange_rates/279934/config.json?cb=https%3A%2F%2Fwww.fiercepharma.com%2Fspecial-report%2F10-most-anticipated-drug-launches-2022-4-deucravacitinib
Requested by: Host: player.mediafuse.com
URL: https://player.mediafuse.com/prebidlink/456758/hb_302826_6936.js
Protocol: H2
Security: TLS 1.3, , AES_256_GCM
Server: 45.133.44.4 Philadelphia, United States, ASN39572 (ADVANCEDHOSTERS-AS, NL),
Reverse DNS
Software: nginx /
Resource Hash: de7174e4a1d44716d1acc4bb9b0e64bcc9ad77bc1ca0a561077e86587c17339b

Request headers

Referer: https://www.fiercepharma.com/
Accept-Language: de-DE,de;q=0.9
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Content-Type: text/plain

Response headers

date: Tue, 08 Feb 2022 14:03:33 GMT
content-encoding: gzip
last-modified: Tue, 08 Feb 2022 12:01:05 GMT
server: nginx
etag: W/"62025b81-2204"
content-type: application/json
access-control-allow-origin: https://www.fiercepharma.com
expires: Tue, 08 Feb 2022 15:03:33 GMT
cache-control: max-age=3600
x-proxy-cache: HIT

GET
H/1.1 200
OK /
p1.parsely.com/plogger/ 43 B
258 B 445ms
103ms Image
image/gif 34.194.161.83
AMAZON-AES

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://p1.parsely.com/plogger/?rand=1644329013621&plid=83083648&idsite=fiercepharma.com&url=https%3A%2F%2Fwww.fiercepharma.com%2Fspecial-report%2F10-most-anticipated-drug-launches-2022-4-deucravacitinib&urlref=&screen=1600x1200%7C1600x1200%7C24&data=%7B%7D&sid=1&surl=https%3A%2F%2Fwww.fiercepharma.com%2Fspecial-report%2F10-most-anticipated-drug-launches-2022-4-deucravacitinib&sref=&sts=1644329013617&slts=0&title=4.+Deucravacitinib+%7C+FiercePharma&date=Tue+Feb+08+2022+14%3A03%3A33+GMT%2B0000+(GMT)&action=pageview&pvid=22527747&u=pid%3D7c909c60890d123c6bb653f8bb6696b3
Requested by: Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/special-report/10-most-anticipated-drug-launches-2022-4-deucravacitinib
Protocol: HTTP/1.1
Security: TLS 1.2, ECDHE_RSA, AES_128_GCM
Server: 34.194.161.83 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS: ec2-34-194-161-83.compute-1.amazonaws.com
Software: nginx /
Resource Hash: cf4724b2f736ed1a0ae6bc28f1ead963d9cd2c1fd87b6ef32e7799fc1c5c8bda

Request headers

Accept-Language: de-DE,de;q=0.9
Referer: https://www.fiercepharma.com/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

Date: Tue, 08 Feb 2022 14:03:34 GMT
Cache-Control: no-cache
Last-Modified: Tuesday, 08-Feb-2022 14:03:34 GMT
Server: nginx
Connection: keep-alive
Content-Length: 43
Content-Type: image/gif

GET
H2 200 11.1.381.js Show response
script.crazyegg.com/pages/versioned/common-scripts/ 72 KB
23 KB 35ms
34ms Script
text/javascript 2606:4700::6813:9308
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL: https://script.crazyegg.com/pages/versioned/common-scripts/11.1.381.js
Requested by: Host: script.crazyegg.com
URL: https://script.crazyegg.com/pages/scripts/0092/4740.js
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 2606:4700::6813:9308 , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software: cloudflare /
Resource Hash: dbd801aa2433b01869ff0b65be422a10ab7c59e680b8aff9a9f093615f37e2e0

Request headers

Accept-Language: de-DE,de;q=0.9
Referer: https://www.fiercepharma.com/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

timing-allow-origin: *
date: Tue, 08 Feb 2022 14:03:33 GMT
content-encoding: gzip
cf-cache-status: HIT
last-modified: Mon, 31 Jan 2022 14:08:13 GMT
server: cloudflare
age: 3967
expect-ct: max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary: Accept-Encoding
content-type: text/javascript
access-control-allow-origin: *
cache-control: public, max-age=31536000, s-maxage=31536000
accept-ranges: bytes
cf-ray: 6da566ef4dc45c68-FRA
content-length: 23750

GET
H2 200 pbm_307825_11600.js Show response
p.nodserving.com/prebidlink/19031/ Frame 447C 35 KB
13 KB 23ms
22ms Script
application/javascript 45.133.44.4
ADVANCEDHOSTERS-AS

General

Check archive.org

Show headers Download Go to

Full URL: https://p.nodserving.com/prebidlink/19031/pbm_307825_11600.js
Requested by: Host: p.nodserving.com
URL: https://p.nodserving.com/prebidlink/19031/j.html?i=11600
Protocol: H2
Security: TLS 1.3, , AES_256_GCM
Server: 45.133.44.4 Philadelphia, United States, ASN39572 (ADVANCEDHOSTERS-AS, NL),
Reverse DNS
Software: nginx /
Resource Hash: 59bfc18a344153d9409a185725e201b2b625c25667b1546ddf2a5fab387ff94d

Request headers

Accept-Language: de-DE,de;q=0.9
Referer: https://p.nodserving.com/prebidlink/19031/j.html?i=11600
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

date: Tue, 08 Feb 2022 14:03:33 GMT
content-encoding: gzip
last-modified: Fri, 04 Feb 2022 15:03:17 GMT
server: nginx
etag: W/"61fd4035-8d88"
content-type: application/javascript; charset=utf-8
access-control-allow-origin: *
cache-control: max-age=3600
expires: Tue, 08 Feb 2022 15:03:33 GMT

GET
H2 200 4740.json Show response
script.crazyegg.com/pages/sampling-data-scripts/0092/ 1 KB
455 B 30ms
30ms XHR
application/json 2606:4700::6813:9308
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL: https://script.crazyegg.com/pages/sampling-data-scripts/0092/4740.json?t=456758
Requested by: Host: script.crazyegg.com
URL: https://script.crazyegg.com/pages/versioned/common-scripts/11.1.381.js
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 2606:4700::6813:9308 , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software: cloudflare /
Resource Hash: dab74169a9865e9ecf8d9a5f5f065488ae86f2b5336132a42d4945883e935d14

Request headers

Accept-Language: de-DE,de;q=0.9
Referer: https://www.fiercepharma.com/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

date: Tue, 08 Feb 2022 14:03:33 GMT
content-encoding: gzip
cf-cache-status: HIT
age: 3735
ce-version: 11.1.381
content-length: 389
timing-allow-origin: *
last-modified: Tue, 08 Feb 2022 13:01:18 GMT
server: cloudflare
expect-ct: max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary: Accept-Encoding
content-type: application/json
access-control-allow-origin: *
access-control-expose-headers: CE-Version
cache-control: public, max-age=300, s-maxage=1209600
accept-ranges: bytes
cf-ray: 6da566ef888690a8-FRA

GET
H/1.1 200
OK tracking Show response
ghb.adtelligent.com/adunit/ Frame 447C 43 B
418 B 141ms
31ms XHR
image/gif 2a0c:5c81:5142::2
24SHELLS

General

Check archive.org

Show headers Download Go to

Full URL: https://ghb.adtelligent.com/adunit/tracking?pubbid=0&event=11&full_page_url=https%3A%2F%2Fwww.fiercepharma.com&adid=1ba4efb87e1009&vpbv=M055&client_id=307825&site_id=11600&lifecycle_tte=111
Requested by: Host: p.nodserving.com
URL: https://p.nodserving.com/prebidlink/19031/pbm_307825_11600.js
Protocol: HTTP/1.1
Security: TLS 1.3, , AES_128_GCM
Server: 2a0c:5c81:5142::2 London, United Kingdom, ASN55081 (24SHELLS, US),
Reverse DNS
Software: VertaMedia 1.0 /
Resource Hash: 2dfe28cbdb83f01c940de6a88ab86200154fd772d568035ac568664e52068363

Request headers

Accept-Language: de-DE,de;q=0.9
Referer: https://p.nodserving.com/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

Access-Control-Allow-Origin: https://p.nodserving.com
Date: Tue, 08 Feb 2022 14:03:33 GMT
Access-Control-Allow-Credentials: true
Server: VertaMedia 1.0
Connection: Keep-Alive
Content-Length: 43
Content-Type: image/gif

GET
H/1.1 200
OK / Show response
ghb.adtelligent.com/geo/ Frame 447C 142 B
394 B 142ms
32ms XHR
application/json 2a0c:5c81:5142::2
24SHELLS

General

Check archive.org

Show headers Download Go to

Full URL: https://ghb.adtelligent.com/geo/
Requested by: Host: p.nodserving.com
URL: https://p.nodserving.com/prebidlink/19031/pbm_307825_11600.js
Protocol: HTTP/1.1
Security: TLS 1.3, , AES_128_GCM
Server: 2a0c:5c81:5142::2 London, United Kingdom, ASN55081 (24SHELLS, US),
Reverse DNS
Software: VertaMedia 1.0 /
Resource Hash: c1ec65706585d1f809e5c8e8eb105d5a55f9b3cbf20bea45cb546ec2b3f9fde3

Request headers

Accept-Language: de-DE,de;q=0.9
Referer: https://p.nodserving.com/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

Access-Control-Allow-Origin: https://p.nodserving.com
Date: Tue, 08 Feb 2022 14:03:33 GMT
Access-Control-Allow-Credentials: true
Server: VertaMedia 1.0
Connection: Keep-Alive
Content-Length: 142
Content-Type: application/json

GET
H2 200 healthcheck Show response
pagestates-tracking.crazyegg.com/ 19 B
417 B 72ms
16ms XHR
binary/octet-stream 99.86.3.25
AMAZON-02

General

Check archive.org

Show headers Download Go to

Full URL: https://pagestates-tracking.crazyegg.com/healthcheck
Requested by: Host: script.crazyegg.com
URL: https://script.crazyegg.com/pages/versioned/common-scripts/11.1.381.js
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 99.86.3.25 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS: server-99-86-3-25.fra6.r.cloudfront.net
Software: AmazonS3 /
Resource Hash: 830e67bda2532cd5880ee86e3b33e69721082f8458bb0df0cd4edbb1577fd375

Request headers

Accept-Language: de-DE,de;q=0.9
Referer: https://www.fiercepharma.com/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

date: Tue, 21 Dec 2021 13:52:43 GMT
via: 1.1 3095e870e1a1a1b03178e40ab1872de4.cloudfront.net (CloudFront)
last-modified: Tue, 05 Oct 2021 13:53:30 GMT
server: AmazonS3
age: 4234251
etag: "d06f04fccf68d0b228a5923187ce1afd"
access-control-max-age: 31536000
access-control-allow-methods: GET, HEAD
content-type: binary/octet-stream
access-control-allow-origin: *
x-cache: Hit from cloudfront
x-amz-cf-pop: FRA6-C1
accept-ranges: bytes
content-length: 19
x-amz-cf-id: 9Lc38L9X4G_44szEnLqrjgzP0Eq-EOlLwPd4z4fQ-5bnEdENgSLe5A==

GET
H2 200 healthcheck Show response
assets-tracking.crazyegg.com/ 19 B
421 B 75ms
20ms XHR
binary/octet-stream 18.66.248.91
AMAZON-02

General

Check archive.org

Show headers Download Go to

Full URL: https://assets-tracking.crazyegg.com/healthcheck
Requested by: Host: script.crazyegg.com
URL: https://script.crazyegg.com/pages/versioned/common-scripts/11.1.381.js
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 18.66.248.91 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS: server-18-66-248-91.dus51.r.cloudfront.net
Software: AmazonS3 /
Resource Hash: 830e67bda2532cd5880ee86e3b33e69721082f8458bb0df0cd4edbb1577fd375

Request headers

Accept-Language: de-DE,de;q=0.9
Referer: https://www.fiercepharma.com/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

date: Tue, 21 Dec 2021 13:24:28 GMT
via: 1.1 5e696cef0c57cc6cd171bf72fe757bf4.cloudfront.net (CloudFront)
last-modified: Tue, 05 Oct 2021 13:53:30 GMT
server: AmazonS3
age: 4235946
etag: "d06f04fccf68d0b228a5923187ce1afd"
access-control-max-age: 31536000
access-control-allow-methods: GET, HEAD
content-type: binary/octet-stream
access-control-allow-origin: *
x-cache: Hit from cloudfront
x-amz-cf-pop: DUS51-P1
accept-ranges: bytes
content-length: 19
x-amz-cf-id: MYalqCDgoP9XcKYK0_atTKxXvQmfCX-YJCXfvmFj51pvbK8MPmj_lg==

GET
BLOB 200
OK 011d9558-baca-44d0-b0c1-1548b9b3945f
https://www.fiercepharma.com/ 53 B
0 Other
text/javascript

General

Check archive.org

Show headers Download Go to

Full URL: blob:https://www.fiercepharma.com/011d9558-baca-44d0-b0c1-1548b9b3945f
Requested by: Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/special-report/10-most-anticipated-drug-launches-2022-4-deucravacitinib
Protocol: BLOB
Server: -, , ASN (),
Reverse DNS
Software: /
Resource Hash: 8ff09cd0ee012fe06ed1b67dc914858cde819f21bb479f629994d9e49f3c0049

Request headers

Accept-Language: de-DE,de;q=0.9
Referer
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

Content-Length: 53
Content-Type: text/javascript

GET
H/1.1 200
OK utsync.ashx Show response
ml314.com/ 62 B
572 B 43ms
40ms Script
application/javascript 52.208.138.90
AMAZON-02

General

Check archive.org

Show headers Download Go to

Full URL: https://ml314.com/utsync.ashx?pub=&adv=&et=0&eid=66459&ct=js&pi=&fp=GA1.2.800578055.1644329014&clid=&if=0&ps=&cl=&mlt=&data=&&cp=https%3A%2F%2Fwww.fiercepharma.com%2Fspecial-report%2F10-most-anticipated-drug-launches-2022-4-deucravacitinib&pv=1644329013770_py351f8cb&bl=en-us&cb=4814555&return=&ht=&d=&dc=&si=1644329013770_py351f8cb&cid=&s=1600x1200&rp=
Requested by: Host: ml314.com
URL: https://ml314.com/tag.aspx?812022
Protocol: HTTP/1.1
Security: TLS 1.2, ECDHE_RSA, AES_128_GCM
Server: 52.208.138.90 Dublin, Ireland, ASN16509 (AMAZON-02, US),
Reverse DNS: ec2-52-208-138-90.eu-west-1.compute.amazonaws.com
Software: Microsoft-IIS/10.0 / ASP.NET
Resource Hash: 5a1ba6ff6db12f791bbbfc4da3cb389e06f0cd53eede09ef3eb3ceb074089ef1

Request headers

Accept-Language: de-DE,de;q=0.9
Referer: https://www.fiercepharma.com/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

Pragma: no-cache
Date: Tue, 08 Feb 2022 14:03:33 GMT
Content-Encoding: gzip
Server: Microsoft-IIS/10.0
X-AspNet-Version: 4.0.30319
X-Powered-By: ASP.NET
Vary: Accept-Encoding
p3P: CP="NON DSP COR ADMo PSAo DEVo BUS COM UNI NAV DEM STA"
Cache-Control: no-cache, no-store, must-revalidate
Connection: keep-alive
Content-Type: application/javascript; charset=utf-8
Content-Length: 147
Expires: 0

GET
H/1.1 200
OK ud.ashx Show response
in.ml314.com/ 20 B
482 B 509ms
176ms Script
application/javascript 34.200.182.42
AMAZON-AES

General

Check archive.org

Show headers Download Go to

Full URL: https://in.ml314.com/ud.ashx?topiclimit=&cb=812022
Requested by: Host: ml314.com
URL: https://ml314.com/tag.aspx?812022
Protocol: HTTP/1.1
Security: TLS 1.2, ECDHE_RSA, AES_128_GCM
Server: 34.200.182.42 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS: ec2-34-200-182-42.compute-1.amazonaws.com
Software: Microsoft-IIS/10.0 / ASP.NET
Resource Hash: d0e4a6372d6fb5ffe9505dbe9e94aee8f1b9b96ec8e5e20684cce8b4c5a88fa7

Request headers

Accept-Language: de-DE,de;q=0.9
Referer: https://www.fiercepharma.com/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

Date: Tue, 08 Feb 2022 14:03:33 GMT
Content-Encoding: gzip
Server: Microsoft-IIS/10.0
X-AspNet-Version: 4.0.30319
X-Powered-By: ASP.NET
Vary: Accept-Encoding
Content-Type: application/javascript; charset=utf-8
Cache-Control: public
Connection: keep-alive
Content-Length: 138
Expires: Wed, 09 Feb 2022 14:03:34 GMT

OPTIONS
H2 200 prebid
prebid.deepintent.com/ Frame 0
0 344ms
110ms Preflight 169.197.150.8
DEEPINTENT

General

Check archive.org

Show headers Download Go to

Full URL: https://prebid.deepintent.com/prebid
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 169.197.150.8 , United States, ASN398989 (DEEPINTENT, US),
Reverse DNS: g.deepintent.com
Software: c /
Resource Hash

Request headers

Accept: */*
Access-Control-Request-Method: POST
Access-Control-Request-Headers: content-type
Origin: https://www.fiercepharma.com
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Sec-Fetch-Mode: cors

Response headers

access-control-allow-origin: https://www.fiercepharma.com
vary: Origin,Access-Control-Request-Method,Access-Control-Request-Headers
access-control-max-age: 3600
access-control-allow-credentials: true
access-control-allow-methods: POST, GET, OPTIONS, DELETE
access-control-allow-headers: Origin, X-Requested-With, Content-Type, Accept, X-CSRF-TOKEN
allow: GET, HEAD, POST, PUT, DELETE, OPTIONS, PATCH
content-length: 0
date: Tue, 08 Feb 2022 14:03:33 GMT
server: c

POST
H/1.1 400
Bad Request auction Show response
prebid.adnxs.com/pbs/v1/openrtb2/ 88 B
481 B 96ms
24ms XHR
text/plain 37.252.161.190
ASN-APPNEX

General

Check archive.org

Show headers Download Go to

Full URL: https://prebid.adnxs.com/pbs/v1/openrtb2/auction
Requested by: Host: player.mediafuse.com
URL: https://player.mediafuse.com/prebidlink/456758/hb_302826_6936.js
Protocol: HTTP/1.1
Security: TLS 1.2, ECDHE_RSA, AES_128_GCM
Server: 37.252.161.190 Southall, United Kingdom, ASN29990 (ASN-APPNEX, US),
Reverse DNS: prebid.ams1.adnexus.net
Software: nginx/1.19.0 /
Resource Hash: d1306870bdb1390bdd65f4db110c6837f6f9fd8f992950c5e257665720440bac

Request headers

Referer: https://www.fiercepharma.com/
Accept-Language: de-DE,de;q=0.9
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Content-Type: text/plain

Response headers

Pragma: no-cache
Date: Tue, 08 Feb 2022 14:03:33 GMT
Server: nginx/1.19.0
X-Prebid: pbs-go/0.194.0
Vary: Origin
Content-Type: text/plain; charset=utf-8
Access-Control-Allow-Origin: https://www.fiercepharma.com
Cache-Control: no-cache, no-store, must-revalidate
Access-Control-Allow-Credentials: true
Connection: keep-alive
Content-Length: 88
Expires: 0

GET
H2 200 bidRequest Show response
c2shb.ssp.yahoo.com/ 62 B
92 B 159ms
104ms XHR
application/json 18.156.195.47
AMAZON-02

General

Check archive.org

Show headers Download Go to

Full URL: https://c2shb.ssp.yahoo.com/bidRequest?dcn=8a96940d017575bc4351bd15f652001f&pos=8a9690f1017575bc3e53bd44ae0500ac&cmd=bid&secure=1
Requested by: Host: player.mediafuse.com
URL: https://player.mediafuse.com/prebidlink/456758/hb_302826_6936.js
Protocol: H2
Security: TLS 1.3, , AES_256_GCM
Server: 18.156.195.47 Frankfurt am Main, Germany, ASN16509 (AMAZON-02, US),
Reverse DNS: ec2-18-156-195-47.eu-central-1.compute.amazonaws.com
Software: ATS/9.1.0.33 /
Resource Hash: 2d71b55377fe52cfb750c83536b807b5ee4180421166dd0a44c2498b552bb257

Request headers

Referer: https://www.fiercepharma.com/
Accept-Language: de-DE,de;q=0.9
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Content-Type: text/plain

Response headers

date: Tue, 08 Feb 2022 14:03:34 GMT
server: ATS/9.1.0.33
age: 1
vary: Origin, Access-Control-Request-Method, Access-Control-Request-Headers
access-control-allow-methods: POST,GET,HEAD,OPTIONS
content-type: application/json;charset=utf-8
access-control-allow-origin: https://www.fiercepharma.com
access-control-allow-credentials: true
content-length: 62

GET
H2 200 bidRequest Show response
c2shb.ssp.yahoo.com/ 62 B
296 B 138ms
84ms XHR
application/json 18.156.195.47
AMAZON-02

General

Check archive.org

Show headers Download Go to

Full URL: https://c2shb.ssp.yahoo.com/bidRequest?dcn=8a96940d017575bc4351bd15f652001f&pos=8a969d82017575bc3922bd44ad1a00b1&cmd=bid&secure=1
Requested by: Host: player.mediafuse.com
URL: https://player.mediafuse.com/prebidlink/456758/hb_302826_6936.js
Protocol: H2
Security: TLS 1.3, , AES_256_GCM
Server: 18.156.195.47 Frankfurt am Main, Germany, ASN16509 (AMAZON-02, US),
Reverse DNS: ec2-18-156-195-47.eu-central-1.compute.amazonaws.com
Software: ATS/9.1.0.33 /
Resource Hash: 2adc428759847560082634985fd8600f56cde71947d5a60c7ea2b7a23f39c3b1

Request headers

Referer: https://www.fiercepharma.com/
Accept-Language: de-DE,de;q=0.9
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Content-Type: text/plain

Response headers

date: Tue, 08 Feb 2022 14:03:33 GMT
server: ATS/9.1.0.33
age: 0
vary: Origin, Access-Control-Request-Method, Access-Control-Request-Headers
access-control-allow-methods: POST,GET,HEAD,OPTIONS
content-type: application/json;charset=utf-8
access-control-allow-origin: https://www.fiercepharma.com
access-control-allow-credentials: true
content-length: 62

GET
H2 200 bidRequest Show response
c2shb.ssp.yahoo.com/ 62 B
92 B 168ms
115ms XHR
application/json 18.156.195.47
AMAZON-02

General

Check archive.org

Show headers Download Go to

Full URL: https://c2shb.ssp.yahoo.com/bidRequest?dcn=8a96940d017575bc4351bd15f652001f&pos=8a9690f1017575bc3e53bd44a8a300aa&cmd=bid&secure=1
Requested by: Host: player.mediafuse.com
URL: https://player.mediafuse.com/prebidlink/456758/hb_302826_6936.js
Protocol: H2
Security: TLS 1.3, , AES_256_GCM
Server: 18.156.195.47 Frankfurt am Main, Germany, ASN16509 (AMAZON-02, US),
Reverse DNS: ec2-18-156-195-47.eu-central-1.compute.amazonaws.com
Software: ATS/9.1.0.33 /
Resource Hash: 3ad3efdb0fad0d4c1dc371ed474afddde3d62b4b447b8b3fe8d8db330a0cceee

Request headers

Referer: https://www.fiercepharma.com/
Accept-Language: de-DE,de;q=0.9
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Content-Type: text/plain

Response headers

date: Tue, 08 Feb 2022 14:03:34 GMT
server: ATS/9.1.0.33
age: 1
vary: Origin, Access-Control-Request-Method, Access-Control-Request-Headers
access-control-allow-methods: POST,GET,HEAD,OPTIONS
content-type: application/json;charset=utf-8
access-control-allow-origin: https://www.fiercepharma.com
access-control-allow-credentials: true
content-length: 62

GET
H2 200 bidRequest Show response
c2shb.ssp.yahoo.com/ 62 B
92 B 168ms
115ms XHR
application/json 18.156.195.47
AMAZON-02

General

Check archive.org

Show headers Download Go to

Full URL: https://c2shb.ssp.yahoo.com/bidRequest?dcn=8a96940d017575bc4351bd15f652001f&pos=8a969d82017575bc3922bd44aa6300b0&cmd=bid&secure=1
Requested by: Host: player.mediafuse.com
URL: https://player.mediafuse.com/prebidlink/456758/hb_302826_6936.js
Protocol: H2
Security: TLS 1.3, , AES_256_GCM
Server: 18.156.195.47 Frankfurt am Main, Germany, ASN16509 (AMAZON-02, US),
Reverse DNS: ec2-18-156-195-47.eu-central-1.compute.amazonaws.com
Software: ATS/9.1.0.33 /
Resource Hash: 70fb921a66529f9facd631a2da433dd769e58e04fde9df5a006e2d474c74e652

Request headers

Referer: https://www.fiercepharma.com/
Accept-Language: de-DE,de;q=0.9
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Content-Type: text/plain

Response headers

date: Tue, 08 Feb 2022 14:03:34 GMT
server: ATS/9.1.0.33
age: 1
vary: Origin, Access-Control-Request-Method, Access-Control-Request-Headers
access-control-allow-methods: POST,GET,HEAD,OPTIONS
content-type: application/json;charset=utf-8
access-control-allow-origin: https://www.fiercepharma.com
access-control-allow-credentials: true
content-length: 62

GET
H2 200 bidRequest Show response
c2shb.ssp.yahoo.com/ 62 B
92 B 144ms
91ms XHR
application/json 18.156.195.47
AMAZON-02

General

Check archive.org

Show headers Download Go to

Full URL: https://c2shb.ssp.yahoo.com/bidRequest?dcn=8a9690f1017575bc3e53bd15f72c001b&pos=8a96940d017575bc4351bd44a97500c0&cmd=bid&secure=1
Requested by: Host: player.mediafuse.com
URL: https://player.mediafuse.com/prebidlink/456758/hb_302826_6936.js
Protocol: H2
Security: TLS 1.3, , AES_256_GCM
Server: 18.156.195.47 Frankfurt am Main, Germany, ASN16509 (AMAZON-02, US),
Reverse DNS: ec2-18-156-195-47.eu-central-1.compute.amazonaws.com
Software: ATS/9.1.0.33 /
Resource Hash: 0afbcd84237cc883ddff36baadf71b03415342e77c3abb04cf528ba361213735

Request headers

Referer: https://www.fiercepharma.com/
Accept-Language: de-DE,de;q=0.9
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Content-Type: text/plain

Response headers

date: Tue, 08 Feb 2022 14:03:33 GMT
server: ATS/9.1.0.33
age: 0
vary: Origin, Access-Control-Request-Method, Access-Control-Request-Headers
access-control-allow-methods: POST,GET,HEAD,OPTIONS
content-type: application/json;charset=utf-8
access-control-allow-origin: https://www.fiercepharma.com
access-control-allow-credentials: true
content-length: 62

GET
H2 200 bidRequest Show response
c2shb.ssp.yahoo.com/ 62 B
92 B 146ms
94ms XHR
application/json 18.156.195.47
AMAZON-02

General

Check archive.org

Show headers Download Go to

Full URL: https://c2shb.ssp.yahoo.com/bidRequest?dcn=8a96940d017575bc4351bd15f652001f&pos=8a9690f1017575bc3e53bd44a8a300aa&cmd=bid&secure=1
Requested by: Host: player.mediafuse.com
URL: https://player.mediafuse.com/prebidlink/456758/hb_302826_6936.js
Protocol: H2
Security: TLS 1.3, , AES_256_GCM
Server: 18.156.195.47 Frankfurt am Main, Germany, ASN16509 (AMAZON-02, US),
Reverse DNS: ec2-18-156-195-47.eu-central-1.compute.amazonaws.com
Software: ATS/9.1.0.33 /
Resource Hash: 230500b28a619490192335e9307ac4957bf3bae910eb7dca0efb6611efc7650d

Request headers

Referer: https://www.fiercepharma.com/
Accept-Language: de-DE,de;q=0.9
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Content-Type: text/plain

Response headers

date: Tue, 08 Feb 2022 14:03:33 GMT
server: ATS/9.1.0.33
age: 0
vary: Origin, Access-Control-Request-Method, Access-Control-Request-Headers
access-control-allow-methods: POST,GET,HEAD,OPTIONS
content-type: application/json;charset=utf-8
access-control-allow-origin: https://www.fiercepharma.com
access-control-allow-credentials: true
content-length: 62

GET
H2 200 bidRequest Show response
c2shb.ssp.yahoo.com/ 62 B
92 B 141ms
88ms XHR
application/json 18.156.195.47
AMAZON-02

General

Check archive.org

Show headers Download Go to

Full URL: https://c2shb.ssp.yahoo.com/bidRequest?dcn=8a96940d017575bc4351bd15f652001f&pos=8a969d82017575bc3922bd44aa6300b0&cmd=bid&secure=1
Requested by: Host: player.mediafuse.com
URL: https://player.mediafuse.com/prebidlink/456758/hb_302826_6936.js
Protocol: H2
Security: TLS 1.3, , AES_256_GCM
Server: 18.156.195.47 Frankfurt am Main, Germany, ASN16509 (AMAZON-02, US),
Reverse DNS: ec2-18-156-195-47.eu-central-1.compute.amazonaws.com
Software: ATS/9.1.0.33 /
Resource Hash: d42dce1ea8bc071664d258b40901777476fb58ddd0c34da161c47f94a8bcac93

Request headers

Referer: https://www.fiercepharma.com/
Accept-Language: de-DE,de;q=0.9
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Content-Type: text/plain

Response headers

date: Tue, 08 Feb 2022 14:03:33 GMT
server: ATS/9.1.0.33
age: 0
vary: Origin, Access-Control-Request-Method, Access-Control-Request-Headers
access-control-allow-methods: POST,GET,HEAD,OPTIONS
content-type: application/json;charset=utf-8
access-control-allow-origin: https://www.fiercepharma.com
access-control-allow-credentials: true
content-length: 62

GET
H2 200 bidRequest Show response
c2shb.ssp.yahoo.com/ 62 B
117 B 153ms
100ms XHR
application/json 18.156.195.47
AMAZON-02

General

Check archive.org

Show headers Download Go to

Full URL: https://c2shb.ssp.yahoo.com/bidRequest?dcn=8a9690f1017575bc3e53bd15f72c001b&pos=8a96940d017575bc4351bd44a97500c0&cmd=bid&secure=1
Requested by: Host: player.mediafuse.com
URL: https://player.mediafuse.com/prebidlink/456758/hb_302826_6936.js
Protocol: H2
Security: TLS 1.3, , AES_256_GCM
Server: 18.156.195.47 Frankfurt am Main, Germany, ASN16509 (AMAZON-02, US),
Reverse DNS: ec2-18-156-195-47.eu-central-1.compute.amazonaws.com
Software: ATS/9.1.0.33 /
Resource Hash: 95e12ad63bff258407a49e675467727e866fa5d251e8e9d394162faf614e79ae

Request headers

Referer: https://www.fiercepharma.com/
Accept-Language: de-DE,de;q=0.9
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Content-Type: text/plain

Response headers

date: Tue, 08 Feb 2022 14:03:34 GMT
server: ATS/9.1.0.33
age: 1
vary: Origin, Access-Control-Request-Method, Access-Control-Request-Headers
access-control-allow-methods: POST,GET,HEAD,OPTIONS
content-type: application/json;charset=utf-8
access-control-allow-origin: https://www.fiercepharma.com
access-control-allow-credentials: true
content-length: 62

GET
H2 200 bidRequest Show response
c2shb.ssp.yahoo.com/ 62 B
92 B 142ms
90ms XHR
application/json 18.156.195.47
AMAZON-02

General

Check archive.org

Show headers Download Go to

Full URL: https://c2shb.ssp.yahoo.com/bidRequest?dcn=8a96940d017575bc4351bd15f652001f&pos=8a9690f1017575bc3e53bd44a8a300aa&cmd=bid&secure=1
Requested by: Host: player.mediafuse.com
URL: https://player.mediafuse.com/prebidlink/456758/hb_302826_6936.js
Protocol: H2
Security: TLS 1.3, , AES_256_GCM
Server: 18.156.195.47 Frankfurt am Main, Germany, ASN16509 (AMAZON-02, US),
Reverse DNS: ec2-18-156-195-47.eu-central-1.compute.amazonaws.com
Software: ATS/9.1.0.33 /
Resource Hash: 6b7a1d00aa01ca41e6f29cd523eb60cb20fea8ed315e28e06e82e1167eca6798

Request headers

Referer: https://www.fiercepharma.com/
Accept-Language: de-DE,de;q=0.9
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Content-Type: text/plain

Response headers

date: Tue, 08 Feb 2022 14:03:33 GMT
server: ATS/9.1.0.33
age: 0
vary: Origin, Access-Control-Request-Method, Access-Control-Request-Headers
access-control-allow-methods: POST,GET,HEAD,OPTIONS
content-type: application/json;charset=utf-8
access-control-allow-origin: https://www.fiercepharma.com
access-control-allow-credentials: true
content-length: 62

GET
H2 200 bidRequest Show response
c2shb.ssp.yahoo.com/ 62 B
92 B 164ms
112ms XHR
application/json 18.156.195.47
AMAZON-02

General

Check archive.org

Show headers Download Go to

Full URL: https://c2shb.ssp.yahoo.com/bidRequest?dcn=8a96940d017575bc4351bd15f652001f&pos=8a969d82017575bc3922bd44aa6300b0&cmd=bid&secure=1
Requested by: Host: player.mediafuse.com
URL: https://player.mediafuse.com/prebidlink/456758/hb_302826_6936.js
Protocol: H2
Security: TLS 1.3, , AES_256_GCM
Server: 18.156.195.47 Frankfurt am Main, Germany, ASN16509 (AMAZON-02, US),
Reverse DNS: ec2-18-156-195-47.eu-central-1.compute.amazonaws.com
Software: ATS/9.1.0.33 /
Resource Hash: b8412495b3ab69312276b43eddfc7ba0c482abc369a15747f8ffeb41a7eef2b2

Request headers

Referer: https://www.fiercepharma.com/
Accept-Language: de-DE,de;q=0.9
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Content-Type: text/plain

Response headers

date: Tue, 08 Feb 2022 14:03:34 GMT
server: ATS/9.1.0.33
age: 1
vary: Origin, Access-Control-Request-Method, Access-Control-Request-Headers
access-control-allow-methods: POST,GET,HEAD,OPTIONS
content-type: application/json;charset=utf-8
access-control-allow-origin: https://www.fiercepharma.com
access-control-allow-credentials: true
content-length: 62

GET
H2 200 bidRequest Show response
c2shb.ssp.yahoo.com/ 62 B
92 B 165ms
114ms XHR
application/json 18.156.195.47
AMAZON-02

General

Check archive.org

Show headers Download Go to

Full URL: https://c2shb.ssp.yahoo.com/bidRequest?dcn=8a9690f1017575bc3e53bd15f72c001b&pos=8a96940d017575bc4351bd44a97500c0&cmd=bid&secure=1
Requested by: Host: player.mediafuse.com
URL: https://player.mediafuse.com/prebidlink/456758/hb_302826_6936.js
Protocol: H2
Security: TLS 1.3, , AES_256_GCM
Server: 18.156.195.47 Frankfurt am Main, Germany, ASN16509 (AMAZON-02, US),
Reverse DNS: ec2-18-156-195-47.eu-central-1.compute.amazonaws.com
Software: ATS/9.1.0.33 /
Resource Hash: 1525f15e6a1c62e39b4d01e7f7aca9d78d5a19bd4f7875de363033113f60908f

Request headers

Referer: https://www.fiercepharma.com/
Accept-Language: de-DE,de;q=0.9
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Content-Type: text/plain

Response headers

date: Tue, 08 Feb 2022 14:03:34 GMT
server: ATS/9.1.0.33
age: 1
vary: Origin, Access-Control-Request-Method, Access-Control-Request-Headers
access-control-allow-methods: POST,GET,HEAD,OPTIONS
content-type: application/json;charset=utf-8
access-control-allow-origin: https://www.fiercepharma.com
access-control-allow-credentials: true
content-length: 62

GET
H/1.1 200
OK fastlane.json Show response
fastlane.rubiconproject.com/a/api/ 261 B
1 KB 260ms
174ms XHR
application/json 2602:803:c003:200::41
RUBICONPROJECT

General

Check archive.org

Show headers Download Go to

Full URL: https://fastlane.rubiconproject.com/a/api/fastlane.json?account_id=17184&site_id=163630&zone_id=2126352&size_id=55&alt_size_ids=57&eid_pubcid.org=b3acf975-6694-4970-9538-76bd2b008d42%5E1&rf=https%3A%2F%2Fwww.fiercepharma.com%2Fspecial-report%2F10-most-anticipated-drug-launches-2022-4-deucravacitinib&tk_flint=pbjs_lite_v6.7.0-pre&x_source.tid=faea3b09-5183-4451-b9d2-3c4c05ae3db7&p_screen_res=1600x1200&rp_secure=1&rp_maxbids=1&slots=1&rand=0.7601881773860544
Requested by: Host: player.mediafuse.com
URL: https://player.mediafuse.com/prebidlink/456758/hb_302826_6936.js
Protocol: HTTP/1.1
Security: TLS 1.2, RSA, AES_128_GCM
Server: 2602:803:c003:200::41 Amsterdam, Netherlands, ASN26667 (RUBICONPROJECT, US),
Reverse DNS
Software: nginx/1.16.0 /
Resource Hash: 0ef2ca95d47ddb90cf4af4893b7a7899a09469097868f890f11c0663a6ac2f06

Request headers

Referer: https://www.fiercepharma.com/
Accept-Language: de-DE,de;q=0.9
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Content-Type: text/plain

Response headers

Pragma: no-cache
Date: Tue, 08 Feb 2022 14:03:34 GMT
Server: nginx/1.16.0
Vary: Accept-Encoding
P3P: CP="NOI CURa ADMa DEVa TAIa OUR BUS IND UNI COM NAV INT"
Access-Control-Allow-Origin: https://www.fiercepharma.com
Cache-Control: no-cache, no-store, max-age=0, must-revalidate
Access-Control-Allow-Credentials: true
Connection: keep-alive
Content-Type: application/json
Content-Length: 261
Expires: Wed, 17 Sep 1975 21:32:10 GMT

GET
H/1.1 200
OK fastlane.json Show response
fastlane.rubiconproject.com/a/api/ 261 B
1 KB 206ms
117ms XHR
application/json 2602:803:c003:200::41
RUBICONPROJECT

General

Check archive.org

Show headers Download Go to

Full URL: https://fastlane.rubiconproject.com/a/api/fastlane.json?account_id=17184&site_id=163630&zone_id=2126352&size_id=15&alt_size_ids=10&eid_pubcid.org=b3acf975-6694-4970-9538-76bd2b008d42%5E1&rf=https%3A%2F%2Fwww.fiercepharma.com%2Fspecial-report%2F10-most-anticipated-drug-launches-2022-4-deucravacitinib&tk_flint=pbjs_lite_v6.7.0-pre&x_source.tid=3a111ff0-7aeb-413d-9ef0-0fc6ae61734a&p_screen_res=1600x1200&rp_secure=1&rp_maxbids=1&slots=1&rand=0.4829058713343808
Requested by: Host: player.mediafuse.com
URL: https://player.mediafuse.com/prebidlink/456758/hb_302826_6936.js
Protocol: HTTP/1.1
Security: TLS 1.2, RSA, AES_128_GCM
Server: 2602:803:c003:200::41 Amsterdam, Netherlands, ASN26667 (RUBICONPROJECT, US),
Reverse DNS
Software: nginx/1.16.0 /
Resource Hash: ca657e87582de6cf620b56d130e1c494e99afddcf204b0971d752d0f54a14173

Request headers

Referer: https://www.fiercepharma.com/
Accept-Language: de-DE,de;q=0.9
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Content-Type: text/plain

Response headers

Pragma: no-cache
Date: Tue, 08 Feb 2022 14:03:34 GMT
Server: nginx/1.16.0
Vary: Accept-Encoding
P3P: CP="NOI CURa ADMa DEVa TAIa OUR BUS IND UNI COM NAV INT"
Access-Control-Allow-Origin: https://www.fiercepharma.com
Cache-Control: no-cache, no-store, max-age=0, must-revalidate
Access-Control-Allow-Credentials: true
Connection: keep-alive
Content-Type: application/json
Content-Length: 261
Expires: Wed, 17 Sep 1975 21:32:10 GMT

GET
H/1.1 200
OK fastlane.json Show response
fastlane.rubiconproject.com/a/api/ 261 B
1 KB 202ms
113ms XHR
application/json 2602:803:c003:200::41
RUBICONPROJECT

General

Check archive.org

Show headers Download Go to

Full URL: https://fastlane.rubiconproject.com/a/api/fastlane.json?account_id=17184&site_id=163630&zone_id=2126352&size_id=15&alt_size_ids=10&eid_pubcid.org=b3acf975-6694-4970-9538-76bd2b008d42%5E1&rf=https%3A%2F%2Fwww.fiercepharma.com%2Fspecial-report%2F10-most-anticipated-drug-launches-2022-4-deucravacitinib&tk_flint=pbjs_lite_v6.7.0-pre&x_source.tid=9e864e7a-e240-41a5-b353-34e356d4ae85&p_screen_res=1600x1200&rp_secure=1&rp_maxbids=1&slots=1&rand=0.8087890697799562
Requested by: Host: player.mediafuse.com
URL: https://player.mediafuse.com/prebidlink/456758/hb_302826_6936.js
Protocol: HTTP/1.1
Security: TLS 1.2, RSA, AES_128_GCM
Server: 2602:803:c003:200::41 Amsterdam, Netherlands, ASN26667 (RUBICONPROJECT, US),
Reverse DNS
Software: nginx/1.16.0 /
Resource Hash: e8a6e7f7653520e7781ce9946aece169aa0dc7ad0e17ea3d3aec8a15e8c030ac

Request headers

Referer: https://www.fiercepharma.com/
Accept-Language: de-DE,de;q=0.9
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Content-Type: text/plain

Response headers

Pragma: no-cache
Date: Tue, 08 Feb 2022 14:03:34 GMT
Server: nginx/1.16.0
Vary: Accept-Encoding
P3P: CP="NOI CURa ADMa DEVa TAIa OUR BUS IND UNI COM NAV INT"
Access-Control-Allow-Origin: https://www.fiercepharma.com
Cache-Control: no-cache, no-store, max-age=0, must-revalidate
Access-Control-Allow-Credentials: true
Connection: keep-alive
Content-Type: application/json
Content-Length: 261
Expires: Wed, 17 Sep 1975 21:32:10 GMT

GET
H/1.1 200
OK fastlane.json Show response
fastlane.rubiconproject.com/a/api/ 4 KB
3 KB 203ms
103ms XHR
application/json 2602:803:c003:200::41
RUBICONPROJECT

General

Check archive.org

Show headers Download Go to

Full URL: https://fastlane.rubiconproject.com/a/api/fastlane.json?account_id=17184&site_id=163630&zone_id=2126352&size_id=15&alt_size_ids=10&eid_pubcid.org=b3acf975-6694-4970-9538-76bd2b008d42%5E1&rf=https%3A%2F%2Fwww.fiercepharma.com%2Fspecial-report%2F10-most-anticipated-drug-launches-2022-4-deucravacitinib&tk_flint=pbjs_lite_v6.7.0-pre&x_source.tid=feee019c-1149-4d18-8e7b-2383552ece21&p_screen_res=1600x1200&rp_secure=1&rp_maxbids=1&slots=1&rand=0.09238751382073773
Requested by: Host: player.mediafuse.com
URL: https://player.mediafuse.com/prebidlink/456758/hb_302826_6936.js
Protocol: HTTP/1.1
Security: TLS 1.2, RSA, AES_128_GCM
Server: 2602:803:c003:200::41 Amsterdam, Netherlands, ASN26667 (RUBICONPROJECT, US),
Reverse DNS
Software: nginx/1.16.0 /
Resource Hash: f99fbe58fea65b2715f93ca4d26ebd864fdb72eac2893ac5e4712c77dcf30d5d

Request headers

Referer: https://www.fiercepharma.com/
Accept-Language: de-DE,de;q=0.9
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Content-Type: text/plain

Response headers

Pragma: no-cache
Date: Tue, 08 Feb 2022 14:03:34 GMT
Content-Encoding: gzip
Server: nginx/1.16.0
Vary: Accept-Encoding
P3P: CP="NOI CURa ADMa DEVa TAIa OUR BUS IND UNI COM NAV INT"
Access-Control-Allow-Origin: https://www.fiercepharma.com
Cache-Control: no-cache, no-store, max-age=0, must-revalidate
Access-Control-Allow-Credentials: true
Connection: keep-alive
Content-Type: application/json
Content-Length: 1748
Expires: Wed, 17 Sep 1975 21:32:10 GMT

GET
H/1.1 200
OK trinity.json Show response
apex.go.sonobi.com/ 179 B
887 B 139ms
62ms XHR
application/json 178.162.133.150
LEASEWEB-NL-AMS-0...

General

Check archive.org

Show headers Download Go to

Full URL

https://apex.go.sonobi.com/trinity.json?key_maker=%7B%2251468ec261389a5%22%3A%226af9de6bbe34255426d7%7C970x90%2C970x250%2C970x415%7Cgpid%3D%2F298443%2Fquestex.lifesciences%2Ffiercepharma%2Fspecialreports%22%2C%225286de9e92b96f9%22%3A%226af9de6bbe34255426d7%7C300x600%2C300x250%7Cgpid%3D%2F298443%2Fquestex.lifesciences%2Ffiercepharma%2Fspecialreports%22%2C%2253631eeb469daf7%22%3A%226af9de6bbe34255426d7%7C300x600%2C300x250%7Cgpid%3D%2F298443%2Fquestex.lifesciences%2Ffiercepharma%2Fspecialreports%22%2C%225462ea710e54ec4%22%3A%226af9de6bbe34255426d7%7C300x600%2C300x250%7Cgpid%3D%2F298443%2Fquestex.lifesciences%2Ffiercepharma%2Fspecialreports%22%2C%2255ccdf1f9a570a6%22%3A%226af9de6bbe34255426d7%7C1600x1000%7Cgpid%3D%2F298443%2Fquestex.lifesciences%2Ffiercepharma%2Fspecialreports%22%7D&ref=https%3A%2F%2Fwww.fiercepharma.com%2Fspecial-report%2F10-most-anticipated-drug-launches-2022-4-deucravacitinib&s=7e320697-1f53-4b34-85e0-a58cb0323993&pv=70048e01-6310-4ac9-8d52-eec59105b095&vp=desktop&lib_name=prebid&lib_v=6.7.0-pre&us=0&ius=1&schain=%7B%22ver%22%3A%221.0%22%2C%22complete%22%3A1%2C%22nodes%22%3A%5B%7B%22asi%22%3A%22mediafuse.com%22%2C%22sid%22%3A%22358%22%2C%22hp%22%3A1%7D%5D%7D&userid=%7B%22pubcid%22%3A%22b3acf975-6694-4970-9538-76bd2b008d42%22%7D&eids=%5B%7B%22source%22%3A%22pubcid.org%22%2C%22uids%22%3A%5B%7B%22id%22%3A%22b3acf975-6694-4970-9538-76bd2b008d42%22%2C%22atype%22%3A1%7D%5D%7D%5D&coppa=0

Requested by

Host: player.mediafuse.com
URL: https://player.mediafuse.com/prebidlink/456758/hb_302826_6936.js

Protocol

HTTP/1.1

Security

TLS 1.2, ECDHE_RSA, AES_128_GCM

Server

178.162.133.150 Rotterdam, Netherlands, ASN60781 (LEASEWEB-NL-AMS-01 Netherlands, NL),

Reverse DNS

ams-1-apex.go.sonobi.com

Software

sonobi-go /

Resource Hash

f99ad6cbbab1d5235b0c8f4869e07a482d0ef45583d1039fde948748bc6c6ecb

Security Headers

Name	Value
X-Xss-Protection	0

Request headers

Referer: https://www.fiercepharma.com/
Accept-Language: de-DE,de;q=0.9
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Content-Type: text/plain

Response headers

Pragma: no-cache
Date: Tue, 08 Feb 2022 14:03:33 GMT
Content-Encoding: gzip
Server: sonobi-go
Vary: negotiate,Accept-Encoding
X-Go-Server: apex-ams-1-6-128
P3p: CP="NOI DSP COR NID CURa ADMa DEVa PSAa PSDa OUR BUS COM INT OTC PUR STA"
Access-Control-Allow-Origin: https://www.fiercepharma.com
Cache-Control: no-cache, no-store, private
Access-Control-Allow-Credentials: true
Tcn: Choice
Content-Type: application/json
Content-Length: 154
X-Xss-Protection: 0
Expires: Sat, 26 Jul 1997 05:00:00 GMT

POST
H/1.1 200
OK / Show response
ghb.adtelligent.com/v2/auction/ 1 KB
598 B 1173ms
1172ms XHR
application/json 2a0c:5c81:5142::2
24SHELLS

General

Check archive.org

Show headers Download Go to

Full URL: https://ghb.adtelligent.com/v2/auction/
Requested by: Host: player.mediafuse.com
URL: https://player.mediafuse.com/prebidlink/456758/hb_302826_6936.js
Protocol: HTTP/1.1
Security: TLS 1.3, , AES_128_GCM
Server: 2a0c:5c81:5142::2 London, United Kingdom, ASN55081 (24SHELLS, US),
Reverse DNS
Software: VertaMedia 1.0 /
Resource Hash: 72052878df69ef7dfdc40564b2ff27f9ac2d90ba1c27fbd6d78dc0d884722b83

Request headers

Referer: https://www.fiercepharma.com/
Accept-Language: de-DE,de;q=0.9
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Content-Type: text/plain

Response headers

Date: Tue, 08 Feb 2022 14:03:34 GMT
Content-Encoding: gzip
Server: VertaMedia 1.0
Content-Type: application/json; charset=UTF-8
Access-Control-Allow-Origin: https://www.fiercepharma.com
Access-Control-Allow-Credentials: true
Connection: Keep-Alive
Content-Length: 303

POST
H/1.1 200
OK / Show response
colossusssp.com/ 2 B
247 B 427ms
126ms XHR
application/json 8.2.111.126
NATCOWEB

General

Check archive.org

Show headers Download Go to

Full URL: https://colossusssp.com/?c=o&m=multi
Requested by: Host: player.mediafuse.com
URL: https://player.mediafuse.com/prebidlink/456758/hb_302826_6936.js
Protocol: HTTP/1.1
Security: TLS 1.2, RSA, AES_128_CBC
Server: 8.2.111.126 , United States, ASN46636 (NATCOWEB, US),
Reverse DNS
Software: nginx /
Resource Hash: 4f53cda18c2baa0c0354bb5f9a3ecbe5ed12ab4d8e11ba873c2f11161202b945

Request headers

Referer: https://www.fiercepharma.com/
Accept-Language: de-DE,de;q=0.9
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Content-Type: text/plain

Response headers

Access-Control-Allow-Origin: https://www.fiercepharma.com
Date: Tue, 08 Feb 2022 14:03:34 GMT
Access-Control-Allow-Credentials: true
Server: nginx
Connection: keep-alive
Content-Length: 2
Content-Type: application/json

POST
H2 204 prebid Show response
prebid.deepintent.com/ 0
235 B 325ms
111ms XHR
text/plain 169.197.150.8
DEEPINTENT

General

Check archive.org

Show headers Download Go to

Full URL: https://prebid.deepintent.com/prebid
Requested by: Host: player.mediafuse.com
URL: https://player.mediafuse.com/prebidlink/456758/hb_302826_6936.js
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 169.197.150.8 , United States, ASN398989 (DEEPINTENT, US),
Reverse DNS: g.deepintent.com
Software: a /
Resource Hash: e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer: https://www.fiercepharma.com/
Accept-Language: de-DE,de;q=0.9
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Content-Type: application/json

Response headers

date: Tue, 08 Feb 2022 14:03:33 GMT
server: a
vary: Origin
access-control-allow-methods: POST, GET, OPTIONS, DELETE
access-control-allow-origin: https://www.fiercepharma.com
access-control-max-age: 3600
access-control-allow-credentials: true
access-control-allow-headers: Origin, X-Requested-With, Content-Type, Accept, X-CSRF-TOKEN

POST
H2 204 translator Show response
hbopenbid.pubmatic.com/ 0
120 B 152ms
84ms XHR
text/plain 185.64.189.112
AS-PUBMATIC

General

Check archive.org

Show headers Download Go to

Full URL: https://hbopenbid.pubmatic.com/translator?source=prebid-client
Requested by: Host: player.mediafuse.com
URL: https://player.mediafuse.com/prebidlink/456758/hb_302826_6936.js
Protocol: H2
Security: TLS 1.2, ECDHE_RSA, AES_128_GCM
Server: 185.64.189.112 , United Kingdom, ASN62713 (AS-PUBMATIC, US),
Reverse DNS
Software: /
Resource Hash: e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer: https://www.fiercepharma.com/
Accept-Language: de-DE,de;q=0.9
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Content-Type: text/plain

Response headers

access-control-allow-origin: https://www.fiercepharma.com
date: Tue, 08 Feb 2022 14:03:34 GMT
cache-control: no-cache, no-store, must-revalidate
access-control-allow-credentials: true

GET
H2 204 prebid Show response
ads.yieldmo.com/exchange/ 0
229 B 143ms
38ms XHR
text/plain 34.251.249.129
AMAZON-02

General

Check archive.org

Show headers Download Go to

Full URL: https://ads.yieldmo.com/exchange/prebid?pbav=6.7.0-pre&p=%5B%7B%22placement_id%22%3A%22header-ad%22%2C%22callback_id%22%3A%228160c2facfc35e%22%2C%22sizes%22%3A%5B%5B970%2C90%5D%2C%5B970%2C250%5D%2C%5B970%2C415%5D%5D%2C%22ym_placement_id%22%3A%222926956988749259211%22%7D%2C%7B%22placement_id%22%3A%22sidebar-ad%22%2C%22callback_id%22%3A%2282b7a5d93c2510a%22%2C%22sizes%22%3A%5B%5B300%2C600%5D%2C%5B300%2C250%5D%5D%2C%22ym_placement_id%22%3A%222926956988749259211%22%7D%2C%7B%22placement_id%22%3A%22sidebar-ad2%22%2C%22callback_id%22%3A%22836db60f75a28e3%22%2C%22sizes%22%3A%5B%5B300%2C600%5D%2C%5B300%2C250%5D%5D%2C%22ym_placement_id%22%3A%222926956988749259211%22%7D%2C%7B%22placement_id%22%3A%22sidebar-ad3%22%2C%22callback_id%22%3A%228442482330b730d%22%2C%22sizes%22%3A%5B%5B300%2C600%5D%2C%5B300%2C250%5D%5D%2C%22ym_placement_id%22%3A%222926956988749259211%22%7D%2C%7B%22placement_id%22%3A%22wallpaper%22%2C%22callback_id%22%3A%228523308a199d636%22%2C%22sizes%22%3A%5B%5B1600%2C1000%5D%5D%2C%22ym_placement_id%22%3A%222926956988749259211%22%7D%5D&page_url=https%3A%2F%2Fwww.fiercepharma.com%2Fspecial-report%2F10-most-anticipated-drug-launches-2022-4-deucravacitinib&bust=1644329013871&dnt=false&description=With%20deucravacitinib%2C%20Bristol%20Myers%20Squibb%20took%20on%20an%20opportunity%20cost%20in%20losing%20out%20on%20Otezla%3B%20this%20year%2C%20industry%20watchers%20will%20start%20to%20see%20whether%20that%20bet%20could%20pay%20off.%20When%20faced%20with%20an%20antitrust%20roadblock%20to%20its%20megamerger%20with%20Celgene%20in%202019%2C%20BMS%20chose%20to%20keep%20experimental%20deucravacitinib%20and%20offload%20growing%20blockbuster%20Otezla%20to%20Amgen%20for%20%2413.4%20billion.&userConsent=%7B%22gdprApplies%22%3A%22%22%2C%22cmp%22%3A%22%22%7D&us_privacy=&pr=&scrd=1&title=4.%20Deucravacitinib%20%7C%20FiercePharma&w=1600&h=1200&pubcid=b3acf975-6694-4970-9538-76bd2b008d42&schain=%7B%22ver%22%3A%221.0%22%2C%22complete%22%3A1%2C%22nodes%22%3A%5B%7B%22asi%22%3A%22mediafuse.com%22%2C%22sid%22%3A%22358%22%2C%22hp%22%3A1%7D%5D%7D&eids=%5B%7B%22source%22%3A%22pubcid.org%22%2C%22uids%22%3A%5B%7B%22id%22%3A%22b3acf975-6694-4970-9538-76bd2b008d42%22%2C%22atype%22%3A1%7D%5D%7D%5D
Requested by: Host: player.mediafuse.com
URL: https://player.mediafuse.com/prebidlink/456758/hb_302826_6936.js
Protocol: H2
Security: TLS 1.2, ECDHE_RSA, AES_128_GCM
Server: 34.251.249.129 Dublin, Ireland, ASN16509 (AMAZON-02, US),
Reverse DNS: ec2-34-251-249-129.eu-west-1.compute.amazonaws.com
Software: /
Resource Hash: e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer: https://www.fiercepharma.com/
Accept-Language: de-DE,de;q=0.9
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Content-Type: text/plain

Response headers

access-control-allow-origin: https://www.fiercepharma.com
pragma: no-cache
date: Tue, 08 Feb 2022 14:03:33 GMT
access-control-allow-credentials: true
x-robots-tag: none,NOINDEX,NOFOLLOW
access-control-allow-methods: POST, GET, OPTIONS
access-control-request-headers: Cache-Control, Pragma

GET
H2 200 ROS Show response
pbjs.e-planning.net/pbjs/1/2e43c/1/www.fiercepharma.com/ 2 B
162 B 94ms
25ms XHR
text/plain 5.178.65.246
SERVERIUS-AS

General

Check archive.org

Show headers Download Go to

Full URL: https://pbjs.e-planning.net/pbjs/1/2e43c/1/www.fiercepharma.com/ROS?rnd=0.11600488881120774&e=970x250_0%3A970x250%2C970x90%2C970x415%2B300x250_0%3A300x250%2C300x600%2B300x250_1%3A300x250%2C300x600%2B300x250_2%3A300x250%2C300x600%2B1600x1000_0%3A1600x1000&ur=https%3A%2F%2Fwww.fiercepharma.com%2Fspecial-report%2F10-most-anticipated-drug-launches-2022-4-deucravacitinib&pbv=6.7.0-pre&ncb=1&vs=FFFFF&crs=UTF-8&fr=https%3A%2F%2Fwww.fiercepharma.com%2Fspecial-report%2F10-most-anticipated-drug-launches-2022-4-deucravacitinib&e_pubcid=b3acf975-6694-4970-9538-76bd2b008d42
Requested by: Host: player.mediafuse.com
URL: https://player.mediafuse.com/prebidlink/456758/hb_302826_6936.js
Protocol: H2
Security: TLS 1.3, , AES_256_GCM
Server: 5.178.65.246 Amsterdam, Netherlands, ASN50673 (SERVERIUS-AS, NL),
Reverse DNS: ads.us.e-planning.net
Software: openresty /
Resource Hash: 44136fa355b3678a1146ad16f7e8649e94fb4fc21fe77e8310c060f61caaff8a

Request headers

Referer: https://www.fiercepharma.com/
Accept-Language: de-DE,de;q=0.9
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Content-Type: text/plain

Response headers

access-control-allow-origin: https://www.fiercepharma.com
date: Tue, 08 Feb 2022 14:03:33 GMT
access-control-allow-credentials: true
server: openresty
content-type: text/plain
content-length: 2
x-sid: AMS-602

POST
H2 204 translator Show response
hbopenbid.pubmatic.com/ 0
64 B 235ms
172ms XHR
text/plain 185.64.189.112
AS-PUBMATIC

General

Check archive.org

Show headers Download Go to

Full URL: https://hbopenbid.pubmatic.com/translator?source=prebid-client
Requested by: Host: player.mediafuse.com
URL: https://player.mediafuse.com/prebidlink/456758/hb_302826_6936.js
Protocol: H2
Security: TLS 1.2, ECDHE_RSA, AES_128_GCM
Server: 185.64.189.112 , United Kingdom, ASN62713 (AS-PUBMATIC, US),
Reverse DNS
Software: /
Resource Hash: e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer: https://www.fiercepharma.com/
Accept-Language: de-DE,de;q=0.9
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Content-Type: text/plain

Response headers

access-control-allow-origin: https://www.fiercepharma.com
date: Tue, 08 Feb 2022 14:03:34 GMT
cache-control: no-cache, no-store, must-revalidate
access-control-allow-credentials: true

POST
H2 204 bids Show response
prebid-us.creativecdn.com/bidder/prebid/ 0
182 B 327ms
110ms XHR
text/plain 185.184.10.30
RTB-HOUSE-ASH

General

Check archive.org

Show headers Download Go to

Full URL: https://prebid-us.creativecdn.com/bidder/prebid/bids
Requested by: Host: player.mediafuse.com
URL: https://player.mediafuse.com/prebidlink/456758/hb_302826_6936.js
Protocol: H2
Security: TLS 1.3, , AES_256_GCM
Server: 185.184.10.30 , Poland, ASN203690 (RTB-HOUSE-ASH, PL),
Reverse DNS: ip-185-184-10-30.rtbhouse.net
Software: /
Resource Hash: e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer: https://www.fiercepharma.com/
Accept-Language: de-DE,de;q=0.9
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Content-Type: text/plain

Response headers

access-control-allow-origin: https://www.fiercepharma.com
date: Tue, 08 Feb 2022 14:03:34 GMT
access-control-allow-credentials: true
access-control-max-age: 3600
vary: Origin
access-control-allow-methods: POST

POST
H2 204 mvo Show response
tag.1rx.io/rmp/212473/0/ 0
176 B 87ms
25ms XHR
text/plain 213.19.147.42
RHYTHMONE

General

Check archive.org

Show headers Download Go to

Full URL: https://tag.1rx.io/rmp/212473/0/mvo?z=1r&hbv=6.7.0-pre,2.1
Requested by: Host: player.mediafuse.com
URL: https://player.mediafuse.com/prebidlink/456758/hb_302826_6936.js
Protocol: H2
Security: TLS 1.2, ECDHE_RSA, AES_128_GCM
Server: 213.19.147.42 , United Kingdom, ASN26120 (RHYTHMONE, US),
Reverse DNS
Software: Tengine /
Resource Hash: e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer: https://www.fiercepharma.com/
Accept-Language: de-DE,de;q=0.9
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Content-Type: text/plain

Response headers

access-control-allow-origin: https://www.fiercepharma.com
pragma: no-cache
date: Tue, 08 Feb 2022 14:03:33 GMT
cache-control: private, max-age=0, no-cache, no-store
access-control-allow-credentials: true
server: Tengine

POST
H/1.1 200
OK bid Show response
ap.lijit.com/rtb/ 25 B
526 B 79ms
27ms XHR
application/json 216.52.2.48
VOXEL-DOT-NET

General

Check archive.org

Show headers Download Go to

Full URL: https://ap.lijit.com/rtb/bid?src=prebid_prebid_6.7.0-pre
Requested by: Host: player.mediafuse.com
URL: https://player.mediafuse.com/prebidlink/456758/hb_302826_6936.js
Protocol: HTTP/1.1
Security: TLS 1.3, , AES_256_GCM
Server: 216.52.2.48 , United States, ASN29791 (VOXEL-DOT-NET, US),
Reverse DNS
Software: /
Resource Hash: c7675aa27a1871ec830b3d0c7af4b63ff47669a4f4689b76fa3685182308feb8

Request headers

Referer: https://www.fiercepharma.com/
Accept-Language: de-DE,de;q=0.9
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Content-Type: text/plain

Response headers

Date: Tue, 08 Feb 2022 14:03:33 GMT
Vary: Accept-Encoding, User-Agent
Access-Control-Allow-Methods: GET, POST, DELETE, PUT
Content-Type: application/json
Access-Control-Allow-Origin: https://www.fiercepharma.com
Access-Control-Allow-Credentials: true
X-Sovrn-Pod: ad_ap5ams1
Access-Control-Allow-Headers: X-Requested-With, Content-Type
Content-Length: 25

POST
H2 204 ortb Show response
bid.contextweb.com/header/ 0
572 B 339ms
105ms XHR
text/plain 198.148.27.133
PULSEPOINT

General

Check archive.org

Show headers Download Go to

Full URL: https://bid.contextweb.com/header/ortb?src=prebid
Requested by: Host: player.mediafuse.com
URL: https://player.mediafuse.com/prebidlink/456758/hb_302826_6936.js
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 198.148.27.133 New York, United States, ASN19189 (PULSEPOINT, US),
Reverse DNS
Software: envoy /
Resource Hash: e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer: https://www.fiercepharma.com/
Accept-Language: de-DE,de;q=0.9
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Content-Type: text/plain

Response headers

date: Tue, 08 Feb 2022 14:03:34 GMT
server: envoy
cwdl: 22/148,22/148,22/148,22/148,22/148,22/148,22/148,22/148,22/148,22/148,22/148,22/148,22/148,22/148,22/148
access-control-allow-origin: https://www.fiercepharma.com
access-control-expose-headers: Access-Control-Allow-Origin
access-control-allow-credentials: true
x-envoy-upstream-service-time: 4
cw-server: bid-deployment-66f4d6749f-nrlht

GET
H2 200 cygnus Show response
htlb.casalemedia.com/ 38 B
336 B 88ms
25ms XHR
application/json 23.37.38.181
AKAMAI-AS

General

Check archive.org

Show headers Download Go to

Full URL: https://htlb.casalemedia.com/cygnus?s=356568&v=7.2&ac=j&sd=1&r=%7B%22id%22%3A%221706ac1d37e2910c%22%2C%22site%22%3A%7B%22page%22%3A%22https%3A%2F%2Fwww.fiercepharma.com%2Fspecial-report%2F10-most-anticipated-drug-launches-2022-4-deucravacitinib%22%7D%2C%22ext%22%3A%7B%22source%22%3A%22prebid%22%2C%22ixdiag%22%3A%7B%22msd%22%3A4%2C%22msi%22%3A4%2C%22mfu%22%3A0%2C%22bu%22%3A4%2C%22iu%22%3A0%2C%22nu%22%3A0%2C%22ou%22%3A0%2C%22allu%22%3A4%2C%22ren%22%3Afalse%2C%22version%22%3A%226.7.0-pre%22%2C%22userIds%22%3A%5B%22pubcid%22%5D%7D%7D%2C%22imp%22%3A%5B%7B%22id%22%3A%221716f89c458d4b1b%22%2C%22banner%22%3A%7B%22topframe%22%3A1%2C%22format%22%3A%5B%7B%22w%22%3A970%2C%22h%22%3A250%2C%22ext%22%3A%7B%22siteID%22%3A%22356568%22%2C%22sid%22%3A%22970x250%22%7D%7D%5D%7D%7D%2C%7B%22id%22%3A%22173e6c4f2f1c7c4d%22%2C%22banner%22%3A%7B%22topframe%22%3A1%2C%22format%22%3A%5B%7B%22w%22%3A300%2C%22h%22%3A250%2C%22ext%22%3A%7B%22siteID%22%3A%22356568%22%2C%22sid%22%3A%22300x250%22%7D%7D%5D%7D%7D%2C%7B%22id%22%3A%22175725abcf0147dc%22%2C%22banner%22%3A%7B%22topframe%22%3A1%2C%22format%22%3A%5B%7B%22w%22%3A300%2C%22h%22%3A250%2C%22ext%22%3A%7B%22siteID%22%3A%22356568%22%2C%22sid%22%3A%22300x250%22%7D%7D%5D%7D%7D%2C%7B%22id%22%3A%22177b500d5d85b45b%22%2C%22banner%22%3A%7B%22topframe%22%3A1%2C%22format%22%3A%5B%7B%22w%22%3A300%2C%22h%22%3A250%2C%22ext%22%3A%7B%22siteID%22%3A%22356568%22%2C%22sid%22%3A%22300x250%22%7D%7D%5D%7D%7D%5D%2C%22at%22%3A1%2C%22user%22%3A%7B%22eids%22%3A%5B%7B%22source%22%3A%22pubcid.org%22%2C%22uids%22%3A%5B%7B%22id%22%3A%22b3acf975-6694-4970-9538-76bd2b008d42%22%7D%5D%7D%5D%7D%7D
Requested by: Host: player.mediafuse.com
URL: https://player.mediafuse.com/prebidlink/456758/hb_302826_6936.js
Protocol: H2
Security: TLS 1.2, ECDHE_RSA, AES_256_GCM
Server: 23.37.38.181 Frankfurt am Main, Germany, ASN16625 (AKAMAI-AS, US),
Reverse DNS: a23-37-38-181.deploy.static.akamaitechnologies.com
Software: Apache /
Resource Hash: 958e317f7d88a18fbc53eb6b932757ddad2790c94f999a87be0140cb7f8f6634

Request headers

Referer: https://www.fiercepharma.com/
Accept-Language: de-DE,de;q=0.9
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Content-Type: text/plain

Response headers

pragma: no-cache
date: Tue, 08 Feb 2022 14:03:33 GMT
x-ak-initial-geo: CC:[DE], RC:[HE], CN:[EU], CIP:[84.19.175.183], XFF:[]
server: Apache
content-type: application/json
access-control-allow-origin: https://www.fiercepharma.com
x-cs-client-geo: 12
cache-control: max-age=0, no-cache, no-store
access-control-allow-credentials: true
content-length: 38
x-ak-client-geo: 12
expires: Tue, 08 Feb 2022 14:03:33 GMT

GET
H2 200 arj Show response
adtelligent-d.openx.net/w/1.0/ 73 B
383 B 78ms
30ms XHR
application/json 35.244.159.8
GOOGLE

General

Check archive.org

Show headers Download Go to

Full URL: https://adtelligent-d.openx.net/w/1.0/arj?ju=https%3A%2F%2Fwww.fiercepharma.com%2Fspecial-report%2F10-most-anticipated-drug-launches-2022-4-deucravacitinib&ch=UTF-8&res=1600x1200x24&ifr=false&tz=0&tws=1600x1200&be=1&bc=hb_pb_3.0.3&dddid=faea3b09-5183-4451-b9d2-3c4c05ae3db7%2C3a111ff0-7aeb-413d-9ef0-0fc6ae61734a%2C9e864e7a-e240-41a5-b353-34e356d4ae85%2Cfeee019c-1149-4d18-8e7b-2383552ece21%2Cfc800c78-cf39-4d82-a550-bf3fa1e209bf&nocache=1644329013882&pubcid=b3acf975-6694-4970-9538-76bd2b008d42&schain=1.0%2C1!adtelligent.com%2C283366%2C1%2C%2C%2C&aus=970x90%2C970x250%2C970x415%7C300x600%2C300x250%7C300x600%2C300x250%7C300x600%2C300x250%7C1600x1000&divids=header-ad%2Csidebar-ad%2Csidebar-ad2%2Csidebar-ad3%2Cwallpaper&aucs=%2C%2C%2C%2C&auid=541177132%2C541177132%2C541177132%2C541177132%2C541177132
Requested by: Host: player.mediafuse.com
URL: https://player.mediafuse.com/prebidlink/456758/hb_302826_6936.js
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 35.244.159.8 Kansas City, United States, ASN15169 (GOOGLE, US),
Reverse DNS: 8.159.244.35.bc.googleusercontent.com
Software: OXGW/17.1.0 /
Resource Hash: a6dd5890bd6d1448cbb4b08f5799ab7ade6a0057431400e539bf33e729422476

Request headers

Referer: https://www.fiercepharma.com/
Accept-Language: de-DE,de;q=0.9
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Content-Type: text/plain

Response headers

pragma: no-cache
date: Tue, 08 Feb 2022 14:03:33 GMT
content-encoding: gzip
server: OXGW/17.1.0
vary: Accept, Accept-Encoding
p3p: CP="CUR ADM OUR NOR STA NID"
access-control-allow-origin: https://www.fiercepharma.com
cache-control: private, max-age=0, no-cache
access-control-allow-credentials: true
content-type: application/json
alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length: 79
via: 1.1 google
expires: Mon, 26 Jul 1997 05:00:00 GMT

POST
H/1.1 200
OK prebid Show response
ib.adnxs.com/ut/v3/ 19 B
857 B 39ms
39ms XHR
application/json 37.252.172.37
ASN-APPNEX

General

Check archive.org

Show headers Download Go to

Full URL

https://ib.adnxs.com/ut/v3/prebid

Requested by

Host: player.mediafuse.com
URL: https://player.mediafuse.com/prebidlink/456758/hb_302826_6936.js

Protocol

HTTP/1.1

Security

TLS 1.2, ECDHE_ECDSA, AES_128_GCM

Server

37.252.172.37 Frankfurt am Main, Germany, ASN29990 (ASN-APPNEX, US),

Reverse DNS

691.bm-nginx-loadbalancer.mgmt.fra1.adnexus.net

Software

nginx/1.17.9 /

Resource Hash

0c09c070833c786cb25be38bc30992b30bad578f817dbc9e34beacd8b8ea44c5

Security Headers

Name	Value
X-Xss-Protection	0

Request headers

Referer: https://www.fiercepharma.com/
Accept-Language: de-DE,de;q=0.9
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Content-Type: text/plain

Response headers

Pragma: no-cache
Date: Tue, 08 Feb 2022 14:03:33 GMT
X-Proxy-Origin: 84.19.175.183; 84.19.175.183; 691.bm-nginx-loadbalancer.mgmt.fra1; adnxs.com
AN-X-Request-Uuid: e899e328-c5a6-40a9-9837-d6946e5a2419
Server: nginx/1.17.9
P3P: policyref="http://cdn.adnxs-simple.com/w3c/policy/p3p.xml", CP="NOI DSP COR ADM PSAo PSDo OURo SAMo UNRo OTRo BUS COM NAV DEM STA PRE"
Access-Control-Allow-Origin: https://www.fiercepharma.com
Cache-Control: no-store, no-cache, private
Access-Control-Allow-Credentials: true
Connection: keep-alive
Content-Type: application/json; charset=utf-8
Content-Length: 19
X-XSS-Protection: 0
Expires: Sat, 15 Nov 2008 16:00:00 GMT

POST
H/1.1 200
OK prebid.1.2.aspx Show response
inv-nets.admixer.net/ 42 B
510 B 105ms
31ms XHR
text/javascript 146.0.227.109
GODADDY

General

Check archive.org

Show headers Download Go to

Full URL

https://inv-nets.admixer.net/prebid.1.2.aspx

Requested by

Host: player.mediafuse.com
URL: https://player.mediafuse.com/prebidlink/456758/hb_302826_6936.js

Protocol

HTTP/1.1

Security

TLS 1.2, ECDHE_ECDSA, AES_256_GCM

Server

146.0.227.109 , Ascension Island, ASN20773 (GODADDY, DE),

Reverse DNS

Software

nginx /

Resource Hash

c979ffd70003be58ccc574778b78d9303e8b5b3494a6cdeb01449d65a5a815e6

Security Headers

Name	Value
X-Xss-Protection	0

Request headers

Referer: https://www.fiercepharma.com/
Accept-Language: de-DE,de;q=0.9
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Content-Type: text/plain

Response headers

Date: Tue, 08 Feb 2022 14:03:33 GMT
Server: nginx
P3p: CP="NID DSP ALL COR"
Access-Control-Allow-Origin: https://www.fiercepharma.com
Access-Control-Allow-Credentials: true
Connection: keep-alive
Content-Type: text/javascript; charset=utf-8
Keep-Alive: timeout=25
Content-Length: 42
X-Xss-Protection: 0

POST
H2 204 c Show response
prebid.a-mo.net/a/ 0
205 B 559ms
335ms XHR
text/plain 147.75.38.124
PACKET

General

Check archive.org

Show headers Download Go to

Full URL: https://prebid.a-mo.net/a/c
Requested by: Host: player.mediafuse.com
URL: https://player.mediafuse.com/prebidlink/456758/hb_302826_6936.js
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 147.75.38.124 Amsterdam, Netherlands, ASN54825 (PACKET, US),
Reverse DNS
Software: envoy /
Resource Hash: e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer: https://www.fiercepharma.com/
Accept-Language: de-DE,de;q=0.9
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Content-Type: text/plain

Response headers

access-control-allow-origin: https://www.fiercepharma.com
date: Tue, 08 Feb 2022 14:03:33 GMT
cache-control: max-age=0, private, must-revalidate
access-control-allow-credentials: true
server: envoy
x-envoy-upstream-service-time: 229
vary: origin, Accept-Encoding

POST
H2 200 prebid-request Show response
onetag-sys.com/ 15 B
367 B 73ms
19ms XHR
application/json 51.38.120.206
OVH

General

Check archive.org

Show headers Download Go to

Full URL

https://onetag-sys.com/prebid-request

Requested by

Host: player.mediafuse.com
URL: https://player.mediafuse.com/prebidlink/456758/hb_302826_6936.js

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

51.38.120.206 , France, ASN16276 (OVH, FR),

Reverse DNS

ip206.ip-51-38-120.eu

Software

Resource Hash

663dab1310a7e64c3bdd7dfdc81b7fc9a28884d4ee290b96077c7b32bbe84707

Security Headers

Name	Value
Strict-Transport-Security	max-age=15552000

Request headers

Referer: https://www.fiercepharma.com/
Accept-Language: de-DE,de;q=0.9
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Content-Type: text/plain

Response headers

strict-transport-security: max-age=15552000
content-encoding: gzip
p3p: CP='CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR'
access-control-allow-origin: https://www.fiercepharma.com
cache-control: no-transform, no-cache
access-control-allow-credentials: true
content-type: application/json
access-control-allow-headers: content-type, origin, referer, user-agent
content-length: 41

POST
H2 200 adjson Show response
ads.betweendigital.com/ 2 B
916 B 224ms
104ms XHR
application/json 88.212.252.22
SERVERS-COM

General

Check archive.org

Show headers Download Go to

Full URL: https://ads.betweendigital.com/adjson?t=prebid
Requested by: Host: player.mediafuse.com
URL: https://player.mediafuse.com/prebidlink/456758/hb_302826_6936.js
Protocol: H2
Security: TLS 1.3, , AES_256_GCM
Server: 88.212.252.22 , Russian Federation, ASN7979 (SERVERS-COM, US),
Reverse DNS
Software: /
Resource Hash: 4f53cda18c2baa0c0354bb5f9a3ecbe5ed12ab4d8e11ba873c2f11161202b945

Request headers

Referer: https://www.fiercepharma.com/
Accept-Language: de-DE,de;q=0.9
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Content-Type: text/plain

Response headers

access-control-allow-origin: https://www.fiercepharma.com
cache-control: no-cache, no-store, max-age=0, must-revalidate
access-control-allow-credentials: true
content-encoding: gzip
vary: Accept-Encoding
content-type: application/json

POST
H2 200 cdb Show response
bidder.criteo.com/ 18 B
317 B 143ms
63ms XHR
application/json 178.250.0.165
ASN-CRITEO-EUROPE

General

Check archive.org

Show headers Download Go to

Full URL

https://bidder.criteo.com/cdb?profileId=207&av=34&wv=6.7.0-pre&cb=87765431518

Requested by

Host: player.mediafuse.com
URL: https://player.mediafuse.com/prebidlink/456758/hb_302826_6936.js

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

178.250.0.165 , France, ASN44788 (ASN-CRITEO-EUROPE, FR),

Reverse DNS

bidder.par.vip.prod.criteo.com

Software

Finatra /

Resource Hash

ad6aa18e132c373e6a0be7543103d4e5dfde8680587cea250550686591419910

Security Headers

Name	Value
Strict-Transport-Security	max-age=31536000; preload;

Request headers

Referer: https://www.fiercepharma.com/
Accept-Language: de-DE,de;q=0.9
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Content-Type: text/plain

Response headers

date: Tue, 08 Feb 2022 14:03:33 GMT
content-encoding: gzip
server: Finatra
vary: Origin
content-type: application/json; charset=utf-8
access-control-allow-origin: https://www.fiercepharma.com
access-control-allow-credentials: true
cross-origin-resource-policy: cross-origin
strict-transport-security: max-age=31536000; preload;
timing-allow-origin: *
content-length: 44

POST
H2 200 prebid Show response
prebid.media.net/rtb/ 1 KB
869 B 119ms
68ms XHR
application/json 34.107.148.139
GOOGLE

General

Check archive.org

Show headers Download Go to

Full URL: https://prebid.media.net/rtb/prebid?cid=8CUO2I9ST
Requested by: Host: player.mediafuse.com
URL: https://player.mediafuse.com/prebidlink/456758/hb_302826_6936.js
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 34.107.148.139 Kansas City, United States, ASN15169 (GOOGLE, US),
Reverse DNS: 139.148.107.34.bc.googleusercontent.com
Software: nginx /
Resource Hash: 4c6b42db7c45f36affdfb23ee816bd45f80d1f192dca5e26e5b773d43a0888e9

Request headers

Referer: https://www.fiercepharma.com/
Accept-Language: de-DE,de;q=0.9
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Content-Type: text/plain

Response headers

pragma: no-cache
date: Tue, 08 Feb 2022 14:03:34 GMT
content-encoding: gzip
server: nginx
content-type: application/json;charset=UTF-8
access-control-allow-origin: https://www.fiercepharma.com
cache-control: no-cache, no-store, must-revalidate
access-control-allow-credentials: true
alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
via: 1.1 google

GET
H/1.1 200
OK fastlane.json Show response
fastlane.rubiconproject.com/a/api/ 260 B
1 KB 281ms
198ms XHR
application/json 2602:803:c003:200::41
RUBICONPROJECT

General

Check archive.org

Show headers Download Go to

Full URL: https://fastlane.rubiconproject.com/a/api/fastlane.json?account_id=12398&site_id=48990&zone_id=1998744&size_id=55&alt_size_ids=57&rp_schain=1.0,1!luponmedia.com,1994122,1,,,&eid_pubcid.org=b3acf975-6694-4970-9538-76bd2b008d42%5E1&rf=https%3A%2F%2Fwww.fiercepharma.com%2Fspecial-report%2F10-most-anticipated-drug-launches-2022-4-deucravacitinib&tk_flint=pbjs_lite_v6.7.0-pre&x_source.tid=faea3b09-5183-4451-b9d2-3c4c05ae3db7&p_screen_res=1600x1200&rp_secure=1&rp_maxbids=1&slots=1&rand=0.6149527456005925
Requested by: Host: player.mediafuse.com
URL: https://player.mediafuse.com/prebidlink/456758/hb_302826_6936.js
Protocol: HTTP/1.1
Security: TLS 1.2, RSA, AES_128_GCM
Server: 2602:803:c003:200::41 Amsterdam, Netherlands, ASN26667 (RUBICONPROJECT, US),
Reverse DNS
Software: nginx/1.16.0 /
Resource Hash: f96087b9045ddc2b32771acdcdc7319ab1b56e24b8740d24d770e097037ab8f5

Request headers

Referer: https://www.fiercepharma.com/
Accept-Language: de-DE,de;q=0.9
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Content-Type: text/plain

Response headers

Pragma: no-cache
Date: Tue, 08 Feb 2022 14:03:34 GMT
Server: nginx/1.16.0
Vary: Accept-Encoding
P3P: CP="NOI CURa ADMa DEVa TAIa OUR BUS IND UNI COM NAV INT"
Access-Control-Allow-Origin: https://www.fiercepharma.com
Cache-Control: no-cache, no-store, max-age=0, must-revalidate
Access-Control-Allow-Credentials: true
Connection: keep-alive
Content-Type: application/json
Content-Length: 260
Expires: Wed, 17 Sep 1975 21:32:10 GMT

GET
H/1.1 200
OK fastlane.json Show response
fastlane.rubiconproject.com/a/api/ 260 B
1 KB 206ms
120ms XHR
application/json 2602:803:c003:200::41
RUBICONPROJECT

General

Check archive.org

Show headers Download Go to

Full URL: https://fastlane.rubiconproject.com/a/api/fastlane.json?account_id=12398&site_id=48990&zone_id=1998744&size_id=15&alt_size_ids=10&rp_schain=1.0,1!luponmedia.com,1994122,1,,,&eid_pubcid.org=b3acf975-6694-4970-9538-76bd2b008d42%5E1&rf=https%3A%2F%2Fwww.fiercepharma.com%2Fspecial-report%2F10-most-anticipated-drug-launches-2022-4-deucravacitinib&tk_flint=pbjs_lite_v6.7.0-pre&x_source.tid=3a111ff0-7aeb-413d-9ef0-0fc6ae61734a&p_screen_res=1600x1200&rp_secure=1&rp_maxbids=1&slots=1&rand=0.7011219033683482
Requested by: Host: player.mediafuse.com
URL: https://player.mediafuse.com/prebidlink/456758/hb_302826_6936.js
Protocol: HTTP/1.1
Security: TLS 1.2, RSA, AES_128_GCM
Server: 2602:803:c003:200::41 Amsterdam, Netherlands, ASN26667 (RUBICONPROJECT, US),
Reverse DNS
Software: nginx/1.16.0 /
Resource Hash: b016b2747c1598a861aeeacf570427137f7a88fa534b1c3437e518ec51cce9e8

Request headers

Referer: https://www.fiercepharma.com/
Accept-Language: de-DE,de;q=0.9
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Content-Type: text/plain

Response headers

Pragma: no-cache
Date: Tue, 08 Feb 2022 14:03:34 GMT
Server: nginx/1.16.0
Vary: Accept-Encoding
P3P: CP="NOI CURa ADMa DEVa TAIa OUR BUS IND UNI COM NAV INT"
Access-Control-Allow-Origin: https://www.fiercepharma.com
Cache-Control: no-cache, no-store, max-age=0, must-revalidate
Access-Control-Allow-Credentials: true
Connection: keep-alive
Content-Type: application/json
Content-Length: 260
Expires: Wed, 17 Sep 1975 21:32:10 GMT

GET
H/1.1 200
OK fastlane.json Show response
fastlane.rubiconproject.com/a/api/ 260 B
1 KB 293ms
117ms XHR
application/json 2602:803:c003:200::41
RUBICONPROJECT

General

Check archive.org

Show headers Download Go to

Full URL: https://fastlane.rubiconproject.com/a/api/fastlane.json?account_id=12398&site_id=48990&zone_id=1998744&size_id=15&alt_size_ids=10&rp_schain=1.0,1!luponmedia.com,1994122,1,,,&eid_pubcid.org=b3acf975-6694-4970-9538-76bd2b008d42%5E1&rf=https%3A%2F%2Fwww.fiercepharma.com%2Fspecial-report%2F10-most-anticipated-drug-launches-2022-4-deucravacitinib&tk_flint=pbjs_lite_v6.7.0-pre&x_source.tid=9e864e7a-e240-41a5-b353-34e356d4ae85&p_screen_res=1600x1200&rp_secure=1&rp_maxbids=1&slots=1&rand=0.057555571509197545
Requested by: Host: player.mediafuse.com
URL: https://player.mediafuse.com/prebidlink/456758/hb_302826_6936.js
Protocol: HTTP/1.1
Security: TLS 1.2, RSA, AES_128_GCM
Server: 2602:803:c003:200::41 Amsterdam, Netherlands, ASN26667 (RUBICONPROJECT, US),
Reverse DNS
Software: nginx/1.16.0 /
Resource Hash: ced8403d1a68d9d30d9e8b27451f0aded7bd3d9bcf20984fb2f8a27fd408af4a

Request headers

Referer: https://www.fiercepharma.com/
Accept-Language: de-DE,de;q=0.9
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Content-Type: text/plain

Response headers

Pragma: no-cache
Date: Tue, 08 Feb 2022 14:03:34 GMT
Server: nginx/1.16.0
Vary: Accept-Encoding
P3P: CP="NOI CURa ADMa DEVa TAIa OUR BUS IND UNI COM NAV INT"
Access-Control-Allow-Origin: https://www.fiercepharma.com
Cache-Control: no-cache, no-store, max-age=0, must-revalidate
Access-Control-Allow-Credentials: true
Connection: keep-alive
Content-Type: application/json
Content-Length: 260
Expires: Wed, 17 Sep 1975 21:32:10 GMT

GET
H/1.1 200
OK fastlane.json Show response
fastlane.rubiconproject.com/a/api/ 260 B
1 KB 299ms
120ms XHR
application/json 2602:803:c003:200::41
RUBICONPROJECT

General

Check archive.org

Show headers Download Go to

Full URL: https://fastlane.rubiconproject.com/a/api/fastlane.json?account_id=12398&site_id=48990&zone_id=1998744&size_id=15&alt_size_ids=10&rp_schain=1.0,1!luponmedia.com,1994122,1,,,&eid_pubcid.org=b3acf975-6694-4970-9538-76bd2b008d42%5E1&rf=https%3A%2F%2Fwww.fiercepharma.com%2Fspecial-report%2F10-most-anticipated-drug-launches-2022-4-deucravacitinib&tk_flint=pbjs_lite_v6.7.0-pre&x_source.tid=feee019c-1149-4d18-8e7b-2383552ece21&p_screen_res=1600x1200&rp_secure=1&rp_maxbids=1&slots=1&rand=0.08536596974154809
Requested by: Host: player.mediafuse.com
URL: https://player.mediafuse.com/prebidlink/456758/hb_302826_6936.js
Protocol: HTTP/1.1
Security: TLS 1.2, RSA, AES_128_GCM
Server: 2602:803:c003:200::41 Amsterdam, Netherlands, ASN26667 (RUBICONPROJECT, US),
Reverse DNS
Software: nginx/1.16.0 /
Resource Hash: 2e2600b8a7f6b404746d40feb94c439ff230759bcb619137ef0be9b2a75341ea

Request headers

Referer: https://www.fiercepharma.com/
Accept-Language: de-DE,de;q=0.9
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Content-Type: text/plain

Response headers

Pragma: no-cache
Date: Tue, 08 Feb 2022 14:03:34 GMT
Server: nginx/1.16.0
Vary: Accept-Encoding
P3P: CP="NOI CURa ADMa DEVa TAIa OUR BUS IND UNI COM NAV INT"
Access-Control-Allow-Origin: https://www.fiercepharma.com
Cache-Control: no-cache, no-store, max-age=0, must-revalidate
Access-Control-Allow-Credentials: true
Connection: keep-alive
Content-Type: application/json
Content-Length: 260
Expires: Wed, 17 Sep 1975 21:32:10 GMT

POST
H2 204 c Show response
prebid.a-mo.net/a/ 0
352 B 549ms
333ms XHR
text/plain 147.75.38.124
PACKET

General

Check archive.org

Show headers Download Go to

Full URL: https://prebid.a-mo.net/a/c
Requested by: Host: player.mediafuse.com
URL: https://player.mediafuse.com/prebidlink/456758/hb_302826_6936.js
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 147.75.38.124 Amsterdam, Netherlands, ASN54825 (PACKET, US),
Reverse DNS
Software: envoy /
Resource Hash: e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer: https://www.fiercepharma.com/
Accept-Language: de-DE,de;q=0.9
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Content-Type: text/plain

Response headers

access-control-allow-origin: https://www.fiercepharma.com
date: Tue, 08 Feb 2022 14:03:33 GMT
cache-control: max-age=0, private, must-revalidate
access-control-allow-credentials: true
server: envoy
x-envoy-upstream-service-time: 227
vary: origin, Accept-Encoding

POST
H2 200 adreq Show response
ads.servenobid.com/ 596 B
638 B 156ms
48ms XHR
application/json 63.32.247.12
AMAZON-02

General

Check archive.org

Show headers Download Go to

Full URL: https://ads.servenobid.com/adreq?cb=7194
Requested by: Host: player.mediafuse.com
URL: https://player.mediafuse.com/prebidlink/456758/hb_302826_6936.js
Protocol: H2
Security: TLS 1.2, ECDHE_RSA, AES_128_GCM
Server: 63.32.247.12 Dublin, Ireland, ASN16509 (AMAZON-02, US),
Reverse DNS: ec2-63-32-247-12.eu-west-1.compute.amazonaws.com
Software: /
Resource Hash: 99515c31921234d243da4528d95a3590ae16d185e9829c0b7d855816f075a34a

Request headers

Referer: https://www.fiercepharma.com/
Accept-Language: de-DE,de;q=0.9
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Content-Type: text/plain

Response headers

date: Tue, 08 Feb 2022 14:03:34 GMT
content-encoding: gzip
amp-access-control-allow-source-origin: *
vary: accept-encoding
content-type: application/json
access-control-allow-origin: https://www.fiercepharma.com
access-control-expose-headers: AMP-Access-Control-Allow-Source-Origin
cache-control: no-store, no-cache, must-revalidate, proxy-revalidate, max-age=0
access-control-allow-credentials: true

POST
H/1.1 200
OK prebid Show response
ib.adnxs.com/ut/v3/ 19 B
857 B 37ms
19ms XHR
application/json 37.252.172.37
ASN-APPNEX

General

Check archive.org

Show headers Download Go to

Full URL

https://ib.adnxs.com/ut/v3/prebid

Requested by

Host: player.mediafuse.com
URL: https://player.mediafuse.com/prebidlink/456758/hb_302826_6936.js

Protocol

HTTP/1.1

Security

TLS 1.2, ECDHE_ECDSA, AES_128_GCM

Server

37.252.172.37 Frankfurt am Main, Germany, ASN29990 (ASN-APPNEX, US),

Reverse DNS

691.bm-nginx-loadbalancer.mgmt.fra1.adnexus.net

Software

nginx/1.17.9 /

Resource Hash

0c09c070833c786cb25be38bc30992b30bad578f817dbc9e34beacd8b8ea44c5

Security Headers

Name	Value
X-Xss-Protection	0

Request headers

Referer: https://www.fiercepharma.com/
Accept-Language: de-DE,de;q=0.9
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Content-Type: text/plain

Response headers

Pragma: no-cache
Date: Tue, 08 Feb 2022 14:03:33 GMT
X-Proxy-Origin: 84.19.175.183; 84.19.175.183; 691.bm-nginx-loadbalancer.mgmt.fra1; adnxs.com
AN-X-Request-Uuid: 674cd8b7-1b15-4620-9645-feff1c979377
Server: nginx/1.17.9
P3P: policyref="http://cdn.adnxs-simple.com/w3c/policy/p3p.xml", CP="NOI DSP COR ADM PSAo PSDo OURo SAMo UNRo OTRo BUS COM NAV DEM STA PRE"
Access-Control-Allow-Origin: https://www.fiercepharma.com
Cache-Control: no-store, no-cache, private
Access-Control-Allow-Credentials: true
Connection: keep-alive
Content-Type: application/json; charset=utf-8
Content-Length: 19
X-XSS-Protection: 0
Expires: Sat, 15 Nov 2008 16:00:00 GMT

POST
H/1.1 200
OK prebid Show response
ib.adnxs.com/ut/v3/ 19 B
857 B 62ms
31ms XHR
application/json 37.252.172.37
ASN-APPNEX

General

Check archive.org

Show headers Download Go to

Full URL

https://ib.adnxs.com/ut/v3/prebid

Requested by

Host: player.mediafuse.com
URL: https://player.mediafuse.com/prebidlink/456758/hb_302826_6936.js

Protocol

HTTP/1.1

Security

TLS 1.2, ECDHE_ECDSA, AES_128_GCM

Server

37.252.172.37 Frankfurt am Main, Germany, ASN29990 (ASN-APPNEX, US),

Reverse DNS

691.bm-nginx-loadbalancer.mgmt.fra1.adnexus.net

Software

nginx/1.17.9 /

Resource Hash

0c09c070833c786cb25be38bc30992b30bad578f817dbc9e34beacd8b8ea44c5

Security Headers

Name	Value
X-Xss-Protection	0

Request headers

Referer: https://www.fiercepharma.com/
Accept-Language: de-DE,de;q=0.9
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Content-Type: text/plain

Response headers

Pragma: no-cache
Date: Tue, 08 Feb 2022 14:03:33 GMT
X-Proxy-Origin: 84.19.175.183; 84.19.175.183; 691.bm-nginx-loadbalancer.mgmt.fra1; adnxs.com
AN-X-Request-Uuid: 45dce81c-1d56-43cd-b210-8c52bf30a3dd
Server: nginx/1.17.9
P3P: policyref="http://cdn.adnxs-simple.com/w3c/policy/p3p.xml", CP="NOI DSP COR ADM PSAo PSDo OURo SAMo UNRo OTRo BUS COM NAV DEM STA PRE"
Access-Control-Allow-Origin: https://www.fiercepharma.com
Cache-Control: no-store, no-cache, private
Access-Control-Allow-Credentials: true
Connection: keep-alive
Content-Type: application/json; charset=utf-8
Content-Length: 19
X-XSS-Protection: 0
Expires: Sat, 15 Nov 2008 16:00:00 GMT

GET
H2 200 integrator.js Show response
adservice.google.de/adsid/ 107 B
792 B 82ms
27ms Script
application/javascript 2a00:1450:4001:813::2002
GOOGLE

General

Check archive.org

Show headers Download Go to

Full URL

https://adservice.google.de/adsid/integrator.js?domain=www.fiercepharma.com

Requested by

Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2022020301.js

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2a00:1450:4001:813::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),

Reverse DNS

Software

cafe /

Resource Hash

a4a1824defec1084ca81d496ee77891684c26196924bdc4fc21dd3482ce15e14

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Xss-Protection	0

Request headers

Accept-Language: de-DE,de;q=0.9
Referer: https://www.fiercepharma.com/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

timing-allow-origin: *
date: Tue, 08 Feb 2022 14:03:33 GMT
content-encoding: gzip
x-content-type-options: nosniff
server: cafe
p3p: CP="This is not a P3P policy! See http://support.google.com/accounts/answer/151657 for more info."
cache-control: private, no-cache, no-store
cross-origin-resource-policy: cross-origin
content-disposition: attachment; filename="f.txt"
content-type: application/javascript; charset=UTF-8
alt-svc: h3="googleads.g.doubleclick.net:443"; ma=2592000,h3=":443"; ma=2592000,h3-29="googleads.g.doubleclick.net:443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43",quic=":443"; ma=2592000; v="46,43"
content-length: 100
x-xss-protection: 0

GET
H2 200 integrator.js Show response
adservice.google.com/adsid/ 107 B
549 B 82ms
27ms Script
application/javascript 2a00:1450:4001:80f::2002
GOOGLE

General

Check archive.org

Show headers Download Go to

Full URL

https://adservice.google.com/adsid/integrator.js?domain=www.fiercepharma.com

Requested by

Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2022020301.js

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2a00:1450:4001:80f::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),

Reverse DNS

Software

cafe /

Resource Hash

a4a1824defec1084ca81d496ee77891684c26196924bdc4fc21dd3482ce15e14

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Xss-Protection	0

Request headers

Accept-Language: de-DE,de;q=0.9
Referer: https://www.fiercepharma.com/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

timing-allow-origin: *
date: Tue, 08 Feb 2022 14:03:33 GMT
content-encoding: gzip
x-content-type-options: nosniff
server: cafe
p3p: CP="This is not a P3P policy! See http://support.google.com/accounts/answer/151657 for more info."
cache-control: private, no-cache, no-store
cross-origin-resource-policy: cross-origin
content-disposition: attachment; filename="f.txt"
content-type: application/javascript; charset=UTF-8
alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length: 100
x-xss-protection: 0

GET
H3 200 ads Show response
securepubads.g.doubleclick.net/gampad/ 11 KB
5 KB 72ms
71ms XHR
text/plain 142.250.184.226
GOOGLE

General

Check archive.org

Show headers Download Go to

Full URL

https://securepubads.g.doubleclick.net/gampad/ads?gdfp_req=1&pvsid=3715860651702850&correlator=2090527831706528&output=ldjh&impl=fifs&vrg=2022020301&ptt=17&sc=1&sfv=1-0-38&ecs=20220208&iu_parts=298443%2Cquestex.lifesciences%2Cfiercepharma%2Cspecialreports&enc_prev_ius=%2F0%2F1%2F2%2F3%2C%2F0%2F1%2F2%2F3%2C%2F0%2F1%2F2%2F3%2C%2F0%2F1%2F2%2F3&prev_iu_szs=1x1%2C1x1%2C1x1%2C1x1&ists=15&prev_scp=pos%3D4%26hb_rfBid%3D0%7Cpos%3D7%26hb_rfBid%3D0%7Cpos%3D9%26hb_rfBid%3D0%7Cpos%3D8%26hb_rfBid%3D0&eri=1&cust_params=section%3DSpecial%2520Reports%26homefront%3D0%26sectionfront%3D0%26article%3D1%26nodeid%3D518261%26fm-tester%3Dundefined%26topic%3Dpsoriasis%252C%2520JAK%2520inhibitor%252C%2520drug%2520launch%252C%2520megamergers%26keyword%3DBristol%2520Myers%2520Squibb%252C%2520Deucravacitinib%252C%2520Otezla%252C%2520Celgene%252C%2520Amgen%252C%2520Novartis%252C%2520Cosentyx%252C%2520Eli%2520Lilly%252C%2520Taltz%252C%2520AbbVie%252C%2520Skyrizi%26tag%3DBristol%2520Myers%2520Squibb%252C%2520Deucravacitinib%252C%2520Otezla%252C%2520Celgene%252C%2520Amgen%252C%2520Novartis%252C%2520Cosentyx%252C%2520Eli%2520Lilly%252C%2520Taltz%252C%2520AbbVie%252C%2520Skyrizi%252Cpsoriasis%252C%2520JAK%2520inhibitor%252C%2520drug%2520launch%252C%2520megamergers%252CSpecial%2520Reports%26path%3D%252Fspecial-report%252F10-most-anticipated-drug-launches-2022-4-deucravacitinib%26browserLargerThan1460%3D1&cookie_enabled=1&bc=31&abxe=1&dt=1644329013933&lmt=1644329012&dlt=1644329013005&idt=591&frm=20&biw=1600&bih=1200&oid=2&adxs=200%2C-12245933%2C800%2C262&adys=24%2C-12245933%2C3143%2C1095&adks=788811237%2C3513369560%2C376738169%2C326019841&ucis=1%7C2%7C3%7C4&ifi=1&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_sd=1&flash=0&dmc=8&url=https%3A%2F%2Fwww.fiercepharma.com%2Fspecial-report%2F10-most-anticipated-drug-launches-2022-4-deucravacitinib&vis=1&scr_x=0&scr_y=0&psz=1200x0%7C1200x0%7C1600x0%7C710x0&msz=1200x0%7C0x0%7C1600x0%7C710x0&ga_vid=800578055.1644329014&ga_sid=1644329014&ga_hid=2005409921&ga_fc=true&fws=0%2C128%2C0%2C0&ohw=0%2C0%2C0%2C0&btvi=0%7C-1%7C1%7C0&uach=WyIiLCIiLCIiLCIiLCIiLFtdLG51bGwsbnVsbCwiIixbXV0.&nvt=1

Requested by

Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2022020301.js

Protocol

Security

QUIC, , AES_128_GCM

Server

142.250.184.226 , United States, ASN15169 (GOOGLE, US),

Reverse DNS

fra24s12-in-f2.1e100.net

Software

cafe /

Resource Hash

ca654ca012f00a16a69a197a73a81f859d7b6bc47b16e7ba2375a2a1bd6b9753

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Xss-Protection	0

Request headers

Accept-Language: de-DE,de;q=0.9
Referer: https://www.fiercepharma.com/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

date: Tue, 08 Feb 2022 14:03:34 GMT
content-encoding: br
x-content-type-options: nosniff
google-mediationgroup-id: -2,-2,-2,-2
p3p: policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
cross-origin-resource-policy: cross-origin
alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length: 4645
x-xss-protection: 0
google-lineitem-id: 4686405525,5899017965,-2,-2
pragma: no-cache
server: cafe
google-mediationtag-id: -2
google-creative-id: 138234349545,138379843108,-2,-2
content-type: text/plain; charset=UTF-8
access-control-allow-origin: https://www.fiercepharma.com
cache-control: no-cache, must-revalidate
access-control-allow-credentials: true
timing-allow-origin: *
expires: Fri, 01 Jan 1990 00:00:00 GMT

GET
H2 200 container.html Show response
88de716fcdb80ed5cefd22d492c50498.safeframe.googlesyndication.com/safeframe/1-0-38/html/ Frame 657D 6 KB
4 KB 91ms
26ms Document
text/html 2a00:1450:4001:810::2001
GOOGLE

General

Check archive.org

Show headers Download Go to

Full URL

https://88de716fcdb80ed5cefd22d492c50498.safeframe.googlesyndication.com/safeframe/1-0-38/html/container.html

Requested by

Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2022020301.js

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2a00:1450:4001:810::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),

Reverse DNS

Software

sffe /

Resource Hash

a73730123a43c3040d889aaee11ec35094277ce5f778076b262c23a293870adb

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Xss-Protection	0

Request headers

Upgrade-Insecure-Requests: 1
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Accept-Language: de-DE,de;q=0.9
Referer: https://www.fiercepharma.com/

Response headers

accept-ranges: bytes
vary: Accept-Encoding
content-encoding: gzip
content-type: text/html
cross-origin-resource-policy: cross-origin
cross-origin-opener-policy-report-only: same-origin; report-to="ads-gpt-scs"
report-to: {"group":"ads-gpt-scs","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/ads-gpt-scs"}]}
timing-allow-origin: *
content-length: 3108
date: Tue, 08 Feb 2022 14:03:34 GMT
expires: Wed, 08 Feb 2023 14:03:34 GMT
cache-control: public, immutable, max-age=31536000
last-modified: Tue, 02 Mar 2021 20:17:03 GMT
x-content-type-options: nosniff
server: sffe
x-xss-protection: 0
alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"

GET
H2 200 clock Show response
tracking.crazyegg.com/ 27 B
134 B 127ms
46ms XHR
text/plain 34.249.212.247
AMAZON-02

General

Check archive.org

Show headers Download Go to

Full URL: https://tracking.crazyegg.com/clock?t=1644329013950
Requested by: Host: script.crazyegg.com
URL: https://script.crazyegg.com/pages/versioned/common-scripts/11.1.381.js
Protocol: H2
Security: TLS 1.2, ECDHE_RSA, AES_128_GCM
Server: 34.249.212.247 Dublin, Ireland, ASN16509 (AMAZON-02, US),
Reverse DNS: ec2-34-249-212-247.eu-west-1.compute.amazonaws.com
Software: awselb/2.0 /
Resource Hash: aa095b0aa406f5e0ca743a71ff9523663e57d3874d514854b4d184075d60590d

Request headers

Accept-Language: de-DE,de;q=0.9
Referer: https://www.fiercepharma.com/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

access-control-allow-origin: *
date: Tue, 08 Feb 2022 14:03:34 GMT
cache-control: no-store
server: awselb/2.0
content-length: 27
content-type: text/plain

POST
H/1.1 200
OK prebid Show response
ib.adnxs.com/ut/v3/ Frame 447C 19 B
853 B 172ms
170ms XHR
application/json 37.252.172.37
ASN-APPNEX

General

Check archive.org

Show headers Download Go to

Full URL

https://ib.adnxs.com/ut/v3/prebid

Requested by

Host: p.nodserving.com
URL: https://p.nodserving.com/prebidlink/19031/pbm_307825_11600.js

Protocol

HTTP/1.1

Security

TLS 1.2, ECDHE_ECDSA, AES_128_GCM

Server

37.252.172.37 Frankfurt am Main, Germany, ASN29990 (ASN-APPNEX, US),

Reverse DNS

691.bm-nginx-loadbalancer.mgmt.fra1.adnexus.net

Software

nginx/1.17.9 /

Resource Hash

0c09c070833c786cb25be38bc30992b30bad578f817dbc9e34beacd8b8ea44c5

Security Headers

Name	Value
X-Xss-Protection	0

Request headers

Referer: https://p.nodserving.com/
Accept-Language: de-DE,de;q=0.9
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Content-Type: text/plain;charset=UTF-8

Response headers

Pragma: no-cache
Date: Tue, 08 Feb 2022 14:03:34 GMT
X-Proxy-Origin: 84.19.175.183; 84.19.175.183; 691.bm-nginx-loadbalancer.mgmt.fra1; adnxs.com
AN-X-Request-Uuid: 0bd30138-b73b-4954-bcb3-241c43f24fad
Server: nginx/1.17.9
P3P: policyref="http://cdn.adnxs-simple.com/w3c/policy/p3p.xml", CP="NOI DSP COR ADM PSAo PSDo OURo SAMo UNRo OTRo BUS COM NAV DEM STA PRE"
Access-Control-Allow-Origin: https://p.nodserving.com
Cache-Control: no-store, no-cache, private
Access-Control-Allow-Credentials: true
Connection: keep-alive
Content-Type: application/json; charset=utf-8
Content-Length: 19
X-XSS-Protection: 0
Expires: Sat, 15 Nov 2008 16:00:00 GMT

POST
H2 204 cdb Show response
bidder.criteo.com/ Frame 447C 0
217 B 55ms
44ms XHR
text/plain 178.250.0.165
ASN-CRITEO-EUROPE

General

Check archive.org

Show headers Download Go to

Full URL

https://bidder.criteo.com/cdb?profileId=207&av=31&wv=3.22&cb=66197187782

Requested by

Host: p.nodserving.com
URL: https://p.nodserving.com/prebidlink/19031/pbm_307825_11600.js

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

178.250.0.165 , France, ASN44788 (ASN-CRITEO-EUROPE, FR),

Reverse DNS

bidder.par.vip.prod.criteo.com

Software

Finatra /

Resource Hash

e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Security Headers

Name	Value
Strict-Transport-Security	max-age=31536000; preload;

Request headers

Referer: https://p.nodserving.com/
Accept-Language: de-DE,de;q=0.9
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Content-Type: text/plain;charset=UTF-8

Response headers

date: Tue, 08 Feb 2022 14:03:33 GMT
server: Finatra
vary: Origin
access-control-allow-origin: https://p.nodserving.com
access-control-allow-credentials: true
cross-origin-resource-policy: cross-origin
strict-transport-security: max-age=31536000; preload;
timing-allow-origin: *

POST
H2 200 prebid-request Show response
onetag-sys.com/ Frame 447C 15 B
363 B 27ms
17ms XHR
application/json 51.38.120.206
OVH

General

Check archive.org

Show headers Download Go to

Full URL

https://onetag-sys.com/prebid-request

Requested by

Host: p.nodserving.com
URL: https://p.nodserving.com/prebidlink/19031/pbm_307825_11600.js

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

51.38.120.206 , France, ASN16276 (OVH, FR),

Reverse DNS

ip206.ip-51-38-120.eu

Software

Resource Hash

663dab1310a7e64c3bdd7dfdc81b7fc9a28884d4ee290b96077c7b32bbe84707

Security Headers

Name	Value
Strict-Transport-Security	max-age=15552000

Request headers

Referer: https://p.nodserving.com/
Accept-Language: de-DE,de;q=0.9
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Content-Type: text/plain;charset=UTF-8

Response headers

strict-transport-security: max-age=15552000
content-encoding: gzip
p3p: CP='CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR'
access-control-allow-origin: https://p.nodserving.com
cache-control: no-transform, no-cache
access-control-allow-credentials: true
content-type: application/json
access-control-allow-headers: content-type, origin, referer, user-agent
content-length: 41

POST
H2 204 bids Show response
prebid-eu.creativecdn.com/bidder/prebid/ Frame 447C 0
178 B 76ms
22ms XHR
text/plain 185.184.8.65
RTB-HOUSE-AMS

General

Check archive.org

Show headers Download Go to

Full URL: https://prebid-eu.creativecdn.com/bidder/prebid/bids
Requested by: Host: p.nodserving.com
URL: https://p.nodserving.com/prebidlink/19031/pbm_307825_11600.js
Protocol: H2
Security: TLS 1.3, , AES_256_GCM
Server: 185.184.8.65 Amsterdam, Netherlands, ASN204995 (RTB-HOUSE-AMS, PL),
Reverse DNS: ip-185-184-8-65.rtbhouse.net
Software: /
Resource Hash: e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer: https://p.nodserving.com/
Accept-Language: de-DE,de;q=0.9
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Content-Type: text/plain;charset=UTF-8

Response headers

access-control-allow-origin: https://p.nodserving.com
date: Tue, 08 Feb 2022 14:03:34 GMT
access-control-allow-credentials: true
access-control-max-age: 3600
vary: Origin
access-control-allow-methods: POST

POST auction
rtb.adxpremium.services/openrtb2/ Frame 447C 0
0

POST
H/1.1 200
OK prebid Show response
ib.adnxs.com/ut/v3/ Frame 447C 19 B
853 B 213ms
207ms XHR
application/json 37.252.172.37
ASN-APPNEX

General

Check archive.org

Show headers Download Go to

Full URL

https://ib.adnxs.com/ut/v3/prebid

Requested by

Host: p.nodserving.com
URL: https://p.nodserving.com/prebidlink/19031/pbm_307825_11600.js

Protocol

HTTP/1.1

Security

TLS 1.2, ECDHE_ECDSA, AES_128_GCM

Server

37.252.172.37 Frankfurt am Main, Germany, ASN29990 (ASN-APPNEX, US),

Reverse DNS

691.bm-nginx-loadbalancer.mgmt.fra1.adnexus.net

Software

nginx/1.17.9 /

Resource Hash

0c09c070833c786cb25be38bc30992b30bad578f817dbc9e34beacd8b8ea44c5

Security Headers

Name	Value
X-Xss-Protection	0

Request headers

Referer: https://p.nodserving.com/
Accept-Language: de-DE,de;q=0.9
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Content-Type: text/plain;charset=UTF-8

Response headers

Pragma: no-cache
Date: Tue, 08 Feb 2022 14:03:34 GMT
X-Proxy-Origin: 84.19.175.183; 84.19.175.183; 691.bm-nginx-loadbalancer.mgmt.fra1; adnxs.com
AN-X-Request-Uuid: 83b7db2e-6954-49e5-93b8-13ae77faa7a9
Server: nginx/1.17.9
P3P: policyref="http://cdn.adnxs-simple.com/w3c/policy/p3p.xml", CP="NOI DSP COR ADM PSAo PSDo OURo SAMo UNRo OTRo BUS COM NAV DEM STA PRE"
Access-Control-Allow-Origin: https://p.nodserving.com
Cache-Control: no-store, no-cache, private
Access-Control-Allow-Credentials: true
Connection: keep-alive
Content-Type: application/json; charset=utf-8
Content-Length: 19
X-XSS-Protection: 0
Expires: Sat, 15 Nov 2008 16:00:00 GMT

POST
H2 204 cdb Show response
bidder.criteo.com/ Frame 447C 0
217 B 53ms
44ms XHR
text/plain 178.250.0.165
ASN-CRITEO-EUROPE

General

Check archive.org

Show headers Download Go to

Full URL

https://bidder.criteo.com/cdb?profileId=207&av=31&wv=3.22&cb=34832903244

Requested by

Host: p.nodserving.com
URL: https://p.nodserving.com/prebidlink/19031/pbm_307825_11600.js

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

178.250.0.165 , France, ASN44788 (ASN-CRITEO-EUROPE, FR),

Reverse DNS

bidder.par.vip.prod.criteo.com

Software

Finatra /

Resource Hash

e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Security Headers

Name	Value
Strict-Transport-Security	max-age=31536000; preload;

Request headers

Referer: https://p.nodserving.com/
Accept-Language: de-DE,de;q=0.9
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Content-Type: text/plain;charset=UTF-8

Response headers

date: Tue, 08 Feb 2022 14:03:33 GMT
server: Finatra
vary: Origin
access-control-allow-origin: https://p.nodserving.com
access-control-allow-credentials: true
cross-origin-resource-policy: cross-origin
strict-transport-security: max-age=31536000; preload;
timing-allow-origin: *

POST
H2 200 prebid-request Show response
onetag-sys.com/ Frame 447C 15 B
363 B 27ms
18ms XHR
application/json 51.38.120.206
OVH

General

Check archive.org

Show headers Download Go to

Full URL

https://onetag-sys.com/prebid-request

Requested by

Host: p.nodserving.com
URL: https://p.nodserving.com/prebidlink/19031/pbm_307825_11600.js

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

51.38.120.206 , France, ASN16276 (OVH, FR),

Reverse DNS

ip206.ip-51-38-120.eu

Software

Resource Hash

663dab1310a7e64c3bdd7dfdc81b7fc9a28884d4ee290b96077c7b32bbe84707

Security Headers

Name	Value
Strict-Transport-Security	max-age=15552000

Request headers

Referer: https://p.nodserving.com/
Accept-Language: de-DE,de;q=0.9
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Content-Type: text/plain;charset=UTF-8

Response headers

strict-transport-security: max-age=15552000
content-encoding: gzip
p3p: CP='CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR'
access-control-allow-origin: https://p.nodserving.com
cache-control: no-transform, no-cache
access-control-allow-credentials: true
content-type: application/json
access-control-allow-headers: content-type, origin, referer, user-agent
content-length: 41

POST
H2 204 bids Show response
prebid-eu.creativecdn.com/bidder/prebid/ Frame 447C 0
178 B 77ms
24ms XHR
text/plain 185.184.8.65
RTB-HOUSE-AMS

General

Check archive.org

Show headers Download Go to

Full URL: https://prebid-eu.creativecdn.com/bidder/prebid/bids
Requested by: Host: p.nodserving.com
URL: https://p.nodserving.com/prebidlink/19031/pbm_307825_11600.js
Protocol: H2
Security: TLS 1.3, , AES_256_GCM
Server: 185.184.8.65 Amsterdam, Netherlands, ASN204995 (RTB-HOUSE-AMS, PL),
Reverse DNS: ip-185-184-8-65.rtbhouse.net
Software: /
Resource Hash: e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer: https://p.nodserving.com/
Accept-Language: de-DE,de;q=0.9
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Content-Type: text/plain;charset=UTF-8

Response headers

access-control-allow-origin: https://p.nodserving.com
date: Tue, 08 Feb 2022 14:03:34 GMT
access-control-allow-credentials: true
access-control-max-age: 3600
vary: Origin
access-control-allow-methods: POST

POST auction
rtb.adxpremium.services/openrtb2/ Frame 447C 0
0

POST
H/1.1 200
OK prebid Show response
ib.adnxs.com/ut/v3/ Frame 447C 19 B
853 B 144ms
134ms XHR
application/json 37.252.172.37
ASN-APPNEX

General

Check archive.org

Show headers Download Go to

Full URL

https://ib.adnxs.com/ut/v3/prebid

Requested by

Host: p.nodserving.com
URL: https://p.nodserving.com/prebidlink/19031/pbm_307825_11600.js

Protocol

HTTP/1.1

Security

TLS 1.2, ECDHE_ECDSA, AES_128_GCM

Server

37.252.172.37 Frankfurt am Main, Germany, ASN29990 (ASN-APPNEX, US),

Reverse DNS

691.bm-nginx-loadbalancer.mgmt.fra1.adnexus.net

Software

nginx/1.17.9 /

Resource Hash

0c09c070833c786cb25be38bc30992b30bad578f817dbc9e34beacd8b8ea44c5

Security Headers

Name	Value
X-Xss-Protection	0

Request headers

Referer: https://p.nodserving.com/
Accept-Language: de-DE,de;q=0.9
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Content-Type: text/plain;charset=UTF-8

Response headers

Pragma: no-cache
Date: Tue, 08 Feb 2022 14:03:34 GMT
X-Proxy-Origin: 84.19.175.183; 84.19.175.183; 691.bm-nginx-loadbalancer.mgmt.fra1; adnxs.com
AN-X-Request-Uuid: a1f65d59-c90a-4c4d-9a59-fe997710b867
Server: nginx/1.17.9
P3P: policyref="http://cdn.adnxs-simple.com/w3c/policy/p3p.xml", CP="NOI DSP COR ADM PSAo PSDo OURo SAMo UNRo OTRo BUS COM NAV DEM STA PRE"
Access-Control-Allow-Origin: https://p.nodserving.com
Cache-Control: no-store, no-cache, private
Access-Control-Allow-Credentials: true
Connection: keep-alive
Content-Type: application/json; charset=utf-8
Content-Length: 19
X-XSS-Protection: 0
Expires: Sat, 15 Nov 2008 16:00:00 GMT

POST
H2 204 cdb Show response
bidder.criteo.com/ Frame 447C 0
217 B 51ms
43ms XHR
text/plain 178.250.0.165
ASN-CRITEO-EUROPE

General

Check archive.org

Show headers Download Go to

Full URL

https://bidder.criteo.com/cdb?profileId=207&av=31&wv=3.22&cb=36878908682

Requested by

Host: p.nodserving.com
URL: https://p.nodserving.com/prebidlink/19031/pbm_307825_11600.js

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

178.250.0.165 , France, ASN44788 (ASN-CRITEO-EUROPE, FR),

Reverse DNS

bidder.par.vip.prod.criteo.com

Software

Finatra /

Resource Hash

e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Security Headers

Name	Value
Strict-Transport-Security	max-age=31536000; preload;

Request headers

Referer: https://p.nodserving.com/
Accept-Language: de-DE,de;q=0.9
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Content-Type: text/plain;charset=UTF-8

Response headers

date: Tue, 08 Feb 2022 14:03:33 GMT
server: Finatra
vary: Origin
access-control-allow-origin: https://p.nodserving.com
access-control-allow-credentials: true
cross-origin-resource-policy: cross-origin
strict-transport-security: max-age=31536000; preload;
timing-allow-origin: *

POST
H2 200 prebid-request Show response
onetag-sys.com/ Frame 447C 15 B
363 B 25ms
18ms XHR
application/json 51.38.120.206
OVH

General

Check archive.org

Show headers Download Go to

Full URL

https://onetag-sys.com/prebid-request

Requested by

Host: p.nodserving.com
URL: https://p.nodserving.com/prebidlink/19031/pbm_307825_11600.js

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

51.38.120.206 , France, ASN16276 (OVH, FR),

Reverse DNS

ip206.ip-51-38-120.eu

Software

Resource Hash

663dab1310a7e64c3bdd7dfdc81b7fc9a28884d4ee290b96077c7b32bbe84707

Security Headers

Name	Value
Strict-Transport-Security	max-age=15552000

Request headers

Referer: https://p.nodserving.com/
Accept-Language: de-DE,de;q=0.9
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Content-Type: text/plain;charset=UTF-8

Response headers

strict-transport-security: max-age=15552000
content-encoding: gzip
p3p: CP='CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR'
access-control-allow-origin: https://p.nodserving.com
cache-control: no-transform, no-cache
access-control-allow-credentials: true
content-type: application/json
access-control-allow-headers: content-type, origin, referer, user-agent
content-length: 41

POST
H2 204 bids Show response
prebid-eu.creativecdn.com/bidder/prebid/ Frame 447C 0
178 B 87ms
35ms XHR
text/plain 185.184.8.65
RTB-HOUSE-AMS

General

Check archive.org

Show headers Download Go to

Full URL: https://prebid-eu.creativecdn.com/bidder/prebid/bids
Requested by: Host: p.nodserving.com
URL: https://p.nodserving.com/prebidlink/19031/pbm_307825_11600.js
Protocol: H2
Security: TLS 1.3, , AES_256_GCM
Server: 185.184.8.65 Amsterdam, Netherlands, ASN204995 (RTB-HOUSE-AMS, PL),
Reverse DNS: ip-185-184-8-65.rtbhouse.net
Software: /
Resource Hash: e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer: https://p.nodserving.com/
Accept-Language: de-DE,de;q=0.9
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Content-Type: text/plain;charset=UTF-8

Response headers

access-control-allow-origin: https://p.nodserving.com
date: Tue, 08 Feb 2022 14:03:34 GMT
access-control-allow-credentials: true
access-control-max-age: 3600
vary: Origin
access-control-allow-methods: POST

POST auction
rtb.adxpremium.services/openrtb2/ Frame 447C 0
0

POST
H/1.1 200
OK prebid Show response
ib.adnxs.com/ut/v3/ Frame 447C 19 B
853 B 63ms
34ms XHR
application/json 37.252.172.37
ASN-APPNEX

General

Check archive.org

Show headers Download Go to

Full URL

https://ib.adnxs.com/ut/v3/prebid

Requested by

Host: p.nodserving.com
URL: https://p.nodserving.com/prebidlink/19031/pbm_307825_11600.js

Protocol

HTTP/1.1

Security

TLS 1.2, ECDHE_ECDSA, AES_128_GCM

Server

37.252.172.37 Frankfurt am Main, Germany, ASN29990 (ASN-APPNEX, US),

Reverse DNS

691.bm-nginx-loadbalancer.mgmt.fra1.adnexus.net

Software

nginx/1.17.9 /

Resource Hash

0c09c070833c786cb25be38bc30992b30bad578f817dbc9e34beacd8b8ea44c5

Security Headers

Name	Value
X-Xss-Protection	0

Request headers

Referer: https://p.nodserving.com/
Accept-Language: de-DE,de;q=0.9
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Content-Type: text/plain;charset=UTF-8

Response headers

Pragma: no-cache
Date: Tue, 08 Feb 2022 14:03:34 GMT
X-Proxy-Origin: 84.19.175.183; 84.19.175.183; 691.bm-nginx-loadbalancer.mgmt.fra1; adnxs.com
AN-X-Request-Uuid: f70e3de8-a09c-4f23-8268-799a7533331d
Server: nginx/1.17.9
P3P: policyref="http://cdn.adnxs-simple.com/w3c/policy/p3p.xml", CP="NOI DSP COR ADM PSAo PSDo OURo SAMo UNRo OTRo BUS COM NAV DEM STA PRE"
Access-Control-Allow-Origin: https://p.nodserving.com
Cache-Control: no-store, no-cache, private
Access-Control-Allow-Credentials: true
Connection: keep-alive
Content-Type: application/json; charset=utf-8
Content-Length: 19
X-XSS-Protection: 0
Expires: Sat, 15 Nov 2008 16:00:00 GMT

POST
H2 204 cdb Show response
bidder.criteo.com/ Frame 447C 0
217 B 52ms
45ms XHR
text/plain 178.250.0.165
ASN-CRITEO-EUROPE

General

Check archive.org

Show headers Download Go to

Full URL

https://bidder.criteo.com/cdb?profileId=207&av=31&wv=3.22&cb=65022985886

Requested by

Host: p.nodserving.com
URL: https://p.nodserving.com/prebidlink/19031/pbm_307825_11600.js

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

178.250.0.165 , France, ASN44788 (ASN-CRITEO-EUROPE, FR),

Reverse DNS

bidder.par.vip.prod.criteo.com

Software

Finatra /

Resource Hash

e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Security Headers

Name	Value
Strict-Transport-Security	max-age=31536000; preload;

Request headers

Referer: https://p.nodserving.com/
Accept-Language: de-DE,de;q=0.9
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Content-Type: text/plain;charset=UTF-8

Response headers

date: Tue, 08 Feb 2022 14:03:33 GMT
server: Finatra
vary: Origin
access-control-allow-origin: https://p.nodserving.com
access-control-allow-credentials: true
cross-origin-resource-policy: cross-origin
strict-transport-security: max-age=31536000; preload;
timing-allow-origin: *

POST
H2 200 prebid-request Show response
onetag-sys.com/ Frame 447C 15 B
363 B 23ms
17ms XHR
application/json 51.38.120.206
OVH

General

Check archive.org

Show headers Download Go to

Full URL

https://onetag-sys.com/prebid-request

Requested by

Host: p.nodserving.com
URL: https://p.nodserving.com/prebidlink/19031/pbm_307825_11600.js

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

51.38.120.206 , France, ASN16276 (OVH, FR),

Reverse DNS

ip206.ip-51-38-120.eu

Software

Resource Hash

663dab1310a7e64c3bdd7dfdc81b7fc9a28884d4ee290b96077c7b32bbe84707

Security Headers

Name	Value
Strict-Transport-Security	max-age=15552000

Request headers

Referer: https://p.nodserving.com/
Accept-Language: de-DE,de;q=0.9
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Content-Type: text/plain;charset=UTF-8

Response headers

strict-transport-security: max-age=15552000
content-encoding: gzip
p3p: CP='CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR'
access-control-allow-origin: https://p.nodserving.com
cache-control: no-transform, no-cache
access-control-allow-credentials: true
content-type: application/json
access-control-allow-headers: content-type, origin, referer, user-agent
content-length: 41

POST
H2 204 bids Show response
prebid-eu.creativecdn.com/bidder/prebid/ Frame 447C 0
178 B 94ms
43ms XHR
text/plain 185.184.8.65
RTB-HOUSE-AMS

General

Check archive.org

Show headers Download Go to

Full URL: https://prebid-eu.creativecdn.com/bidder/prebid/bids
Requested by: Host: p.nodserving.com
URL: https://p.nodserving.com/prebidlink/19031/pbm_307825_11600.js
Protocol: H2
Security: TLS 1.3, , AES_256_GCM
Server: 185.184.8.65 Amsterdam, Netherlands, ASN204995 (RTB-HOUSE-AMS, PL),
Reverse DNS: ip-185-184-8-65.rtbhouse.net
Software: /
Resource Hash: e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer: https://p.nodserving.com/
Accept-Language: de-DE,de;q=0.9
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Content-Type: text/plain;charset=UTF-8

Response headers

access-control-allow-origin: https://p.nodserving.com
date: Tue, 08 Feb 2022 14:03:34 GMT
access-control-allow-credentials: true
access-control-max-age: 3600
vary: Origin
access-control-allow-methods: POST

POST auction
rtb.adxpremium.services/openrtb2/ Frame 447C 0
0

POST
H/1.1 200
OK prebid Show response
ib.adnxs.com/ut/v3/ Frame 447C 19 B
853 B 49ms
21ms XHR
application/json 37.252.172.37
ASN-APPNEX

General

Check archive.org

Show headers Download Go to

Full URL

https://ib.adnxs.com/ut/v3/prebid

Requested by

Host: p.nodserving.com
URL: https://p.nodserving.com/prebidlink/19031/pbm_307825_11600.js

Protocol

HTTP/1.1

Security

TLS 1.2, ECDHE_ECDSA, AES_128_GCM

Server

37.252.172.37 Frankfurt am Main, Germany, ASN29990 (ASN-APPNEX, US),

Reverse DNS

691.bm-nginx-loadbalancer.mgmt.fra1.adnexus.net

Software

nginx/1.17.9 /

Resource Hash

0c09c070833c786cb25be38bc30992b30bad578f817dbc9e34beacd8b8ea44c5

Security Headers

Name	Value
X-Xss-Protection	0

Request headers

Referer: https://p.nodserving.com/
Accept-Language: de-DE,de;q=0.9
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Content-Type: text/plain;charset=UTF-8

Response headers

Pragma: no-cache
Date: Tue, 08 Feb 2022 14:03:34 GMT
X-Proxy-Origin: 84.19.175.183; 84.19.175.183; 691.bm-nginx-loadbalancer.mgmt.fra1; adnxs.com
AN-X-Request-Uuid: b4ecff5d-54ec-41dd-b3d7-bbc70baa560f
Server: nginx/1.17.9
P3P: policyref="http://cdn.adnxs-simple.com/w3c/policy/p3p.xml", CP="NOI DSP COR ADM PSAo PSDo OURo SAMo UNRo OTRo BUS COM NAV DEM STA PRE"
Access-Control-Allow-Origin: https://p.nodserving.com
Cache-Control: no-store, no-cache, private
Access-Control-Allow-Credentials: true
Connection: keep-alive
Content-Type: application/json; charset=utf-8
Content-Length: 19
X-XSS-Protection: 0
Expires: Sat, 15 Nov 2008 16:00:00 GMT

POST
H2 204 cdb Show response
bidder.criteo.com/ Frame 447C 0
217 B 37ms
32ms XHR
text/plain 178.250.0.165
ASN-CRITEO-EUROPE

General

Check archive.org

Show headers Download Go to

Full URL

https://bidder.criteo.com/cdb?profileId=207&av=31&wv=3.22&cb=78221222204

Requested by

Host: p.nodserving.com
URL: https://p.nodserving.com/prebidlink/19031/pbm_307825_11600.js

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

178.250.0.165 , France, ASN44788 (ASN-CRITEO-EUROPE, FR),

Reverse DNS

bidder.par.vip.prod.criteo.com

Software

Finatra /

Resource Hash

e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Security Headers

Name	Value
Strict-Transport-Security	max-age=31536000; preload;

Request headers

Referer: https://p.nodserving.com/
Accept-Language: de-DE,de;q=0.9
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Content-Type: text/plain;charset=UTF-8

Response headers

date: Tue, 08 Feb 2022 14:03:33 GMT
server: Finatra
vary: Origin
access-control-allow-origin: https://p.nodserving.com
access-control-allow-credentials: true
cross-origin-resource-policy: cross-origin
strict-transport-security: max-age=31536000; preload;
timing-allow-origin: *

POST
H2 200 prebid-request Show response
onetag-sys.com/ Frame 447C 15 B
363 B 38ms
34ms XHR
application/json 51.38.120.206
OVH

General

Check archive.org

Show headers Download Go to

Full URL

https://onetag-sys.com/prebid-request

Requested by

Host: p.nodserving.com
URL: https://p.nodserving.com/prebidlink/19031/pbm_307825_11600.js

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

51.38.120.206 , France, ASN16276 (OVH, FR),

Reverse DNS

ip206.ip-51-38-120.eu

Software

Resource Hash

663dab1310a7e64c3bdd7dfdc81b7fc9a28884d4ee290b96077c7b32bbe84707

Security Headers

Name	Value
Strict-Transport-Security	max-age=15552000

Request headers

Referer: https://p.nodserving.com/
Accept-Language: de-DE,de;q=0.9
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Content-Type: text/plain;charset=UTF-8

Response headers

strict-transport-security: max-age=15552000
content-encoding: gzip
p3p: CP='CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR'
access-control-allow-origin: https://p.nodserving.com
cache-control: no-transform, no-cache
access-control-allow-credentials: true
content-type: application/json
access-control-allow-headers: content-type, origin, referer, user-agent
content-length: 41

POST
H2 204 bids Show response
prebid-eu.creativecdn.com/bidder/prebid/ Frame 447C 0
178 B 92ms
43ms XHR
text/plain 185.184.8.65
RTB-HOUSE-AMS

General

Check archive.org

Show headers Download Go to

Full URL: https://prebid-eu.creativecdn.com/bidder/prebid/bids
Requested by: Host: p.nodserving.com
URL: https://p.nodserving.com/prebidlink/19031/pbm_307825_11600.js
Protocol: H2
Security: TLS 1.3, , AES_256_GCM
Server: 185.184.8.65 Amsterdam, Netherlands, ASN204995 (RTB-HOUSE-AMS, PL),
Reverse DNS: ip-185-184-8-65.rtbhouse.net
Software: /
Resource Hash: e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer: https://p.nodserving.com/
Accept-Language: de-DE,de;q=0.9
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Content-Type: text/plain;charset=UTF-8

Response headers

access-control-allow-origin: https://p.nodserving.com
date: Tue, 08 Feb 2022 14:03:34 GMT
access-control-allow-credentials: true
access-control-max-age: 3600
vary: Origin
access-control-allow-methods: POST

POST auction
rtb.adxpremium.services/openrtb2/ Frame 447C 0
0

GET
H/1.1 200
OK csyncs Show response
ghb.hbmp.mediafuse.com/ 441 B
578 B 33ms
29ms XHR
application/json 2a0c:5c81:5142::2
24SHELLS

General

Check archive.org

Show headers Download Go to

Full URL: https://ghb.hbmp.mediafuse.com/csyncs?aid1=535746&aid2=535749&aid3=undefined
Requested by: Host: player.hbmp.mediafuse.com
URL: https://player.hbmp.mediafuse.com/prebidlink/456758/hbw_master_302826_6936.js
Protocol: HTTP/1.1
Security: TLS 1.3, , AES_128_GCM
Server: 2a0c:5c81:5142::2 London, United Kingdom, ASN55081 (24SHELLS, US),
Reverse DNS
Software: VertaMedia 1.0 /
Resource Hash: 8511f98206804fb8c0075966c6b5d03399d359e87c22aa0a4285ed906fdeffe0

Request headers

Accept-Language: de-DE,de;q=0.9
Referer: https://www.fiercepharma.com/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

Date: Tue, 08 Feb 2022 14:03:33 GMT
Content-Encoding: gzip
Server: VertaMedia 1.0
Content-Type: application/json; charset=UTF-8
Access-Control-Allow-Origin: https://www.fiercepharma.com
Access-Control-Allow-Credentials: true
Connection: Keep-Alive
Content-Length: 283

GET
H2 200 7c3.js Show response
sync.medidexs.com/ps/10/ 57 KB
21 KB 71ms
27ms Script
application/javascript 45.133.44.3
ADVANCEDHOSTERS-AS

General

Check archive.org

Show headers Download Go to

Full URL: https://sync.medidexs.com/ps/10/7c3.js
Requested by: Host: player.hbmp.mediafuse.com
URL: https://player.hbmp.mediafuse.com/prebidlink/456758/hbw_master_302826_6936.js
Protocol: H2
Security: TLS 1.3, , AES_256_GCM
Server: 45.133.44.3 Philadelphia, United States, ASN39572 (ADVANCEDHOSTERS-AS, NL),
Reverse DNS
Software: nginx /
Resource Hash: baf0ab84c1595ad02bf60b1d84cb1f271fd13486fd76dc599ec425f0c91c65be

Request headers

Accept-Language: de-DE,de;q=0.9
Referer: https://www.fiercepharma.com/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

date: Tue, 08 Feb 2022 14:03:34 GMT
content-encoding: gzip
last-modified: Mon, 07 Feb 2022 10:35:22 GMT
server: nginx
etag: W/"6200f5ea-e3ef"
content-type: application/javascript; charset=utf-8
access-control-allow-origin: *
cache-control: max-age=3600
expires: Tue, 08 Feb 2022 15:03:34 GMT

GET
H2 200 170 Show response
a.ad.gt/api/v1/u/matches/ 3 KB
4 KB 556ms
193ms Script
application/javascript 54.149.174.3
AMAZON-02

General

Check archive.org

Show headers Download Go to

Full URL: https://a.ad.gt/api/v1/u/matches/170
Requested by: Host: player.hbmp.mediafuse.com
URL: https://player.hbmp.mediafuse.com/prebidlink/456758/hbw_master_302826_6936.js
Protocol: H2
Security: TLS 1.2, ECDHE_RSA, AES_128_GCM
Server: 54.149.174.3 Boardman, United States, ASN16509 (AMAZON-02, US),
Reverse DNS: ec2-54-149-174-3.us-west-2.compute.amazonaws.com
Software: nginx/1.18.0 /
Resource Hash: 621905724521efdbc3275b3656e78a7441085d19eca88217d46bb827dd6046eb

Request headers

Accept-Language: de-DE,de;q=0.9
Referer: https://www.fiercepharma.com/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

date: Tue, 08 Feb 2022 14:03:34 GMT
server: nginx/1.18.0
content-length: 3210
content-type: application/javascript

GET
H2 200 init-1016mnvd6jvjr44ajs9g.js Show response
api.fouanalytics.com/api/ 473 B
929 B 268ms
205ms Script
text/javascript 2606:4700:3033::6815:3a2a
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL: https://api.fouanalytics.com/api/init-1016mnvd6jvjr44ajs9g.js
Requested by: Host: player.hbmp.mediafuse.com
URL: https://player.hbmp.mediafuse.com/prebidlink/456758/hbw_master_302826_6936.js
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 2606:4700:3033::6815:3a2a , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software: cloudflare /
Resource Hash: 5e828d5a3812a8c7d5599ea964aee835230f4581353e1d4745981773df5d6bd9

Request headers

Accept-Language: de-DE,de;q=0.9
Referer: https://www.fiercepharma.com/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

date: Tue, 08 Feb 2022 14:03:34 GMT
content-encoding: br
cf-cache-status: DYNAMIC
nel: {"success_fraction":0,"report_to":"cf-nel","max_age":604800}
server: cloudflare
expect-ct: max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
report-to: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=CMgGsVPM46U8gWDF3TwUYh4o7TIgLAhY9rLJHKyeFw8ttBaakMdyZcwumVvJC4liROhw1Bf0NZM60pnd87rqqgtH%2B972TGC4pmiv92VMpWEeDpTqpdDQVq34afFMRrYjCGAPiBChD%2Fx6vmkbT4WMWfrFEg%3D%3D"}],"group":"cf-nel","max_age":604800}
content-type: text/javascript
cache-control: no-cache, no-store, must-revalidate
cf-ray: 6da566f1ca9d924d-FRA
alt-svc: h3=":443"; ma=86400, h3-29=":443"; ma=86400
expires: 0

GET
H2 404 /
c405.fiercepharma.com/DG/DEFAULT/rest/rpc/ 0
0 403ms
403ms Script
text/html 99.86.3.109
AMAZON-02

General

Check archive.org

Show headers Download Go to

Full URL: https://c405.fiercepharma.com/DG/DEFAULT/rest/rpc/?requests=%5B%7B%22method%22%3A%22getProfile%22%2C%22params%22%3A%22null%22%2C%22id%22%3A%221644329013130%22%7D%2C%7B%22method%22%3A%22setProperties%22%2C%22params%22%3A%22%7B%5C%22properties%5C%22%3A%7B%5C%22language%5C%22%3A%5B%5C%22en%5C%22%5D%2C%5C%22currentscreenwidth%5C%22%3A%5B1600%5D%2C%5C%22currentscreenheight%5C%22%3A%5B1200%5D%2C%5C%22currentresolution%5C%22%3A%5B%5C%221600x1200%5C%22%5D%2C%5C%22entrypage%5C%22%3A%5B%5C%22https%3A%2F%2Fwww.fiercepharma.com%2Fspecial-report%2F10-most-anticipated-drug-launches-2022-4-deucravacitinib%5C%22%5D%2C%5C%22new_visit_bc%5C%22%3A%5B%5C%22true%5C%22%5D%7D%2C%5C%22sources%5C%22%3A%7B%5C%22listenerinteractiontype%5C%22%3A%5B%5C%22language%5C%22%2C%5C%22currentscreenwidth%5C%22%2C%5C%22currentscreenheight%5C%22%2C%5C%22currentresolution%5C%22%2C%5C%22entrypage%5C%22%5D%2C%5C%22newvisitlistener%5C%22%3A%5B%5C%22new_visit_bc%5C%22%5D%7D%7D%22%2C%22id%22%3A%221644329013132%22%7D%2C%7B%22method%22%3A%22addProperties%22%2C%22params%22%3A%22%7B%5C%22properties%5C%22%3A%7B%5C%22resolution%5C%22%3A%5B%5C%221600x1200%5C%22%5D%7D%2C%5C%22sources%5C%22%3A%7B%5C%22listenerinteractiontype%5C%22%3A%5B%5C%22resolution%5C%22%5D%7D%7D%22%2C%22id%22%3A%221644329013133%22%7D%2C%7B%22method%22%3A%22createEvent%22%2C%22params%22%3A%22%7B%5C%22type%5C%22%3A%5B%5C%22PAGEVIEW%5C%22%5D%2C%5C%22referrer%5C%22%3A%5B%5C%22%5C%22%5D%2C%5C%22profile%5C%22%3A%5B%5D%7D%22%2C%22id%22%3A%221644329013134%22%7D%5D&referer=https%3A%2F%2Fwww.fiercepharma.com%2Fspecial-report%2F10-most-anticipated-drug-launches-2022-4-deucravacitinib&bcsessionid=&bctempid=&overruleReferrer=&time=2022-02-08T14%3A03%3A33%2B00%3A00&callback=bc_json796
Requested by: Host: cdn.blueconic.net
URL: https://cdn.blueconic.net/questex.js
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 99.86.3.109 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS: server-99-86-3-109.fra6.r.cloudfront.net
Software: /
Resource Hash

Request headers

Accept-Language: de-DE,de;q=0.9
Referer: https://www.fiercepharma.com/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

GET
H/1.1

200
OK

1px-matching-adtelligent.gif
t.trafmag.com/images/images/
Redirect Chain

https://sync.adtelligent.com/csync?&redir=https%3A%2F%2Ft.trafmag.com%2Fimages%2Fimages%2F1px-matching-adtelligent.gif%3Fid%3D%7Buid%7D
https://t.trafmag.com/images/images/1px-matching-adtelligent.gif?id=dee7590cecd5b9a6

35 B
351 B

69ms
23ms

Image
image/gif

193.200.65.5
GIVEME-CLOUD

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://t.trafmag.com/images/images/1px-matching-adtelligent.gif?id=dee7590cecd5b9a6
Requested by: Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/special-report/10-most-anticipated-drug-launches-2022-4-deucravacitinib
Protocol: HTTP/1.1
Server: 193.200.65.5 Amsterdam, Netherlands, ASN6681 (GIVEME-CLOUD, PL),
Reverse DNS: t.trafmag.com
Software: nginx /
Resource Hash: 6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Accept-Language: de-DE,de;q=0.9
Referer: https://www.fiercepharma.com/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

Date: Tue, 08 Feb 2022 14:03:36 GMT
Server: nginx
Connection: keep-alive
Content-Type: image/gif
Content-Length: 35
P3P: CP="NON DSP COR CURa TIA"

Redirect headers

Location: https://t.trafmag.com/images/images/1px-matching-adtelligent.gif?id=dee7590cecd5b9a6
Date: Tue, 08 Feb 2022 14:03:35 GMT
Server: VertaMedia 1.0
Etag: dee7590cecd5b9a6
Content-Length: 0

GET
H2 204 match
dm.hybrid.ai/ 0
238 B 237ms
90ms Image
text/plain 37.18.16.16
HYBRID-AS

General

Check archive.org

Show headers Download Go to Show image

Full URL

https://dm.hybrid.ai/match?id=186&burl=https%3A%2F%2Fsync.adtelligent.com%2Fcsync%3Ft%3Da%26ep%3D324902%26extuid%3D%24%7BVID%7D

Requested by

Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/special-report/10-most-anticipated-drug-launches-2022-4-deucravacitinib

Protocol

Security

TLS 1.3, , AES_256_GCM

Server

37.18.16.16 , Russian Federation, ASN205675 (HYBRID-AS, RU),

Reverse DNS

Software

Hybrid Web Server /

Resource Hash

e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Security Headers

Name	Value
X-Xss-Protection	1; mode=block

Request headers

Accept-Language: de-DE,de;q=0.9
Referer: https://www.fiercepharma.com/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

pragma: no-cache
date: Tue, 08 Feb 2022 14:03:34 GMT
server: Hybrid Web Server
p3p: CP="NOI DSP COR CUR ADMa DEVo TAIo PSAo PSDo IVAo IVDo OUR IND COM NAV INT STA OTC"
access-control-allow-origin: *
cache-control: no-cache, no-store
x-mode: 106
x-xss-protection: 1; mode=block
expires: -1

GET universal-tag.js
ads.spotible.com/tag/ Frame 8F33 0
0

GET
DATA 200
OK truncated
/ Frame 8F33 212 B
0 Image
image/png

General

Check archive.org

Show headers Download Go to Show image

Full URL: data:truncated
Protocol: DATA
Server: -, , ASN (),
Reverse DNS
Software: /
Resource Hash: 7dbd08f38e653616e532e19722470d509ea90219f9f1285f19f60587e71e1dae

Request headers

Accept-Language: de-DE,de;q=0.9
Referer
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

Content-Type: image/png

GET
H2 200 allstream.js Show response
creative.spotible.com/tag/ Frame 8C21 4 KB
2 KB 364ms
100ms Script
application/javascript 54.144.118.149
AMAZON-AES

General

Check archive.org

Show headers Download Go to

Full URL: https://creative.spotible.com/tag/allstream.js
Requested by: Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2022020301.js
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 54.144.118.149 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS: ec2-54-144-118-149.compute-1.amazonaws.com
Software: /
Resource Hash: 13b3e0ebce53b1bad544de9ab941325c97244335a255d701f964667fdcec7e12

Request headers

Accept-Language: de-DE,de;q=0.9
Referer: https://www.fiercepharma.com/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

date: Tue, 08 Feb 2022 14:03:33 GMT
cache-control: public, max-age=3600
content-encoding: gzip
etag: "13d60a009d7a4ed35e01731ee02c2db7"
vary: accept-encoding
content-type: application/javascript

GET
H/1.1 200 spinner.gif
cdn.omeda.com/hosted/images/dragon/generic/ Frame 8E4A 9 KB
9 KB 729ms
121ms Image
image/gif 205.162.42.5
QTS-AS

General

Check archive.org

Show headers Download Go to Show image

Full URL

https://cdn.omeda.com/hosted/images/dragon/generic/spinner.gif

Requested by

Host: sample.dragonforms.com
URL: https://sample.dragonforms.com/init.do?omedasite=FiercePharma_short

Protocol

HTTP/1.1

Security

TLS 1.2, ECDHE_RSA, AES_256_GCM

Server

205.162.42.5 , United States, ASN53866 (QTS-AS, US),

Reverse DNS

cdn.omeda.com

Software

Apache /

Resource Hash

056dd44aece96c67e45ba421d734f125e1497bbdb3b70194b7aadb8a68d10085

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Frame-Options	SAMEORIGIN
X-Xss-Protection	1; mode=block

Request headers

Accept-Language: de-DE,de;q=0.9
Referer: https://sample.dragonforms.com/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

Date: Tue, 08 Feb 2022 15:03:34 CET
X-Content-Type-Options: nosniff
Last-Modified: Mon, 10 Oct 2016 22:45:02 CEST
Server: Apache
ETag: W/"8851-1476132302920"
X-Frame-Options: SAMEORIGIN
Content-Type: image/gif
Access-Control-Allow-Origin: *
Access-Control-Expose-Headers: Access-Control-Allow-Origin,Access-Control-Allow-Credentials
Transfer-Encoding: chunked
Accept-Ranges: bytes
X-XSS-Protection: 1; mode=block

GET
H/1.1

200
OK

index.php Show response
a.dpmsrv.com/dpmpxl/
Redirect Chain

https://cm.g.doubleclick.net/pixel?google_nid=datapoint_dmp&google_cm&ap_id=5611407578940007418&pixelIndex=0&_=1644329013516
https://a.dpmsrv.com/dpmpxl/index.php?q=dfp&ap_id=5611407578940007418&pixelIndex=0&_=1644329013516&google_gid=CAESEA3-l_Gnaz_pvXyZ-K0qbeA&google_cver=1

0
597 B

101ms
101ms

Script
text/javascript

3.226.203.17
AMAZON-AES

General

Check archive.org

Show headers Download Go to

Full URL: https://a.dpmsrv.com/dpmpxl/index.php?q=dfp&ap_id=5611407578940007418&pixelIndex=0&_=1644329013516&google_gid=CAESEA3-l_Gnaz_pvXyZ-K0qbeA&google_cver=1
Requested by: Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/special-report/10-most-anticipated-drug-launches-2022-4-deucravacitinib
Protocol: HTTP/1.1
Server: 3.226.203.17 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS: ec2-3-226-203-17.compute-1.amazonaws.com
Software: /
Resource Hash: e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Accept-Language: de-DE,de;q=0.9
Referer: https://www.fiercepharma.com/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

Pragma: no-cache
Access-Control-Max-Age: 10
Access-Control-Allow-Methods: GET, POST, PUT, DELETE, OPTIONS
P3P: CP="IDC DSP COR ADM DEVi TAIi PSA PSD IVAi IVDi CONi HIS OUR IND CNT"
Access-Control-Allow-Origin: *
Cache-Control: no-cache, no-store, must-revalidate
Connection: keep-alive
Content-Type: text/javascript
Access-Control-Allow-Headers: content-type, accept
Content-Length: 0
Expires: 0

Redirect headers

pragma: no-cache
date: Tue, 08 Feb 2022 14:03:34 GMT
server: HTTP server (unknown)
p3p: policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
location: https://a.dpmsrv.com/dpmpxl/index.php?q=dfp&ap_id=5611407578940007418&pixelIndex=0&_=1644329013516&google_gid=CAESEA3-l_Gnaz_pvXyZ-K0qbeA&google_cver=1
cache-control: no-cache, must-revalidate
cross-origin-resource-policy: cross-origin
content-type: text/html; charset=UTF-8
alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length: 368
x-xss-protection: 0
expires: Fri, 01 Jan 1990 00:00:00 GMT

GET
H2 451 423396.gif
idsync.rlcdn.com/ 0
66 B 116ms
29ms Image
text/plain 35.244.174.68
GOOGLE

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://idsync.rlcdn.com/423396.gif?partner_uid=5611407578940007418
Requested by: Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/special-report/10-most-anticipated-drug-launches-2022-4-deucravacitinib
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 35.244.174.68 Kansas City, United States, ASN15169 (GOOGLE, US),
Reverse DNS: 68.174.244.35.bc.googleusercontent.com
Software: /
Resource Hash: e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Accept-Language: de-DE,de;q=0.9
Referer: https://www.fiercepharma.com/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

date: Tue, 08 Feb 2022 14:03:34 GMT
via: 1.1 google
alt-svc: clear
content-length: 0

GET
H2 200 pp.js Show response
api-54-185-136-237.b2c.com/s/ 13 KB
5 KB 108ms
29ms Script
text/javascript 2606:4700:20::681a:723
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL: https://api-54-185-136-237.b2c.com/s/pp.js
Requested by: Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/special-report/10-most-anticipated-drug-launches-2022-4-deucravacitinib
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 2606:4700:20::681a:723 , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software: cloudflare /
Resource Hash: 4f999f96da9bb7bd681b62c42ef5e5e2c9d80896b8aafa4a030279c0d05ea674

Request headers

Accept-Language: de-DE,de;q=0.9
Referer: https://www.fiercepharma.com/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

date: Tue, 08 Feb 2022 14:03:34 GMT
content-encoding: br
cf-cache-status: HIT
last-modified: Mon, 03 Jan 2022 15:12:15 GMT
server: cloudflare
age: 811
etag: W/"61d3124f-3346"
expect-ct: max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary: Accept-Encoding
report-to: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=3ZWcX7rYSIwvZLgTAWV66zIN4qBgQmLKu%2BS993CiRB6d447%2BPUQs%2BrMiMldRKrZxSggv1zPLtCNshKKqey7ZGt7QT%2BtqIfWpp68uu1wPruWyq%2FgPgPP2hgG%2BuhGTV%2B4UeMDHwVZZWUCvKcdJRV%2B%2B0sx0yJ45cvbJ"}],"group":"cf-nel","max_age":604800}
content-type: text/javascript
nel: {"success_fraction":0,"report_to":"cf-nel","max_age":604800}
cf-ray: 6da566f39de59116-FRA

GET
H2 200 ad.gif
api-54-185-136-237.b2c.com/s/ 43 B
379 B 24ms
23ms Image
image/gif 2606:4700:20::681a:723
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://api-54-185-136-237.b2c.com/s/ad.gif
Requested by: Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/special-report/10-most-anticipated-drug-launches-2022-4-deucravacitinib
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 2606:4700:20::681a:723 , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software: cloudflare /
Resource Hash: dcecab1355b5c2b9ecef281322bf265ac5840b4688748586e9632b473a5fe56b

Request headers

Accept-Language: de-DE,de;q=0.9
Referer: https://www.fiercepharma.com/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

date: Tue, 08 Feb 2022 14:03:34 GMT
cf-cache-status: HIT
last-modified: Mon, 03 Jan 2022 15:12:15 GMT
server: cloudflare
age: 812
etag: "61d3124f-2b"
expect-ct: max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary: Accept-Encoding
report-to: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=RohicjZ9Un6pC%2F%2BvwRMSeEBbq0tOLefQWGWwQy5N6QJ%2BIAmD%2Bx%2FbUUvZ6KkfGeIVyarpBbECys1I2JBngtrjvLD3OAC5ztc4ANjjx9cgF8mztYXRuOFKP20T2PpBp5oXrfDWCUF4xg8wE7IemvDZPfbf9CVOLQE3"}],"group":"cf-nel","max_age":604800}
content-type: text/plain; charset=utf-8
nel: {"success_fraction":0,"report_to":"cf-nel","max_age":604800}
accept-ranges: bytes
cf-ray: 6da566f41f3b9116-FRA
content-length: 43

GET
H2 404 /
c405.fiercepharma.com/DG/DEFAULT/rest/rpc/ 0
0 602ms
601ms Script
text/html 99.86.3.109
AMAZON-02

General

Check archive.org

Show headers Download Go to

Full URL: https://c405.fiercepharma.com/DG/DEFAULT/rest/rpc/?requests=%5B%7B%22method%22%3A%22getProfile%22%2C%22params%22%3A%22null%22%2C%22id%22%3A%221644329013130%22%7D%2C%7B%22method%22%3A%22setProperties%22%2C%22params%22%3A%22%7B%5C%22properties%5C%22%3A%7B%5C%22language%5C%22%3A%5B%5C%22en%5C%22%5D%2C%5C%22currentscreenwidth%5C%22%3A%5B1600%5D%2C%5C%22currentscreenheight%5C%22%3A%5B1200%5D%2C%5C%22currentresolution%5C%22%3A%5B%5C%221600x1200%5C%22%5D%2C%5C%22entrypage%5C%22%3A%5B%5C%22https%3A%2F%2Fwww.fiercepharma.com%2Fspecial-report%2F10-most-anticipated-drug-launches-2022-4-deucravacitinib%5C%22%5D%2C%5C%22new_visit_bc%5C%22%3A%5B%5C%22true%5C%22%5D%7D%2C%5C%22sources%5C%22%3A%7B%5C%22listenerinteractiontype%5C%22%3A%5B%5C%22language%5C%22%2C%5C%22currentscreenwidth%5C%22%2C%5C%22currentscreenheight%5C%22%2C%5C%22currentresolution%5C%22%2C%5C%22entrypage%5C%22%5D%2C%5C%22newvisitlistener%5C%22%3A%5B%5C%22new_visit_bc%5C%22%5D%7D%7D%22%2C%22id%22%3A%221644329013132%22%7D%2C%7B%22method%22%3A%22addProperties%22%2C%22params%22%3A%22%7B%5C%22properties%5C%22%3A%7B%5C%22resolution%5C%22%3A%5B%5C%221600x1200%5C%22%5D%7D%2C%5C%22sources%5C%22%3A%7B%5C%22listenerinteractiontype%5C%22%3A%5B%5C%22resolution%5C%22%5D%7D%7D%22%2C%22id%22%3A%221644329013133%22%7D%2C%7B%22method%22%3A%22createEvent%22%2C%22params%22%3A%22%7B%5C%22type%5C%22%3A%5B%5C%22PAGEVIEW%5C%22%5D%2C%5C%22referrer%5C%22%3A%5B%5C%22%5C%22%5D%2C%5C%22profile%5C%22%3A%5B%5D%7D%22%2C%22id%22%3A%221644329013134%22%7D%5D&referer=https%3A%2F%2Fwww.fiercepharma.com%2Fspecial-report%2F10-most-anticipated-drug-launches-2022-4-deucravacitinib&bcsessionid=&bctempid=&overruleReferrer=&time=2022-02-08T14%3A03%3A34%2B00%3A00&callback=bc_json797
Requested by: Host: cdn.blueconic.net
URL: https://cdn.blueconic.net/questex.js
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 99.86.3.109 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS: server-99-86-3-109.fra6.r.cloudfront.net
Software: /
Resource Hash

Request headers

Accept-Language: de-DE,de;q=0.9
Referer: https://www.fiercepharma.com/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

GET
H2 200 storage-delegate.html Show response
creative.spotible.com/tag/ Frame 9E39 581 B
498 B 100ms
100ms Document
text/html 54.144.118.149
AMAZON-AES

General

Check archive.org

Show headers Download Go to

Full URL: https://creative.spotible.com/tag/storage-delegate.html
Requested by: Host: creative.spotible.com
URL: https://creative.spotible.com/tag/allstream.js
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 54.144.118.149 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS: ec2-54-144-118-149.compute-1.amazonaws.com
Software: /
Resource Hash: 3560bdf6b103e68c5e0aa13507ad74e7e2ced19d36257d4f7685e121fa4fa30d

Request headers

Upgrade-Insecure-Requests: 1
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Accept-Language: de-DE,de;q=0.9
Referer: https://www.fiercepharma.com/

Response headers

etag: "60fdf8d946db5045a34df20232ae250b"
cache-control: public, max-age=3600
vary: accept-encoding
content-encoding: gzip
content-type: text/html
date: Tue, 08 Feb 2022 14:03:33 GMT

GET
H2 200 delivery.js Show response
creative.spotible.com/creative/GxHs/ 75 KB
25 KB 101ms
100ms Script
application/javascript 54.144.118.149
AMAZON-AES

General

Check archive.org

Show headers Download Go to

Full URL: https://creative.spotible.com/creative/GxHs/delivery.js?referrer=https%3A%2F%2Fwww.fiercepharma.com%2Fspecial-report%2F10-most-anticipated-drug-launches-2022-4-deucravacitinib
Requested by: Host: creative.spotible.com
URL: https://creative.spotible.com/tag/allstream.js
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 54.144.118.149 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS: ec2-54-144-118-149.compute-1.amazonaws.com
Software: /
Resource Hash: c791e7be198c73b6ed9350db2456e8f132f2b89d81e9a8c4cc75fee614ecc77d

Request headers

Accept-Language: de-DE,de;q=0.9
Referer: https://www.fiercepharma.com/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

date: Tue, 08 Feb 2022 14:03:33 GMT
cache-control: no-cache
content-encoding: gzip
etag: "8faf25c4203e7c4a91631eeb4b78c34e"
vary: accept-encoding
content-type: application/javascript;charset=utf-8

OPTIONS
H/1.1 200 olytics
oqs.omeda.com/oqs/rest/ Frame 0
0 616ms
122ms Preflight
text/plain 204.180.130.165
QTS-AS

General

Check archive.org

Show headers Download Go to

Full URL

https://oqs.omeda.com/oqs/rest/olytics

Protocol

HTTP/1.1

Security

TLS 1.2, ECDHE_RSA, AES_256_GCM

Server

204.180.130.165 , United States, ASN53866 (QTS-AS, US),

Reverse DNS

Software

Apache /

Resource Hash

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Frame-Options	SAMEORIGIN
X-Xss-Protection	1; mode=block

Request headers

Accept: */*
Access-Control-Request-Method: POST
Access-Control-Request-Headers: content-type
Origin: https://www.fiercepharma.com
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Sec-Fetch-Mode: cors

Response headers

X-Frame-Options: SAMEORIGIN
X-Content-Type-Options: nosniff
X-XSS-Protection: 1; mode=block
Access-Control-Max-Age: 600
Access-Control-Allow-Origin: *
Access-Control-Allow-Headers: Access-Control-Request-Headers, Content-Type, Origin, Accept, Accept-Encoding, Accept-Language, HOST, User-Agent, Access-Control-Request-Method, Access-Control-Max-Age
Content-Type: text/plain
Content-Length: 0
Date: Tue, 08 Feb 2022 14:03:34 GMT
Server: Apache

HEAD
H2 200 adsbygoogle.js
pagead2.googlesyndication.com/pagead/js/ 0
0 90ms
45ms Fetch
text/javascript 2a00:1450:4001:827::2002
GOOGLE

General

Check archive.org

Show headers Download Go to

Full URL

https://pagead2.googlesyndication.com/pagead/js/adsbygoogle.js

Requested by

Host: olytics.omeda.com
URL: https://olytics.omeda.com/olytics/js/v3/p/olytics.min.js

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2a00:1450:4001:827::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),

Reverse DNS

Software

cafe /

Resource Hash

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Xss-Protection	0

Request headers

Accept-Language: de-DE,de;q=0.9
Referer: https://www.fiercepharma.com/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

timing-allow-origin: *
date: Tue, 08 Feb 2022 14:03:34 GMT
content-encoding: gzip
x-content-type-options: nosniff
server: cafe
etag: 2869578527140438266
vary: Accept-Encoding, Origin
p3p: policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
cache-control: private, max-age=3600
cross-origin-resource-policy: cross-origin
content-disposition: attachment; filename="f.txt"
content-type: text/javascript; charset=UTF-8
alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
x-xss-protection: 0
expires: Tue, 08 Feb 2022 14:03:34 GMT

POST
H/1.1 200 olytics Show response
oqs.omeda.com/oqs/rest/ 15 B
307 B 130ms
130ms XHR
application/json 204.180.130.165
QTS-AS

General

Check archive.org

Show headers Download Go to

Full URL

https://oqs.omeda.com/oqs/rest/olytics

Requested by

Host: olytics.omeda.com
URL: https://olytics.omeda.com/olytics/js/v3/p/olytics.min.js

Protocol

HTTP/1.1

Security

TLS 1.2, ECDHE_RSA, AES_256_GCM

Server

204.180.130.165 , United States, ASN53866 (QTS-AS, US),

Reverse DNS

Software

Apache /

Resource Hash

ee2bd946a7a0e25dd3f7606bf975cfaa824c7eb902568f5e711f361be35196ee

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Frame-Options	SAMEORIGIN
X-Xss-Protection	1; mode=block

Request headers

Referer: https://www.fiercepharma.com/
Accept-Language: de-DE,de;q=0.9
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Content-Type: application/json

Response headers

Date: Tue, 08 Feb 2022 14:03:34 GMT
X-Content-Type-Options: nosniff
Server: Apache
X-Frame-Options: SAMEORIGIN
Content-Type: application/json
Access-Control-Allow-Origin: *
Cache-Control: no-cache
Transfer-Encoding: chunked
X-XSS-Protection: 1; mode=block

GET
H2 200 haloid Show response
aufp.io/api/v1/ 6 KB
3 KB 542ms
179ms Script
application/javascript 52.35.70.100
AMAZON-02

General

Check archive.org

Show headers Download Go to

Full URL: https://aufp.io/api/v1/haloid
Requested by: Host: a.ad.gt
URL: https://a.ad.gt/api/v1/u/matches/170
Protocol: H2
Security: TLS 1.2, ECDHE_RSA, AES_128_GCM
Server: 52.35.70.100 Boardman, United States, ASN16509 (AMAZON-02, US),
Reverse DNS: ec2-52-35-70-100.us-west-2.compute.amazonaws.com
Software: nginx/1.18.0 /
Resource Hash: 85e50082d7ce113bfa87dbade18dbf747d1bacfcffdbd628296dcffa98a08f94

Request headers

Accept-Language: de-DE,de;q=0.9
Referer: https://www.fiercepharma.com/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

date: Tue, 08 Feb 2022 14:03:35 GMT
content-encoding: gzip
last-modified: Wed, 02 Feb 2022 00:28:16 GMT
server: nginx/1.18.0
etag: W/"1643761696.0-6132-2958560116"
access-control-allow-methods: GET, POST, OPTIONS
content-type: application/javascript
access-control-allow-origin: *, *
access-control-expose-headers: DNT,X-CustomHeader,Keep-Alive,User-Agent,X-Requested-With,If-Modified-Since,Cache-Control,Content-Type,Content-Range,Range
cache-control: public, max-age=43200
origin-trial: A/KTxPuSXtwcggydvUxw5B4dXspsb2iweedc7KDi2xv9M89MtnOpULTs7DQJVHBxGDV5wj5a3LW9S4ev3WfQkwIAAAB+eyJvcmlnaW4iOiJodHRwczovL2hhbG9mbG9jLmNvbTo0NDMiLCJmZWF0dXJlIjoiSW50ZXJlc3RDb2hvcnRBUEkiLCJleHBpcnkiOjE2MjYyMjA3OTksImlzU3ViZG9tYWluIjp0cnVlLCJpc1RoaXJkUGFydHkiOnRydWV9
access-control-allow-headers: DNT,X-CustomHeader,Keep-Alive,User-Agent,X-Requested-With,If-Modified-Since,Cache-Control,Content-Type,Content-Range,Range
expires: Wed, 09 Feb 2022 02:03:35 GMT

GET
H2 200 170 Show response
p.ad.gt/api/v1/p/ 26 KB
8 KB 547ms
182ms Script
application/javascript 44.230.193.23
AMAZON-02

General

Check archive.org

Show headers Download Go to

Full URL: https://p.ad.gt/api/v1/p/170
Requested by: Host: a.ad.gt
URL: https://a.ad.gt/api/v1/u/matches/170
Protocol: H2
Security: TLS 1.2, ECDHE_RSA, AES_128_GCM
Server: 44.230.193.23 Boardman, United States, ASN16509 (AMAZON-02, US),
Reverse DNS: ec2-44-230-193-23.us-west-2.compute.amazonaws.com
Software: nginx/1.18.0 /
Resource Hash: e6974b62b821dafba979149e0d3dd2d2942c2f49be62d2d2c581c1e2899a9027

Request headers

Accept-Language: de-DE,de;q=0.9
Referer: https://www.fiercepharma.com/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

date: Tue, 08 Feb 2022 14:03:35 GMT
content-encoding: gzip
last-modified: Wed, 02 Feb 2022 00:25:44 GMT
server: nginx/1.18.0
etag: W/"1643761544.0-26279-2710964840"
access-control-allow-methods: GET, POST, OPTIONS
content-type: application/javascript
access-control-allow-origin: *
access-control-expose-headers: DNT,X-CustomHeader,Keep-Alive,User-Agent,X-Requested-With,If-Modified-Since,Cache-Control,Content-Type,Content-Range,Range
cache-control: public, max-age=43200
access-control-allow-headers: DNT,X-CustomHeader,Keep-Alive,User-Agent,X-Requested-With,If-Modified-Since,Cache-Control,Content-Type,Content-Range,Range
expires: Wed, 09 Feb 2022 02:03:35 GMT

GET
H2

200

match
ids.ad.gt/api/v1/
Redirect Chain

https://secure.adnxs.com/getuid?https://ids.ad.gt/api/v1/match?id=71ea94e0-0093-44cb-b4dd-d08066fc43e4&adnxs_id=$UID
https://ids.ad.gt/api/v1/match?id=71ea94e0-0093-44cb-b4dd-d08066fc43e4&adnxs_id=5611407578940007418

43 B
565 B

484ms
191ms

Image
image/gif

52.43.149.174
AMAZON-02

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://ids.ad.gt/api/v1/match?id=71ea94e0-0093-44cb-b4dd-d08066fc43e4&adnxs_id=5611407578940007418
Requested by: Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/special-report/10-most-anticipated-drug-launches-2022-4-deucravacitinib
Protocol: H2
Server: 52.43.149.174 Boardman, United States, ASN16509 (AMAZON-02, US),
Reverse DNS: ec2-52-43-149-174.us-west-2.compute.amazonaws.com
Software: nginx/1.18.0 /
Resource Hash: afe0dcfca292a0fae8bce08a48c14d3e59c9d82c6052ab6d48a22ecc6c48f277

Request headers

Accept-Language: de-DE,de;q=0.9
Referer: https://www.fiercepharma.com/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

date: Tue, 08 Feb 2022 14:03:35 GMT
cache-control: public, max-age=43200
server: nginx/1.18.0
content-type: image/gif
expires: Wed, 09 Feb 2022 02:03:35 GMT

Redirect headers

Pragma: no-cache
Date: Tue, 08 Feb 2022 14:03:34 GMT
X-Proxy-Origin: 84.19.175.183; 84.19.175.183; 721.bm-nginx-loadbalancer.mgmt.ams1; adnxs.com
AN-X-Request-Uuid: e162a994-a6a2-47a5-a8b2-89eebe3488ac
Server: nginx/1.17.9
Access-Control-Allow-Origin: *
P3P: policyref="http://cdn.adnxs-simple.com/w3c/policy/p3p.xml", CP="NOI DSP COR ADM PSAo PSDo OURo SAMo UNRo OTRo BUS COM NAV DEM STA PRE"
Location: https://ids.ad.gt/api/v1/match?id=71ea94e0-0093-44cb-b4dd-d08066fc43e4&adnxs_id=5611407578940007418
Cache-Control: no-store, no-cache, private
Access-Control-Allow-Credentials: true
Connection: keep-alive
Content-Type: text/html; charset=utf-8
Content-Length: 0
X-XSS-Protection: 0
Expires: Sat, 15 Nov 2008 16:00:00 GMT

GET
H2

200

t_match
ids.ad.gt/api/v1/
Redirect Chain

https://match.adsrvr.org/track/cmf/generic?ttd_pid=8gkxb6n&ttd_tpi=1&gpdr=0&ttd_puid=71ea94e0-0093-44cb-b4dd-d08066fc43e4
https://match.adsrvr.org/track/cmb/generic?ttd_pid=8gkxb6n&ttd_tpi=1&gpdr=0&ttd_puid=71ea94e0-0093-44cb-b4dd-d08066fc43e4
https://ids.ad.gt/api/v1/t_match?tdid=5f6d2359-c211-4f10-9b58-14dbad0adcf8&id=71ea94e0-0093-44cb-b4dd-d08066fc43e4

43 B
569 B

377ms
192ms

Image
image/gif

52.43.149.174
AMAZON-02

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://ids.ad.gt/api/v1/t_match?tdid=5f6d2359-c211-4f10-9b58-14dbad0adcf8&id=71ea94e0-0093-44cb-b4dd-d08066fc43e4
Requested by: Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/special-report/10-most-anticipated-drug-launches-2022-4-deucravacitinib
Protocol: H2
Server: 52.43.149.174 Boardman, United States, ASN16509 (AMAZON-02, US),
Reverse DNS: ec2-52-43-149-174.us-west-2.compute.amazonaws.com
Software: nginx/1.18.0 /
Resource Hash: afe0dcfca292a0fae8bce08a48c14d3e59c9d82c6052ab6d48a22ecc6c48f277

Request headers

Accept-Language: de-DE,de;q=0.9
Referer: https://www.fiercepharma.com/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

date: Tue, 08 Feb 2022 14:03:35 GMT
cache-control: public, max-age=43200
server: nginx/1.18.0
content-type: image/gif
expires: Wed, 09 Feb 2022 02:03:35 GMT

Redirect headers

pragma: no-cache
date: Tue, 08 Feb 2022 14:03:34 GMT
x-aspnet-version: 4.0.30319
p3p: CP="NOI DSP COR CUR ADMo DEVo PSAo PSDo OUR SAMo BUS UNI NAV"
location: https://ids.ad.gt/api/v1/t_match?tdid=5f6d2359-c211-4f10-9b58-14dbad0adcf8&id=71ea94e0-0093-44cb-b4dd-d08066fc43e4
cache-control: private,no-cache, must-revalidate
content-type: text/html
content-length: 259

GET
H2

200

pbm_match
ids.ad.gt/api/v1/
Redirect Chain

https://image2.pubmatic.com/AdServer/UCookieSetPug?rd=https%3A%2F%2Fids.ad.gt%2Fapi%2Fv1%2Fpbm_match%3Fpbm%3D%23PM_USER_ID%26id%3D71ea94e0-0093-44cb-b4dd-d08066fc43e4
https://image2.pubmatic.com/AdServer/UCookieSetPug?ird=1&rd=https%3A%2F%2Fids.ad.gt%2Fapi%2Fv1%2Fpbm_match%3Fpbm%3D%23PM_USER_ID%26id%3D71ea94e0-0093-44cb-b4dd-d08066fc43e4
https://ids.ad.gt/api/v1/pbm_match?pbm=BBFBF67E-52FE-430F-93B6-E6A55E905C12&id=71ea94e0-0093-44cb-b4dd-d08066fc43e4

43 B
573 B

613ms
355ms

Image
image/gif

52.43.149.174
AMAZON-02

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://ids.ad.gt/api/v1/pbm_match?pbm=BBFBF67E-52FE-430F-93B6-E6A55E905C12&id=71ea94e0-0093-44cb-b4dd-d08066fc43e4
Requested by: Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/special-report/10-most-anticipated-drug-launches-2022-4-deucravacitinib
Protocol: H2
Server: 52.43.149.174 Boardman, United States, ASN16509 (AMAZON-02, US),
Reverse DNS: ec2-52-43-149-174.us-west-2.compute.amazonaws.com
Software: nginx/1.18.0 /
Resource Hash: afe0dcfca292a0fae8bce08a48c14d3e59c9d82c6052ab6d48a22ecc6c48f277

Request headers

Accept-Language: de-DE,de;q=0.9
Referer: https://www.fiercepharma.com/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

date: Tue, 08 Feb 2022 14:03:35 GMT
cache-control: public, max-age=43200
server: nginx/1.18.0
content-type: image/gif
expires: Wed, 09 Feb 2022 02:03:35 GMT

Redirect headers

location: https://ids.ad.gt/api/v1/pbm_match?pbm=BBFBF67E-52FE-430F-93B6-E6A55E905C12&id=71ea94e0-0093-44cb-b4dd-d08066fc43e4
date: Tue, 08 Feb 2022 14:03:34 GMT
cache-control: no-store, no-cache, private
server: nginx
p3p: CP="NOI DSP COR LAW CUR ADMo DEVo TAIo PSAo PSDo IVAo IVDo HISo OTPo OUR SAMo BUS UNI COM NAV INT DEM CNT STA PRE LOC"

GET
H2

200

g_match
ids.ad.gt/api/v1/
Redirect Chain

https://cm.g.doubleclick.net/pixel?google_nid=audigent_w_appnexus_3985&google_cm&google_sc&google_ula=450542624&id=71ea94e0-0093-44cb-b4dd-d08066fc43e4
https://ids.ad.gt/api/v1/g_match?id=71ea94e0-0093-44cb-b4dd-d08066fc43e4&google_gid=CAESEK46dYDDn1ptvDyhgNKmnDA&google_cver=1&google_ula=450542624,0

43 B
572 B

661ms
355ms

Image
image/gif

52.43.149.174
AMAZON-02

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://ids.ad.gt/api/v1/g_match?id=71ea94e0-0093-44cb-b4dd-d08066fc43e4&google_gid=CAESEK46dYDDn1ptvDyhgNKmnDA&google_cver=1&google_ula=450542624,0
Requested by: Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/special-report/10-most-anticipated-drug-launches-2022-4-deucravacitinib
Protocol: H2
Server: 52.43.149.174 Boardman, United States, ASN16509 (AMAZON-02, US),
Reverse DNS: ec2-52-43-149-174.us-west-2.compute.amazonaws.com
Software: nginx/1.18.0 /
Resource Hash: afe0dcfca292a0fae8bce08a48c14d3e59c9d82c6052ab6d48a22ecc6c48f277

Request headers

Accept-Language: de-DE,de;q=0.9
Referer: https://www.fiercepharma.com/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

date: Tue, 08 Feb 2022 14:03:35 GMT
cache-control: public, max-age=43200
server: nginx/1.18.0
content-type: image/gif
expires: Wed, 09 Feb 2022 02:03:35 GMT

Redirect headers

pragma: no-cache
date: Tue, 08 Feb 2022 14:03:34 GMT
server: HTTP server (unknown)
p3p: policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
location: https://ids.ad.gt/api/v1/g_match?id=71ea94e0-0093-44cb-b4dd-d08066fc43e4&google_gid=CAESEK46dYDDn1ptvDyhgNKmnDA&google_cver=1&google_ula=450542624,0
cache-control: no-cache, must-revalidate
cross-origin-resource-policy: cross-origin
content-type: text/html; charset=UTF-8
alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length: 357
x-xss-protection: 0
expires: Fri, 01 Jan 1990 00:00:00 GMT

GET
H3

200

pixel
cm.g.doubleclick.net/
Redirect Chain

https://ids.ad.gt/api/v1/g_hosted?id=71ea94e0-0093-44cb-b4dd-d08066fc43e4
https://cm.g.doubleclick.net/pixel?google_nid=audigent_w_appnexus_3985&google_hm=NzFlYTk0ZTAtMDA5My00NGNiLWI0ZGQtZDA4MDY2ZmM0M2U0

170 B
188 B

26ms
26ms

Image
image/png

142.250.185.66
GOOGLE

General

Check archive.org

Show headers Download Go to Show image

Full URL

https://cm.g.doubleclick.net/pixel?google_nid=audigent_w_appnexus_3985&google_hm=NzFlYTk0ZTAtMDA5My00NGNiLWI0ZGQtZDA4MDY2ZmM0M2U0

Requested by

Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/special-report/10-most-anticipated-drug-launches-2022-4-deucravacitinib

Protocol

Server

142.250.185.66 , United States, ASN15169 (GOOGLE, US),

Reverse DNS

fra16s48-in-f2.1e100.net

Software

HTTP server (unknown) /

Resource Hash

0b8a20373c6dd04e091902226d922b3688143a8938afb9d283d889de7b55ceb5

Security Headers

Name	Value
X-Xss-Protection	0

Request headers

Accept-Language: de-DE,de;q=0.9
Referer: https://www.fiercepharma.com/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

pragma: no-cache
date: Tue, 08 Feb 2022 14:03:35 GMT
server: HTTP server (unknown)
content-type: image/png
cache-control: no-cache, must-revalidate
cross-origin-resource-policy: cross-origin
alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length: 170
x-xss-protection: 0
expires: Fri, 01 Jan 1990 00:00:00 GMT

Redirect headers

location: https://cm.g.doubleclick.net/pixel?google_nid=audigent_w_appnexus_3985&google_hm=NzFlYTk0ZTAtMDA5My00NGNiLWI0ZGQtZDA4MDY2ZmM0M2U0
date: Tue, 08 Feb 2022 14:03:35 GMT
server: nginx/1.18.0
content-length: 473
content-type: text/html; charset=utf-8

GET
H2

200

impr_match
ids.ad.gt/api/v1/
Redirect Chain

https://ad.360yield.com/ux?&publisher_dmp_id=15&r=https%3A%2F%2Fids.ad.gt%2Fapi%2Fv1%2Fimpr_match%3Fid%3D71ea94e0-0093-44cb-b4dd-d08066fc43e4%26impr_uid%3D%7BPUB_USER_ID%7D
https://ad.360yield.com/ul_cb/ux?&publisher_dmp_id=15&r=https%3A%2F%2Fids.ad.gt%2Fapi%2Fv1%2Fimpr_match%3Fid%3D71ea94e0-0093-44cb-b4dd-d08066fc43e4%26impr_uid%3D%7BPUB_USER_ID%7D
https://ids.ad.gt/api/v1/impr_match?id=71ea94e0-0093-44cb-b4dd-d08066fc43e4&impr_uid=bcc9beb1-8e48-4422-8855-3bd127e27e5e

43 B
484 B

383ms
193ms

Image
image/gif

52.43.149.174
AMAZON-02

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://ids.ad.gt/api/v1/impr_match?id=71ea94e0-0093-44cb-b4dd-d08066fc43e4&impr_uid=bcc9beb1-8e48-4422-8855-3bd127e27e5e
Requested by: Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/special-report/10-most-anticipated-drug-launches-2022-4-deucravacitinib
Protocol: H2
Server: 52.43.149.174 Boardman, United States, ASN16509 (AMAZON-02, US),
Reverse DNS: ec2-52-43-149-174.us-west-2.compute.amazonaws.com
Software: nginx/1.18.0 /
Resource Hash: afe0dcfca292a0fae8bce08a48c14d3e59c9d82c6052ab6d48a22ecc6c48f277

Request headers

Accept-Language: de-DE,de;q=0.9
Referer: https://www.fiercepharma.com/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

date: Tue, 08 Feb 2022 14:03:35 GMT
cache-control: public, max-age=43200
server: nginx/1.18.0
content-type: image/gif
expires: Wed, 09 Feb 2022 02:03:35 GMT

Redirect headers

location: https://ids.ad.gt/api/v1/impr_match?id=71ea94e0-0093-44cb-b4dd-d08066fc43e4&impr_uid=bcc9beb1-8e48-4422-8855-3bd127e27e5e
date: Tue, 08 Feb 2022 14:03:34 GMT
access-control-allow-origin: *
content-type: text/plain
content-length: 0
p3p: CP="NOI DSP COR NID CURa ADMa DEVa PSAa PSDa OUR BUS COM INT OTC PUR STA"

GET
H2

200

beeswax_match
ids.ad.gt/api/v1/
Redirect Chain

https://match.prod.bidr.io/cookie-sync/audigent?buyer_user_id=71ea94e0-0093-44cb-b4dd-d08066fc43e4
https://match.prod.bidr.io/cookie-sync/audigent?buyer_user_id=71ea94e0-0093-44cb-b4dd-d08066fc43e4&_bee_ppp=1
https://ids.ad.gt/api/v1/beeswax_match?beeswax_id=AAFhKk7EBPAAAAJ4odOVww&id=71ea94e0-0093-44cb-b4dd-d08066fc43e4

43 B
478 B

523ms
356ms

Image
image/gif

52.43.149.174
AMAZON-02

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://ids.ad.gt/api/v1/beeswax_match?beeswax_id=AAFhKk7EBPAAAAJ4odOVww&id=71ea94e0-0093-44cb-b4dd-d08066fc43e4
Requested by: Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/special-report/10-most-anticipated-drug-launches-2022-4-deucravacitinib
Protocol: H2
Server: 52.43.149.174 Boardman, United States, ASN16509 (AMAZON-02, US),
Reverse DNS: ec2-52-43-149-174.us-west-2.compute.amazonaws.com
Software: nginx/1.18.0 /
Resource Hash: afe0dcfca292a0fae8bce08a48c14d3e59c9d82c6052ab6d48a22ecc6c48f277

Request headers

Accept-Language: de-DE,de;q=0.9
Referer: https://www.fiercepharma.com/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

date: Tue, 08 Feb 2022 14:03:35 GMT
cache-control: public, max-age=43200
server: nginx/1.18.0
content-type: image/gif
expires: Wed, 09 Feb 2022 02:03:35 GMT

Redirect headers

location: https://ids.ad.gt/api/v1/beeswax_match?beeswax_id=AAFhKk7EBPAAAAJ4odOVww&id=71ea94e0-0093-44cb-b4dd-d08066fc43e4
Date: Tue, 08 Feb 2022 14:03:34 GMT
Server: nginx
Connection: keep-alive
Content-Length: 0
strict-transport-security: max-age=2592000; includeSubDomains

GET
H/1.1

204
No Content

token
token.rubiconproject.com/
Redirect Chain

https://ids.ad.gt/api/v1/rub?id=71ea94e0-0093-44cb-b4dd-d08066fc43e4
https://token.rubiconproject.com/token?pid=50242&puid=71ea94e0-0093-44cb-b4dd-d08066fc43e4&gdpr=0

0
214 B

186ms
19ms

Image
text/plain

69.173.144.165
RUBICONPROJECT

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://token.rubiconproject.com/token?pid=50242&puid=71ea94e0-0093-44cb-b4dd-d08066fc43e4&gdpr=0
Requested by: Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/special-report/10-most-anticipated-drug-launches-2022-4-deucravacitinib
Protocol: HTTP/1.1
Server: 69.173.144.165 Frankfurt am Main, Germany, ASN26667 (RUBICONPROJECT, US),
Reverse DNS
Software: /
Resource Hash: e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Accept-Language: de-DE,de;q=0.9
Referer: https://www.fiercepharma.com/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

Pragma: no-cache
Expires: 0
Cache-Control: no-cache,no-store,must-revalidate
X-RPHost: 78e3bdce5107450057bade54d54a0a7e
P3P: CP="NOI CURa ADMa DEVa TAIa OUR BUS IND UNI COM NAV INT"

Redirect headers

location: https://token.rubiconproject.com/token?pid=50242&puid=71ea94e0-0093-44cb-b4dd-d08066fc43e4&gdpr=0
date: Tue, 08 Feb 2022 14:03:35 GMT
server: nginx/1.18.0
content-length: 417
content-type: text/html; charset=utf-8

GET
H/1.1

200
OK

4 Show response
v4-api-54-185-136-237.b2c.com/api/
Redirect Chain

https://api-54-185-136-237.b2c.com/api/x?OgzmBuJbPLPWQouR$dXJsJDAkaHR0cHM6Ly93d3cuZmllcmNlcGhhcm1hLmNvbS9zcGVjaWFsLXJlcG9ydC8xMC1tb3N0LWFudGljaXBhdGVkLWRydWctbGF1bmNoZXMtMjAyMi00LWRldWNyYXZhY2l0aW5...
https://v4-api-54-185-136-237.b2c.com:444/api/4?OgzmBuJbPLPWQouR

0
141 B

543ms
180ms

XHR
text/plain

54.185.136.237
AMAZON-02

General

Check archive.org

Show headers Download Go to

Full URL: https://v4-api-54-185-136-237.b2c.com:444/api/4?OgzmBuJbPLPWQouR
Requested by: Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/special-report/10-most-anticipated-drug-launches-2022-4-deucravacitinib
Protocol: HTTP/1.1
Server: 54.185.136.237 Boardman, United States, ASN16509 (AMAZON-02, US),
Reverse DNS: ec2-54-185-136-237.us-west-2.compute.amazonaws.com
Software: /
Resource Hash: e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Accept-Language: de-DE,de;q=0.9
Referer: https://www.fiercepharma.com/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

Access-Control-Allow-Origin: *
Connection: keep-alive
Transfer-Encoding: chunked
Access-Control-Allow-Methods: *

Redirect headers

date: Tue, 08 Feb 2022 14:03:34 GMT
cf-cache-status: DYNAMIC
nel: {"success_fraction":0,"report_to":"cf-nel","max_age":604800}
server: cloudflare
expect-ct: max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
location: https://v4-api-54-185-136-237.b2c.com:444/api/4?OgzmBuJbPLPWQouR
access-control-allow-methods: *
content-type: text/html
access-control-allow-origin: *
report-to: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=qwIf8INWjDVufuaJ8xRL18G5jE2Njhhd%2F1M5xslul8gQwpvHN8XJiROyjC4wqx%2FXFN8G3MCmQz7ngZrQIy3C6pxY8dRlFVcHbnWd6A%2FCwZJUoi8145mTKE8OyaW6%2F8lTWi9p720lBaGizQzrIcMZzjtWKTDTbOkl"}],"group":"cf-nel","max_age":604800}
cf-ray: 6da566f5beae9193-FRA

GET
H2 200 Carlsbad_RollAd_BG_LoRes_MS_1920x1080_updated.png
cdn.spotible.com/creative/GxHs/hashed/6132531ad7b4768e3db434f032381d4d/ 123 KB
124 KB 79ms
20ms Image
image/png 99.86.3.4
AMAZON-02

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://cdn.spotible.com/creative/GxHs/hashed/6132531ad7b4768e3db434f032381d4d/Carlsbad_RollAd_BG_LoRes_MS_1920x1080_updated.png
Requested by: Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/special-report/10-most-anticipated-drug-launches-2022-4-deucravacitinib
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 99.86.3.4 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS: server-99-86-3-4.fra6.r.cloudfront.net
Software: /
Resource Hash: 2e70a27b585fe780d4d8089fc032feeb2849cc36140e542d5092535911fa2b5a

Request headers

Accept-Language: de-DE,de;q=0.9
Referer: https://www.fiercepharma.com/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

date: Tue, 08 Feb 2022 05:20:48 GMT
via: 1.1 d357d5d597708d2b41e0fea397aa2620.cloudfront.net (CloudFront)
age: 31365
etag: "6132531ad7b4768e3db434f032381d4d"
x-cache: Hit from cloudfront
content-type: image/png
cache-control: public, max-age=604800
x-amz-cf-pop: FRA6-C1
accept-ranges: bytes
content-length: 126039
x-amz-cf-id: ATdWRIP95hTzMO3gB3eLSVqxFsPUe2VceED2XWjGz_2H6E5u7y4_4Q==

GET
H2 200 Carlsbad_RollAd_FG_LoRes_720x900.png
cdn.spotible.com/creative/GxHs/hashed/d8c4a5fa958a1671af168cbfcdb57b3a/ 60 KB
60 KB 79ms
21ms Image
image/png 99.86.3.4
AMAZON-02

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://cdn.spotible.com/creative/GxHs/hashed/d8c4a5fa958a1671af168cbfcdb57b3a/Carlsbad_RollAd_FG_LoRes_720x900.png
Requested by: Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/special-report/10-most-anticipated-drug-launches-2022-4-deucravacitinib
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 99.86.3.4 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS: server-99-86-3-4.fra6.r.cloudfront.net
Software: /
Resource Hash: 81eba80f4d17808b3c750f78ed8033d24e359092cb2a7241046341b2f759fa71

Request headers

Accept-Language: de-DE,de;q=0.9
Referer: https://www.fiercepharma.com/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

date: Tue, 08 Feb 2022 05:20:48 GMT
via: 1.1 d357d5d597708d2b41e0fea397aa2620.cloudfront.net (CloudFront)
age: 31365
etag: "d8c4a5fa958a1671af168cbfcdb57b3a"
x-cache: Hit from cloudfront
content-type: image/png
cache-control: public, max-age=604800
x-amz-cf-pop: FRA6-C1
accept-ranges: bytes
content-length: 61330
x-amz-cf-id: Tr1rDnJxOjbYGrxUs5x-trrc3U3QL7h8ipvOh8Az1qHBKU6B9n1aYg==

HEAD
H2 200 gpt.js
www.googletagservices.com/tag/js/ 0
0 74ms
25ms Fetch
text/javascript 2a00:1450:4001:812::2002
GOOGLE

General

Check archive.org

Show headers Download Go to

Full URL

https://www.googletagservices.com/tag/js/gpt.js

Requested by

Host: olytics.omeda.com
URL: https://olytics.omeda.com/olytics/js/v3/p/olytics.min.js

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2a00:1450:4001:812::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),

Reverse DNS

Software

sffe /

Resource Hash

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Xss-Protection	0

Request headers

Accept-Language: de-DE,de;q=0.9
Referer: https://www.fiercepharma.com/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

date: Tue, 08 Feb 2022 14:03:34 GMT
content-encoding: gzip
x-content-type-options: nosniff
server: sffe
etag: "1125 / 76 of 1000 / last-modified: 1644322105"
vary: Accept-Encoding
report-to: {"group":"ads-gpt-scs","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/ads-gpt-scs"}]}
content-type: text/javascript
cache-control: private, max-age=900, stale-while-revalidate=3600
cross-origin-resource-policy: cross-origin
timing-allow-origin: *
alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
x-xss-protection: 0
cross-origin-opener-policy-report-only: same-origin; report-to="ads-gpt-scs"
expires: Tue, 08 Feb 2022 14:03:34 GMT

POST
H/1.1 204
No Content multitracking Show response
ghb.hbmp.mediafuse.com/adunit/ 0
211 B 92ms
90ms XHR
text/plain 2a0c:5c81:5142::2
24SHELLS

General

Check archive.org

Show headers Download Go to

Full URL: https://ghb.hbmp.mediafuse.com/adunit/multitracking
Requested by: Host: player.hbmp.mediafuse.com
URL: https://player.hbmp.mediafuse.com/prebidlink/456758/hbw_master_302826_6936.js
Protocol: HTTP/1.1
Security: TLS 1.3, , AES_128_GCM
Server: 2a0c:5c81:5142::2 London, United Kingdom, ASN55081 (24SHELLS, US),
Reverse DNS
Software: VertaMedia 1.0 /
Resource Hash: e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer: https://www.fiercepharma.com/
Accept-Language: de-DE,de;q=0.9
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Content-Type: text/plain;charset=UTF-8

Response headers

Access-Control-Allow-Origin: https://www.fiercepharma.com
Date: Tue, 08 Feb 2022 14:03:34 GMT
Access-Control-Allow-Credentials: true
Server: VertaMedia 1.0
Connection: Keep-Alive

POST
H/1.1 204
No Content mut Show response
ghb.adtelligent.com/adunit/ Frame 447C 0
207 B 112ms
31ms XHR
text/plain 2a0c:5c81:5142::2
24SHELLS

General

Check archive.org

Show headers Download Go to

Full URL: https://ghb.adtelligent.com/adunit/mut
Requested by: Host: p.nodserving.com
URL: https://p.nodserving.com/prebidlink/19031/pbm_307825_11600.js
Protocol: HTTP/1.1
Security: TLS 1.3, , AES_128_GCM
Server: 2a0c:5c81:5142::2 London, United Kingdom, ASN55081 (24SHELLS, US),
Reverse DNS
Software: VertaMedia 1.0 /
Resource Hash: e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer: https://p.nodserving.com/
Accept-Language: de-DE,de;q=0.9
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Content-Type: text/plain;charset=UTF-8

Response headers

Access-Control-Allow-Origin: https://p.nodserving.com
Date: Tue, 08 Feb 2022 14:03:34 GMT
Access-Control-Allow-Credentials: true
Server: VertaMedia 1.0
Connection: Keep-Alive

GET
H/1.1 200 loading.do Show response
sample.dragonforms.com/ Frame 8E4A 21 KB
6 KB 154ms
154ms Document
text/html 204.180.130.190
QTS-AS

General

Check archive.org

Show headers Download Go to

Full URL

https://sample.dragonforms.com/loading.do?omedasite=FiercePharma_short

Requested by

Host: sample.dragonforms.com
URL: https://sample.dragonforms.com/init.do?omedasite=FiercePharma_short

Protocol

HTTP/1.1

Security

TLS 1.2, ECDHE_RSA, AES_256_GCM

Server

204.180.130.190 , United States, ASN53866 (QTS-AS, US),

Reverse DNS

Software

Apache /

Resource Hash

d041c9665e943501277d812df8c037ded41e8e8534038426103c6b0a98892e92

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Xss-Protection	1; mode=block

Request headers

Upgrade-Insecure-Requests: 1
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Accept-Language: de-DE,de;q=0.9
Referer: https://sample.dragonforms.com/init.do?omedasite=FiercePharma_short

Response headers

X-Content-Type-Options: nosniff
X-XSS-Protection: 1; mode=block
Access-Control-Allow-Origin: *
Content-Type: text/html;charset=ISO-8859-1
Date: Tue, 08 Feb 2022 14:03:34 GMT
Server: Apache
Vary: Accept-Encoding
Content-Encoding: gzip
Transfer-Encoding: chunked

GET
H2 200 halo_match
ids.ad.gt/api/v1/ 43 B
653 B 195ms
195ms Image
image/gif 52.43.149.174
AMAZON-02

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://ids.ad.gt/api/v1/halo_match?id=71ea94e0-0093-44cb-b4dd-d08066fc43e4&halo_id=0201tlxlfd07jv2yg08xizqr0bwpa1w0evvljv1k7cm961o8b5po0ntek210qskvk40trr7270wqxik90zq3u2c12pa5j31k0gxf118nmsj90fzd0bt1elzfjf1hl5r1i1kkc2jl
Requested by: Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/special-report/10-most-anticipated-drug-launches-2022-4-deucravacitinib
Protocol: H2
Security: TLS 1.2, ECDHE_RSA, AES_128_GCM
Server: 52.43.149.174 Boardman, United States, ASN16509 (AMAZON-02, US),
Reverse DNS: ec2-52-43-149-174.us-west-2.compute.amazonaws.com
Software: nginx/1.18.0 /
Resource Hash: afe0dcfca292a0fae8bce08a48c14d3e59c9d82c6052ab6d48a22ecc6c48f277

Request headers

Accept-Language: de-DE,de;q=0.9
Referer: https://www.fiercepharma.com/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

date: Tue, 08 Feb 2022 14:03:35 GMT
cache-control: public, max-age=43200
server: nginx/1.18.0
content-type: image/gif
expires: Wed, 09 Feb 2022 02:03:35 GMT

GET
H2 204 getpixels Show response
pixels.ad.gt/api/v1/ 0
344 B 556ms
185ms Script
text/plain 35.83.23.20
AMAZON-02

General

Check archive.org

Show headers Download Go to

Full URL: https://pixels.ad.gt/api/v1/getpixels?tagger_id=e0fc5aa47bed062e265fc29d169e5770&url=https%3A%2F%2Fwww.fiercepharma.com%2Fspecial-report%2F10-most-anticipated-drug-launches-2022-4-deucravacitinib&code=%27none%27
Requested by: Host: p.ad.gt
URL: https://p.ad.gt/api/v1/p/170
Protocol: H2
Security: TLS 1.2, ECDHE_RSA, AES_128_GCM
Server: 35.83.23.20 Boardman, United States, ASN16509 (AMAZON-02, US),
Reverse DNS: ec2-35-83-23-20.us-west-2.compute.amazonaws.com
Software: nginx/1.18.0 /
Resource Hash: e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Accept-Language: de-DE,de;q=0.9
Referer: https://www.fiercepharma.com/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

access-control-allow-origin: *
date: Tue, 08 Feb 2022 14:03:35 GMT
server: nginx/1.18.0
access-control-allow-headers: DNT,X-CustomHeader,Keep-Alive,User-Agent,X-Requested-With,If-Modified-Since,Cache-Control,Content-Type,Content-Range,Range
access-control-allow-methods: GET, POST, OPTIONS
access-control-expose-headers: DNT,X-CustomHeader,Keep-Alive,User-Agent,X-Requested-With,If-Modified-Since,Cache-Control,Content-Type,Content-Range,Range

GET
H3 200 ecommerce.js Show response
www.google-analytics.com/plugins/ua/ 1 KB
763 B 18ms
17ms Script
text/javascript 2a00:1450:4001:810::200e
GOOGLE

General

Check archive.org

Show headers Download Go to

Full URL

https://www.google-analytics.com/plugins/ua/ecommerce.js

Requested by

Host: www.google-analytics.com
URL: https://www.google-analytics.com/analytics.js

Protocol

Security

QUIC, , AES_128_GCM

Server

2a00:1450:4001:810::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),

Reverse DNS

Software

sffe /

Resource Hash

8e1b84265e633c043720dd0921476c16bc9f75e393e855c9116ca7c3a847b5c7

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Xss-Protection	0

Request headers

Accept-Language: de-DE,de;q=0.9
Referer: https://www.fiercepharma.com/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

date: Tue, 08 Feb 2022 13:13:54 GMT
content-encoding: gzip
x-content-type-options: nosniff
age: 2981
cross-origin-resource-policy: cross-origin
alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length: 738
x-xss-protection: 0
last-modified: Tue, 22 Oct 2019 18:15:00 GMT
server: sffe
vary: Accept-Encoding
report-to: {"group":"static-on-bigtable","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/static-on-bigtable"}]}
content-type: text/javascript
cache-control: public, max-age=3600
accept-ranges: bytes
cross-origin-opener-policy-report-only: same-origin; report-to="static-on-bigtable"
expires: Tue, 08 Feb 2022 14:13:54 GMT

GET
H3 200 ec.js Show response
www.google-analytics.com/plugins/ua/ 3 KB
1 KB 16ms
16ms Script
text/javascript 2a00:1450:4001:810::200e
GOOGLE

General

Check archive.org

Show headers Download Go to

Full URL

https://www.google-analytics.com/plugins/ua/ec.js

Requested by

Host: www.google-analytics.com
URL: https://www.google-analytics.com/analytics.js

Protocol

Security

QUIC, , AES_128_GCM

Server

2a00:1450:4001:810::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),

Reverse DNS

Software

sffe /

Resource Hash

058ed961bfe422af7bfc65865f4c08531ec8ace995f8a1ec560a46581cb7712c

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Xss-Protection	0

Request headers

Accept-Language: de-DE,de;q=0.9
Referer: https://www.fiercepharma.com/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

date: Tue, 08 Feb 2022 13:38:33 GMT
content-encoding: br
x-content-type-options: nosniff
age: 1502
cross-origin-resource-policy: cross-origin
alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length: 1129
x-xss-protection: 0
last-modified: Thu, 30 Dec 2021 12:48:00 GMT
server: sffe
vary: Accept-Encoding
report-to: {"group":"static-on-bigtable","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/static-on-bigtable"}]}
content-type: text/javascript
cache-control: public, max-age=3600
accept-ranges: bytes
cross-origin-opener-policy-report-only: same-origin; report-to="static-on-bigtable"
expires: Tue, 08 Feb 2022 14:38:33 GMT

GET
H2 200 cm
u.openx.net/w/1.0/ 43 B
131 B 34ms
29ms Image
image/gif 35.244.159.8
GOOGLE

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://u.openx.net/w/1.0/cm?id=998eaf06-9905-4eae-9e26-9fac75960c53&r=https%3A%2F%2Fids.ad.gt%2Fapi%2Fv1%2Fopenx%3Fopenx_id%3D%7BOPENX_ID%7D%26id%3D0201tlxlfd07jv2yg08xizqr0bwpa1w0evvljv1k7cm961o8b5po0ntek210qskvk40trr7270wqxik90zq3u2c12pa5j31k0gxf118nmsj90fzd0bt1elzfjf1hl5r1i1kkc2jl%26auid%3D71ea94e0-0093-44cb-b4dd-d08066fc43e4
Requested by: Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/special-report/10-most-anticipated-drug-launches-2022-4-deucravacitinib
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 35.244.159.8 Kansas City, United States, ASN15169 (GOOGLE, US),
Reverse DNS: 8.159.244.35.bc.googleusercontent.com
Software: OXGW/17.1.0 /
Resource Hash: 4e0705327480ad2323cb03d9c450ffcae4a98bf3a5382fa0c7882145ed620e49

Request headers

Accept-Language: de-DE,de;q=0.9
Referer: https://www.fiercepharma.com/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

pragma: no-cache
date: Tue, 08 Feb 2022 14:03:35 GMT
content-encoding: gzip
server: OXGW/17.1.0
vary: Accept, Accept-Encoding
p3p: CP="CUR ADM OUR NOR STA NID"
via: 1.1 google
cache-control: private, max-age=0, no-cache
content-type: image/gif
alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length: 56
expires: Mon, 26 Jul 1997 05:00:00 GMT

GET
H/1.1 200 entity_313b.css
hostedcontent.dragonforms.com/hosted/images/dragon/generic/313/ Frame 8E4A 19 KB
19 KB 862ms
120ms Stylesheet
text/css 205.162.42.5
QTS-AS

General

Check archive.org

Show headers Download Go to

Full URL

https://hostedcontent.dragonforms.com/hosted/images/dragon/generic/313/entity_313b.css

Requested by

Host: sample.dragonforms.com
URL: https://sample.dragonforms.com/loading.do?omedasite=FiercePharma_short

Protocol

HTTP/1.1

Security

TLS 1.2, ECDHE_RSA, AES_256_GCM

Server

205.162.42.5 , United States, ASN53866 (QTS-AS, US),

Reverse DNS

cdn.omeda.com

Software

Apache /

Resource Hash

a33614a196d3854d7d068b3d73dca4806956c548d1ae3163bcd8e0b7664a2ed6

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Frame-Options	SAMEORIGIN
X-Xss-Protection	1; mode=block

Request headers

Accept-Language: de-DE,de;q=0.9
Referer: https://sample.dragonforms.com/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

Date: Tue, 08 Feb 2022 15:03:35 CET
X-Content-Type-Options: nosniff
Last-Modified: Fri, 22 Nov 2019 15:51:34 CET
Server: Apache
ETag: W/"19161-1574434294969"
X-Frame-Options: SAMEORIGIN
Content-Type: text/css
Access-Control-Allow-Origin: *
Access-Control-Expose-Headers: Access-Control-Allow-Origin,Access-Control-Allow-Credentials
Transfer-Encoding: chunked
Accept-Ranges: bytes
X-XSS-Protection: 1; mode=block

GET
H2 200 jquery-2.2.4.min.js Show response
code.jquery.com/ Frame 8E4A 84 KB
29 KB 58ms
20ms Script
application/javascript 2001:4de0:ac18::1:a:2a
HIGHWINDS3

General

Check archive.org

Show headers Download Go to

Full URL: https://code.jquery.com/jquery-2.2.4.min.js
Requested by: Host: sample.dragonforms.com
URL: https://sample.dragonforms.com/loading.do?omedasite=FiercePharma_short
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 2001:4de0:ac18::1:a:2a , Netherlands, ASN20446 (HIGHWINDS3, US),
Reverse DNS
Software: nginx /
Resource Hash: 05b85d96f41fff14d8f608dad03ab71e2c1017c2da0914d7c59291bad7a54f8e

Request headers

Referer: https://sample.dragonforms.com/
Origin: https://sample.dragonforms.com
Accept-Language: de-DE,de;q=0.9
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

date: Tue, 08 Feb 2022 14:03:35 GMT
content-encoding: gzip
last-modified: Fri, 20 Aug 2021 17:47:53 GMT
server: nginx
etag: W/"611feac9-14e4a"
vary: Accept-Encoding
x-hw: 1644329015.dop201.fr8.t,1644329015.cds236.fr8.hn,1644329015.cds130.fr8.c
content-type: application/javascript; charset=utf-8
access-control-allow-origin: *
cache-control: max-age=315360000, public
accept-ranges: bytes
content-length: 29811

GET
H/1.1 200 conditional.js Show response
sample.dragonforms.com/js/ Frame 8E4A 31 KB
32 KB 448ms
120ms Script
application/javascript 204.180.130.190
QTS-AS

General

Check archive.org

Show headers Download Go to

Full URL

https://sample.dragonforms.com/js/conditional.js

Requested by

Host: sample.dragonforms.com
URL: https://sample.dragonforms.com/loading.do?omedasite=FiercePharma_short

Protocol

HTTP/1.1

Security

TLS 1.2, ECDHE_RSA, AES_256_GCM

Server

204.180.130.190 , United States, ASN53866 (QTS-AS, US),

Reverse DNS

Software

Apache /

Resource Hash

d7993cf613408050b47ca5417eac7f90986d57213211a6b27f7579894e306389

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Xss-Protection	1; mode=block

Request headers

Accept-Language: de-DE,de;q=0.9
Referer: https://sample.dragonforms.com/loading.do?omedasite=FiercePharma_short
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

Date: Tue, 08 Feb 2022 14:03:34 GMT
X-Content-Type-Options: nosniff
Last-Modified: Fri, 03 Sep 2021 16:11:38 GMT
Server: Apache
ETag: W/"31881-1630685498000"
Transfer-Encoding: chunked
Content-Type: application/javascript
Access-Control-Allow-Origin: *
Accept-Ranges: bytes
X-XSS-Protection: 1; mode=block

GET
H/1.1 200 dragonCampaign.js Show response
sample.dragonforms.com/js/ Frame 8E4A 13 KB
13 KB 478ms
122ms Script
application/javascript 204.180.130.190
QTS-AS

General

Check archive.org

Show headers Download Go to

Full URL

https://sample.dragonforms.com/js/dragonCampaign.js

Requested by

Host: sample.dragonforms.com
URL: https://sample.dragonforms.com/loading.do?omedasite=FiercePharma_short

Protocol

HTTP/1.1

Security

TLS 1.2, ECDHE_RSA, AES_256_GCM

Server

204.180.130.190 , United States, ASN53866 (QTS-AS, US),

Reverse DNS

Software

Apache /

Resource Hash

0dbc0190864fe5c6e0bd63e7b5233f94265ee535dc3c3e2031f27a251bbb2f60

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Xss-Protection	1; mode=block

Request headers

Accept-Language: de-DE,de;q=0.9
Referer: https://sample.dragonforms.com/loading.do?omedasite=FiercePharma_short
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

Date: Tue, 08 Feb 2022 14:03:34 GMT
X-Content-Type-Options: nosniff
Last-Modified: Mon, 30 Aug 2021 17:56:04 GMT
Server: Apache
ETag: W/"13235-1630346164000"
Transfer-Encoding: chunked
Content-Type: application/javascript
Access-Control-Allow-Origin: *
Accept-Ranges: bytes
X-XSS-Protection: 1; mode=block

GET
H/1.1 200 generic.css
sample.dragonforms.com/style/ Frame 8E4A 2 KB
1 KB 213ms
117ms Stylesheet
text/css 204.180.130.190
QTS-AS

General

Check archive.org

Show headers Download Go to

Full URL

https://sample.dragonforms.com/style/generic.css

Requested by

Host: sample.dragonforms.com
URL: https://sample.dragonforms.com/loading.do?omedasite=FiercePharma_short

Protocol

HTTP/1.1

Security

TLS 1.2, ECDHE_RSA, AES_256_GCM

Server

204.180.130.190 , United States, ASN53866 (QTS-AS, US),

Reverse DNS

Software

Apache /

Resource Hash

a75268aabd3efca2333dda30048a44d566fca0fa0c70f87249784d6c4dbaaa50

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Xss-Protection	1; mode=block

Request headers

Accept-Language: de-DE,de;q=0.9
Referer: https://sample.dragonforms.com/loading.do?omedasite=FiercePharma_short
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

Date: Tue, 08 Feb 2022 14:03:34 GMT
Content-Encoding: gzip
X-Content-Type-Options: nosniff
Last-Modified: Thu, 10 Jun 2021 15:35:48 GMT
Server: Apache
ETag: W/"2478-1623339348000"
Vary: Accept-Encoding
Content-Type: text/css;charset=UTF-8
Access-Control-Allow-Origin: *
Transfer-Encoding: chunked
Accept-Ranges: bytes
X-XSS-Protection: 1; mode=block

GET
H/1.1 200 962.css
hostedcontent.dragonforms.com/hosted/images/dragon/12247/ Frame 8E4A 3 KB
3 KB 871ms
123ms Stylesheet
text/css 205.162.42.5
QTS-AS

General

Check archive.org

Show headers Download Go to

Full URL

https://hostedcontent.dragonforms.com/hosted/images/dragon/12247/962.css

Requested by

Host: sample.dragonforms.com
URL: https://sample.dragonforms.com/loading.do?omedasite=FiercePharma_short

Protocol

HTTP/1.1

Security

TLS 1.2, ECDHE_RSA, AES_256_GCM

Server

205.162.42.5 , United States, ASN53866 (QTS-AS, US),

Reverse DNS

cdn.omeda.com

Software

Apache /

Resource Hash

9b7e5dca586aec7050576b4dad559ab2688067149e60467be5ca505970455229

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Frame-Options	SAMEORIGIN
X-Xss-Protection	1; mode=block

Request headers

Accept-Language: de-DE,de;q=0.9
Referer: https://sample.dragonforms.com/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

Date: Tue, 08 Feb 2022 15:03:35 CET
X-Content-Type-Options: nosniff
Last-Modified: Mon, 04 Oct 2021 19:31:31 CEST
Server: Apache
ETag: W/"2856-1633368691606"
X-Frame-Options: SAMEORIGIN
Content-Type: text/css
Access-Control-Allow-Origin: *
Access-Control-Expose-Headers: Access-Control-Allow-Origin,Access-Control-Allow-Credentials
Transfer-Encoding: chunked
Accept-Ranges: bytes
X-XSS-Protection: 1; mode=block

GET
H/1.1 200 363.js Show response
hostedcontent.dragonforms.com/hosted/images/dragon/12247/ Frame 8E4A 5 KB
6 KB 884ms
132ms Script
application/javascript 205.162.42.5
QTS-AS

General

Check archive.org

Show headers Download Go to

Full URL

https://hostedcontent.dragonforms.com/hosted/images/dragon/12247/363.js

Requested by

Host: sample.dragonforms.com
URL: https://sample.dragonforms.com/loading.do?omedasite=FiercePharma_short

Protocol

HTTP/1.1

Security

TLS 1.2, ECDHE_RSA, AES_256_GCM

Server

205.162.42.5 , United States, ASN53866 (QTS-AS, US),

Reverse DNS

cdn.omeda.com

Software

Apache /

Resource Hash

3f680ec1d9f173ca064c4fc16850d78e3b0bd291f4e0908f203245011861567d

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Frame-Options	SAMEORIGIN
X-Xss-Protection	1; mode=block

Request headers

Accept-Language: de-DE,de;q=0.9
Referer: https://sample.dragonforms.com/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

Date: Tue, 08 Feb 2022 15:03:35 CET
X-Content-Type-Options: nosniff
Last-Modified: Fri, 28 May 2021 16:35:55 CEST
Server: Apache
ETag: W/"5462-1622212555637"
X-Frame-Options: SAMEORIGIN
Content-Type: application/javascript
Access-Control-Allow-Origin: *
Access-Control-Expose-Headers: Access-Control-Allow-Origin,Access-Control-Allow-Credentials
Transfer-Encoding: chunked
Accept-Ranges: bytes
X-XSS-Protection: 1; mode=block

GET
H/1.1 200 olyticsLinkAssistance.js Show response
sample.dragonforms.com/js/ Frame 8E4A 4 KB
4 KB 489ms
128ms Script
application/javascript 204.180.130.190
QTS-AS

General

Check archive.org

Show headers Download Go to

Full URL

https://sample.dragonforms.com/js/olyticsLinkAssistance.js

Requested by

Host: sample.dragonforms.com
URL: https://sample.dragonforms.com/loading.do?omedasite=FiercePharma_short

Protocol

HTTP/1.1

Security

TLS 1.2, ECDHE_RSA, AES_256_GCM

Server

204.180.130.190 , United States, ASN53866 (QTS-AS, US),

Reverse DNS

Software

Apache /

Resource Hash

f88e771cd7aeeb1241c61b165090b9d197534d937e2bd53a62631a738439a2e6

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Xss-Protection	1; mode=block

Request headers

Accept-Language: de-DE,de;q=0.9
Referer: https://sample.dragonforms.com/loading.do?omedasite=FiercePharma_short
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

Date: Tue, 08 Feb 2022 14:03:34 GMT
X-Content-Type-Options: nosniff
Last-Modified: Fri, 16 Nov 2018 20:46:06 GMT
Server: Apache
ETag: W/"3961-1542401166000"
Transfer-Encoding: chunked
Content-Type: application/javascript
Access-Control-Allow-Origin: *
Accept-Ranges: bytes
X-XSS-Protection: 1; mode=block

POST
H/1.1 200 p Show response
olytics.omeda.com/olytics/segments/ 4 KB
4 KB 4188ms
4061ms XHR
application/json 204.180.130.159
QTS-AS

General

Check archive.org

Show headers Download Go to

Full URL

https://olytics.omeda.com/olytics/segments/p

Requested by

Host: olytics.omeda.com
URL: https://olytics.omeda.com/olytics/js/v3/p/olytics.min.js

Protocol

HTTP/1.1

Security

TLS 1.2, ECDHE_RSA, AES_256_GCM

Server

204.180.130.159 , United States, ASN53866 (QTS-AS, US),

Reverse DNS

my.omedastaging.com

Software

Apache /

Resource Hash

7b2b374ce8411a9f72ad8a653ccc664539713019af44251db340600d0d90e80a

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Frame-Options	SAMEORIGIN
X-Xss-Protection	1; mode=block

Request headers

Referer: https://www.fiercepharma.com/
Accept-Language: de-DE,de;q=0.9
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Content-Type: application/json

Response headers

Date: Tue, 08 Feb 2022 14:03:40 GMT
X-Content-Type-Options: nosniff
Server: Apache
X-Frame-Options: SAMEORIGIN
Content-Type: application/json
Access-Control-Allow-Origin: *
Cache-Control: no-cache
Transfer-Encoding: chunked
X-XSS-Protection: 1; mode=block

POST
H/1.1 200 / Show response
olytics.omeda.com/olytics/segments/form/check/ 20 B
313 B 128ms
126ms XHR
application/json 204.180.130.159
QTS-AS

General

Check archive.org

Show headers Download Go to

Full URL

https://olytics.omeda.com/olytics/segments/form/check/

Requested by

Host: olytics.omeda.com
URL: https://olytics.omeda.com/olytics/js/v3/p/olytics.min.js

Protocol

HTTP/1.1

Security

TLS 1.2, ECDHE_RSA, AES_256_GCM

Server

204.180.130.159 , United States, ASN53866 (QTS-AS, US),

Reverse DNS

my.omedastaging.com

Software

Apache /

Resource Hash

a8e427db11a8744bebbcdfd050f7b9d0a84b5a1754d086f1787c40db21955264

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Frame-Options	SAMEORIGIN
X-Xss-Protection	1; mode=block

Request headers

Referer: https://www.fiercepharma.com/
Accept-Language: de-DE,de;q=0.9
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Content-Type: application/json

Response headers

Date: Tue, 08 Feb 2022 14:03:36 GMT
X-Content-Type-Options: nosniff
Server: Apache
X-Frame-Options: SAMEORIGIN
Content-Type: application/json
Access-Control-Allow-Origin: *
Cache-Control: no-cache
Transfer-Encoding: chunked
X-XSS-Protection: 1; mode=block

POST
H/1.1 200 cswitch Show response
olytics.omeda.com/olytics/segments/ 88 B
381 B 288ms
123ms XHR
application/json 204.180.130.159
QTS-AS

General

Check archive.org

Show headers Download Go to

Full URL

https://olytics.omeda.com/olytics/segments/cswitch

Requested by

Host: olytics.omeda.com
URL: https://olytics.omeda.com/olytics/js/v3/p/olytics.min.js

Protocol

HTTP/1.1

Security

TLS 1.2, ECDHE_RSA, AES_256_GCM

Server

204.180.130.159 , United States, ASN53866 (QTS-AS, US),

Reverse DNS

my.omedastaging.com

Software

Apache /

Resource Hash

4b16ddf00cd9cdaa8a4cb691e7fcc2ca860dee5ba2fe2a1a05c85678f48dd4da

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Frame-Options	SAMEORIGIN
X-Xss-Protection	1; mode=block

Request headers

Referer: https://www.fiercepharma.com/
Accept-Language: de-DE,de;q=0.9
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Content-Type: application/json

Response headers

Date: Tue, 08 Feb 2022 14:03:36 GMT
X-Content-Type-Options: nosniff
Server: Apache
X-Frame-Options: SAMEORIGIN
Content-Type: application/json
Access-Control-Allow-Origin: *
Cache-Control: no-cache
Transfer-Encoding: chunked
X-XSS-Protection: 1; mode=block

GET
H2 200 report
creative.spotible.com/creative/GxHs/ 43 B
113 B 104ms
99ms Image
image/gif 54.144.118.149
AMAZON-AES

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://creative.spotible.com/creative/GxHs/report?,1644329014,595001;UNIQUE_USER_GLOBAL!0,1,0;UNIQUE_USER_DAILY!0,1,0;UNIQUE_USER_HOURLY!0,1,0;IMPRESSION!0,1,0!18,1,0!55,1,0!69,1,0!113,1,0!120,1,0;IN_VIEW!0,1,1!18,1,1!55,1,1!69,1,1!113,1,1!120,1,1&referrer=https%3A%2F%2Fwww.fiercepharma.com%2Fspecial-report%2F10-most-anticipated-drug-launches-2022-4-deucravacitinib
Requested by: Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/special-report/10-most-anticipated-drug-launches-2022-4-deucravacitinib
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 54.144.118.149 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS: ec2-54-144-118-149.compute-1.amazonaws.com
Software: /
Resource Hash: b1442e85b03bdcaf66dc58c7abb98745dd2687d86350be9a298a1d9382ac849b

Request headers

Accept-Language: de-DE,de;q=0.9
Referer: https://www.fiercepharma.com/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

date: Tue, 08 Feb 2022 14:03:35 GMT
cache-control: no-store
content-length: 43
content-type: image/gif

GET
H3 200 view
securepubads.g.doubleclick.net/pcs/ 0
23 B 56ms
52ms Image
image/gif 142.250.184.226
GOOGLE

General

Check archive.org

Show headers Download Go to Show image

Full URL

https://securepubads.g.doubleclick.net/pcs/view?xai=AKAOjsu1jP8SjAE_Y5QLtDbkL7oxJ93EtE_PBg4Fn4p5UHnvjxb65IC-mCpVDSlA9RJYEFDjX5TESr_8ovOrDCUj52-22XBT_8LrQvrIp34NzXf1LFPTzJRCTrI3qrDHM9Hk0wV6BZ9N2l8hc9D8n1BMQYRt0gHTZYrn7lhuH0K0QtupLI9pT_G_Q1YueqQ_Mcpevb9E11F9DD2m9FWIpwsjw8rRjHr-HdYaD1oPMzLUIhj8fFtVfW837J3E-Cd_Kx4A7OQzZLWZIG1mhK-ItB9lrwgrTv5KmmdOJPDch8vyno-Jwpbun6e3UxwVKe9JbWXMi81jze4ytF27VSQk_8bDaLoQJwnqY22AS-LZvjKxQl-Gufjbsap53cRChdo0uCRaPyRJGLUY6emKUqG5gaVtsA&sai=AMfl-YQrzgZ_M__aeR9HPV5vD28VyI2mwlND1ZyEdI7mJ9991kXoslbTLivvMmqv2lxM2h_FgpSJBhSr1HS7NjrLL2ImxsNY440xySLpJFZokWlhYWuFAko9VfoX2Uua6t0z&sig=Cg0ArKJSzHE5OjXfPtxGEAE&uach_m=[UACH]&urlfix=1&adurl=

Requested by

Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/special-report/10-most-anticipated-drug-launches-2022-4-deucravacitinib

Protocol

Security

QUIC, , AES_128_GCM

Server

142.250.184.226 , United States, ASN15169 (GOOGLE, US),

Reverse DNS

fra24s12-in-f2.1e100.net

Software

cafe /

Resource Hash

e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Xss-Protection	0

Request headers

Accept-Language: de-DE,de;q=0.9
Referer: https://www.fiercepharma.com/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

timing-allow-origin: *
date: Tue, 08 Feb 2022 14:03:35 GMT
x-content-type-options: nosniff
accept-ch: Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version, Sec-CH-UA-Arch, Sec-CH-UA-Model, Sec-CH-UA-Full-Version
p3p: policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
access-control-allow-origin: *
cache-control: private
cross-origin-resource-policy: cross-origin
content-type: image/gif
alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length: 0
x-xss-protection: 0
server: cafe

OPTIONS
H/1.1 200 p
olytics.omeda.com/olytics/segments/ Frame 0
0 734ms
125ms Preflight 204.180.130.159
QTS-AS

General

Check archive.org

Show headers Download Go to

Full URL: https://olytics.omeda.com/olytics/segments/p
Protocol: HTTP/1.1
Security: TLS 1.2, ECDHE_RSA, AES_256_GCM
Server: 204.180.130.159 , United States, ASN53866 (QTS-AS, US),
Reverse DNS: my.omedastaging.com
Software: Apache /
Resource Hash

Request headers

Accept: */*
Access-Control-Request-Method: POST
Access-Control-Request-Headers: content-type
Origin: https://www.fiercepharma.com
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Sec-Fetch-Mode: cors

Response headers

Access-Control-Allow-Origin: *
vary: Access-Control-Request-Headers,Access-Control-Request-Headers,access-control-request-method
Access-Control-Max-Age: 1800
Access-Control-Allow-Methods: HEAD,DELETE,POST,GET,OPTIONS,PUT
Access-Control-Allow-Headers: access-control-max-age,accept-language,origin,x-requested-with,access-control-request-headers,host,content-type,access-control-request-method,accept-encoding,accept,user-agent
Content-Length: 0
Date: Tue, 08 Feb 2022 14:03:36 GMT
Server: Apache

OPTIONS
H/1.1 200 /
olytics.omeda.com/olytics/segments/form/check/ Frame 0
0 733ms
124ms Preflight 204.180.130.159
QTS-AS

General

Check archive.org

Show headers Download Go to

Full URL: https://olytics.omeda.com/olytics/segments/form/check/
Protocol: HTTP/1.1
Security: TLS 1.2, ECDHE_RSA, AES_256_GCM
Server: 204.180.130.159 , United States, ASN53866 (QTS-AS, US),
Reverse DNS: my.omedastaging.com
Software: Apache /
Resource Hash

Request headers

Accept: */*
Access-Control-Request-Method: POST
Access-Control-Request-Headers: content-type
Origin: https://www.fiercepharma.com
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Sec-Fetch-Mode: cors

Response headers

Access-Control-Allow-Origin: *
vary: Access-Control-Request-Headers,Access-Control-Request-Headers,access-control-request-method
Access-Control-Max-Age: 1800
Access-Control-Allow-Methods: HEAD,DELETE,POST,GET,OPTIONS,PUT
Access-Control-Allow-Headers: access-control-max-age,accept-language,origin,x-requested-with,access-control-request-headers,host,content-type,access-control-request-method,accept-encoding,accept,user-agent
Content-Length: 0
Date: Tue, 08 Feb 2022 14:03:35 GMT
Server: Apache

OPTIONS
H/1.1 200 cswitch
olytics.omeda.com/olytics/segments/ Frame 0
0 857ms
125ms Preflight 204.180.130.159
QTS-AS

General

Check archive.org

Show headers Download Go to

Full URL: https://olytics.omeda.com/olytics/segments/cswitch
Protocol: HTTP/1.1
Security: TLS 1.2, ECDHE_RSA, AES_256_GCM
Server: 204.180.130.159 , United States, ASN53866 (QTS-AS, US),
Reverse DNS: my.omedastaging.com
Software: Apache /
Resource Hash

Request headers

Accept: */*
Access-Control-Request-Method: POST
Access-Control-Request-Headers: content-type
Origin: https://www.fiercepharma.com
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Sec-Fetch-Mode: cors

Response headers

Access-Control-Allow-Origin: *
vary: Access-Control-Request-Headers,Access-Control-Request-Headers,access-control-request-method
Access-Control-Max-Age: 1800
Access-Control-Allow-Methods: HEAD,DELETE,POST,GET,OPTIONS,PUT
Access-Control-Allow-Headers: access-control-max-age,accept-language,origin,x-requested-with,access-control-request-headers,host,content-type,access-control-request-method,accept-encoding,accept,user-agent
Content-Length: 0
Date: Tue, 08 Feb 2022 14:03:36 GMT
Server: Apache

GET
H/1.1 200
OK index.php Show response
a.dpmsrv.com/dpmpxl/ 5 B
1 KB 105ms
105ms Script
text/javascript 3.226.203.17
AMAZON-AES

General

Check archive.org

Show headers Download Go to

Full URL: https://a.dpmsrv.com/dpmpxl/index.php?q=xSeg&v=1.x&ep%5Bids%5D=29315642%2C29315652%2C29028703%2C16013439%2C16671093&cl=913&pixelIndex=0&r=471413&tzOffset=0&url=https%3A%2F%2Fwww.fiercepharma.com%2Fspecial-report%2F10-most-anticipated-drug-launches-2022-4-deucravacitinib&id=5611407578940007418&_=1644329013517
Requested by: Host: s.dpmsrv.com
URL: https://s.dpmsrv.com/dpm_fa5b7e293127b3837c39f7fbd05598f32c8ce1c9.min.js
Protocol: HTTP/1.1
Security: TLS 1.2, ECDHE_RSA, AES_128_GCM
Server: 3.226.203.17 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS: ec2-3-226-203-17.compute-1.amazonaws.com
Software: /
Resource Hash: fbc45fe018830de401f0cf801177a57d0039bc72d922b8ff2c82af7af05dd32b

Request headers

Accept-Language: de-DE,de;q=0.9
Referer: https://www.fiercepharma.com/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

Pragma: no-cache
content-encoding: gzip
Access-Control-Max-Age: 10
Access-Control-Allow-Methods: GET, POST, PUT, DELETE, OPTIONS
P3P: CP="IDC DSP COR ADM DEVi TAIi PSA PSD IVAi IVDi CONi HIS OUR IND CNT"
Access-Control-Allow-Origin: *
Cache-Control: no-cache, no-store, must-revalidate
Connection: keep-alive
Content-Type: text/javascript
Access-Control-Allow-Headers: content-type, accept
Content-Length: 31
Expires: 0

GET
H/1.1 200
OK seg
ib.adnxs.com/ 43 B
1021 B 25ms
25ms Image
image/gif 37.252.172.37
ASN-APPNEX

General

Check archive.org

Show headers Download Go to Show image

Full URL

https://ib.adnxs.com/seg?member=827&add=29315642,29315652,29028703,16013439,16671093

Requested by

Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/special-report/10-most-anticipated-drug-launches-2022-4-deucravacitinib

Protocol

HTTP/1.1

Security

TLS 1.2, ECDHE_ECDSA, AES_128_GCM

Server

37.252.172.37 Frankfurt am Main, Germany, ASN29990 (ASN-APPNEX, US),

Reverse DNS

691.bm-nginx-loadbalancer.mgmt.fra1.adnexus.net

Software

nginx/1.17.9 /

Resource Hash

4b5b6b15c6255109e06720cce42a06d3aead8b7874423d9c52cb0303212c25ef

Security Headers

Name	Value
X-Xss-Protection	0

Request headers

Accept-Language: de-DE,de;q=0.9
Referer: https://www.fiercepharma.com/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

Pragma: no-cache
Date: Tue, 08 Feb 2022 14:03:35 GMT
X-Proxy-Origin: 84.19.175.183; 84.19.175.183; 691.bm-nginx-loadbalancer.mgmt.fra1; adnxs.com
AN-X-Request-Uuid: d4012bcb-e37a-4313-bfab-072c520baeae
Server: nginx/1.17.9
P3P: policyref="http://cdn.adnxs-simple.com/w3c/policy/p3p.xml", CP="NOI DSP COR ADM PSAo PSDo OURo SAMo UNRo OTRo BUS COM NAV DEM STA PRE"
Access-Control-Allow-Origin: *
Cache-Control: no-store, no-cache, private
Access-Control-Allow-Credentials: true
Connection: keep-alive
Content-Type: image/gif
Content-Length: 43
X-XSS-Protection: 0
Expires: Sat, 15 Nov 2008 16:00:00 GMT

GET
H3 200 integrator.js Show response
adservice.google.de/adsid/ 107 B
122 B 54ms
27ms Script
application/javascript 2a00:1450:4001:82a::2002
GOOGLE

General

Check archive.org

Show headers Download Go to

Full URL

https://adservice.google.de/adsid/integrator.js?domain=www.fiercepharma.com

Requested by

Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2022020301.js

Protocol

Security

QUIC, , AES_128_GCM

Server

2a00:1450:4001:82a::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),

Reverse DNS

Software

cafe /

Resource Hash

a4a1824defec1084ca81d496ee77891684c26196924bdc4fc21dd3482ce15e14

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Xss-Protection	0

Request headers

Accept-Language: de-DE,de;q=0.9
Referer: https://www.fiercepharma.com/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

timing-allow-origin: *
date: Tue, 08 Feb 2022 14:03:35 GMT
content-encoding: gzip
x-content-type-options: nosniff
server: cafe
p3p: CP="This is not a P3P policy! See http://support.google.com/accounts/answer/151657 for more info."
cache-control: private, no-cache, no-store
cross-origin-resource-policy: cross-origin
content-disposition: attachment; filename="f.txt"
content-type: application/javascript; charset=UTF-8
alt-svc: h3="googleads.g.doubleclick.net:443"; ma=2592000,h3=":443"; ma=2592000,h3-29="googleads.g.doubleclick.net:443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43",quic=":443"; ma=2592000; v="46,43"
content-length: 100
x-xss-protection: 0

GET
H3 200 integrator.js Show response
adservice.google.com/adsid/ 107 B
122 B 54ms
28ms Script
application/javascript 2a00:1450:4001:80f::2002
GOOGLE

General

Check archive.org

Show headers Download Go to

Full URL

https://adservice.google.com/adsid/integrator.js?domain=www.fiercepharma.com

Requested by

Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2022020301.js

Protocol

Security

QUIC, , AES_128_GCM

Server

2a00:1450:4001:80f::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),

Reverse DNS

Software

cafe /

Resource Hash

a4a1824defec1084ca81d496ee77891684c26196924bdc4fc21dd3482ce15e14

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Xss-Protection	0

Request headers

Accept-Language: de-DE,de;q=0.9
Referer: https://www.fiercepharma.com/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

timing-allow-origin: *
date: Tue, 08 Feb 2022 14:03:35 GMT
content-encoding: gzip
x-content-type-options: nosniff
server: cafe
p3p: CP="This is not a P3P policy! See http://support.google.com/accounts/answer/151657 for more info."
cache-control: private, no-cache, no-store
cross-origin-resource-policy: cross-origin
content-disposition: attachment; filename="f.txt"
content-type: application/javascript; charset=UTF-8
alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length: 100
x-xss-protection: 0

GET
H3 200 ads Show response
securepubads.g.doubleclick.net/gampad/ 2 KB
311 B 71ms
71ms XHR
text/plain 142.250.184.226
GOOGLE

General

Check archive.org

Show headers Download Go to

Full URL

https://securepubads.g.doubleclick.net/gampad/ads?gdfp_req=1&pvsid=3715860651702850&correlator=3696035797536368&output=ldjh&impl=fifs&vrg=2022020301&ptt=17&sc=1&sfv=1-0-38&ecs=20220208&iu_parts=298443%2Cquestex.lifesciences%2Cfiercepharma%2Cspecialreports&enc_prev_ius=%2F0%2F1%2F2%2F3%2C%2F0%2F1%2F2%2F3%2C%2F0%2F1%2F2%2F3%2C%2F0%2F1%2F2%2F3%2C%2F0%2F1%2F2%2F3&prev_iu_szs=970x90%7C970x250%7C970x415%2C300x600%7C300x250%2C300x600%7C300x250%2C300x600%7C300x250%2C1600x1000&prev_scp=pos%3D0%26hb_rfBid%3D0%26excl_cat%3DPREPOST%7Cpos%3D1%26hb_rfBid%3D0%26excl_cat%3DPREPOST%7Cpos%3D2%26hb_rfBid%3D0%26excl_cat%3DPREPOST%7Cpos%3D3%26hb_rfBid%3D0%26excl_cat%3DPREPOST%7Cpos%3D5%26hb_rfBid%3D0%26excl_cat%3DPREPOST&eri=1&cust_params=section%3DSpecial%2520Reports%26homefront%3D0%26sectionfront%3D0%26article%3D1%26nodeid%3D518261%26fm-tester%3Dundefined%26topic%3Dpsoriasis%252C%2520JAK%2520inhibitor%252C%2520drug%2520launch%252C%2520megamergers%26keyword%3DBristol%2520Myers%2520Squibb%252C%2520Deucravacitinib%252C%2520Otezla%252C%2520Celgene%252C%2520Amgen%252C%2520Novartis%252C%2520Cosentyx%252C%2520Eli%2520Lilly%252C%2520Taltz%252C%2520AbbVie%252C%2520Skyrizi%26tag%3DBristol%2520Myers%2520Squibb%252C%2520Deucravacitinib%252C%2520Otezla%252C%2520Celgene%252C%2520Amgen%252C%2520Novartis%252C%2520Cosentyx%252C%2520Eli%2520Lilly%252C%2520Taltz%252C%2520AbbVie%252C%2520Skyrizi%252Cpsoriasis%252C%2520JAK%2520inhibitor%252C%2520drug%2520launch%252C%2520megamergers%252CSpecial%2520Reports%26path%3D%252Fspecial-report%252F10-most-anticipated-drug-launches-2022-4-deucravacitinib%26browserLargerThan1460%3D1&cookie=ID%3Da10b70ecd31ee878-226e80d238cd00b6%3AT%3D1644329013%3AS%3DALNI_MbrV_GTIfaNb9Zl-5yagvuFtFGsWA&bc=31&abxe=1&dt=1644329015866&lmt=1644329012&dlt=1644329013005&idt=591&frm=20&biw=1600&bih=1200&oid=2&adxs=200%2C1100%2C1100%2C1100%2C-12245933&adys=988%2C1196%2C1658%2C1658%2C-12245933&adks=313090359%2C2965285993%2C3032192005%2C3032192004%2C3031910803&ucis=5%7C6%7C7%7C8%7C9&ifi=5&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_sd=1&flash=0&dmc=8&url=https%3A%2F%2Fwww.fiercepharma.com%2Fspecial-report%2F10-most-anticipated-drug-launches-2022-4-deucravacitinib&vis=1&scr_x=0&scr_y=0&psz=1200x0%7C300x0%7C300x0%7C300x0%7C1200x0&msz=1200x0%7C300x0%7C300x0%7C300x0%7C1600x0&psts=AGkb-H-wQ_RHzdFIx_stTghXhihM2LECFPUQCWqCwEzfOYqRlZ9aHporyagUDUyVIiGjq8mFnW9UxVxqFFxghqFt%2CAGkb-H80_Q_89g_JffIaAGB9oTASVyzNc2y9bKFMNaq9lGZg5mu-xTH_q0llOe2mNR9VSxTCzu5Aw0Ozw_qXrw0T%2CAGkb-H9awlplzm3R5rYar7qljqzk%2CAGkb-H9awlplzm3R5rYar7qljqzk&ga_vid=800578055.1644329014&ga_sid=1644329014&ga_hid=2005409921&ga_fc=true&fws=4%2C4%2C4%2C4%2C132&ohw=1600%2C1600%2C1600%2C1600%2C1600&btvi=0%7C0%7C2%7C3%7C-1&uach=WyIiLCIiLCIiLCIiLCIiLFtdLG51bGwsbnVsbCwiIixbXV0.&nvt=1

Requested by

Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2022020301.js

Protocol

Security

QUIC, , AES_128_GCM

Server

142.250.184.226 , United States, ASN15169 (GOOGLE, US),

Reverse DNS

fra24s12-in-f2.1e100.net

Software

cafe /

Resource Hash

349cecd2f73253633d5a2b6276457c3f79d79efae59888bf75af0849407558a9

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Xss-Protection	0

Request headers

Accept-Language: de-DE,de;q=0.9
Referer: https://www.fiercepharma.com/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

date: Tue, 08 Feb 2022 14:03:35 GMT
content-encoding: br
x-content-type-options: nosniff
google-mediationgroup-id: -2,-2,-2,-2,-2
p3p: policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
cross-origin-resource-policy: cross-origin
alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length: 282
x-xss-protection: 0
google-lineitem-id: -2,-2,-2,-2,-2
pragma: no-cache
server: cafe
google-mediationtag-id: -2
google-creative-id: -2,-2,-2,-2,-2
content-type: text/plain; charset=UTF-8
access-control-allow-origin: https://www.fiercepharma.com
cache-control: no-cache, must-revalidate
access-control-allow-credentials: true
timing-allow-origin: *
expires: Fri, 01 Jan 1990 00:00:00 GMT

GET
H2 200 publishertag.prebid.117.js Show response
static.criteo.net/js/ld/ 87 KB
28 KB 336ms
51ms Script
text/javascript 2a02:2638::3
ASN-CRITEO-EUROPE

General

Check archive.org

Show headers Download Go to

Full URL

https://static.criteo.net/js/ld/publishertag.prebid.117.js

Requested by

Host: player.mediafuse.com
URL: https://player.mediafuse.com/prebidlink/456758/hb_302826_6936.js

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2a02:2638::3 , France, ASN44788 (ASN-CRITEO-EUROPE, FR),

Reverse DNS

Software

nginx /

Resource Hash

90c9017a8a6447588520f38cd94ba14cdb9839c92626aa06bb8a4a1052c2ab7e

Security Headers

Name	Value
Strict-Transport-Security	max-age=31536000; preload;

Request headers

Accept-Language: de-DE,de;q=0.9
Referer: https://www.fiercepharma.com/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

date: Tue, 08 Feb 2022 14:03:36 GMT
content-encoding: gzip
last-modified: Wed, 29 Dec 2021 12:30:46 GMT
server: nginx
etag: W/"61cc54f6-15c19"
strict-transport-security: max-age=31536000; preload;
content-type: text/javascript
access-control-allow-origin: *
cache-control: max-age=86400, public
cross-origin-resource-policy: cross-origin
timing-allow-origin: *
expires: Wed, 09 Feb 2022 14:03:36 GMT

GET
H/1.1 200
OK async_usersync.html Show response
acdn.adnxs.com/ib/static/usersync/v3/ Frame 4A1D 995 B
1 KB 86ms
36ms Document
text/html 151.101.1.108
FASTLY

General

Check archive.org

Show headers Download Go to

Full URL: https://acdn.adnxs.com/ib/static/usersync/v3/async_usersync.html
Requested by: Host: p.nodserving.com
URL: https://p.nodserving.com/prebidlink/19031/pbm_307825_11600.js
Protocol: HTTP/1.1
Security: TLS 1.2, ECDHE_RSA, AES_128_GCM
Server: 151.101.1.108 , United States, ASN54113 (FASTLY, US),
Reverse DNS
Software: nginx/1.13.10 /
Resource Hash: 8730c26defc411dd8a51f1da47e5ae3804fab6868f7914a26b09d8e0791bbe39

Request headers

Upgrade-Insecure-Requests: 1
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Accept-Language: de-DE,de;q=0.9
Referer: https://p.nodserving.com/

Response headers

Connection: keep-alive
Content-Length: 506
Server: nginx/1.13.10
Content-Type: text/html
Last-Modified: Fri, 20 May 2016 02:07:09 GMT
ETag: W/"573e714d-3e3"
Expires: Thu, 06 May 2021 05:24:22 GMT
Cache-Control: max-age=31536000
Access-Control-Allow-Origin: *
Content-Encoding: gzip
Via: 1.1 varnish, 1.1 varnish
Accept-Ranges: bytes
Date: Tue, 08 Feb 2022 14:03:36 GMT
Age: 24050350
X-Served-By: cache-lga21980-LGA, cache-hhn4034-HHN
X-Cache: HIT, HIT
X-Cache-Hits: 194520, 531902
X-Timer: S1644329016.035647,VS0,VE0
Vary: Accept-Encoding

GET
H2 200 / Show response
onetag-sys.com/usync/ Frame 7C76 2 KB
814 B 21ms
20ms Document
text/html 51.38.120.206
OVH

General

Check archive.org

Show headers Download Go to

Full URL

https://onetag-sys.com/usync/?cb=1644329015956

Requested by

Host: p.nodserving.com
URL: https://p.nodserving.com/prebidlink/19031/pbm_307825_11600.js

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

51.38.120.206 , France, ASN16276 (OVH, FR),

Reverse DNS

ip206.ip-51-38-120.eu

Software

Resource Hash

37a31642af0a7fe695ed0fd68a06a55af44e854d083dc7f5d0e70535f0189ae0

Security Headers

Name	Value
Strict-Transport-Security	max-age=15552000

Request headers

Upgrade-Insecure-Requests: 1
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Accept-Language: de-DE,de;q=0.9
Referer: https://p.nodserving.com/

Response headers

content-type: text/html
cache-control: no-transform, no-cache
content-encoding: gzip
content-length: 731
strict-transport-security: max-age=15552000

GET
H2 200 / Show response
onetag-sys.com/usync/ Frame C0BB 2 KB
814 B 22ms
21ms Document
text/html 51.38.120.206
OVH

General

Check archive.org

Show headers Download Go to

Full URL

https://onetag-sys.com/usync/?cb=1644329015958

Requested by

Host: p.nodserving.com
URL: https://p.nodserving.com/prebidlink/19031/pbm_307825_11600.js

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

51.38.120.206 , France, ASN16276 (OVH, FR),

Reverse DNS

ip206.ip-51-38-120.eu

Software

Resource Hash

37a31642af0a7fe695ed0fd68a06a55af44e854d083dc7f5d0e70535f0189ae0

Security Headers

Name	Value
Strict-Transport-Security	max-age=15552000

Request headers

Upgrade-Insecure-Requests: 1
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Accept-Language: de-DE,de;q=0.9
Referer: https://p.nodserving.com/

Response headers

content-type: text/html
cache-control: no-transform, no-cache
content-encoding: gzip
content-length: 731
strict-transport-security: max-age=15552000

GET
H2 200 / Show response
onetag-sys.com/usync/ Frame 6B8E 2 KB
814 B 21ms
20ms Document
text/html 51.38.120.206
OVH

General

Check archive.org

Show headers Download Go to

Full URL

https://onetag-sys.com/usync/?cb=1644329015960

Requested by

Host: p.nodserving.com
URL: https://p.nodserving.com/prebidlink/19031/pbm_307825_11600.js

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

51.38.120.206 , France, ASN16276 (OVH, FR),

Reverse DNS

ip206.ip-51-38-120.eu

Software

Resource Hash

37a31642af0a7fe695ed0fd68a06a55af44e854d083dc7f5d0e70535f0189ae0

Security Headers

Name	Value
Strict-Transport-Security	max-age=15552000

Request headers

Upgrade-Insecure-Requests: 1
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Accept-Language: de-DE,de;q=0.9
Referer: https://p.nodserving.com/

Response headers

content-type: text/html
cache-control: no-transform, no-cache
content-encoding: gzip
content-length: 731
strict-transport-security: max-age=15552000

GET
H2 200 / Show response
onetag-sys.com/usync/ Frame 717D 2 KB
814 B 26ms
26ms Document
text/html 51.38.120.206
OVH

General

Check archive.org

Show headers Download Go to

Full URL

https://onetag-sys.com/usync/?cb=1644329015961

Requested by

Host: p.nodserving.com
URL: https://p.nodserving.com/prebidlink/19031/pbm_307825_11600.js

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

51.38.120.206 , France, ASN16276 (OVH, FR),

Reverse DNS

ip206.ip-51-38-120.eu

Software

Resource Hash

37a31642af0a7fe695ed0fd68a06a55af44e854d083dc7f5d0e70535f0189ae0

Security Headers

Name	Value
Strict-Transport-Security	max-age=15552000

Request headers

Upgrade-Insecure-Requests: 1
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Accept-Language: de-DE,de;q=0.9
Referer: https://p.nodserving.com/

Response headers

content-type: text/html
cache-control: no-transform, no-cache
content-encoding: gzip
content-length: 731
strict-transport-security: max-age=15552000

GET
H2 200 / Show response
onetag-sys.com/usync/ Frame 19DD 2 KB
814 B 24ms
24ms Document
text/html 51.38.120.206
OVH

General

Check archive.org

Show headers Download Go to

Full URL

https://onetag-sys.com/usync/?cb=1644329015963

Requested by

Host: p.nodserving.com
URL: https://p.nodserving.com/prebidlink/19031/pbm_307825_11600.js

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

51.38.120.206 , France, ASN16276 (OVH, FR),

Reverse DNS

ip206.ip-51-38-120.eu

Software

Resource Hash

37a31642af0a7fe695ed0fd68a06a55af44e854d083dc7f5d0e70535f0189ae0

Security Headers

Name	Value
Strict-Transport-Security	max-age=15552000

Request headers

Upgrade-Insecure-Requests: 1
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Accept-Language: de-DE,de;q=0.9
Referer: https://p.nodserving.com/

Response headers

content-type: text/html
cache-control: no-transform, no-cache
content-encoding: gzip
content-length: 731
strict-transport-security: max-age=15552000

GET
H/1.1 200
OK async_usersync Show response
secure.adnxs.com/ Frame 4A1D 0
731 B 304ms
304ms Script
text/html 185.33.221.91
ASN-APPNEX

General

Check archive.org

Show headers Download Go to

Full URL

https://secure.adnxs.com/async_usersync?cbfn=AN_async_load

Requested by

Host: acdn.adnxs.com
URL: https://acdn.adnxs.com/ib/static/usersync/v3/async_usersync.html

Protocol

HTTP/1.1

Security

TLS 1.2, ECDHE_ECDSA, AES_128_GCM

Server

185.33.221.91 Amsterdam, Netherlands, ASN29990 (ASN-APPNEX, US),

Reverse DNS

721.bm-nginx-loadbalancer.mgmt.ams1.adnexus.net

Software

nginx/1.17.9 /

Resource Hash

e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Security Headers

Name	Value
X-Xss-Protection	0

Request headers

Accept-Language: de-DE,de;q=0.9
Referer: https://acdn.adnxs.com/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

Pragma: no-cache
Date: Tue, 08 Feb 2022 14:03:36 GMT
X-Proxy-Origin: 84.19.175.183; 84.19.175.183; 721.bm-nginx-loadbalancer.mgmt.ams1; adnxs.com
AN-X-Request-Uuid: 69d710b0-9912-475c-a94a-c78de724b2bc
Server: nginx/1.17.9
P3P: policyref="http://cdn.adnxs-simple.com/w3c/policy/p3p.xml", CP="NOI DSP COR ADM PSAo PSDo OURo SAMo UNRo OTRo BUS COM NAV DEM STA PRE"
Cache-Control: no-store, no-cache, private
Connection: keep-alive
Content-Type: text/html; charset=utf-8
Content-Length: 0
X-XSS-Protection: 0
Expires: Sat, 15 Nov 2008 16:00:00 GMT

GET
H3 200 gtm.js Show response
www.googletagmanager.com/ Frame 8E4A 95 KB
37 KB 53ms
27ms Script
application/javascript 2a00:1450:4001:808::2008
GOOGLE

General

Check archive.org

Show headers Download Go to

Full URL

https://www.googletagmanager.com/gtm.js?id=GTM-MV5SCJ

Requested by

Host: sample.dragonforms.com
URL: https://sample.dragonforms.com/loading.do?omedasite=FiercePharma_short

Protocol

Security

QUIC, , AES_128_GCM

Server

2a00:1450:4001:808::2008 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),

Reverse DNS

Software

Google Tag Manager /

Resource Hash

7a14b326f560d86d6470ec65457774646164c34a19fe70a474ca43e88e9fd812

Security Headers

Name	Value
Strict-Transport-Security	max-age=31536000; includeSubDomains
X-Xss-Protection	0

Request headers

Accept-Language: de-DE,de;q=0.9
Referer: https://sample.dragonforms.com/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

date: Tue, 08 Feb 2022 14:03:36 GMT
content-encoding: br
vary: Accept-Encoding
cross-origin-resource-policy: cross-origin
alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length: 37945
x-xss-protection: 0
last-modified: Tue, 08 Feb 2022 12:00:00 GMT
server: Google Tag Manager
strict-transport-security: max-age=31536000; includeSubDomains
content-type: application/javascript; charset=UTF-8
access-control-allow-origin: *
cache-control: private, max-age=900
access-control-allow-credentials: true
access-control-allow-headers: Cache-Control
expires: Tue, 08 Feb 2022 14:03:36 GMT

GET
H/1.1 200 olytics.min.js Show response
olytics.omeda.com/olytics/js/v3/p/ Frame 8E4A 271 KB
73 KB 132ms
131ms Script
application/javascript 204.180.130.159
QTS-AS

General

Check archive.org

Show headers Download Go to

Full URL

https://olytics.omeda.com/olytics/js/v3/p/olytics.min.js

Requested by

Host: sample.dragonforms.com
URL: https://sample.dragonforms.com/loading.do?omedasite=FiercePharma_short

Protocol

HTTP/1.1

Security

TLS 1.2, ECDHE_RSA, AES_256_GCM

Server

204.180.130.159 , United States, ASN53866 (QTS-AS, US),

Reverse DNS

my.omedastaging.com

Software

Apache /

Resource Hash

a054aa97d11e81c0b049b5eeb2bda656aece2bf407995fd19e4a459ce60cec28

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Frame-Options	SAMEORIGIN
X-Xss-Protection	1; mode=block

Request headers

Accept-Language: de-DE,de;q=0.9
Referer: https://sample.dragonforms.com/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

Date: Tue, 08 Feb 2022 14:03:36 GMT
Content-Encoding: gzip
X-Content-Type-Options: nosniff
Last-Modified: Tue, 18 Jan 2022 16:42:56 GMT
Server: Apache
ETag: W/"277838-1642524176000"
X-Frame-Options: SAMEORIGIN
Content-Type: application/javascript
Access-Control-Allow-Origin: *
Cache-Control: max-age=21600
Transfer-Encoding: chunked
Accept-Ranges: bytes
vary: accept-encoding
X-XSS-Protection: 1; mode=block
Expires: Tue, 08 Feb 2022 20:03:36 GMT

GET
H/1.1 200 956.svg
hostedcontent.dragonforms.com/hosted/images/dragon/12247/ Frame 8E4A 2 KB
2 KB 128ms
128ms Image
image/svg+xml 205.162.42.5
QTS-AS

General

Check archive.org

Show headers Download Go to Show image

Full URL

https://hostedcontent.dragonforms.com/hosted/images/dragon/12247/956.svg

Requested by

Host: hostedcontent.dragonforms.com
URL: https://hostedcontent.dragonforms.com/hosted/images/dragon/12247/962.css

Protocol

HTTP/1.1

Security

TLS 1.2, ECDHE_RSA, AES_256_GCM

Server

205.162.42.5 , United States, ASN53866 (QTS-AS, US),

Reverse DNS

cdn.omeda.com

Software

Apache /

Resource Hash

576f1c20a3f2469e8fc92810450d9d4f25642aa38c0777307cc47ce8c59c6cef

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Frame-Options	SAMEORIGIN
X-Xss-Protection	1; mode=block

Request headers

Accept-Language: de-DE,de;q=0.9
Referer: https://hostedcontent.dragonforms.com/hosted/images/dragon/12247/962.css
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

Date: Tue, 08 Feb 2022 15:03:36 CET
X-Content-Type-Options: nosniff
Last-Modified: Mon, 04 Oct 2021 19:02:01 CEST
Server: Apache
ETag: W/"1609-1633366921496"
X-Frame-Options: SAMEORIGIN
Content-Type: image/svg+xml
Access-Control-Allow-Origin: *
Access-Control-Expose-Headers: Access-Control-Allow-Origin,Access-Control-Allow-Credentials
Transfer-Encoding: chunked
Accept-Ranges: bytes
X-XSS-Protection: 1; mode=block

GET
H/1.1 200 evaluateConditionalContent.do;jsessionid=2E77801E27CA7D0047C0ADB1A335285D Show response
sample.dragonforms.com/ Frame 8E4A 277 B
468 B 125ms
124ms XHR
text/x-json 204.180.130.190
QTS-AS

General

Check archive.org

Show headers Download Go to

Full URL

https://sample.dragonforms.com/evaluateConditionalContent.do;jsessionid=2E77801E27CA7D0047C0ADB1A335285D?demo147906=short&demo147907=&demo147908=&opt147912=1&demo147915=LS-FP-FORM-NSL-FPShort&dragon_pagenumber=1&jsessionid=2E77801E27CA7D0047C0ADB1A335285D&timestemp=1644329016183

Requested by

Host: code.jquery.com
URL: https://code.jquery.com/jquery-2.2.4.min.js

Protocol

HTTP/1.1

Security

TLS 1.2, ECDHE_RSA, AES_256_GCM

Server

204.180.130.190 , United States, ASN53866 (QTS-AS, US),

Reverse DNS

Software

Apache /

Resource Hash

de7fb728cb39a5400c73eba1a03035da14f877e20e474fc60c7c6bd68a735acb

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Xss-Protection	1; mode=block

Request headers

Accept: application/json, text/javascript, */*; q=0.01
Referer: https://sample.dragonforms.com/loading.do?omedasite=FiercePharma_short
X-Requested-With: XMLHttpRequest
Accept-Language: de-DE,de;q=0.9
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

Date: Tue, 08 Feb 2022 14:03:35 GMT
Content-Encoding: gzip
X-Content-Type-Options: nosniff
Server: Apache
Vary: Accept-Encoding
Content-Type: text/x-json;charset=UTF-8
Access-Control-Allow-Origin: *
Transfer-Encoding: chunked
X-XSS-Protection: 1; mode=block

GET
H/1.1 200 evaluateConditionalContent.do;jsessionid=2E77801E27CA7D0047C0ADB1A335285D Show response
sample.dragonforms.com/ Frame 8E4A 277 B
468 B 127ms
127ms XHR
text/x-json 204.180.130.190
QTS-AS

General

Check archive.org

Show headers Download Go to

Full URL

Requested by

Host: code.jquery.com
URL: https://code.jquery.com/jquery-2.2.4.min.js

Protocol

HTTP/1.1

Security

TLS 1.2, ECDHE_RSA, AES_256_GCM

Server

204.180.130.190 , United States, ASN53866 (QTS-AS, US),

Reverse DNS

Software

Apache /

Resource Hash

de7fb728cb39a5400c73eba1a03035da14f877e20e474fc60c7c6bd68a735acb

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Xss-Protection	1; mode=block

Request headers

Accept: application/json, text/javascript, */*; q=0.01
Referer: https://sample.dragonforms.com/loading.do?omedasite=FiercePharma_short
X-Requested-With: XMLHttpRequest
Accept-Language: de-DE,de;q=0.9
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

Date: Tue, 08 Feb 2022 14:03:35 GMT
Content-Encoding: gzip
X-Content-Type-Options: nosniff
Server: Apache
Vary: Accept-Encoding
Content-Type: text/x-json;charset=UTF-8
Access-Control-Allow-Origin: *
Transfer-Encoding: chunked
X-XSS-Protection: 1; mode=block

GET
H3 200 analytics.js Show response
www.google-analytics.com/ Frame 8E4A 49 KB
20 KB 17ms
16ms Script
text/javascript 2a00:1450:4001:810::200e
GOOGLE

General

Check archive.org

Show headers Download Go to

Full URL

https://www.google-analytics.com/analytics.js

Requested by

Host: www.googletagmanager.com
URL: https://www.googletagmanager.com/gtm.js?id=GTM-MV5SCJ

Protocol

Security

QUIC, , AES_128_GCM

Server

2a00:1450:4001:810::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),

Reverse DNS

Software

Golfe2 /

Resource Hash

a1925038db769477ab74b4df34350c35688a795bb718727b0f4292a4a78a6210

Security Headers

Name	Value
Strict-Transport-Security	max-age=10886400; includeSubDomains; preload
X-Content-Type-Options	nosniff

Request headers

Accept-Language: de-DE,de;q=0.9
Referer: https://sample.dragonforms.com/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

strict-transport-security: max-age=10886400; includeSubDomains; preload
content-encoding: gzip
x-content-type-options: nosniff
last-modified: Tue, 02 Nov 2021 17:39:06 GMT
server: Golfe2
age: 1722
date: Tue, 08 Feb 2022 13:34:54 GMT
vary: Accept-Encoding
content-type: text/javascript
cache-control: public, max-age=7200
cross-origin-resource-policy: cross-origin
alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length: 20006
expires: Tue, 08 Feb 2022 15:34:54 GMT

GET
H2 200 publishertag.prebid.js Show response
static.criteo.net/js/ld/ 90 KB
28 KB 92ms
31ms XHR
text/javascript 2a02:2638::3
ASN-CRITEO-EUROPE

General

Check archive.org

Show headers Download Go to

Full URL

https://static.criteo.net/js/ld/publishertag.prebid.js

Requested by

Host: static.criteo.net
URL: https://static.criteo.net/js/ld/publishertag.prebid.117.js

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2a02:2638::3 , France, ASN44788 (ASN-CRITEO-EUROPE, FR),

Reverse DNS

Software

nginx /

Resource Hash

2c8ae0c883c62c03c5800ca91a31d1f0e00088683fb5f4131667c0504ce99e64

Security Headers

Name	Value
Strict-Transport-Security	max-age=31536000; preload;

Request headers

Accept-Language: de-DE,de;q=0.9
Referer: https://www.fiercepharma.com/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

date: Tue, 08 Feb 2022 14:03:36 GMT
content-encoding: gzip
last-modified: Mon, 31 Jan 2022 09:04:35 GMT
server: nginx
etag: W/"61f7a623-16685"
strict-transport-security: max-age=31536000; preload;
content-type: text/javascript
access-control-allow-origin: *
cache-control: max-age=86400, public
cross-origin-resource-policy: cross-origin
timing-allow-origin: *
expires: Wed, 09 Feb 2022 14:03:36 GMT

GET
H/1.1 200 evaluateConditionalContent.do;jsessionid=2E77801E27CA7D0047C0ADB1A335285D Show response
sample.dragonforms.com/ Frame 8E4A 277 B
468 B 129ms
129ms XHR
text/x-json 204.180.130.190
QTS-AS

General

Check archive.org

Show headers Download Go to

Full URL

Requested by

Host: code.jquery.com
URL: https://code.jquery.com/jquery-2.2.4.min.js

Protocol

HTTP/1.1

Security

TLS 1.2, ECDHE_RSA, AES_256_GCM

Server

204.180.130.190 , United States, ASN53866 (QTS-AS, US),

Reverse DNS

Software

Apache /

Resource Hash

de7fb728cb39a5400c73eba1a03035da14f877e20e474fc60c7c6bd68a735acb

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Xss-Protection	1; mode=block

Request headers

Accept: application/json, text/javascript, */*; q=0.01
Referer: https://sample.dragonforms.com/loading.do?omedasite=FiercePharma_short
X-Requested-With: XMLHttpRequest
Accept-Language: de-DE,de;q=0.9
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

Date: Tue, 08 Feb 2022 14:03:35 GMT
Content-Encoding: gzip
X-Content-Type-Options: nosniff
Server: Apache
Vary: Accept-Encoding
Content-Type: text/x-json;charset=UTF-8
Access-Control-Allow-Origin: *
Transfer-Encoding: chunked
X-XSS-Protection: 1; mode=block

HEAD
H3 200 adsbygoogle.js
pagead2.googlesyndication.com/pagead/js/ Frame 8E4A 0
0 67ms
40ms Fetch
text/javascript 2a00:1450:4001:827::2002
GOOGLE

General

Check archive.org

Show headers Download Go to

Full URL

https://pagead2.googlesyndication.com/pagead/js/adsbygoogle.js

Requested by

Host: olytics.omeda.com
URL: https://olytics.omeda.com/olytics/js/v3/p/olytics.min.js

Protocol

Security

QUIC, , AES_128_GCM

Server

2a00:1450:4001:827::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),

Reverse DNS

Software

cafe /

Resource Hash

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Xss-Protection	0

Request headers

Accept-Language: de-DE,de;q=0.9
Referer: https://sample.dragonforms.com/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

date: Tue, 08 Feb 2022 14:03:36 GMT
content-encoding: gzip
x-content-type-options: nosniff
p3p: policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
cross-origin-resource-policy: cross-origin
content-disposition: attachment; filename="f.txt"
alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length: 53839
x-xss-protection: 0
server: cafe
etag: 3720849935734544028
vary: Accept-Encoding, Origin
content-type: text/javascript; charset=UTF-8
cache-control: private, max-age=3600
timing-allow-origin: *
expires: Tue, 08 Feb 2022 14:03:36 GMT

HEAD
H3 200 gpt.js
www.googletagservices.com/tag/js/ Frame 8E4A 0
0 49ms
25ms Fetch
text/javascript 2a00:1450:4001:812::2002
GOOGLE

General

Check archive.org

Show headers Download Go to

Full URL

https://www.googletagservices.com/tag/js/gpt.js

Requested by

Host: olytics.omeda.com
URL: https://olytics.omeda.com/olytics/js/v3/p/olytics.min.js

Protocol

Security

QUIC, , AES_128_GCM

Server

2a00:1450:4001:812::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),

Reverse DNS

Software

sffe /

Resource Hash

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Xss-Protection	0

Request headers

Accept-Language: de-DE,de;q=0.9
Referer: https://sample.dragonforms.com/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

date: Tue, 08 Feb 2022 14:03:36 GMT
content-encoding: gzip
x-content-type-options: nosniff
cross-origin-resource-policy: cross-origin
alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length: 27199
x-xss-protection: 0
server: sffe
etag: "1125 / 395 of 1000 / last-modified: 1644322105"
vary: Accept-Encoding
report-to: {"group":"ads-gpt-scs","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/ads-gpt-scs"}]}
content-type: text/javascript
cache-control: private, max-age=900, stale-while-revalidate=3600
timing-allow-origin: *
cross-origin-opener-policy-report-only: same-origin; report-to="ads-gpt-scs"
expires: Tue, 08 Feb 2022 14:03:36 GMT

POST
H/1.1 204
No Content multitracking Show response
ghb.hbmp.mediafuse.com/adunit/ 0
211 B 31ms
30ms XHR
text/plain 2a0c:5c81:5142::2
24SHELLS

General

Check archive.org

Show headers Download Go to

Full URL: https://ghb.hbmp.mediafuse.com/adunit/multitracking
Requested by: Host: player.hbmp.mediafuse.com
URL: https://player.hbmp.mediafuse.com/prebidlink/456758/hbw_master_302826_6936.js
Protocol: HTTP/1.1
Security: TLS 1.3, , AES_128_GCM
Server: 2a0c:5c81:5142::2 London, United Kingdom, ASN55081 (24SHELLS, US),
Reverse DNS
Software: VertaMedia 1.0 /
Resource Hash: e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer: https://www.fiercepharma.com/
Accept-Language: de-DE,de;q=0.9
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Content-Type: text/plain;charset=UTF-8

Response headers

Access-Control-Allow-Origin: https://www.fiercepharma.com
Date: Tue, 08 Feb 2022 14:03:36 GMT
Access-Control-Allow-Credentials: true
Server: VertaMedia 1.0
Connection: Keep-Alive

POST
H/1.1 204
No Content mut Show response
ghb.adtelligent.com/adunit/ Frame 447C 0
207 B 27ms
27ms XHR
text/plain 2a0c:5c81:5142::2
24SHELLS

General

Check archive.org

Show headers Download Go to

Full URL: https://ghb.adtelligent.com/adunit/mut
Requested by: Host: p.nodserving.com
URL: https://p.nodserving.com/prebidlink/19031/pbm_307825_11600.js
Protocol: HTTP/1.1
Security: TLS 1.3, , AES_128_GCM
Server: 2a0c:5c81:5142::2 London, United Kingdom, ASN55081 (24SHELLS, US),
Reverse DNS
Software: VertaMedia 1.0 /
Resource Hash: e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer: https://p.nodserving.com/
Accept-Language: de-DE,de;q=0.9
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Content-Type: text/plain;charset=UTF-8

Response headers

Access-Control-Allow-Origin: https://p.nodserving.com
Date: Tue, 08 Feb 2022 14:03:36 GMT
Access-Control-Allow-Credentials: true
Server: VertaMedia 1.0
Connection: Keep-Alive

OPTIONS
H/1.1 200 p
olytics.omeda.com/olytics/segments/ Frame 0
0 124ms
124ms Preflight 204.180.130.159
QTS-AS

General

Check archive.org

Show headers Download Go to

Full URL: https://olytics.omeda.com/olytics/segments/p
Protocol: HTTP/1.1
Security: TLS 1.2, ECDHE_RSA, AES_256_GCM
Server: 204.180.130.159 , United States, ASN53866 (QTS-AS, US),
Reverse DNS: my.omedastaging.com
Software: Apache /
Resource Hash

Request headers

Accept: */*
Access-Control-Request-Method: POST
Access-Control-Request-Headers: content-type
Origin: https://sample.dragonforms.com
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Sec-Fetch-Mode: cors

Response headers

Access-Control-Allow-Origin: *
vary: Access-Control-Request-Headers,Access-Control-Request-Headers,access-control-request-method
Access-Control-Max-Age: 1800
Access-Control-Allow-Methods: HEAD,DELETE,POST,GET,OPTIONS,PUT
Access-Control-Allow-Headers: access-control-max-age,accept-language,origin,x-requested-with,access-control-request-headers,host,content-type,access-control-request-method,accept-encoding,accept,user-agent
Content-Length: 0
Date: Tue, 08 Feb 2022 14:03:37 GMT
Server: Apache

POST
H/1.1 204 p Show response
olytics.omeda.com/olytics/segments/ Frame 8E4A 0
197 B 153ms
153ms XHR
text/plain 204.180.130.159
QTS-AS

General

Check archive.org

Show headers Download Go to

Full URL

https://olytics.omeda.com/olytics/segments/p

Requested by

Host: olytics.omeda.com
URL: https://olytics.omeda.com/olytics/js/v3/p/olytics.min.js

Protocol

HTTP/1.1

Security

TLS 1.2, ECDHE_RSA, AES_256_GCM

Server

204.180.130.159 , United States, ASN53866 (QTS-AS, US),

Reverse DNS

my.omedastaging.com

Software

Apache /

Resource Hash

e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Frame-Options	SAMEORIGIN
X-Xss-Protection	1; mode=block

Request headers

Referer: https://sample.dragonforms.com/
Accept-Language: de-DE,de;q=0.9
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Content-Type: application/json

Response headers

Access-Control-Allow-Origin: *
Date: Tue, 08 Feb 2022 14:03:37 GMT
X-Content-Type-Options: nosniff
Server: Apache
X-XSS-Protection: 1; mode=block
X-Frame-Options: SAMEORIGIN

POST
H/1.1 200 cswitch Show response
olytics.omeda.com/olytics/segments/ Frame 8E4A 94 B
387 B 135ms
134ms XHR
application/json 204.180.130.159
QTS-AS

General

Check archive.org

Show headers Download Go to

Full URL

https://olytics.omeda.com/olytics/segments/cswitch

Requested by

Host: olytics.omeda.com
URL: https://olytics.omeda.com/olytics/js/v3/p/olytics.min.js

Protocol

HTTP/1.1

Security

TLS 1.2, ECDHE_RSA, AES_256_GCM

Server

204.180.130.159 , United States, ASN53866 (QTS-AS, US),

Reverse DNS

my.omedastaging.com

Software

Apache /

Resource Hash

3dfa79f74fa390a90f9d1806c6c64f3cf789b1be61749662de88aca1ab9139a3

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Frame-Options	SAMEORIGIN
X-Xss-Protection	1; mode=block

Request headers

Referer: https://sample.dragonforms.com/
Accept-Language: de-DE,de;q=0.9
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Content-Type: application/json

Response headers

Date: Tue, 08 Feb 2022 14:03:37 GMT
X-Content-Type-Options: nosniff
Server: Apache
X-Frame-Options: SAMEORIGIN
Content-Type: application/json
Access-Control-Allow-Origin: *
Cache-Control: no-cache
Transfer-Encoding: chunked
X-XSS-Protection: 1; mode=block

OPTIONS
H/1.1 200 cswitch
olytics.omeda.com/olytics/segments/ Frame 0
0 121ms
121ms Preflight 204.180.130.159
QTS-AS

General

Check archive.org

Show headers Download Go to

Full URL: https://olytics.omeda.com/olytics/segments/cswitch
Protocol: HTTP/1.1
Security: TLS 1.2, ECDHE_RSA, AES_256_GCM
Server: 204.180.130.159 , United States, ASN53866 (QTS-AS, US),
Reverse DNS: my.omedastaging.com
Software: Apache /
Resource Hash

Request headers

Accept: */*
Access-Control-Request-Method: POST
Access-Control-Request-Headers: content-type
Origin: https://sample.dragonforms.com
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Sec-Fetch-Mode: cors

Response headers

Access-Control-Allow-Origin: *
vary: Access-Control-Request-Headers,Access-Control-Request-Headers,access-control-request-method
Access-Control-Max-Age: 1800
Access-Control-Allow-Methods: HEAD,DELETE,POST,GET,OPTIONS,PUT
Access-Control-Allow-Headers: access-control-max-age,accept-language,origin,x-requested-with,access-control-request-headers,host,content-type,access-control-request-method,accept-encoding,accept,user-agent
Content-Length: 0
Date: Tue, 08 Feb 2022 14:03:37 GMT
Server: Apache

GET
H2 200 report
creative.spotible.com/creative/GxHs/ 43 B
98 B 100ms
100ms Image
image/gif 54.144.118.149
AMAZON-AES

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://creative.spotible.com/creative/GxHs/report?,1644329014,595003;IN_VIEW_TIME!0,4,0!18,4,0!55,4,0!69,4,0!113,4,0!120,4,0&referrer=https%3A%2F%2Fwww.fiercepharma.com%2Fspecial-report%2F10-most-anticipated-drug-launches-2022-4-deucravacitinib
Requested by: Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/special-report/10-most-anticipated-drug-launches-2022-4-deucravacitinib
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 54.144.118.149 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS: ec2-54-144-118-149.compute-1.amazonaws.com
Software: /
Resource Hash: b1442e85b03bdcaf66dc58c7abb98745dd2687d86350be9a298a1d9382ac849b

Request headers

Accept-Language: de-DE,de;q=0.9
Referer: https://www.fiercepharma.com/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

date: Tue, 08 Feb 2022 14:03:38 GMT
cache-control: no-store
content-length: 43
content-type: image/gif

GET
H2

200

sid Show response
mug.criteo.com/
Redirect Chain

https://gum.criteo.com/sid/json?origin=prebid&topUrl=https%3A%2F%2Fwww.fiercepharma.com%2F&domain=www.fiercepharma.com&cw=1&pbt=1&lsw=1
https://mug.criteo.com/sid?cpp=DvZvzHwzWWNyRS9zbCtmQWFwQVBoT1BxeS9yMlhVc0pYbG9GZTczMWFZS3VVbE9OKzZBb0dWejV4ZHAyVjJwcmY4QUJGemFRdkg2Mmk4WWtXMmlUYVU0N2Rab04vUzBlNTJJR1d5SHRCelBJaStLeGhwZjdGZVdYWXlJTF...

339 B
611 B

72ms
25ms

XHR
application/json

178.250.2.146
ASN-CRITEO-EUROPE

General

Check archive.org

Show headers Download Go to

Full URL

https://mug.criteo.com/sid?cpp=DvZvzHwzWWNyRS9zbCtmQWFwQVBoT1BxeS9yMlhVc0pYbG9GZTczMWFZS3VVbE9OKzZBb0dWejV4ZHAyVjJwcmY4QUJGemFRdkg2Mmk4WWtXMmlUYVU0N2Rab04vUzBlNTJJR1d5SHRCelBJaStLeGhwZjdGZVdYWXlJTFhQZDFPc25DdmtueStDU29SUjlWNy83bnlhY09UOVRJOXMzd2h5RGlWdFhrNTAwRmc0RGw1d3VyeFVSdVNxbzR3TStYWmFScVhkTGdOOURZWnN4L1dlNW9GcHdnNlN1UkpiQmt3THFuNDVUNFNwYjU3RWhHN0d2Y2xlVXNIT2JJZTMyakRoMzlwfA&cppv=2

Requested by

Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/special-report/10-most-anticipated-drug-launches-2022-4-deucravacitinib

Protocol

Server

178.250.2.146 , France, ASN44788 (ASN-CRITEO-EUROPE, FR),

Reverse DNS

Software

Resource Hash

1f6a83834d6b0a2b528773f7ea5cfe1a42d5b6cd68d6a4f837e86fa55e24f80a

Security Headers

Name	Value
Strict-Transport-Security	max-age=31536000; preload;

Request headers

Accept-Language: de-DE,de;q=0.9
Referer: https://www.fiercepharma.com/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

pragma: no-cache
date: Tue, 08 Feb 2022 14:03:38 GMT
content-encoding: gzip
vary: Accept-Encoding
access-control-allow-methods: GET
content-type: application/json; charset=utf-8
access-control-allow-origin: null
cache-control: no-cache, no-store, must-revalidate
access-control-allow-credentials: true
server-processing-duration-in-ticks: 3119
strict-transport-security: max-age=31536000; preload;
expires: 0

Redirect headers

pragma: no-cache
date: Tue, 08 Feb 2022 14:03:38 GMT
location: https://mug.criteo.com/sid?cpp=DvZvzHwzWWNyRS9zbCtmQWFwQVBoT1BxeS9yMlhVc0pYbG9GZTczMWFZS3VVbE9OKzZBb0dWejV4ZHAyVjJwcmY4QUJGemFRdkg2Mmk4WWtXMmlUYVU0N2Rab04vUzBlNTJJR1d5SHRCelBJaStLeGhwZjdGZVdYWXlJTFhQZDFPc25DdmtueStDU29SUjlWNy83bnlhY09UOVRJOXMzd2h5RGlWdFhrNTAwRmc0RGw1d3VyeFVSdVNxbzR3TStYWmFScVhkTGdOOURZWnN4L1dlNW9GcHdnNlN1UkpiQmt3THFuNDVUNFNwYjU3RWhHN0d2Y2xlVXNIT2JJZTMyakRoMzlwfA&cppv=2
strict-transport-security: max-age=31536000; preload;
access-control-allow-methods: GET
content-type: text/html; charset=utf-8
access-control-allow-origin: https://www.fiercepharma.com
cache-control: no-cache, no-store, must-revalidate
access-control-allow-credentials: true
server-processing-duration-in-ticks: 1931
content-length: 509
expires: 0

POST
H/1.1 200 692.json Show response
id5-sync.com/g/v2/ 213 B
538 B 119ms
25ms XHR
application/json 51.89.7.110
OVH

General

Check archive.org

Show headers Download Go to

Full URL

https://id5-sync.com/g/v2/692.json

Requested by

Host: player.mediafuse.com
URL: https://player.mediafuse.com/prebidlink/456758/hb_302826_6936.js

Protocol

HTTP/1.1

Security

TLS 1.2, ECDHE_RSA, AES_128_GCM

Server

51.89.7.110 London, United Kingdom, ASN16276 (OVH, FR),

Reverse DNS

p23.id5-sync.com

Software

Resource Hash

a3a01e6d4d86e74c95101f4abf4061a84f9729b1e2b82a75da7b8f32066af3f0

Security Headers

Name	Value
Strict-Transport-Security	max-age=63072000; includeSubDomains; preload

Request headers

Referer: https://www.fiercepharma.com/
Accept-Language: de-DE,de;q=0.9
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Content-Type: text/plain

Response headers

Access-Control-Allow-Origin: https://www.fiercepharma.com
Date: Tue, 08 Feb 2022 14:03:38 GMT
Access-Control-Allow-Credentials: true
Vary: Origin
Transfer-Encoding: chunked
Strict-Transport-Security: max-age=63072000; includeSubDomains; preload
Content-Type: application/json;charset=UTF-8

OPTIONS
H2 200 json
gum.criteo.com/sid/ Frame 0
0 109ms
31ms Preflight
application/json 2a02:2638::1c
ASN-CRITEO-EUROPE

General

Check archive.org

Show headers Download Go to

Full URL

https://gum.criteo.com/sid/json?origin=prebid&topUrl=https%3A%2F%2Fwww.fiercepharma.com%2F&domain=www.fiercepharma.com&cw=1&pbt=1&lsw=1

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2a02:2638::1c , France, ASN44788 (ASN-CRITEO-EUROPE, FR),

Reverse DNS

Software

Resource Hash

Security Headers

Name	Value
Strict-Transport-Security	max-age=31536000; preload;

Request headers

Accept: */*
Access-Control-Request-Method: GET
Access-Control-Request-Headers: content-type
Origin: https://www.fiercepharma.com
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Sec-Fetch-Mode: cors

Response headers

cache-control: no-cache, no-store, must-revalidate
pragma: no-cache
content-type: application/json; charset=utf-8
expires: 0
access-control-allow-origin: https://www.fiercepharma.com
access-control-allow-headers: content-type
access-control-allow-credentials: true
access-control-allow-methods: GET
server-processing-duration-in-ticks: 1596
date: Tue, 08 Feb 2022 14:03:38 GMT
strict-transport-security: max-age=31536000; preload;
content-encoding: gzip
vary: Accept-Encoding

OPTIONS
H2 200 sid
mug.criteo.com/ Frame 0
0 77ms
24ms Preflight
application/json 178.250.2.146
ASN-CRITEO-EUROPE

General

Check archive.org

Show headers Download Go to

Full URL

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

178.250.2.146 , France, ASN44788 (ASN-CRITEO-EUROPE, FR),

Reverse DNS

Software

Resource Hash

Security Headers

Name	Value
Strict-Transport-Security	max-age=31536000; preload;

Request headers

Accept: */*
Access-Control-Request-Method: GET
Access-Control-Request-Headers: content-type
Origin: null
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Sec-Fetch-Mode: cors

Response headers

cache-control: no-cache, no-store, must-revalidate
pragma: no-cache
content-type: application/json; charset=utf-8
expires: 0
access-control-allow-origin: null
access-control-allow-headers: content-type
access-control-allow-credentials: true
access-control-allow-methods: GET
server-processing-duration-in-ticks: 992
date: Tue, 08 Feb 2022 14:03:38 GMT
strict-transport-security: max-age=31536000; preload;
content-encoding: gzip
vary: Accept-Encoding

Failed requests

These URLs were requested, but there was no response received. You will also see them in the list above.

Domain: c405.fiercepharma.com
URL: https://c405.fiercepharma.com/DG/DEFAULT/rest/rpc/794?referer=https%3A%2F%2Fwww.fiercepharma.com%2Fspecial-report%2F10-most-anticipated-drug-launches-2022-4-deucravacitinib&bcsessionid=&bctempid=&overruleReferrer=&time=2022-02-08T14%3A03%3A33%2B00%3A00&ts=1644329013468

Domain: rtb.adxpremium.services
URL: https://rtb.adxpremium.services/openrtb2/auction

Domain: rtb.adxpremium.services
URL: https://rtb.adxpremium.services/openrtb2/auction

Domain: rtb.adxpremium.services
URL: https://rtb.adxpremium.services/openrtb2/auction

Domain: rtb.adxpremium.services
URL: https://rtb.adxpremium.services/openrtb2/auction

Domain: rtb.adxpremium.services
URL: https://rtb.adxpremium.services/openrtb2/auction

Domain: ads.spotible.com
URL: https://ads.spotible.com/tag/universal-tag.js

Verdicts & Comments Add Verdict or Comment

103 JavaScript Global Variables

These are the non-standard "global" variables defined on the window object. These can be helpful in identifying possible client-side frameworks and code.

79 Cookies

Cookies are little pieces of information stored in the browser of a user. Whenever a user visits the site again, he will also send his cookie values, thus allowing the website to re-identify him even if he changed locations. This is how permanent logins work.

Domain/Path	Expires	Name / Value
www.fiercepharma.com/special-report	1969-12-31 23:59:59	Name: hasLiveRampMatch Value: true
www.fiercepharma.com/	1970-01-20 09:31:05	Name: last_visit_bc Value: 1644329013128
.app-sj10.marketo.com/	1970-01-20 00:45:30	Name: __cf_bm Value: g5Lx5V6dxbfnzrsU5o_5Cx8OsstB_gpPww1I8lmJ60c-1644329013-0-Aeiz2unaZ1FKixzMNgKjbVCSXCVI3zpPDuSIWXC1/WEu/mtQXaWK7TeGgjk2fgjvNbw3qUgYMoYPhstYDm6lp4k=
.fiercepharma.com/	1970-01-20 18:16:41	Name: _ga Value: GA1.2.800578055.1644329014
.fiercepharma.com/	1970-01-20 00:46:55	Name: _gid Value: GA1.2.421591499.1644329014
.fiercepharma.com/	1970-01-20 00:45:29	Name: _gat_UA-336524-28 Value: 1
www.fiercepharma.com/	1969-12-31 23:59:59	Name: dpm_url_count Value: 1
.fiercepharma.com/	1970-01-20 18:16:41	Name: _mkto_trk Value: id:294-MQF-056&token:_mch-fiercepharma.com-1644329013575-25283
.adnxs.com/	1970-01-20 02:55:05	Name: uuid2 Value: 5611407578940007418
.fiercepharma.com/	1970-01-20 00:45:30	Name: _parsely_session Value: {%22sid%22:1%2C%22surl%22:%22https://www.fiercepharma.com/special-report/10-most-anticipated-drug-launches-2022-4-deucravacitinib%22%2C%22sref%22:%22%22%2C%22sts%22:1644329013617%2C%22slts%22:0}
.fiercepharma.com/	1970-01-20 10:14:53	Name: _parsely_visitor Value: {%22id%22:%22pid=7c909c60890d123c6bb653f8bb6696b3%22%2C%22session_count%22:1%2C%22last_session_ts%22:1644329013617}
.ws.zoominfo.com/	1970-01-20 09:31:05	Name: visitorId Value: d2f3e0c2bed1c3e83568062f7e22b5e79495d293784b40d3be92de746223ff87
.hbmp.mediafuse.com/	1970-01-20 02:59:24	Name: vmuid Value: a588dd692d2223c1
www.fiercepharma.com/	1970-01-20 01:28:41	Name: _pbjs_userid_consent_data Value: 3524755945110770
.fiercepharma.com/	1970-01-20 09:31:05	Name: _pubcid Value: b3acf975-6694-4970-9538-76bd2b008d42
.adtelligent.com/	1970-01-20 02:14:45	Name: vmuid Value: dee7590cecd5b9a6
.lijit.com/	1970-01-20 09:31:05	Name: ljtrtb Value: eJyrrgUAAXUA%2BQ%3D%3D
.admixer.net/	1970-01-20 02:55:05	Name: am-uid Value: a8d164efc01546ef85842406b01a90a4
.go.sonobi.com/	1970-01-20 00:45:29	Name: __uih Value: 1
.go.sonobi.com/	1969-12-31 23:59:59	Name: HAPLB5A Value: s56128\|YgJ4O
sample.dragonforms.com/	1969-12-31 23:59:59	Name: JSESSIONID Value: 2E77801E27CA7D0047C0ADB1A335285D
.dpmsrv.com/	1970-04-11 01:12:09	Name: dpm_pxl Value: 55f4c5a04a9bcdfda03ed1afef3377e0eb46b049
.dpmsrv.com/	1970-04-11 01:12:09	Name: dpm_pxl_aid Value: 5611407578940007418
.betweendigital.com/	1970-01-20 09:31:05	Name: dc Value: mow1
.betweendigital.com/	1970-01-20 09:31:05	Name: tuuid Value: ba90f581-3f66-5127-a6b9-6233c4bb1a05
.betweendigital.com/	1970-01-20 09:31:05	Name: ut Value: YgJ4NgABU9iZ0l4JeSNz-prHbRFfHYRkj8diPA==
.betweendigital.com/	1970-01-20 09:31:05	Name: ss Value: 1
.betweendigital.com/	1970-01-20 09:31:05	Name: unm Value: 1
.doubleclick.net/	1970-01-20 10:07:05	Name: IDE Value: AHWqTUk-oOPV5mn-0Qi2JeV9LQNK-S91VIlB9IRHXbqcPIHRAgCUm2Qc7CXXJVOfsL4
.rubiconproject.com/	1970-01-20 09:31:05	Name: khaos Value: KZE71FF7-1F-MBLT
.rubiconproject.com/	1970-01-20 09:31:05	Name: audit Value: 1\|SDziDG3X/EjOCL5oZInRXebASkO6QPb7E03ikE5KqM12wHsFnqwQFFQuMMdx5ksT2Viil87TsQADU4L+VXaOPcBQn6AvuCLFQXFQM5ICNxAdOKW1qRBjyg==
.contextweb.com/	1970-01-20 09:23:53	Name: V Value: Tw2CeqoIXBHo
prebid.a-mo.net/	1970-01-20 09:31:05	Name: __amc Value: 1_1644329014_1644329014
.ad.gt/	1970-01-20 18:16:41	Name: au_id Value: 71ea94e0-0093-44cb-b4dd-d08066fc43e4
.ad.gt/	1970-01-20 00:46:55	Name: au_idmatch Value: {"apn": "2022-02-08", "ttd": "2022-02-08", "pub": "2022-02-08", "adx": "2022-02-08", "halo": "2022-02-08", "goo": "2022-02-08", "impr": "2022-02-08", "bees": "2022-02-08", "rub": "2022-02-08"}
.fiercepharma.com/	1970-01-20 09:31:05	Name: oly_enc_id Value: null
.fiercepharma.com/	1970-01-20 09:31:05	Name: oly_anon_id Value: %226682244b-7143-4ba5-82f6-a1f8c72d7e4e%22
.pubmatic.com/	1970-01-20 02:55:05	Name: KTPCACOOKIE Value: true
.pubmatic.com/	1970-01-20 02:55:05	Name: KADUSERCOOKIE Value: BBFBF67E-52FE-430F-93B6-E6A55E905C12
.360yield.com/	1970-01-20 02:55:05	Name: tuuid Value: bcc9beb1-8e48-4422-8855-3bd127e27e5e
.360yield.com/	1970-01-20 02:55:05	Name: tuuid_lu Value: 1644329014
.adsrvr.org/	1970-01-20 09:31:05	Name: TDID Value: 5f6d2359-c211-4f10-9b58-14dbad0adcf8
.adsrvr.org/	1970-01-20 09:31:05	Name: TDCPM Value: CAEYBSABKAIyCwjg7vPv0MW1OhAFOAE.
.bidr.io/	1970-01-20 10:13:59	Name: bito Value: AAFhKk7EBPAAAAJ4odOVww
.bidr.io/	1970-01-20 10:13:59	Name: bitoIsSecure Value: ok
c405.fiercepharma.com/	1970-01-20 00:55:33	Name: AWSALB Value: H1vrA8dDz+QnBDshHI9y35PDb0IFKADU/qDBWjVDSDfnx8YxeFwhkjvMd3qlRRmXljpv+BsDrhU3rCOZeenfHeZdup2SpR6tCpc0INtjz6wee0gXGZXIJz6O7M5W
c405.fiercepharma.com/	1970-01-20 00:55:33	Name: AWSALBCORS Value: H1vrA8dDz+QnBDshHI9y35PDb0IFKADU/qDBWjVDSDfnx8YxeFwhkjvMd3qlRRmXljpv+BsDrhU3rCOZeenfHeZdup2SpR6tCpc0INtjz6wee0gXGZXIJz6O7M5W
.ad.gt/	1970-01-20 18:16:41	Name: last_seeng_hosted Value: 1644329015026
.ad.gt/	1970-01-20 18:16:41	Name: g_hosted Value:
.ad.gt/	1970-01-20 18:16:41	Name: last_seenadnxs Value: 1644329015037
.ad.gt/	1970-01-20 18:16:41	Name: adnxs_id Value: 5611407578940007418
.ad.gt/	1970-01-20 18:16:41	Name: first_seenadnxs Value: 1644329015037
.ad.gt/	1970-01-20 18:16:41	Name: last_seentd Value: 1644329015037
.ad.gt/	1970-01-20 18:16:41	Name: tdid Value: 5f6d2359-c211-4f10-9b58-14dbad0adcf8
.ad.gt/	1970-01-20 18:16:41	Name: first_seentd Value: 1644329015038
.ad.gt/	1970-01-20 18:16:41	Name: last_seenimprove Value: 1644329015039
.ad.gt/	1970-01-20 18:16:41	Name: impr_uid Value: bcc9beb1-8e48-4422-8855-3bd127e27e5e
.ad.gt/	1970-01-20 18:16:41	Name: last_seenadx Value: 1644329015039
.ad.gt/	1970-01-20 18:16:41	Name: google_gid Value: CAESEK46dYDDn1ptvDyhgNKmnDA
.ad.gt/	1970-01-20 18:16:41	Name: first_seenadx Value: 1644329015039
.ad.gt/	1970-01-20 18:16:41	Name: last_seenpbm Value: 1644329015042
.ad.gt/	1970-01-20 18:16:41	Name: pbm Value: BBFBF67E-52FE-430F-93B6-E6A55E905C12
.ad.gt/	1970-01-20 18:16:41	Name: first_seenpbm Value: 1644329015042
.ad.gt/	1970-01-20 18:16:41	Name: last_seenrub Value: 1644329015044
.ad.gt/	1970-01-20 18:16:41	Name: rub Value:
.ad.gt/	1970-01-20 18:16:41	Name: last_seenbeeswax Value: 1644329015051
.ad.gt/	1970-01-20 18:16:41	Name: beeswax_id Value: AAFhKk7EBPAAAAJ4odOVww
.ad.gt/	1970-01-20 18:16:41	Name: last_seenhaloid Value: 1644329015235
.ad.gt/	1970-01-20 18:16:41	Name: halo_id Value: 0201tlxlfd07jv2yg08xizqr0bwpa1w0evvljv1k7cm961o8b5po0ntek210qskvk40trr7270wqxik90zq3u2c12pa5j31k0gxf118nmsj90fzd0bt1elzfjf1hl5r1i1kkc2jl
.ad.gt/	1970-01-20 18:16:41	Name: first_seenhaloid Value: 1644329015235
.adnxs.com/	1970-01-20 02:55:05	Name: anj Value: dTM7k!M4/8CxrEQF']wIg2In@d?pgc!]tbP6j2F-XstGt!@Dd]$l-/M
.dpmsrv.com/	1970-04-11 01:12:09	Name: xdpm_segsid_913 Value: 16013439%2C16671093%2C29315652%2C29315642%2C29028703
.dpmsrv.com/	1970-04-11 01:12:09	Name: xdpm_segs_913 Value:
.fiercepharma.com/	1970-01-20 10:07:05	Name: __gads Value: ID=a10b70ecd31ee878:T=1644329013:S=ALNI_MZsm7Wnc7_eQhKrhueLNPLik0Vgww
.dragonforms.com/	1970-01-20 00:45:36	Name: oly_enc_id Value: null
.dragonforms.com/	1970-01-20 00:45:36	Name: oly_anon_id Value: %22bcd030a0-6b5c-4fff-8bb4-6bcfafbc13b3%22
.fiercepharma.com/	1970-01-20 10:07:05	Name: cto_bundle Value: TUZ0zF9jSFJ2ODRlZE83Y0xrUEVDOU83aDB4a21EdWRjUGpJNnNWNSUyRjNCSzBYOHglMkJlYmpreGhsMWRqYUtNRmJ1M3J1SXBST0k1M01mSDRyeHlIV2ZURmpJcDh5eVZJVENGQm12RDA1dHkyQnl0M2hvYmNXR01FblgxTVlGb3ZhZzVROWU
.fiercepharma.com/	1970-01-20 10:07:05	Name: cto_bidid Value: pb4bzl96VVpLMjNZVFZmUjhnVHN6T3g5V2JTdWNZRHdzdE5GUUlPcW9jWVdhTXVRWXdyYWpyWXo5Tm01Y3Q0dzF5WmJkRFVMQWxaVU4lMkI2bk1PR1k2WTZub0h3JTNEJTNE
www.fiercepharma.com/	1969-12-31 23:59:59	Name: dpm_time_site Value: 6.006

7 Console Messages

A page may trigger messages to the console to be logged. These are often error messages about being unable to load a resource or execute a piece of JavaScript. Sometimes they also provide insight into the technology behind a website.

Source	Level	URL Text
network	error	URL: https://questex.blueconic.net/DG/DEFAULT/cs?&callback=bc_json795 Message: Failed to load resource: the server responded with a status of 404 ()
network	error	URL: https://prebid.adnxs.com/pbs/v1/openrtb2/auction Message: Failed to load resource: the server responded with a status of 400 (Bad Request)
javascript	error	URL: https://www.fiercepharma.com/special-report/10-most-anticipated-drug-launches-2022-4-deucravacitinib Message: Access to XMLHttpRequest at 'https://c405.fiercepharma.com/DG/DEFAULT/rest/rpc/794?referer=https%3A%2F%2Fwww.fiercepharma.com%2Fspecial-report%2F10-most-anticipated-drug-launches-2022-4-deucravacitinib&bcsessionid=&bctempid=&overruleReferrer=&time=2022-02-08T14%3A03%3A33%2B00%3A00&ts=1644329013468' from origin 'https://www.fiercepharma.com' has been blocked by CORS policy: No 'Access-Control-Allow-Origin' header is present on the requested resource.
network	error	URL: https://c405.fiercepharma.com/DG/DEFAULT/rest/rpc/794?referer=https%3A%2F%2Fwww.fiercepharma.com%2Fspecial-report%2F10-most-anticipated-drug-launches-2022-4-deucravacitinib&bcsessionid=&bctempid=&overruleReferrer=&time=2022-02-08T14%3A03%3A33%2B00%3A00&ts=1644329013468 Message: Failed to load resource: net::ERR_FAILED
network	error	URL: https://idsync.rlcdn.com/423396.gif?partner_uid=5611407578940007418 Message: Failed to load resource: the server responded with a status of 451 ()
network	error	URL: https://c405.fiercepharma.com/DG/DEFAULT/rest/rpc/?requests=%5B%7B%22method%22%3A%22getProfile%22%2C%22params%22%3A%22null%22%2C%22id%22%3A%221644329013130%22%7D%2C%7B%22method%22%3A%22setProperties%22%2C%22params%22%3A%22%7B%5C%22properties%5C%22%3A%7B%5C%22language%5C%22%3A%5B%5C%22en%5C%22%5D%2C%5C%22currentscreenwidth%5C%22%3A%5B1600%5D%2C%5C%22currentscreenheight%5C%22%3A%5B1200%5D%2C%5C%22currentresolution%5C%22%3A%5B%5C%221600x1200%5C%22%5D%2C%5C%22entrypage%5C%22%3A%5B%5C%22https%3A%2F%2Fwww.fiercepharma.com%2Fspecial-report%2F10-most-anticipated-drug-launches-2022-4-deucravacitinib%5C%22%5D%2C%5C%22new_visit_bc%5C%22%3A%5B%5C%22true%5C%22%5D%7D%2C%5C%22sources%5C%22%3A%7B%5C%22listenerinteractiontype%5C%22%3A%5B%5C%22language%5C%22%2C%5C%22currentscreenwidth%5C%22%2C%5C%22currentscreenheight%5C%22%2C%5C%22currentresolution%5C%22%2C%5C%22entrypage%5C%22%5D%2C%5C%22newvisitlistener%5C%22%3A%5B%5C%22new_visit_bc%5C%22%5D%7D%7D%22%2C%22id%22%3A%221644329013132%22%7D%2C%7B%22method%22%3A%22addProperties%22%2C%22params%22%3A%22%7B%5C%22properties%5C%22%3A%7B%5C%22resolution%5C%22%3A%5B%5C%221600x1200%5C%22%5D%7D%2C%5C%22sources%5C%22%3A%7B%5C%22listenerinteractiontype%5C%22%3A%5B%5C%22resolution%5C%22%5D%7D%7D%22%2C%22id%22%3A%221644329013133%22%7D%2C%7B%22method%22%3A%22createEvent%22%2C%22params%22%3A%22%7B%5C%22type%5C%22%3A%5B%5C%22PAGEVIEW%5C%22%5D%2C%5C%22referrer%5C%22%3A%5B%5C%22%5C%22%5D%2C%5C%22profile%5C%22%3A%5B%5D%7D%22%2C%22id%22%3A%221644329013134%22%7D%5D&referer=https%3A%2F%2Fwww.fiercepharma.com%2Fspecial-report%2F10-most-anticipated-drug-launches-2022-4-deucravacitinib&bcsessionid=&bctempid=&overruleReferrer=&time=2022-02-08T14%3A03%3A33%2B00%3A00&callback=bc_json796 Message: Failed to load resource: the server responded with a status of 404 ()
network	error	URL: https://c405.fiercepharma.com/DG/DEFAULT/rest/rpc/?requests=%5B%7B%22method%22%3A%22getProfile%22%2C%22params%22%3A%22null%22%2C%22id%22%3A%221644329013130%22%7D%2C%7B%22method%22%3A%22setProperties%22%2C%22params%22%3A%22%7B%5C%22properties%5C%22%3A%7B%5C%22language%5C%22%3A%5B%5C%22en%5C%22%5D%2C%5C%22currentscreenwidth%5C%22%3A%5B1600%5D%2C%5C%22currentscreenheight%5C%22%3A%5B1200%5D%2C%5C%22currentresolution%5C%22%3A%5B%5C%221600x1200%5C%22%5D%2C%5C%22entrypage%5C%22%3A%5B%5C%22https%3A%2F%2Fwww.fiercepharma.com%2Fspecial-report%2F10-most-anticipated-drug-launches-2022-4-deucravacitinib%5C%22%5D%2C%5C%22new_visit_bc%5C%22%3A%5B%5C%22true%5C%22%5D%7D%2C%5C%22sources%5C%22%3A%7B%5C%22listenerinteractiontype%5C%22%3A%5B%5C%22language%5C%22%2C%5C%22currentscreenwidth%5C%22%2C%5C%22currentscreenheight%5C%22%2C%5C%22currentresolution%5C%22%2C%5C%22entrypage%5C%22%5D%2C%5C%22newvisitlistener%5C%22%3A%5B%5C%22new_visit_bc%5C%22%5D%7D%7D%22%2C%22id%22%3A%221644329013132%22%7D%2C%7B%22method%22%3A%22addProperties%22%2C%22params%22%3A%22%7B%5C%22properties%5C%22%3A%7B%5C%22resolution%5C%22%3A%5B%5C%221600x1200%5C%22%5D%7D%2C%5C%22sources%5C%22%3A%7B%5C%22listenerinteractiontype%5C%22%3A%5B%5C%22resolution%5C%22%5D%7D%7D%22%2C%22id%22%3A%221644329013133%22%7D%2C%7B%22method%22%3A%22createEvent%22%2C%22params%22%3A%22%7B%5C%22type%5C%22%3A%5B%5C%22PAGEVIEW%5C%22%5D%2C%5C%22referrer%5C%22%3A%5B%5C%22%5C%22%5D%2C%5C%22profile%5C%22%3A%5B%5D%7D%22%2C%22id%22%3A%221644329013134%22%7D%5D&referer=https%3A%2F%2Fwww.fiercepharma.com%2Fspecial-report%2F10-most-anticipated-drug-launches-2022-4-deucravacitinib&bcsessionid=&bctempid=&overruleReferrer=&time=2022-02-08T14%3A03%3A34%2B00%3A00&callback=bc_json797 Message: Failed to load resource: the server responded with a status of 404 ()

Security Headers

This page lists any security headers set by the main page. If you want to understand what these mean and how to use them, head on over to this page

Header	Value
X-Content-Type-Options	nosniff
X-Frame-Options	SAMEORIGIN

Indicators

This is a term in the security industry to describe indicators such as IPs, Domains, Hashes, etc. This does not imply that any of these indicate malicious activity.

294-mqf-056.mktoresp.com
88de716fcdb80ed5cefd22d492c50498.safeframe.googlesyndication.com
a.ad.gt
a.dpmsrv.com
acdn.adnxs.com
ad.360yield.com
ads.betweendigital.com
ads.servenobid.com
ads.spotible.com
ads.yieldmo.com
adservice.google.com
adservice.google.de
adtelligent-d.openx.net
ajax.googleapis.com
ap.lijit.com
apex.go.sonobi.com
api-54-185-136-237.b2c.com
api.fouanalytics.com
app-sj10.marketo.com
assets-tracking.crazyegg.com
aufp.io
bid.contextweb.com
bidder.criteo.com
c2shb.ssp.yahoo.com
c405.fiercepharma.com
cdn.blueconic.net
cdn.omeda.com
cdn.parsely.com
cdn.spotible.com
cm.g.doubleclick.net
code.jquery.com
colossusssp.com
creative.spotible.com
d1z2jf7jlzjs58.cloudfront.net
dm.hybrid.ai
fastlane.rubiconproject.com
fonts.googleapis.com
fonts.gstatic.com
ghb.adtelligent.com
ghb.hbmp.mediafuse.com
gum.criteo.com
hbopenbid.pubmatic.com
hostedcontent.dragonforms.com
htlb.casalemedia.com
ib.adnxs.com
id5-sync.com
ids.ad.gt
idsync.rlcdn.com
image2.pubmatic.com
in.ml314.com
inv-nets.admixer.net
match.adsrvr.org
match.prod.bidr.io
ml314.com
mug.criteo.com
munchkin.marketo.net
olytics.omeda.com
onetag-sys.com
oqs.omeda.com
p.ad.gt
p.nodserving.com
p1.parsely.com
pagead2.googlesyndication.com
pagestates-tracking.crazyegg.com
pbjs.e-planning.net
pixel-a.basis.net
pixel.sitescout.com
pixels.ad.gt
player.adtelligent.com
player.hbmp.mediafuse.com
player.mediafuse.com
prebid-eu.creativecdn.com
prebid-us.creativecdn.com
prebid.a-mo.net
prebid.adnxs.com
prebid.deepintent.com
prebid.media.net
qtxasset.com
questex.blueconic.net
rtb.adxpremium.services
s.dpmsrv.com
sample.dragonforms.com
script.crazyegg.com
secure.adnxs.com
securepubads.g.doubleclick.net
static.addtoany.com
static.criteo.net
stats.g.doubleclick.net
sync.adtelligent.com
sync.medidexs.com
t.trafmag.com
tag.1rx.io
token.rubiconproject.com
tracking.crazyegg.com
u.openx.net
v4-api-54-185-136-237.b2c.com
ws.zoominfo.com
www.fiercepharma.com
www.google-analytics.com
www.googletagmanager.com
www.googletagservices.com
ads.spotible.com
c405.fiercepharma.com
rtb.adxpremium.services
104.111.234.67
104.16.92.165
104.16.94.80
104.18.14.141
142.250.184.226
142.250.185.66
143.204.215.21
146.0.227.109
147.75.38.124
151.101.1.108
169.197.150.8
178.162.133.150
178.250.0.165
178.250.2.146
18.156.195.47
18.66.248.91
185.184.10.30
185.184.8.65
185.33.221.91
185.64.189.112
185.64.190.80
192.28.147.68
193.200.65.5
198.148.27.133
2001:4de0:ac18::1:a:2a
204.180.130.159
204.180.130.165
204.180.130.190
205.162.42.5
213.19.147.42
216.52.2.48
23.37.38.181
2602:803:c003:200::41
2606:4700:10::6816:47c5
2606:4700:20::681a:723
2606:4700:3033::6815:3a2a
2606:4700::6810:a852
2606:4700::6813:9308
2a00:1450:4001:808::2008
2a00:1450:4001:80f::2002
2a00:1450:4001:810::2001
2a00:1450:4001:810::2003
2a00:1450:4001:810::200e
2a00:1450:4001:812::2002
2a00:1450:4001:813::2002
2a00:1450:4001:827::2002
2a00:1450:4001:827::200a
2a00:1450:4001:82a::2002
2a00:1450:4001:82b::200a
2a00:1450:400c:c08::9c
2a02:2638::1c
2a02:2638::3
2a0c:5c81:5142::2
3.226.203.17
3.251.21.8
34.107.148.139
34.194.161.83
34.200.182.42
34.249.212.247
34.251.249.129
35.244.159.8
35.244.174.68
35.83.23.20
37.18.16.16
37.252.161.190
37.252.172.37
44.230.193.23
45.133.44.3
45.133.44.4
5.178.65.246
51.38.120.206
51.89.7.110
52.208.138.90
52.223.40.198
52.35.70.100
52.43.149.174
52.50.101.149
54.144.118.149
54.149.174.3
54.185.136.237
54.72.7.92
62.149.0.72
63.32.247.12
65.9.58.62
65.9.61.60
65.9.63.73
66.155.71.150
69.173.144.165
8.2.111.126
88.212.252.22
99.86.3.109
99.86.3.25
99.86.3.4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www.fiercepharma.com Open in urlscan Pro 104.18.14.141 Public Scan

Summary

urlscan.io Verdict: No classification

Domain & IP information

Screenshot Live screenshot Full Image

Page Title

Detected technologies

Page Statistics

233 Requests

91 %HTTPS

24 %IPv6

67 Domains

101 Subdomains

89 IPs

12 Countries

1713 kBTransfer

4568 kBSize

79 Cookies

13 Outgoing links

Redirected requests

233 HTTP transactions Everything HTML Script AJAX CSS Image Expand all 2 data transactions

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Redirect headers

Request headers

Response headers

Redirect headers

Request headers

Response headers

Redirect headers

Request headers

Response headers

www.fiercepharma.com Open in urlscan Pro
104.18.14.141 Public Scan

Screenshot
Live screenshot

Full Image

233
Requests

91 %
HTTPS

24 %
IPv6

67
Domains

101
Subdomains

89
IPs

12
Countries

1713 kB
Transfer

4568 kB
Size

79
Cookies

233 HTTP transactions
2 data transactions